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Preface to ”Smart and Functional Polymers”
Smart and functional polymers have attracted increasing interest in recent years thanks to their 
full range of applications in various fields, such as industry, bioengineering, and medicine. Polymers 
with different physicochemical properties can be synthesized through the polymerization of 
functional monomers or the modification of different active groups after polymerization. Compared 
with small molecules, these polymers have relatively large surface-to-volume ratio, adjustable 
size and surface, enhanced sensitivity and specificity, excellent targeting binding affinity, 
and stimuli-responsive ability. With the development of synthesis and characterization techniques, 
a series of smart and functional polymer materials, including shape memory polymers, drug release 
polymer nanosystems, polymer gels, polymer films, polymer fibers, and so forth, have been 
successfully designed and achieved rapid progress. However, the synthesis technology, structure and 
performance, stability, and biosafety of smart and functional polymers need to be further improved 
to meet the increasing needs of different fields.
This book is based on the Special Issue of the journal Molecules on “Smart and Functional 
Polymers”. The collected research and review articles focus on the synthesis and characterizations of 
advanced functional polymers, polymers with specific structures and performances, current 
improvements in advanced polymer-based materials for various applications, and the opportunities 
and challenges in the future. The topics cover the emerging synthesis and characterization 
technologies of smart polymers, core–shell structure polymers, stimuli-responsive polymers, anhydrous 
electrorheological materials fabricated from conducting polymers, reversible polymerization systems, 
and biomedical polymers for drug delivery and disease theranostics.
In summary, this book provides a comprehensive overview of the latest synthesis approaches, 
representative structures and performances, and various applications of smart and functional 
polymers. It will serve as a useful reference for all researchers and readers interested in polymer 
sciences and technologies.
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Polymerization provides an efficient strategy for synthesizing macromolecules with versatile
functionality [1,2]. Smart and functional polymers with various active groups have attracted
increasing interest as they hold considerable promise for a variety of applications [3,4]. The advanced
polymers can be constructed via the polymerization of functional monomers or post-polymerization
modification [5–7]. These polymers possess a combination of the physical properties of nanoscale
or microscale architectures and the physiochemical reactivities of the attached functional groups [8].
Moreover, their ability to form microscopic and macroscopic assemblies in response to external targets
or signals gives them unique physiochemical properties (e.g., a large surface-to-volume ratio, variable
composition and size, dynamic association, and reversible phase separation) and tailored functionalities
(e.g., enhanced sensitivity and specificity, extraordinary target binding affinity, and tunable surface
chemistry), which are absent in small molecules [9,10].
Eleven original research articles and six review papers have been collected in this Special Issue.
These articles focus on functional polymers with specific structures and performances.
Six original research articles focus on the synthesis and characterization of advanced functional
polymers. Chen et al. synthesized an amphiphilic polyurea consisting of cyclohexyl-tert-butyl polyurea
and poly(ethylene glycol) (PEG) for the encapsulation of chemotherapeutic drug paclitaxel (PTX) [11].
The PEGylated polyurea micelle showed more efficient delivery of PTX into 4T1 cells, with enhanced
antitumor efficacy. Guerrero et al. proposed a method to purify poly(vinyl alcohol)−polyaniline
(PVA−PANI) copolymers at different aniline concentrations [12]. After activation with glutaraldehyde
exposure, reduction of the polymer was detected, along with an increase of the benzenoid
section of PANI. Ndugire et al. developed carbohydrate-grafted glycopolymers via a catalyst-free
perfluorophenyl azide-mediated Staudinger reaction [13]. Using this method, they successfully
conjugated maltoheptaose and mannose onto poly(lactic acid). Valero and co-workers prepared
different polyurethanes with castor oil and isophorone diisocyanate by adding polycaprolactone diol
and chitosan [14]. The change of polyols from using castor oil significantly increased the mechanical
Molecules 2019, 24, 2976; doi:10.3390/molecules24162976 www.mdpi.com/journal/molecules1
Molecules 2019, 24, 2976
properties of interest. Guo et al. immobilized three polyether imidazole ionic liquids onto ZSM-5
zeolite to acquire three immobilized catalysts [15]. The prepared catalysts maintain excellent stability
and high catalytic activity after eight cycles. Wen, Chen, and co-workers reported the purification
and characterization of a water-soluble exopolysaccharide (EPS-2) from the fermentation culture of
endophytic fungus CSL-27 of saffron [16]. It was found that EPS-2 could protect cochlear hair cells
from ototoxicity exposure.
Five original research articles report polymers with specific structures and performances, including
core−shell structure and stimuli-responsive properties. Nanoparticles with a core−shell structure
have shown advantageous performance. Xu et al. used cheap rare earth hydroxide as a precursor to
develop a monodisperse hexagonal NaYF4:Yb3+/Ln3+ core and NaYF4:Yb3+/Ln3+@NaGdF4 core−shell
nanoparticles with well-controlled shapes [17]. The sizes of the nanocrystals were tunable, and the
core−shell nanoparticles showed intense emission under 980-nm laser excitation. Kredel et al. prepared
core−shell particles with highly fluorinated shell materials [18]. The incorporation of fluoropolymers
into core−shell particle structures can be used for the melt/shear organization technique, which produced
free-standing fluoropolymer opal and inverse films with different hydrophobic properties and reflection
colors. Tang et al. used bovine serum albumin to fabricate vitamin E (VE)-albumin core−shell
nanoparticles for the delivery of PTX and VE [19]. Owing to the existence of VE as an oil core,
the nanoparticles achieved higher PTX-loading efficiency and also overcame the P-gp-mediated drug
efflux. Stimuli-responsive (e.g., pH, temperature, and light) polymers have shown great promise
in the design of smart materials for various biomedical applications, such as drug delivery and
molecular imaging. Fan and co-workers developed reversible pH-responsive copolymers by using
tertiary amine-based monomers, 2-(dibutyl amino)ethyl methacrylate, and 2-(dimethylamino)ethyl
methacrylate [20]. These polymers were pH-sensitive and could be responsively fine-tuned in aqueous
solution. At low pH, the polymers were in unimer state, while a high pH would lead to polymer
aggregation. The pKa values of these polymers fall into the physiological pH range, making them
ideal carriers for therapeutic drugs and imaging contrast agents to the tumor microenvironment or
cytosol. Han and co-workers synthesized a series of methoxy poly(ethylene glycol)−poly(L-alanine)
thermosensitive hydrogels with different degrees of polymerization (DPs) [21]. They found that
hydrogels with higher DPs had better gelation ability than those with lower ones.
In addition, six review articles summarize the current improvements in advanced polymer-based
materials for various applications. Lu et al. introduced anhydrous electrorheological materials,
fabricated from conducting polymers and nanocomposites [22]. They mainly focused on the study
of the electrical conductivity and thermal or mechanical stability of nanocomposites. Due to the
emergence of various reversible materials bearing reversible-covalent linkages, reversible sol−gel
transition, or reversible bonds, there has been a rapid development in reversible polymerization in
recent years. In this context, Tang et al. summarized recent progress made in this area and provided
insight into future reversible polymerization systems [23]. In order to investigate the effect of drug
ratios used in polymer nanoparticles, Pan et al. reviewed polymer-based co-delivery systems and drug
combinations for synergistic antitumor efficacy [24]. They pointed out that understanding the drug
ratio of therapeutic agents and heterogeneity of tumors helped with optimizing the therapeutic effect.
In another review, Tang et al. highlighted recent advances in pH-responsive nanomaterials in cancer
diagnosis and treatment [25]. They summarized the recent advances in polymer design, mechanistic
investigation, drug delivery, and bioimaging applications. Wang et al. reviewed the recent development
of phenylboronic acid-based glucose-sensitive gels for self-regulated drug delivery, which might
promote a drug delivery system for diabetes therapy [26]. In another review article, Narayanaswamy
and Torchilin discussed methods of manipulating hydrogels for targeted drug delivery in diverse
diseases [27].
Smart and functional polymer materials represent an interdisciplinary field that integrates physics,
chemistry, material science, engineering, and biology. Over the past decade, the field has experienced
rapid progress as a result of unmet needs in various areas. This Special Issue aims to provide
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a comprehensive collection of the latest advances in the development of synthetic approaches, the
mechanisms underlying structure-property correlations, and the current and emerging applications of
smart and functional polymers. The issue covers smart and functional polymers for a diverse range of
applications, involving synthetic chemistry, materials science, and biomedical technology. It mentions
state-of-the-art breakthroughs that will provide guidance and references for interested readers.
Acknowledgments: The editors appreciate the contributions of all authors to the Special Issue, the constructive
comments of all the reviewers, and the editorial support from Genie Lu and other editorial staffmembers of MDPI.
Conflicts of Interest: The authors declare no conflict of interest.
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Abstract: In recent years, polyureas with dynamic hindered urea bonds (HUBs), a class of promising
biomedical polymers, have attracted wide attention as a result of their controlled hydrolytic properties.
The effect of the chemical structures on the properties of polyureas and their assemblies has rarely
been reported. In this study, four kinds of polyureas with different chemical groups have been
synthesized, and the polyureas from cyclohexyl diisocyanate and tert-butyl diamine showed the
fastest hydrolytic rate. The amphiphilic polyurea composed of hydrophobic cyclohexyl-tert-butyl
polyurea and hydrophilic poly(ethylene glycol) (PEG) was synthesized for the controlled delivery of
the antitumor drug paclitaxel (PTX). The PTX-loaded PEGylated polyurea micelle more effectively
entered into the murine breast cancer 4T1 cells and inhibited the corresponding tumor growth in vitro
and in vivo. Therefore, the PEGylated polyurea with adjustable degradation might be a promising
polymer matrix for drug delivery.
Keywords: amphiphilic copolymer; hydrolyzable polyurea; micelle; controlled drug delivery;
cancer chemotherapy
1. Introduction
Polyureas bearing hindered urea bonds (HUBs) are able to be synthesized by the reaction between
the monomers with diisocyanate or diamine groups [1,2]. As the orbital coplanarity of the amide bonds
can be disturbed [3], HUBs are hydrolyzable, and the hydrolytic products are biologically safe [4].
Furthermore, the hydrolyzability can be regulated by changing the units of polyureas [5]. Due to
their excellent hydrolyzability and biocompatibility, polyureas have been developed for biomedical
applications, including drug delivery [6–8].
As drug carriers, the drug release profiles of polyureas can be adjusted by changing the hydrolytic
rates [4], and the accumulation of therapeutic drugs at the desired tissues can also be enhanced
by passive and active targeting. For instance, Shoaib et al. developed several polyurethane-urea
elastomers with various diisocyanate groups to deliver the antitumor drug doxorubicin (DOX). The drug
release could be adjusted by changing the pH of media and hard segment chemical structures of the
polyureas [9]. Morral-Ruiz et al. developed the biotinylated polyurethane-urea nanoparticles for target
delivery of plasmids and drugs [10]. The nanoparticles were loaded with a reporter gene containing
plasmids and antitumor drugs for simultaneous theranostics of cancer cells. The nanoplatforms based
on biotinylated polyurethane-ureas were potentially used for the therapy of other types of cancer.
John et al. synthesized a series of polyureas with disulfide linkages in the backbone, and the antitumor
Molecules 2019, 24, 1538; doi:10.3390/molecules24081538 www.mdpi.com/journal/molecules5
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drug DOX was encapsulated by the nanocarriers [7]. The drug-loaded nanocarriers demonstrated
the glutathione-responsive drug release behavior, indicating significant potential for controlled drug
delivery. Although polyureas have been widely explored as a nanocarrier due to their biological safety
and modifiability, the effect of the chemical structures of HUBs on the properties of hydrolyzable
polyureas as a drug nanocarrier has rarely been reported.
In our study, a series of hydrolyzable polyureas with different chemical structures were synthesized
through different diisocyanate monomers (i.e., cyclohexyl and benzyl diisocyanates) and diamine
monomers (i.e., isopropyl, tert-butyl, and hydroxyethyl diamines). The polyureas were denoted as
poly(1/3), poly(1/4), poly(2/3), and poly(2/5), as depicted in Scheme 1. The four polyureas showed
distinct hydrolytic rates. Among the obtained polyureas, poly(1/3), with the fastest hydrolytic
property, had the most ideal potential as a nanocarrier for drug release. As the amphiphilic PEGylated
polyurea, methoxy poly(ethylene glycol)−poly(1/3) (mPEG−poly(1/3)), composed of hydrophilic
amino-terminated mPEG (mPEG113-NH2) and hydrophobic poly(1/3), was synthesized according to
the reaction between the amino group of mPEG and the isocyanate group of polyurea. In addition,
paclitaxel (PTX), a traditional hydrophobic antitumor agent, was loaded into mPEG−poly(1/3) to obtain
the drug-loaded polyurea micelle (PUM/PTX), as shown in Scheme 2. PUM/PTX could be efficiently
internalized by mouse breast cancer 4T1 cells and showed noticeable cytotoxicity in vitro. Moreover,
PUM/PTX was also proven to be potent in inhibiting the growth of murine breast tumor compared to
PTX treatment alone in vivo. Both histopathology and immunofluorescence were further conducted to
validate the enhanced antitumor effect and biological safety of PUM/PTX. In conclusion, the PEGylated
polyurea with adjustable degradation might be a meaningful polymer for drug delivery.
Scheme 1. Synthetic routes of hydrolyzable polyureas.
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Scheme 2. Encapsulation of paclitaxel (PTX) into methoxy poly(ethylene glycol)−poly(1/3)
(mPEG−poly(1/3)) micelle to obtain paclitaxel-loaded polyurea micelle (PUM/PTX), and cell uptake
and intracellular PTX release of PUM/PTX after intratumoral administration.
2. Results and Discussion
2.1. Syntheses and Characterizations
Four kinds of hydrolyzable polyureas with different chemical groups were successfully synthesized.
Briefly, equal amounts (1.0 mmol) of each monomer (1 and 3, 1 and 4, 2 and 3, or 2 and 5) were
mixed in deuterated chloroform (CDCl3, 5.0 g). The solutions were vigorously stirred at room
temperature overnight, two-fold diluted without purification, and directly characterized by proton
nuclear magnetic resonance (1H NMR). All peaks in the 1H NMR spectra of polymers were accurately
assigned (Figure 1a,b). The characteristic peaks at 5.87, 6.29, and 6.46 ppm were attributed to the
hydrogen atom in HUBs. The typical resonances at 1.12–1.30 and 3.62–4.70 ppm represented the
substituents on a nitrogen atom. Fourier-transform infrared (FT-IR) spectroscopy further confirmed
the chemical structures of polyureas as the 1H NMR results. The typical signals of ureas were at
3300–3320 cm−1. The typical wavenumbers of PEG were at 1360, 1297, and 1249 cm−1. These results
demonstrate that the hydrolyzable polyureas were successfully synthesized (Figure 1c,d).
The number-average molecular weights (Mns) of polyureas were obtained from gel permeation
chromatography (GPC) at the scheduled time points (Figure 1e). It was observed that the hydrolytic
rates of poly(1/3) and poly(2/3) in a mixed solution were faster than poly(1/4) and poly(2/5). After 48 h,
Mns reduction percentages of poly(1/3), poly(2/3), poly(1/4), and poly(2/5) were 78.4%, 74.6%, 6.4%,
and 4.8%, respectively. The hydrolytic rate of poly(1/3) increased to 82.5% after incubation for 72 h.
The results could be explained as the bulky substituents incorporating into one of the nitrogen
atoms [11]. Urea bonds could be easily destabilized by disarranging the orbital coplanarity of the amide
bonds and diminished the conjugation effect. Urea bonds with a bulky substituent could dissociate
into isocyanate and amines reversibly. Isocyanates could hydrolyze into amines and carbon dioxide
(CO2) in an aqueous solution. It was an irreversible reaction that shifted the balance to aid the HUBs
dissociation reaction and finally led to the complete hydrolysis of HUBs. Since poly(1/3) had a suitable
hydrolytic time, it was selected for the following experiments.
In order to increase the hydrophilia of polyureas, mPEG was attached to both ends of poly(1/3).
The 1H NMR spectrum of mPEG−poly(1/3) dissolved in CDCl3 demonstrated the successful synthesis
of PEGylated polyurea (Figure 1a). In mPEG−poly(1/3), the mPEG segment was the hydrophilic
segment, and the poly(1/3) moiety was the hydrophobic moiety. The amphiphilic mPEG−poly(1/3)
self-assembled into micelle in phosphate-buffered saline (PBS). Observed by transmission electron
microscopy (TEM; Figure 2a), the PUM showed a spherical structure with a mean radius of around
38 nm. The hydrodynamic radius (Rh) of PUM determined by dynamic laser light scattering (DLS)
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was 39.6 ± 8.1 nm. The radius of PUM examined by TEM showed the similar result to that by DLS.
In order to explore the hydrolytic characteristic of mPEG−poly(1/3), the Mns were detected at the
scheduled time points. PUM exhibited the desired hydrolytic rates in PBS, which was similar to
poly(1/3). After incubation for 48 h, the Mn of PEGylated PUM was reduced to 71.5% (Figure 2b).
Figure 1. Characterizations of polyureas bearing hindered urea bonds (HUBs). (a) Proton nuclear
magnetic resonance (1H NMR) spectra of poly(1/3), poly(1/4), and mPEG−poly(1/3) in deuterated
chloroform (CDCl3); (b) 1H NMR spectra of poly(2/3) and poly(2/5) in CDCl3; (c) Fourier-transform
infrared (FT-IR) spectra of poly(1/3), poly(1/4), and mPEG−poly(1/3); (d) FT-IR spectra of poly(2/3) and
poly(2/5); (e) Changes of number-average molecular weights (Mns) of four polyureas with different
chemical groups by gel permeation chromatography (GPC).
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Figure 2. Characterizations of PUM and PUM/PTX. (a) Transmission electron microscopy (TEM) image
and hydrodynamic radius (Rh) of PUM in PBS; (b) Mn change of PUM by GPC; (c) TEM image and Rh
of PUM/PTX in PBS; (d,e) PTX release behavior of PUM/PTX in phosphate-buffered saline (PBS) at pH
7.4 (d) and pH 6.8 (e).
The drug encapsulation capability is another important requirement for a suitable and robust
drug delivery system [12–14]. In order to explore the drug loading properties of the polymer, PTX was
loaded into mPEG−poly(1/3) micelle to obtain PUM/PTX. The drug loading content (DLC) and drug
loading efficiency (DLE) were computed using the following Equations (1) and (2) [15,16]:
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DLC =
Weight of drug in PUM/PTX
Weight of drug− loaded micelle × 100% (1)
DLE =
Weight of drug in PUM/PTX
Weight of feeding drug
× 100% (2)
PTX was successfully loaded into mPEG−poly(1/3) micelle with DLC of 8.7% and DLE of 87.5%.
The morphological characteristic of PUM/PTX was observed by TEM (Figure 2c), and the average
nanoparticle size was around 43 nm. The Rh was 44.7 ± 11.6 nm by the DLS test, showing a similar
result with TEM. The results suggested that PUM/PTX was a monodisperse micelle and had a uniform
particle size distribution.
2.2. PTX Release, In Vitro Cell Uptake, and Cell Proliferation Inhibition
The release characteristics of PTX from PUM/PTX were detected in PBS. As depicted in Figure 2d,
the release profile showed no apparent burst release of PTX from PUM/PTX in PBS at pH 7.4 within
24 h. The amount of PTX released from PUM/PTX was lower than 45% during the first 12 h. At 48 h,
over 65% of PTX was released. Since the tumoral microenvironment is more acidic, the PTX release
behavior was also tested in PBS at pH 6.8 (Figure 2e). The amount of PTX released from PUM/PTX was
46% in the first 12 h. At 60 h, about 69% of PTX was released. These two release rates indicated that
the hydrolytic rate of PUM was faster in the acidic condition. This controlled release pattern indicated
that polyurea could be used as a suitable drug delivery system.
Drug release was a complicated process [13]. To just explain the nature of drug release behaviors,
a classic empirical equation was established by Peppas et al. [17]. The equations were written as:
Mt
M∞





= lg k + n lg t (4)
In Equations (3) and (4), Mt and M∞ were the cumulative drug release at time t and infinite time,
respectively; k was the proportionality constant, and n was the release exponent that was related to the
release mechanism of payloads. In the study of drug release, an increase in n indicates that the release
was more influenced in a swelling-controlled way. n was calculated using the Equations (3) and (4),
and the values for a pH of 6.8 and 7.4 were 0.32 and 0.21, respectively. The value of n was larger at pH
6.8 than pH 7.4, which was attributed to the faster hydrolysis of polyurea in an acidic environment.
Coumarin-6 (C6) as a hydrophobic model fluorescence molecule was used for cell uptake study [18].
C6 was loaded into mPEG−poly(1/3) micelle to form PUM/C6. The internalization of PUM/C6 by 4T1
cells was monitored through flow cytometry (FCM) and confocal laser scanning microscopy (CLSM).
As shown in Figure 3a, after 1 h incubation, the control group had no fluorescence signal of C6, while in
the PUM/C6 group the fluorescence signals were significantly increased, and fluorescence intensity was
further increased at 6 h. Similarly, CLSM images in Figure 3b,c showed that the highest fluorescence
intensity was detected when PUM/C6 was incubated with 4T1 cells for 6 h. The results demonstrated
that the PUM micelle could efficiently deliver PTX into 4T1 cells.
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Figure 3. Cell uptake of PUM/C6 after incubation with 4T1 cells detected by (a) flow cytometry (FCM)
and (b,c) confocal laser scanning microscopy (CLSM) analyses in 1 h (b) and 6 h (c).
PUM with HUBs was synthesized by the reversible reaction between cyclohexyl diisocyanate
and tert-butyl diamine. With the hydrolysis of PUM, the degradation products were
cyclohexane-1,3-diyldimethanamine and tert-butyl diamine. The cytotoxicity of the hydrolytic products
of HUBs to 4T1 and L929 cells was tested by methyl thiazolyl tetrazolium (MTT) assays (Figure 4a, b).
After incubation with PUM at the concentration of 100.0 μg mL−1 for 72 h, the viability of L929 cells
was kept around 93%, indicating negligible toxicity of PUM to normal cells. After incubation with
PUM for 72 h at a concentration of 50.0 μg mL−1, the cell viability of 4T1 cells was 86.97%, indicating
that the polymer had little effect on the growth of tumor cells. MTT assays compared the toxicity of
free PTX and PUM/PTX toward 4T1 cells. Both free PTX and PUM/PTX inhibited the growth of 4T1
cells. The cell viability was reduced to 51.9% after incubation with free PTX for 48 h at a concentration
of 10.0 μg mL−1, while the cells treated with an equivalent dose of PUM/PTX showed viability of
46.6% (Figure 4c). As shown in Figure 4d, the cell proliferation was further suppressed at 72 h with
cell viability reduced to around 45.9%. The data above confirmed that PUM/PTX could be efficiently
endocytosed by 4T1 cells and release PTX to perform the antitumor effect. In vitro experiments proved
that the polymer could make a proper drug delivery vehicle.
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Figure 4. In vitro cytotoxicity of (a) L929 and (b) 4T1 cells in 72 h; (c) PUM/PTX in 48 h and (d)
PUM/PTX in 72 h after incubation with 4T1 cells. The error bars represent the standard deviation (n = 3;
* p < 0.05, ** p < 0.01, *** p < 0.001).
2.3. In Vivo Antitumor Efficacy
The antitumor activity was investigated in a BALB/c model of mice bearing allograft orthotopic
murine 4T1 breast tumors. The antitumor efficacy of PUM/PTX was further detected in vivo. Free PTX
was dissolved in the mixture of castor oil and ethanol [19], and diluted with PBS. The mice were treated
with free PTX or PUM/PTX at a dosage of 5.0 mg kg−1 PTX, and the mice treated with PBS were set as
a control group. The treatment started at the time when the tumor volumes reached approximately
200 mm3. As shown in Figure 5a, free PTX showed modest antitumor efficacy compared with the
control group within 18 days, whereas PUM/PTX showed the best inhibition rate of 32.7%. This result
suggests that PUM/PTX could well inhibit tumor growth. The photograph of the tumors had a similar
result (Figure 5b).
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Figure 5. In vivo antitumor efficacy, safety assessment, and immunofluorescence experiments.
(a) Tumor volumes and (b) photograph of the isolated tumors. Data were presented as a mean
± SD (n = 6; * p < 0.05, ** p < 0.01, *** p < 0.001); (c) Hematoxylin and eosin (H&E) staining of normal
organs (the lungs and spleens) and tumor tissues; (d) Ki-67 staining of tumor tissues; (e) Caspase-3
staining of tumor tissues; (f) Changes of body weight in each group (n = 3).
Histopathology and immunofluorescence analyses were further conducted on the isolated
tumors to evaluate the antitumor efficacies of PBS as control, free PTX, and PUM/PTX. In this work,
lung metastasis, the trauma to healthy tissue, and the antitumor efficacies of all groups were evaluated
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by hematoxylin and eosin (H&E) staining. As shown in Figure 5c, without the appearance of lung
metastasis, intratumoral administration of PTX and PUM/PTX at a dose of 5.0 mg kg−1 did not cause
a noticeable change in the histopathological morphologies of the lungs and spleens. In the PTX and
PUM/PTX groups, tumor cells showed a decrease in volume and denser cytoplasm compared with
those of the control group. A large area of apoptosis appeared in the tumor tissue. The H&E results
were further verified by immunofluorescence staining of Ki-67 and caspase-3. Immunofluorescence
staining of Ki-67 was used to evaluate the effect of PTX formulations on the growth of tumor [20].
As shown in Figure 5d, both PUM/PTX and free PTX-treated group showed less Ki-67-positive cells.
Especially, a slightly stronger antitumor effect was observed in the PUM/PTX group. The caspase-3
analysis is a standard method to analyze the apoptosis of tumor cells [21]. The amount of caspase-3
suggests the apoptosis level of cells in different tumor tissues. Compared with the control group,
more strong signals of caspase-3 were manifested in tumor tissues of the free PTX and PUM/PTX group,
indicating a larger apoptosis area (Figure 5e). These results were consistent with histopathological
H&E analyses.
The body weight is an essential physiological factor to assess the toxicity of drugs [22]. As exhibited
in Figure 5f, mice treated with free PTX showed an apparent decrease in body weight compared
with the control group, while the body weight of mice in the PUM/PTX group remained stable.
This phenomenon indicates that mPEG−poly(1/3) could efficiently improve safety. All experiments
validated that mPEG−poly(1/3) could act as a suitable and biological safety drug delivery vehicle.
3. Materials and Methods
3.1. Materials
1,3-Bis(isocyanatomethyl) cyclohexane (1) and 3-bis(isocyanatomethyl) benzene
(2) were purchased from Tokyo Chemical Industry Co., Ltd. (Shanghai, China),
N,N’-di-tert-butyl-ethylenediamine (3) was purchased from Biological Science and Technology Co.,
Ltd. (Shanghai, China), and N,N’-di-iso-propylethylenediamine (4) was purchased from Aladdin
(Shanghai, China), and all of them were used as obtained. N,N’-Bis(2-hydroxyethyl)ethylenediamine
(5) was purchased from Energy Chemical (Shanghai, China). N,N-dimethylformamide (DMF) and
ethyl ether were bought from Tiantai Fine Chemical Co., Ltd. (Tianjin, China). DMF was stored
over calcium hydride (CaH2) and purified by vacuum distillation. C6 and mPEG113 were purchased
from Sigma-Aldrich (Shanghai, China). mPEG113−NH2 was prepared as the protocol reported in
our previous work [23]. PTX was purchased from Huafeng United Technology Co., Ltd. (Beijing,
China). Dulbecco’s modified Eagle’s medium (DMEM) and newborn bovine serum (NBS) were
bought from Gibco (Grand Island, NY, USA) and Every Green (Hangzhou China), respectively.
Methyl thiazolyl tetrazolium (MTT) and 4’,6-diamidino-2-phenylindole dihydrochloride (DAPI) were
purchased from Sigma-Aldrich (Shanghai, China). The primary antibody was purchased from Abcam
Company (Cambridge, UK). The secondary antibody was purchased from ABclonal (Wuhan, China).
The purified deionized water was prepared by the Milli-Q plus system (Millipore Co., Billerica,
MA, USA).
3.2. Syntheses of Four Different Polyureas
The equimolar of 1 (1.94 g, 10.0 mmol) and 3 (1.72 g, 10.0 mmol), 1 (1.94 g, 10.0 mmol) and 4
(1.44 g, 10.0 mmol), 2 (1.88 g, 10.0 mmol) and 5 (1.48 g, 10.0 mmol), 2 (1.88 g, 10.0 mmol) and 3 (1.72 g,
10.0 mmol) were separately dissolved in anhydrous DMF (10.0 g). The solutions were vigorously
stirred at room temperature overnight. The polymer solutions had 5% water added to them, and they
were then shaken at 80 rpm in a 37 ◦C incubator. Then they were used for the study of hydrolysis
directly [5].
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3.3. Synthesis of mPEG−poly(1/3)
The 1 (1.3 g, 6.7 mmol) and 3 (1.1 g, 6.5 mmol) were dissolved in anhydrous DMF, separately,
and vigorously stirred at room temperature overnight. mPEG113-NH2 (2.5 g, 0.5 mmol) was dissolved
in toluene, and residual water in the solution was removed by azeotropic distillation. The dehydrated
mPEG113-NH2 was dissolved in anhydrous DMF, and then added into the reaction flask. The mixture
was stirred at room temperature for three days and was precipitated by anhydrous ethyl ether.
3.4. Preparation of PUM
mPEG−poly(1/3) was dissolved in dimethyl sulfoxide (DMSO) and slowly added into 0 ◦C
PBS. The mixture solution was ultrafiltrated by an ultrafiltration tube (molecular weight cut-off
(MWCO) = 10,000 Da; Millipore Co., Billerica, MA, USA). Finally, the concentration of mPEG−poly(1/3)
solution was kept at 1.0 mg mL−1.
To investigate the hydrolysis of mPEG−poly(1/3), PUM was shaken at 80 rpm in a 37 ◦C incubator,
3.0 mL of the liquid was pipetted at different time points, and the liquid was lyophilized. Finally,
the lyophilized solids were dissolved in DMF, and Mns were monitored by GPC.
3.5. Preparation of PUM/PTX
First, mPEG−poly(1/3) and PTX were dissolved in DMSO with a mass ratio of 9:1. Then, the two
solutions were mixed evenly. The mixture was added into 0 ◦C PBS slowly while stirring quickly.
Finally, the DMSO of the mixture solution was removed by ultrafiltration.
3.6. Characterizations
1H NMR spectra were recorded on a Bruker AV 400 NMR spectrometer in CDCl3. FT-IR spectra
were recorded on a Bio-Rad Win-IR instrument (Cambridge, MA, USA). GPC analyses of polymers were
conducted on a Waters 2414 system (Waters Co., Milford, MA, USA) equipped with Ultrahydrogel™
linear columns and a Waters 2414 refractive index detector (injection volume: 30.0 μL, column
temperature: 50 ◦C, eluant: DMF through 0.45 and 0.22 μm filters, flow rate: 1.0 mL min−1).
TEM measurements were performed on a JEOL JEM-1011 transmission electron microscope with
an accelerating voltage of 100 kV. DLS measurements were performed with a vertically polarized
He−Ne laser (DAWN EOS, Wyatt Technology Co., Santa Barbara, CA, USA). The high-performance
liquid chromatography (HPLC) analyses of PTX were performed with a Symmetry® C18 column
connected to a Waters 2487 (Waters Co., Milford, MA, USA) at a flow rate of 1.0 mL min−1. The DLC
and DLE of PUM/PTX were determined according to the following protocol. A volume of 200.0 μL
of the PUM/PTX sample was mixed into 800.0 μL of acetonitrile, and the detection wavelength was
227 nm.
3.7. In Vitro PTX Release
The PUM/PTX solution was placed into dialysis bags (MWCO = 3500 Da). The dialysis bags
were transferred into PBS at pH 6.8 and 7.4, 37 ◦C with 80 rpm. HPLC tests detected the amount of
released PTX.
3.8. Cell Cultures
4T1 cells were cultured in complete DMEM, supplemented with 10% (V/V) NBS, penicillin
(50.0 IU mL−1), and streptomycin (50.0 IU mL−1) at 37 ◦C in a 5% (V/V) CO2 atmosphere.
3.9. Cell Uptakes
PUM/C6 was used for the cell uptake study. Both CLSM and FCM investigated the cell uptake of
PUM/C6 toward 4T1 cells.
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3.9.1. FCM
The cell uptake study was conducted with C6, which was used as a hydrophobic model fluorescence
probe. The cells were seeded in 6-well plates at a density of 2.0 × 105 cells to each well and cultured for
12 h. Then, 100.0 μL of PUM/C6 was added into the wells, and the cells were further incubated at 37 ◦C
for 1 or 6 h. Next, the harvested cells were suspended in PBS and centrifuged at 1,000 rpm for 5 min.
All the cells were washed with PBS. Finally, the cells were resuspended with 500.0 μL of PBS. Data were
analyzed by FCM on a Guava® easyCyteTM flow cytometer (Merck Millipore, Darmstadt, Germany).
3.9.2. CLSM
The cells were seeded on the coverslips in 6-well plates with a density of 2.0 × 105 cells/well.
A volume of 2.0 mL of DMEM was added into the cells per well and cultured for 12 h. Then 100.0 μL
of PUM/C6 was added to each well. After incubation for 1 or 6 h, the cells were fixed with 4% (W/V)
formaldehyde for 15 min. Then, the fixed cells were incubated with DAPI for 3 min and washed with
PBS. The images of cell localization were observed under LSM 780 CLSM (Carl Zeiss, Jena, Germany)
with 10× eyepiece and 40× objective.
3.10. Cytotoxicity Assays
The MTT assays evaluated the cytotoxicity of PUM/PTX. 4T1 cells with a density of
5.0 × 103 cells/well were seeded in 96-well plates in 180.0 μL of DMEM and incubated for 24 h.
A volume of 20.0 μL of free PTX or PUM/PTX was added in each well with a maximum PTX
concentration of 200.0 μg mL−1. The cells were subjected to MTT assay after being incubated for
another 48 or 72 h. The absorbance of the above solution was measured on a Bio-Rad 680 microplate
reader (Hercules, CA, USA) at 490 nm. The cells viability was calculated based on the following
Equation (5):




In Equation (5), Asample was denoted as the absorbance of the sample, and Acontrol was denoted as
the absorbance of the control.
The cytotoxicity of PUM to 4T1 and L929 cells was also tested at 72 h. The specific steps were the
same as above.
3.11. Animal Procedures
Female BALB/c mice at five weeks of age were obtained from Vital River Laboratory Animal
Technology Co., Ltd. (Beijing, China). The body weight of the mice was kept between 18 to 20 g
before the start of the experiment. The experiments on the animals were carried out according to
the guidelines outlined in the Guide for the Care and Use of Laboratory Animals, provided by Jilin
University (Changchun, China) and the procedures were approved by the Animal Care and Use
Committee of Jilin University (Protocol No. 2017-154).
3.12. In Vivo Antitumor Efficacy
BALB/c mice were inoculated with 4T1 cells to develop the breast tumor xenograft model.
The breasts were injected with 1.0 × 106 cells in 0.1 mL of PBS. The mice were treated with PBS,
PUM/PTX, or free PTX on day 0, 4, 8, 12, and 16 through intratumoral injections. The tumor volumes





In Equation (6), a and b (mm) were the largest and the smallest axes of the tumor, measured by
a caliper.
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3.13. Histopathological and Immunofluorescence Analyses
The mice were sacrificed two days after the last injection. According to the protocol reported
in previous studies, the lung is the most common organ for breast cancer metastasis, while the
spleen is the primary immune organ that should be observed at the end of the experiments [25].
The tumors and major organs (i.e., the lungs and spleens) were collected, fixed in 4% (W/V) PBS-buffered
paraformaldehyde overnight, and then embedded in paraffin. The paraffin-embedded tissues were cut
into ~5 μm slices for H&E staining and ~3 μm sheets for immunofluorescence analyses (i.e., Ki-67 and
caspase-3). The histological and immunofluorescence alterations were detected by a microscope (Nikon
Eclipse Ti, Optical Apparatus Co., Ardmore, PA, USA).
4. Conclusions
In this study, we synthesized four kinds of hydrolyzable polyureas with different hydrolytic rates by
changing the chemical groups on the polyureas. Among them, poly(1/3) from cyclohexyl diisocyanate
and tert-butyl diamine showed the fastest hydrolytic rate. After modification by hydrophilic mPEG,
the amphiphilic mPEG−poly(1/3) was synthesized for delivery of PTX. The PTX was successfully
encapsulated by mPEG−poly(1/3) micelle with a DLC and DLE of 8.75% and 87.5%, respectively.
PUM/PTX could be efficiently internalized by murine breast cancer 4T1 cells and released PTX along
with the hydrolysis of polyurea. The results showed that PUM/PTX drastically suppressed the
proliferation of tumor cells in vitro and significantly inhibited tumor growth in an orthotopic 4T1 breast
tumor model in vivo. Therefore, the hydrolyzable PEGylated polyureas with adjustable degradation
might become a promising platform for controlled drug delivery.
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Abstract: In this work, we report the synthesis and purification of polyvinyl alcohol-polyaniline
(PVA–PANI) copolymers at different aniline concentrations, and their molecular (1H-NMR and
FTIR), thermal (TGA/DTG/DSC), optical (UV–Vis-NIR), and microstructural (XRD and SEM)
properties before and after activation with glutaraldehyde (GA) in order to obtain an active membrane.
The PVA–PANI copolymers were synthesized by chemical oxidation of aniline using ammonium
persulfate (APS) in an acidified (HCl) polyvinyl alcohol matrix. The obtained copolymers were
purified by dialysis and the precipitation–redispersion method in order to eliminate undesired
products and compare changes due to purification. PVA–PANI products were analyzed as gels,
colloidal dispersions, and thin films. 1H-NMR confirmed the molecular structure of PVA–PANI
as the proposed skeletal formula, and FTIR of the obtained purified gels showed the characteristic
functional groups of PVA gels with PANI nanoparticles. After exposing the material to a GA solution,
the presence of the FTIR absorption bands at 1595 cm−1, 1650 cm−1, and 1717 cm−1 confirmed
the activation of the material. FTIR and UV–Vis-NIR characterization showed an increase of the
benzenoid section of PANI with GA exposure, which can be interpreted as a reduction of the polymer
with the time of activation and concentration of the solution.
Keywords: polymerization dispersion method; polyaniline; polyvinyl alcohol; glutaraldehyde;
chemical activation
1. Introduction
Conductive polymers have been studied since their discovery in 1977 [1]. Among all known
conductive polymers, polyaniline (PANI) has been one of the most studied due its high environmental
stability, straightforward control of its chemical and physical properties through doping, and relatively
low cost of development in comparison to other conductive polymers. PANI has been the subject in
numerous studies for applications such as membranes [2], anticorrosive coatings [3], biosensors [4–7],
and electronic devices [8,9]. However, the implementation of PANI has been limited because of
its poor mechanical properties and its poor solubility in most organic solvents. This insolubility
results in heterogeneous solutions, where the presence of microparticles hinders the formation of
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homogeneous PANI thin films at low cost by physical methods such as spin or dip coating. To overcome
these drawbacks, several methods have been studied, such as the possibility of processing PANI in
the form of mixtures with electrically insulating polymers, improving the presented deficiencies,
and opening a range of potential applications. In recent years, several publications report on the use
of polystyrene (PS) [10], polyvinyl chloride (PVC) [11], and polyvinyl alcohol (PVA) [12], to stabilize
PANI nanoparticles and improve the processing and formation of thin films.
The preparation of PVA–PANI copolymers by polymerization dispersion has already been
reported showing a stable colloidal dispersion without sedimentation [13]. Also, with the increase of
PVA content the stability of the colloidal dispersion increases, improving its mechanical properties [14].
Nevertheless, PVA addition affects the conductivity of the material. Work has been done to correlate
the mechanical and electrical properties of PVA–PANI as function of aniline concentration [15].
Both PANI and PVA–PANI have been activated with glutaraldehyde (GA) to obtain PANI-G
and PVA–PANI-G materials that can be used as biological platforms for the detection of different
analytes such as enzymes and proteins [16,17]. The biocompatibility of PVA is already known,
but PVA–PANI obtained by polymerization dispersion requires further purification in order to be
applied in the biomedical field because of the presence of undesired byproducts produced by the
chemical polymerization of aniline [18], which can also affect the activation of the material.
The present work is focused on the study of purified PVA–PANI copolymers at different
concentrations of aniline. The molecular, thermal, optical, and microstructural properties before
and after PVA–PANI copolymer activation with GA have been studied. The aim of this work is to
provide information about the effects of purified PANI in a PVA matrix with GA activation.
2. Results and Discussion
2.1. Molecular Structure Variation and Modification of PVA–PANI Copolymers
2.1.1. Proton Nuclear Magnetic Resonance Spectroscopy (1H-NMR)
To obtain the molecular structure of PVA–PANI copolymers, 1H-NMR analysis (500 MHz, TMS)
was carried out using deuterium oxide (D2O) as solvent. The obtained spectrum for PVA–PANI
is shown in Figure 1 where at δ = 7.3 ppm and δ = 7.5 ppm there is evidence of a doublet of
doublets (d, J = 6.5 Hz, C6H4) corresponding to the benzenoid and quinoid sections of PANI in
emeraldine phase, then δ = 4.7 ppm (s, D2O). The doublet located at δ = 3.9 ppm (d, J = 28.5 Hz)
corresponds to the characteristic signal of α proton of oxygen binding PVA–PANI, while the multiplet
located at δ = 1.5 ppm (m, J = 18.7 Hz) suggests the integration of methylene protons from the PVA
backbone [19,20].
The smooth baseline of the spectrum suggests absence of impurities in the obtained material
(Figure 2). After water suppression the actual PVA:PANI ratio can be calculated by integrating the
signal corresponding to PVA and PANI, obtaining a 2:1 ratio (PVA:PANI). Moreover, two sharp singlets
can be clearly seen at δ = 2 ppm and δ = 3.25 ppm corresponding to absorbed solvent in the copolymer.
The δ = 4.7 ppm (d, J = 19 Hz), can correspond to the proton of PVA hydroxyl (–OH), pendant groups
or PANI secondary amine (–NH) groups within the polymer chain. The doublet located at δ = 3.9 ppm
(d, J = 28.5 Hz) corresponds to the characteristic signal of α proton of oxygen binding PVA–PANI,
this completes the molecular structure of the PVA–PANI copolymers as proposed from the skeletal
formula in Figure 2. Is important to mention that the signals could be clearly seen only after the water
suppression and is considered to be masked by the solvent peak in Figure 1.
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Figure 1. 1H-NMR spectra for PVA–PANI in D2O (*).
 
Figure 2. 1H-NMR spectra for PVA–PANI with water suppression.
2.1.2. Fourier Transform Infrared Spectroscopy (FTIR)
To confirm the structure of PVA–PANI and evaluate chemical changes upon activation with GA,
an FTIR analysis was carried out. First, a comparison of both purification methods was made through
a study of the functional groups present (Figure 3). It was observed that PVA–PANI purified by the
precipitation–redispersion method presents the characteristic bands as follows, O–H between 3600 and
3000 cm−1, aliphatic groups for the PVA backbone between 2900 and 2800 cm−1, and stretching of
C=O and C–O acetate groups from hydrolyzed PVA in the fingerprint region [21]. The presence of the
bands at 1179, 1031, 739, and 689 cm−1 corresponding to C–N and C–H vibrations from the benzenoid
and quinoid section of PANI confirm the presence of the polymer in the PVA matrix. On the other
hand, the spectrum for the dialysis purified material shows the characteristic bands for PVA–PANI at
a medium–high concentration of aniline in a PVA matrix, according to previous studies [15]. The N-H,
C=C, C–C, and C–N vibrations centered at 3383, 1600, 1423, and 1297 cm−1, respectively, can be seen
along with the C–H in plane and out of plane vibrations from the quinoid and benzenoid rings [22].
Also, from Figure 3, it is seen that both purification methods do not show any uncoupled or overlapped
bands by the content of unreacted material, especially in the fingerprint region of the spectrum.
21
Molecules 2019, 24, 63
Figure 3. FTIR spectra of PVA–PANI purified by dialysis (-) and by precipitation–redispersion (-).
The implementation of dialysis has been used for the purification of PANI, since it provides a better
dispersion of particles and minimizes product loss. However, filtration of the product obtained from
precipitation–redispersion is highly recommended, since it takes a short time and allows the obtaining
of only the desired copolymer in gel form through precipitation. Figure 4 shows the corresponding
bands of PVA gels modified with PANI (ES) nanoparticles obtained by the precipitation–redispersion
method with different concentrations of aniline (Table 1). An increase in the absorption bands with the
increase of monomer in the PVA matrix was observed.
Figure 4. FTIR spectra of PVA–PANI gels at different PANI concentrations.
The absorption bands located between 3600 and 3000 cm−1, attributed to O–H and N–H groups
of PVA and PANI, respectively, show an intensity increase which is due to the functional groups in
this range and widening due to minimum wavenumber displacements. Subsequently, in the range
of 2350 to 1750 cm−1, small absorption bands can be observed corresponding to the presence of
overtones from PVA–PANI. These bands show an intensity decrease with increasing aniline in the
polymer matrix. The latter can be attributed to chain length variation of the obtained PANI for each
experiment. An increase in the absorption band located at 1586 cm−1 indicates an increase in C=C
bonds associated to quinoid rings which can also be correlated to significant production of PANI in the
22
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PVA matrix. The absorption bands found at 1416, 1369, and 1320 cm−1 correspond to the absorption
of C–C stretching of the quinoid ring in PANI, the flexion of the C–H group, and the stretching
vibration of the C–N bond of the amine in the aromatic ring, respectively. Absorption bands due to
the vibration of the C–N bond and the stretching of the C–H group from the aromatic ring within the
plane are shown at 1230 and 1130 cm−1, respectively. The band located at 1090 cm−1 corresponds to
the stretching vibration of the C–O bond which tends to be much higher in PVA–PANI composites,
showing a more pronounced shoulder in 1031 cm−1 with the increase of monomer, demonstrating
a cross-linking between the materials [23]. The FTIR spectra obtained for the activated material with
1% GA solution for an activation time of 5, 15, and 30 min can be observed in Figure 5a–c, respectively.
Table 1. Experiment of aniline concentration variation against PVA 5 wt %.
Concentration Sample PVA 5 wt % Aniline PVA–PANI (wt/wt)
Low
PVA–PANI-1 0.0202 mmol 3.5203 mmol 12.5 wt %
PVA–PANI-2 0.0202 mmol 7.0640 mmol 25 wt %
Medium
PVA–PANI-3 0.0202 mmol 14.1281 mmol 37.5 wt %
PVA–PANI-4 0.0202 mmol 17.6601 mmol 50 wt %
PVA–PANI-5 0.0202 mmol 21.1921 mmol 62.5 wt %





Figure 5. FTIR spectra of PVA–PANI gels at low, medium and high concentration of PANI activated
with GA at 1% for: (a) 5 min, (b) 15 min, and (c) 30 min.
In Figure 5, a reduction in the intensity of the absorption bands corresponding to the O–H and
N–H groups of PVA–PANI is shown, indicating an interaction between the activating solution and
the polymer [24]. The inset shows the range from 1550 to 1750 cm−1, where the presence of three
absorption bands can be observed at 1595, 1650, and 1717 cm−1, corresponding to the presence of C=N
(Schiff base) bonds formed by the linkage of primary amines with C=O groups, and the presence of
23
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free C=O groups [24,25]. As the activation time so does the absorption band at 1595 cm−1, correlated to
the vibration of the C=N (imine) bond, overlapping the vibration of the C=C bond of the quinoid
section of PANI. Moreover, an increase in the absorption band located at 1490 cm−1 can be observed,
which is associated to the benzenoid ring stretching [22], along with a reduction of the intensity of the
C–C stretching from the quinoid section, which can indicate a reduction of the purified material with
the increase of activation time [26]. Further activation of PVA–PANI with a more concentrated solution
(2.5% GA) confirmed the reduction of the material as well as a branching between both materials
(Figure S1).
2.1.3. UV–Visible-Near-Infrared Spectroscopy (UV–Vis-NIR)
UV–Vis-NIR absorption spectra and its normalized form for PVA–PANI films at low, medium,
and high concentrations of PANI can be observed in Figure 6. Absorption bands corresponding
to π–π∗ transitions from the excitation of benzenoid segments (~330 nm), polaron-π∗ transitions
associated with benzenoid and quinoid ring (~430 nm), and π-polaron transitions from the excitation
of quinoid rings from doped PANI (~800 nm) can be seen in each experiment [3,27]. The absorption
bands corresponding to π–π∗ transitions show a bathochromic effect as a function of the increase
in aniline concentration in the PVA matrix, attributed to an increase in the molecular weight of the
produced PANI [28]. Furthermore, a clear hyperchromic effect is observed, associated to the increase
in concentration of the material, as established by Beer–Lambert’s law.
Figure 6. (a) UV–Vis-NIR absorbance and (b) normalized UV–Vis-NIR absorbance spectra of
PVA–PANI thin films at low, medium, and high concentrations of PANI.
According to the results of activated PVA–PANI obtained by FTIR, an immersion time of 30 min
was used for the PVA–PANI-G films. The UV–Vis-NIR absorption spectra and its normalized form for
PVA–PANI-G films at low, medium, and high aniline concentrations are shown in Figure 7.
It can be seen that the absorption bands of the obtained PVA–PANI-G films present an
hypsochromic effect for low and medium aniline concentrations, and a bathochromic effect for medium
and high aniline concentrations, which can be attributed to a change in polarity of the molecule when
interacting with the aldehyde groups of GA. The characteristic absorption bands for the electronic
transitions of PANI, as well as the characteristic shift due to the increase in aniline concentration,
according to the PVA–PANI experiment shown in Table 1, are also seen in Figure 7. A hyperchromic
effect can be seen in the absorption band located at 380 nm, which can be related to an increase of
the benzenoid section of PANI due to the activation time and concentration of GA. Comparison of
bandgap variations due to concentration and activation of the material are shown in Figure S2.
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Figure 7. (a) UV–Vis-NIR absorbance spectra and (b) normalized UV–Vis-NIR absorbance spectra of
PVA–PANI thin films activated with 1% GA for 30 min.
2.2. Purity, Thermal Stability and Cross-Linking of PVA–PANI Copolymers
Thermogravimetric Analysis, Derivative Thermogravimetric Analysis, and Differential Scanning
Calorimetry (TGA/DTG/DSC)
In order to evaluate the thermal stability, the purity of the obtained materials by both purification
methods, and to correlate an increase in hydroxyl and amine functional groups, TGA-DTG analysis
were carried out. DSC study was performed to observe the cross-linking effects on PVA–PANI
and PVA–PANI-G in order to evaluate the sensitivity of the material towards GA. First, to confirm
purification of the material, an analysis of the transition temperatures and molecular weight for the
obtained byproducts and sideproducts of the synthesis route for PVA–PANI (Figure 8) was attained as
shown in Figure 9.
Figure 8. Synthesis route of PVA–PANI and generated byproducts.
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Figure 9. Molecular weight and transition temperatures of byproducts, sideproducts, and reagents
present during synthesis.
We expected to observe a weight loss for each undesired product along with an exothermic peak
in the temperature range of the thermograms presented in Figure 10. TGA and DTG of the material
purified by precipitation–redispersion method (Figure 10a) show a loss of 8.41 wt % between 25 to
172 ◦C, which can be attributed to solvent and moisture loss at the surface of the material. The absence
of an exothermic peak in this range and a gradual weight loss can be related to the absence of undesired
products that can present a transition in this range of temperature, such as APS and HCl. Subsequently,
the presence of two exothermic peaks located at 173.9 and 193.3 ◦C is associated to the removal of
bound water, moisture, and dopant molecules inside the polymer matrix, as well as the loss of free
hydroxyl functional groups due to the decomposition of PVA [29] (mass loss of 21.97 wt %). At ~250 ◦C
an exothermic peak is shown as a shoulder corresponding to the breaking of free amine functional
groups associated to the decomposition of the PANI polymeric chain, which continues to gradually
decrease along with the dehydroxylation of the copolymer up to 395 ◦C (total mass loss of 44 wt %).
In the range of 400 to 500 ◦C several peaks associated with the degradation of similar materials can be
observed, which can be related to a variation in distribution of different molecular weights of PANI.
On the other hand, PVA–PANI purified by dialysis (Figure 10b) shows a weight loss of 12.37%, which is
attributed to moisture and the removal of HCl from the material [12], showing an exothermic peak at
52.94 ◦C. In the same way as the material purified by precipitation–redispersion, the decomposition
of PVA and PANI is shown at 199.55 ◦C and 250.74 ◦C, respectively, to which the gradual loss of
hydroxyl and amine functional groups can be related, having a total weight loss of 20.6% of the
material. The presence of a small exothermic band at 355.25 ◦C can be attributed to a cross-linking
reaction in the polymer matrix and not to the presence of oligomers in the material, which can be
confirmed with the presence of a single exothermic peak at 489.15 ◦C associated with the degradation
of the copolymer with a loss of 16.95 wt %. Also, from Figure 10, it can be seen that PVA–PANI purified
by dialysis shows improved thermal stability and molecular integration which is evidenced by the
presence of peaks correlated to decomposition and degradation of PVA and PANI only; this can be
attributed to the processing of the material during the purification process.
After analyzing the thermal stability and purity of the material obtained by both purification
methods, the effect of aniline concentration was studied. Figure 11 shows three weight losses. The first
weight loss in the temperature range from 25 to 160 ◦C can be attributed to the loss of moisture and
free acid, corresponding to a weight loss of 9.76%. There is another weight loss between 160 and 400 ◦C
which is attributed to degradation of short polymer chains along with the removal of hydrogen bonds
and Coulomb interactions from O–H and N–H functional groups, corresponding to a weight loss of
40.24% [30,31]. With regard to the increase of aniline, a shift to higher temperatures of 21.14 ◦C
can be observed starting from a low concentration level to a high concentration of PANI from
room temperature to 400 ◦C, which corresponds to a weight loss of 27%, 29%, and 30% for low,
medium, and high concentrations, respectively, indicating that an increase in molecular weight of
26
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PANI contributes to a higher thermal stability, but also a mayor weight loss because of the presence of
more hydroxyl and amine functional groups in the polymer chain. The decomposition of the purified
PVA–PANI gels tends to be gradual until 400 ◦C where there is another pronounced weight loss of
36.3% due to the degradation of the material, leaving a residue of 14.5 wt % with a variation of 1.21%
between each concentration.
Figure 10. TGA-DTG of PVA–PANI purified by (a) precipitation–redispersion and (b) dialysis.
Figure 11. (a) TGA and (b) DTG of purified PVA–PANI gels at low, medium, and high concentrations
of PANI.
Correlation of previously obtained thermal stability and cross-linking was studied by DSC,
in order to observe energy variations associated to interactions of the polymer matrix with the PANI
nanoparticles. According to the obtained DSC results (Figure 12), the presence of an endothermic peak
at ~200 ◦C can be attributed to a cross-linking reaction between PVA and PANI at that temperature,
where enthalpy changes are inversely proportional to the concentration of chemically linked PANI [32];
indicating that PVA–PANI at low concentration of monomer shows a better cross-linking between the
materials. Also, it can be seen that no other prominent transition peaks are shown in the thermogram,
indicating that the purified material is amorphous.
The obtained TGA-DTG results for PVA–PANI-G gels are shown in Figure 13. First, a weight
loss of 6 to 9% can be observed, which corresponds to the loss of absorbed solvent and moisture.
Subsequently there is a weight loss of 33 to 41% corresponding to the loss of pendant functional groups
and hydroxyl and/or amino terminal groups. Starting at 400 ◦C, the degradation of the copolymer is
seen, which no longer presents a gradual and constant decomposition as shown in Figure 11. At this
range of temperature, the material shows two stages of weight loss, one with an almost linear loss with
respect to the increase in temperature and another with gradual degradation, which can be attributed
27
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to a modification in the main chain of the polymer caused by the interaction with GA. PVA–PANI at




Figure 12. DSC of purified PVA–PANI gels at low, medium, and high concentrations of PANI.
Figure 13. TGA and DTG thermograms of purified PVA–PANI-G gels, activated with 1% GA for
(a) 5 min, (b) 15 min, and (c) 30 min.
The DSC analysis for the previous gels is shown in Figure 14. Comparing the thermogram
from Figure 12 to the obtained results for the activated copolymers, it is seen that a decrease in
transition temperatures is obtained for low aniline concentration along with a decrease in enthalpy from
−285.95 J/g to a minimum of −320.86 J/g at 15 min of activation, which indicates that cross-linking
is favored with an increase of GA for this particular concentration. However, with an increase in
activation time, the material shows an increase of enthalpy up to a maximum of −56.69 J/g for a high
28
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concentration of PANI at 30 min of activation, meaning that cross-linking between PVA–PANI and
GA is disfavored, which can be related to a molecular disarrangement produced by branching of











Figure 14. DSC thermograms of purified PVA–PANI-G gels, activated with 1% GA for (a) 5 min,
(b) 15 min, and (c) 30 min.
2.3. Microstructural Variation of PVA–PANI Copolymers
2.3.1. X-ray Diffraction (XRD)
XRD analysis was carried out to observe if the material crystallinity is affected by the
purification process or the concentration of PANI nanoparticles in the PVA matrix. In Figure 15,
it is observed that both purification processes seem to reduce the crystallinity of the thin films
showing a broad peak between 16 and 40◦ (2θ), where PVA–PANI thin films purified by dialysis
tend to show a better molecular order than PVA–PANI purified by the precipitation–redispersion
method, presenting a diffraction peak located at 2θ = 19.77◦ which corresponds to the (101) plane
of semicrystalline PVA with d101 = 4.485 Å [29,33]. These results were compared to the XRD results
obtained from unpurified PVA–PANI thin films with high PVA concentration, showing the discussed
diffraction peak without any trace of PANI peaks at 2θ ≈ 25◦, which indicates that the obtained PANI
is amorphous.
From the data shown in Figure 16a, it can be observed that the purified PVA–PANI doped with
HCl 1 M (pH = 1) has a low atomic order regardless of aniline concentration, showing a broad peak
with a maximum intensity found at 2θ = 23.29◦, which is in agreement with the reported for PANI
doped with HCl [34,35]. It is expected to have a lower crystallinity of the copolymer with GA activation
due to the disarrangement produced by cross-linking, increasing molecular dispersion, and broadening
of the XRD peaks [36]. This behavior can be observed for PVA–PANI-G thin films at low, medium, and
high concentrations of aniline (Figure 16b).
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θ
Figure 15. XRD diffractogram comparison for unpurified and purified PVA–PANI by precipitation
–redispersion and dialysis.
θ θ
Figure 16. XRD diffractogram of (a) PVA–PANI thin films at different concentrations of aniline and
(b) its comparison with PVA–PANI-G thin films.
2.3.2. Scanning Electron Microscopy (SEM)
Figure 17 shows the SEM micrographs obtained for PVA–PANI films purified by the
precipitation–redispersion method for low, medium, and high aniline concentrations with respect to
the PVA polymer matrix. Similar results were obtained for PVA–PANI-G thin films (Figure S4).
The morphology of the particles presents as needles which changed with increasing aniline
concentration, generating particles in granular form which tend to agglomerate in different nucleation
points, according to the reports of Gangopadhyay et al. [12]. On the other hand, the morphology
observed for both PVA–PANI and PVA–PANI-G purified by dialysis maintained a spherical shape
with an average size of 156 nm (Figure 18), which has been reported for various PANI synthesis
processes [37]. This indicates that the precipitation–redispersion process (Figure 17) influences
morphological changes in the material, along with pH, temperature, and solvents used.
Even though a significant difference in morphology is shown between both purification methods,
we found no significant difference in the crystallinity of the material according to Figure 15,
where PVA–PANI purified by dialysis tends to show a better molecular order due to the stabilizing
effect of the PVA, promoting better control in the growth of nucleation sites for the obtained films.
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Figure 17. SEM micrographs of purified PVA–PANI thin films and its morphologic variations at (a) low
concentration, (b) medium concentration, and (c,d) high concentration.
  
Figure 18. SEM micrographs of (a) PVA–PANI and (b) PVA–PANI-G purified by dialysis.
3. Materials and Methods
3.1. Materials
The reagents used for the synthesis of PVA–PANI copolymers are as follows. Polyvinyl alcohol
(PVA) (130,000 MW, 99% hydrolyzed), high purity aniline monomer (≥99.5%), and ammonium
persulfate (APS) (ACS ≥ 98%) (Sigma Aldrich Co., Toluca, Edo. Mex., Mexico). Hydrochloric
acid (36–38%) (J.T. Baker, Phillipsburg, NJ, USA) and glutaraldehyde solution (50 wt % in H2O)
(Sigma Aldrich Co.) for the activation of the obtained PVA–PANI blends. Aniline was stored in a dark
environment and under refrigeration, all reagents were used as acquired.
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3.2. Synthesis of PVA–PANI
First a solution of PVA 5 wt % was made by dissolving 0.0202 mmol (2.6315 g) of PVA
(MW = 130,000 g/mol) in 50 mL of deionized water (Milli-Q) under constant magnetic stirring
at 80 ◦C until a clear solution was obtained. Then, the PVA 5 wt % was used as a polymer matrix for
the polymerization of aniline at different ratios with respect to the PVA as shown in Table 1.
Subsequently, the pH of the matrix was adjusted to a value of ≤2, and it was taken immediately to
an ice bath (T ≤ 5 ◦C) where ammonium persulfate was added drop wise at a ratio of 1:1 M to aniline
according to Table 2. After a few minutes, the color change of the colloidal dispersion was observed,
obtaining a dark green dispersion without sedimentation as reported in the literature [13].
Table 2. Monomer and intermediary molar ratios.
PVA (mmol) Aniline (mmol) Aniline (M) HCl (mmol) APS (mmol) APS (M)
0.0202 3.532 0.070 100 3.532 0.070
0.0202 7.064 0.141 100 7.064 0.141
0.0202 10.596 0.212 100 10.596 0.212
0.0202 14.128 0.282 100 14.128 0.282
0.0202 17.660 0.353 100 17.660 0.353
0.0202 21.192 0.423 100 21.192 0.423
3.3. Purification Process
When carrying out the PVA–PANI synthesis by the polymerization dispersion method, a number
of byproducts related to doping, oxidant material (APS) and oligomers are generated (Figure 8).
Therefore, these byproducts must be eliminated by means of a purification process, in order to obtain
the PVA–PANI material without any other product that influences the effects produced by the material
in future characterizations.
The purification of PVA–PANI copolymers was carried out mainly by two methods:
precipitation–redispersion based on a solvent system CH3OH:H2O (5:1) in which the copolymer
precipitates, then this precipitate is filtered, dried in vacuum, and redispersed in deionized water
(Milli-Q) under temperature and continuous agitation. As well as a dialysis process, which is
based on the implementation of membranes with a cut out molecular weight (MWCO) of 12,000 Da
(Obtained from Sigma Aldrich Co.), where a certain amount of PVA–PANI is placed against deionized
water (Milli-Q) for 48 h so that most byproducts permeate through the membrane. Prior to its chemical
and thermal characterization, the obtained PVA–PANI was vacuum-filtered and dried.
3.4. Thin Film Development
PVA–PANI thin films were obtained by dip coating (for precipitation–redispersion purification)
and spin coating (for dialysis purification) physical methods using Corning glass substrates previously
cleaned with acetone, isopropanol, and deionized water (Milli-Q). Once the thin films were obtained
they were washed, dried with N2 gas, and kept in a desiccator before being analyzed.
3.5. Activation of PVA–PANI Thin Films
Activation of PVA–PANI films with GA was carried out by immersing them in a 1% dilution of
GA for a time of 5, 15, and 30 min at room temperature. Followed by a wash with deionized water
(Milli-Q) to remove any agent that did not reacted. Later they were placed in a desiccator for storage.
3.6. Characterization Methods
Purity and molecular structure of the obtained PVA–PANI blend was confirmed by 1H-NMR using
a Brucker NMR equipment (Brucker, Billerica, MA., USA) at a frequency of 500 MHz, using tetramethyl
silane (TMS) as standard at room temperature. To complement molecular structure and observe
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the present functional groups in the material an FTIR analysis was carried out using a Thermo
Scientific Nicolet iS10 FT-IR spectrometer (ATR) in the region from 400 to 4000 cm−1 in air atmosphere
and at room temperature. Optical properties and transitions of the developed PVA–PANI thin
films were analyzed using a Jenway 6850 UV–Vis-NIR spectrophotometer (Bibby Scientific, Staffs.,
UK) in the region from 1000 to 300 nm in absorption mode. The thermal stability, composition,
purity, and cross-linking effect of the PVA–PANI gels were analyzed using a TGA/DSC SDT-Q600
implementing a temperature program from 25 ◦C to 600 ◦C with a heating speed of 10 ◦C/min and
controlled N2 atmosphere. Microstructural characteristics for the thin films were obtained by XRD
using a Panalytical diffractometer with a Cu kα radiation with a 1.54 wavelength used at a glancing
angle. And the morphological variations of the material were observed with a Nova NanoSEM
200 equipment (FEI, Tokyo, Japan) using secondary electrons.
4. Conclusions
The purification of HCl-doped PVA–PANI copolymers at different aniline concentrations and the
effect of their activation with GA was studied. 1H-NMR and FTIR analysis was used to confirm the
molecular structure of the material as proposed from the skeletal formula before carrying out further
characterizations. Regarding the activation of the material, it was observed that GA has a reduction
effect on the PVA–PANI copolymer (increasing the number of benzene units of PANI), which increases
proportionally with immersion time and concentration as confirmed by FTIR and UV–Vis-NIR.
The activation of the material was confirmed by FTIR showing the characteristic absorption bands
in the 1550 to 1750 cm−1 range, where the C=N (Schiff base) bond corresponding to the formation
of imines can be found. Further analysis of cross-linking between PVA–PANI and GA was carried
out by DSC, showing that the interaction of GA towards the material is favored at low aniline
concentration, where minor variations where observed due to doping level. The purity of the material
was confirmed by TGA-DTG, which showed bands corresponding to weight losses and exothermic
peaks of PVA–PANI only. Moreover, it was seen that the precipitation–redispersion method seems to
affect the structural and morphological properties of the PVA–PANI at different aniline concentrations,
even after GA activation, as shown from the XRD and SEM results. Therefore, the dialysis purification
method is recommended for upcoming experiments. We propose, as future work, to carry out
experiments immobilizing an antibody on the activated material to test it as a platform for biological
detection, in order to apply it as an active membrane in future in vitro diagnostic devices.
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Abstract: Glycopolymers have gained increasing importance in investigating glycan-lectin
interactions, as drug delivery vehicles and in modulating interactions with proteins. The synthesis
of these glycopolymers is still a challenging and rigorous exercise. In this regard, the highly
efficient click reaction, copper (I)-catalyzed alkyne-azide cycloaddition, has been widely applied
not only for its efficiency but also for its tolerance of the appended carbohydrate groups. However,
a significant drawback of this method is the use of the heavy metal catalyst which is difficult to
remove completely, and ultimately toxic to biological systems. In this work, we present the synthesis
of carbohydrate-grafted glycopolymers utilizing a mild and catalyst-free perfluorophenyl azide
(PFPA)-mediated Staudinger reaction. Using this strategy, mannose (Man) and maltoheptaose (MH)
were grafted onto the biodegradable poly(lactic acid) (PLA) by stirring a PFAA-functionalized
PLA with a phosphine-derivatized Man or MH in DMSO at room temperature within an hour.
The glycopolymers were characterized by 1H-NMR, 19F-NMR, 31P-NMR and FTIR.
Keywords: Glycopolymer; post-polymerization functionalization; perfluoroaryl azides;
Staudinger reaction
1. Introduction
Carbohydrates are not only the core of metabolism in many biological systems, but are
also integral in many cells as structural [1], communication [2], and recognition [3] elements.
Synthetic carbohydrate-functionalized polymers, i.e., glycopolymers, has become an important
tool in fundamental glycobiology research, and in biomedical applications such as sensing [4,5],
drug delivery [6], and cryopreservation [7,8]. Synthetic glycopolymers can be categorized broadly
into two types based on the mode of synthesis: (1) polymerization of carbohydrate-derivatized
monomers (such as allyl [9], acrylamide [10] and acrylate [11]), and (2) grafting of carbohydrates
onto a polymer backbone [12–17]. The latter technique, typically referred to as post-polymerization
modification, allows facile synthesis of the polymer backbone and control over carbohydrate grafting
density. To successfully graft carbohydrates onto the polymer, the conjugation reaction must be highly
efficient, of high yield, and tolerant of the functional groups on the polymer. The popular ‘click’ type
of reactions, particularly the copper(I)-catalyzed alkyne-azide cycloaddition (CuAAC), meet these
requirements and have been applied in the synthesis of glycopolymers by post-polymerization and in
glycosylation of surfaces [18–20]. This reaction tolerates a wide variety of carbohydrate side groups.
Analytically, it offers the advantage in the form of the distinct chemical shift of the triazole proton
in 1H-NMR that facilitates straightforward characterization [21,22]. However, a drawback of this
reaction is the necessity of Cu (I) catalyst that has proved difficult to be removed completely from the
products. While at least 2–5 mol% of Cu (I) is required to achieve a respectable reaction rate, even
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small amounts of residual metal in the final product has been shown to denature proteins and cause
oxidative damage to cells [21,23,24]. Other click-type reactions that do not require metal catalysts
include SPAAC (strain-promoted azide-alkyne cycloaddition), azide-aryne based “benzyne click”
reaction, and iEDDA (inverse electron demand Diels–Alder) reaction [25–27], but these have not been
applied directly in the synthesis of glycopolymers.
Another click-type reaction is the phosphine-azide Staudinger reaction [28]. The recent
improvement by Bertozzi via the introduction of an ester trap [29] rendered this bioorthogonal
reaction suitable for in vivo conjugations [30,31] and in oligosaccharide metabolic engineering for
cell-surface labelling [29,32]. Despite its versatility, the Staudinger ligation suffers from a slow
reaction rate. To overcome this issue, we have recently shown that by using an electron-deficient
perfluoroaryl azide (PFPA), the rate of reaction can be increased up to four orders of magnitude
to give an iminophosphorane product [33]. The rate enhancement can be attributed to the highly
electronegative F atoms lowering the LUMO of PFPA thus accelerating the reactions with dienophiles
and nucleophiles [34–37]. In addition, the PFPA-iminophosphorane formed in this reaction was stable
and not readily hydrolyzed in vivo, as demonstrated in the metabolic labeling of A549 cells [33].
The fast reaction rate and high yield make this PFPA-Staudinger reaction an excellent candidate for
polymerization. In an earlier work, we demonstrated that the reaction of bis-PFPA and a bisphosphene
occurred at room temperature in 30 min to yield poly(iminophosphorane) having molecular weight
of over 59,000 and a narrow dispersity of 1.1–1.2 [38]. In this work, we applied this reaction in
the post-polymerization synthesis of carbohydrate–grafted glycopolymers. By taking advantage of
the fast reaction rate, mild reaction conditions, and high chemoselectivity of the PFPA-Staudinger
reaction, we conjugated maltoheptaose and mannose onto poly(lactic acid) (PLA), a biocompatible
and biodegradable glycopolymer.
2. Results and Discussion
While the availability of pendant functional groups like the hydroxyl on the polymer would be
suited for condensation with a carboxyl-modified sugar, this strategy is less desirable as it requires the
use of coupling agents that can be difficult to remove like DCC/DMAP [39] or strong acid [40] that
would hydrolyze the polymer.
Our design for grafting carbohydrates to PLA was to functionalize PLA with PFPA followed by
reaction with a phosphine-derivatized carbohydrate. A PLA-co-PLA-PFPA copolymer is synthesized so
that the density of PFPA and the carbohydrate can be varied and controlled. A hydroxy-functionalized
polylactide copolymer 4 (Scheme 1A) was synthesized to conjugate PFPA and subsequently graft the
carbohydrate. The benzyl-derivatized lactide monomer 1 was synthesized according to Scheme 1B.
Ring-opening copolymerization of lactide 1 and lactide 2 in toluene using stannous octoate as the
catalyst gave polylactide copolymer 4 in 74% yield [5]. The ratio of the two monomers can be varied
so as to control the grafting density of carbohydrate on the PLA polymer. In this work, the polymer
obtained had a monomer ratio (m:n) of 1:22 for 1 and 2 after copolymerization. Deprotection of the
benzyl group on 3 gave the hydroxy-functionalized polylactide copolymer 4 in 63% yield [5]. The m:n
ratio was calculated from the 1H-NMR spectrum of 4 (Figure 1A) by taking the ratio of the methine
protons (H-a and H-c) that overlap at 5.2 ppm. The integral value of the H-a is equivalent to methylene
protons H-b/2. Subtraction of this value from the overlapped (H-a + H-c) gives the integration of H-c
and therefore H-a/H-c can be calculated.
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Scheme 1. Synthesis of (A) hydroxy-functionalized polylactide copolymer 4, and (B) lactide
monomer 1.
Figure 1. 1H-NMR spectra of copolymers 4 (A) and 5 (B) in CDCl3.
PFPA-functionalized PLA copolymer 5 was prepared by esterification of 4 with
carboxy-derivatized PFPA using DCC and a catalytic amount of DMAP giving 5 in 86% yield
(Scheme 2).
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Scheme 2. Synthesis of PFPA-PLA copolymer 5.
The 1H-NMR spectrum of 5 showed a near complete reaction as demonstrated by a marked shift
of the methylene proton H-b from 4.05 ppm to 4.83 ppm (Figure 1). No degradation of the copolymers
to the free lactic acid monomer was observed during the reaction, as evidenced by the absence of
peaks at ~1.2 ppm which belongs to the free lactic acid. In addition, the characteristic azide peak at
2133 cm−1 appeared in the Fourier transform-infrared spectroscopy (FTIR) spectrum of copolymer 5
(Figure 2).
Figure 2. FTIR spectra of PLA copolymers 4 and 5.
The phosphine-derivatized carbohydrates were prepared from an amine-derivatized carbohydrate
and the NHS-functionalized phosphine (Scheme 3). A monosaccharide, D-mannose (Man),
and an oligosaccharide, D-maltoheptaose (MH), were used as model carbohydrates in this study.
The amine-Man 6 was synthesized according to previously reported procedure (see Scheme S2 and
detailed procedures in SI) [41]. The amine-MH 7 was synthesized following the procedure in Scheme
S1 (see detailed procedures in SI). Reaction of NHS-functionalized triphenylphosphine with excess of
6 or 7 in DMSO at room temperature gave the triphenylphosphine-derivatized Man (8) or MH (9).
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Scheme 3. Synthesis of phosphine-derivatized mannose 8 and maltoheptaose 9, and subsequent
grafting to PFPA-PLA copolymer 5 to yield mannose-polymer 10 and maltoheptaose-polymer
11, respectively.
To prepare Man- or MH-grafted PLA 10 and 11, copolymer 5 was added directly to the reaction
mixture of 8 or 9 in DMSO and stirred at room temperature for 1 h. The products were purified by
dialysis for 48 h and dried by lyophilization. After the carbohydrate was grafted, the aromatic and the
carbohydrate peaks appeared in the 1H-NMR spectra of 10 and 11 at 7.5–7.7 ppm and 3.0–6.0 ppm,
respectively (Figure 3). In the 31P-NMR spectra of the products (Figure 4), a new peak was observed at
13 ppm after conjugation of the phosphine onto the copolymer. The absence of any peaks higher than
13 ppm confirmed the absence of byproducts resulting from the oxidation of phosphine.
The yield of conjugation was obtained from the 1H-NMR spectrum by taking the ratio of peak
integration of the phenyl protons (Ph) at 7.5–7.7 ppm and the methyl protons H-b at 1.48 ppm, together









Using this equation, the yields were calculated to be 25% and 35% for the Man-grafted
PLA copolymer 10 and MH-grafted PLA copolymer 11, respectively (see Figures S5 and S6 for
peak integrations).
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Figure 3. 1H-NMR spectra of Man- and MH-grafted copolymers 10 (top) and 11 (bottom) in DMSO-d6.
Figure 4. 31P-NMR spectra of copolymer 10 (top) and 11 (bottom) in DMSO-d6.
3. Conclusions
In this work, we utilized an electron-deficient perfluorophenyl azide-mediated fast
Staudinger reaction to efficiently synthesize carbohydrate grafted-polylactide glycopolymers
by post-polymerization modification. A polylactide copolymer was synthesized by stannous
octoate-catalyzed cationic ring-opening copolymerization, which was subsequently modified
with PFPA. Conjugation with a phosphine-derivatized carbohydrate yield mannose- and
maltoheptaose-grafted polylactide glycopolymers in 35% and 25% yields. These yields are comparable
to those obtained by other groups in post-polymerization synthesis of glycopolymers using other
techniques [42,43]. The main limiting factor of efficient grafting being steric hindrance between ligands
and the polymer backbone restricting access to the reactive sites. In our work, this occurs between
carbohydrate-phosphines reaction with the pendant PFPA groups, which is further complicated by the
difference in polarity between the PLA and D-mannose/maltoheptaose. However, the grafting reaction
is fast, carried out under mild conditions without the use of any catalyst. This metal catalyst-free
approach to glycopolymer synthesis is significant as it eliminates the concerns over the potential
toxicity of heavy metals, making these glycopolymers attractive for biomedical applications.
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4. Experimental Procedures
4.1. Materials and Instruments
All chemicals and solvents were purchased from Sigma-Aldrich (St. Louis, MO, USA),
TCI America (Portland, Oregon, USA) or Fisher Scientific (Hampton, NH, USA), and were used
without further purification unless otherwise noted. Dichloromethane (DCM), dimethylformamide
(DMF), ethyl acetate (EtOAc) and dimethyl sulfoxide (DMSO) were purified by distillation over
CaH2. Deuterated solvents were acquired from Cambridge Isotope Lab., Inc. (Tewksbury, MA, USA).
Amberlite IRC-120H+ resin was activated by washing with NaOH and HCl, followed by water, ethanol
and toluene.
Nuclear magnetic resonance spectroscopy data were collected on either a Bruker 500 MHz
spectrometer (1H-NMR) or a Bruker 200 MHz spectrometer (19F- and 31P-NMR) (Bruker Corporation,
Billerica, MA, USA). FT-IR spectra were recorded on a Nicolet 6700 FT-IR spectrometer (Thermo Fisher
Scientific, Waltham, MA, USA).
4-Azido-2,3,5,6-tetrafluorobenzoic acid (PFPA-COOH) was synthesized
following our previously developed protocol [44,45]. The detailed synthesis of
1-(2-(2-(2-aminoethoxy)ethoxy)ethoxy-α-D-mannopyranoside (6, Scheme S2) [41,46] and
1-(2-(2-(2-aminoethoxy)ethoxy)ethoxy-maltoheptaoside (7, Scheme S1) can be found in the
Supporting Information.
4.2. Synthesis of 3-benzyloxy-2-hydroxypropionic acid (II)
Synthesized according to literature procedure [47]. To a 200 mL of 0.7 M aqueous solution of
trifluoroacetic acid, H-Ser(benzyl)-OH (I, 10.0 g, 52 mmol) was added, and the mixture was stirred at
room temperature until all solids were dissolved. Then, 50 mL of aqueous NaNO2 (5.3 g, 77 mmol)
was added dropwise with a syringe pump under Ar protection and the reaction was stirred for another
3 h. After confirming of the consumption of starting material by TLC, NaCl (10 g) was added and
the mixture was extracted with ethyl acetate three times followed by washing with brine and dried
over MgSO4. After passing through a flash column using CH2Cl2/MeOH/AcOH (v/v/v 100:8:1),
compound II was obtained (7.2 g, 72%).3 1H-NMR (500 MHz, DMSO-d6) δ 7.35–7.26 (m, 5H, Ar-H),
4.60 (s, 2H, PhCH2O-), 4.38 (s, 1H, -OCH2CH(COOH)O-) 3.83 (d, J = 15 Hz, 2H, -OCH2CH-). IR: 3324,
3070, 3032, 2925, 2871, 2645, 2537, 1693, 1495, 1455, 1412, 1379, 1274, 1225, 1202, 1161, 1019, 1001, 973,
926, 827, 791, 732, 610, 529 cm−1.
4.3. Synthesis of 3-(benzyloxy)-2-(2-bromopropanoyloxy)propanoic acid (III)
Synthesized per literature [47]. Compound II (10.0 g, 51 mmol) and 2-bromopropionyl chloride
(6.3 mL, 61.2 mmol) were mixed in a 50-mL round-bottom flask backfilled with Ar. The reaction
mixture was heated to 70 ◦C and stirred for 6 h. Upon the completion of the reaction, the crude product
was heated at 60 ◦C under reduced pressure to remove unreacted 2-bromopropionyl chloride and
2-bromopropionyl acid. After cooling to room temperature, the residue was washed with water and
extracted with ethyl acetate 3 times. The combined organic phase was washed with brine and dried
over MgSO4. Compound III was obtained as a brown oil after further purification by flash column
CH2Cl2/MeOH/AcOH (v/v/v 100:2:0.5) (12.6 g, 75%). 1H-NMR (500 MHz, CDCl3): 7.35–7.25 (m,
5H, Ar-H), 5.34–5.32 (m, 1H, -OCH2CH(COOH)O-), 4.62–4.38 (m, 3H, PhCH2O- and -OCCH(Br)CH3),
3.97–3.85 (m, 2H, -OCH2CH-), 1.88–1.83 (m, 3H, -CH(Br)CH3). IR: 3442, 3031, 2928, 2871, 1732, 1452,
1362, 1211, 1155, 1097, 1070, 985, 910, 738, 697, 610 cm−1.
4.4. Synthesis of 3-(benzyloxy)-2-(2-iodopropanoyloxy)propanoic acid (IV)
Prepare following literature procedures [47]. Compound III (8.0 g, 24 mmol) and potassium
iodide (40 g, 0.24 mol) were mixed with 100 mL of anhydrous acetone. The mixture was heated at
60 ◦C overnight under Ar. The solid salt was removed by passing through a layer of Celite® and the
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filtrate was concentrated under vacuum. Ethyl acetate was added to the oily residue and the solution
was filtered again to remove trace potassium iodide/potassium bromide. The organic phase was
washed with 2 M aq. Na2S2O3 for 3 times and dried over MgSO4. After removing the solvent from
the filtrate, the product IV was obtained and used directly in the next step without purification (7.5 g,
82%). 1H-NMR (500 MHz, CDCl3): δ 10.26 (s, 1H, -COOH), 7.50–7.16 (m, 5H, Ar-H), 5.39 (m, 1H,
-OCH2CH(COOH)O-), 4.84–4.41 (m, 3H, PhCH2O- and –OCCH(Br)CH3), 3.94 (dd, J = 48.3, 10.4 Hz,
2H, -OCH2CH-), 2.29–1.87 (m, 3H, -CH(I)CH3). IR: 2923, 1728, 1496, 1452, 1362, 1197, 1124, 1094, 1043,
1026, 977, 909, 737, 697, 633, 603, 582, 570, 563, 554, 548, 538, 529, 526 cm−1.
4.5. Synthesis of 3-(benzyloxymethyl)-6-methyl-1,4-dioxane-2,5-dione (Monomer 1)
Synthesized as described in literature [7]. A solution of compound IV (10.0 g, 26.8 mmol) in
dry CH2Cl2 (100 mL) was added dropwise to refluxing dry acetone (1 L) containing DIEA (8.8 mL,
53.6 mmol) under Ar. It took 10 h to finish the addition and the reaction was refluxed for another
hour. The solvents were removed under reduced pressure and ether was added to dissolve the crude
product. Insoluble ammonium iodide was filtered and the filtrate was concentrated. After purification
by flash column chromatography using hexanes/ethyl acetate (v/v 4:1), the title compound 1 was
obtained as a yellow oil (2.1 g, 31%). The diastereomers were used directly without separation.
1H-NMR (500 MHz, CDCl3): (SS) δ 7.34–7.26 (m, 5H, Ar H), 5.24–5.04 (2H; -OCCH(CH2O-)O- and
- OCCH(CH3)O-), 4.61–4.56 (2H; ArCH2O-), 3.97 (2H; -OCH2CH-), 1.63 (3H; -CHCH3). IR: 2993 (w,
νs(aromatic C-H)), 2942 (w, νas(-CH2- and –CH3)), 2872 (w, νs(-CH2- and aliphatic -CH-)), 1748 (vs,
νs(ester C=O)), 1453 (m, δs(-CH2-)), 1365 (w), 1268 (w), 1182 (s), 1084 (vs), 1046 (m), 865 (w), 739 (m,
ω(aromatic C-H)), 698 (m, τ(aromatic ring)) cm−1.
4.6. Synthesis of PLA copolymer 3
Monomer 1 (1.0 g, 4.0 mmol), recrystallized L-lactide (2, 1.0 g, 6.9 mmol) and Sn(Oct)2 (10 mg in
1 mL anhydrous toluene) were added into a 5-mL round-bottom flask. The mixture was heated to
70 ◦C under vacuum for 1 h. Ar was filled in the flask and the temperature was increased to 140 ◦C.
The mixture was stirred until the stir bar stopped moving. After cooling to room temperature, the solid
was dissolved in CH2Cl2 and hexanes was added. The precipitate was re-dissolved in CH2Cl2, and
this dissolution/precipitation was repeated three times, and the precipitate was finally dried under
vacuum to give copolymer 1c as a dark brown solid (1.48 g, 74%). 1H-NMR (500 MHz, CDCl3) δ
5.20 (-OCH2CH(COOH)O- and -OCH(CH3)CO-), 4.59 (PhCH2O-), 3.90 (-OCH2CH-), 1.56 (-CHCH3).
IR (ATR) 2942, 1747, 1497, 1452, 1365, 1192, 1084, 1046, 865, 739, 698 cm−1.
4.7. Synthesis of PLA copolymer 4
Following literature synthesis [47]. Copolymer 3 (1.0 g) was dissolved in 50 mL ethyl
acetate/methanol (3:1), and catalytic amount of Pd/C was added. The mixture was purged with Ar for
20 min and filled with H2 under vigorous stirring. After 12 h, the solution was passed through a pile of
Celite to remove Pd/C and the filtrate was dried under vacuum to give copolymer 4 as a light brown
solid (630 mg, 63%). 1H-NMR (500 MHz, CDCl3): δ 5.0–5.5 (-OCH(CH2OH)CO- and -OCH(CH3)CO-),
3.78 (HOCH2CH-), 1.49 (-CHCH3). IR (ATR): ~3500 (br, w), 2995 (m), 2945 (m), 1744 (s), 1452 (m), 1380
(w), 1182 (s), 1129 (s), 1084 (s), 864 (m), 743 (m) cm−1.
4.8. Synthesis of PFPA-grafted PLA copolymer 5
Copolymer 4 (100 mg) and PFPA-COOH (20 mg, 0.09 mmol) were added together with DCC
(41 mg, 0.2 mmol) and DMAP (2.4 mg, 0.02 mmol) to 10 mL anhydrous dichloromethane under Ar,
and the mixture was stirred at room temperature overnight. The solution was then concentrated
to 3 mL and was poured into 50 mL of hexane/methanol (v/v 9:1) to precipitate the crude product.
The yellow precipitate was dissolved in dichloromethane and was precipitated in hexane/methanol.
This dissolution/ precipitation was repeated for a total of 3 times. Finally, the precipitate was
43
Molecules 2019, 24, 157
dried under vacuum to give PFPA-grafted PLA copolymer 5 as a bright yellow solid (104 mg,
86%). 1H-NMR (500 MHz, CDCl3): δ 5.56 (-OCH(-CH2OCOPFPA)CO-), 5.19 (-OCH(CH3)CO),
4.83 (-OCH2(OCOPFPA)CH-), 1.59 (-CHCH3). 19F-NMR (188 MHz, CDCl3): δ −137.5 (doublet),
−149.62 (singlet). FTIR (ATR): 2995 (m), 2945 (m), 2133 (m), 1747 (s), 1648 (w), 1563 (m), 1490 (s), 1381
(m), 1363 (m), 1258 (s), 1182 (s), 1128 (s), 1082 (s), 1044 (s), 957 (w), 865 (m), 751 (s), 667 (m) cm−1.
4.9. Synthesis of Man- or MH-grafted PLA glycopolymers 10 or 11
General Procedures
The mole ratio of N-succinimidyl 2-(diphenylphosphanyl)benzoate:amine-carbohydrate: PFPA in
polymer 10 or 11 was set as 4:6:1. N-Succinimidyl 2-(diphenylphosphanyl) benzoate and amine-Man
6 or amine-MH 7 were added to 5 mL anhydrous DMSO, and the solution was stirred for 3 h. Then,
the mixture was added to a DMSO solution containing copolymer 5. Afterwards, the mixture was
stirred for another hour. The mixture was transferred into a dialysis tube (molecule cutoff: 3500) and
dialyzed in water for 2 days. Finally, the product was obtained after lyophilization.
Polymer 10: yellow powder (yield: 92%). 1H-NMR (500 MHz, DMSO-d6): δ 7.70–7.20 (Ar-H),
5.21 (-OCH(CH3)CO-), 5.80–3.00 (carbohydrate), 1.48 (-CHCH3); IR (ATR): 3362, 2945, 1747, 1651, 1489,
1451, 1381, 1515, 1184, 1082, 1043, 865, 749, 695 cm−1.
Polymer 11: a white powder (yield: 94%). 1H-NMR (500 MHz, DMSO-d6): 7.75–7.40 (Ar-H), 5.21
(-OCH(CH3)CO-), 4.90–3.00 (carbohydrate), 1.48 (-CHCH3); IR (ATR): 3371, 2945, 1748, 1651, 1503,
1452, 1381, 1133, 1084, 865, 752, 695 cm−1.
Supplementary Materials: Supporting information including detailed synthetic protocols, 1H, 19F and 31P NMR
and IR spectra are available online.
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Abstract: Polyurethanes are widely used in the development of medical devices due to their
biocompatibility, degradability, non-toxicity and chemical versatility. Polyurethanes were obtained
from polyols derived from castor oil, and isophorone diisocyanate, with the incorporation of
polycaprolactone-diol (15% w/w) and chitosan (3% w/w). The objective of this research was to
evaluate the effect of the type of polyol and the incorporation of polycaprolactone-diol and chitosan
on the mechanical and biological properties of the polyurethanes to identify the optimal ones for
applications such as wound dressings or tissue engineering. Polyurethanes were characterized by
stress-strain, contact angle by sessile drop method, thermogravimetric analysis, differential scanning
calorimetry, water uptake and in vitro degradation by enzymatic processes. In vitro biological
properties were evaluated by a 24 h cytotoxicity test using the colorimetric assay MTT and the
LIVE/DEAD kit with cell line L-929 (mouse embryonic fibroblasts). In vitro evaluation of the possible
inflammatory effect of polyurethane-based materials was evaluated by means of the expression
of anti-inflammatory and proinflammatory cytokines expressed in a cellular model such as THP-1
cells by means of the MILLIPLEX® MAP kit. The modification of polyols derived from castor oil
increases the mechanical properties of interest for a wide range of applications. The polyurethanes
evaluated did not generate a cytotoxic effect on the evaluated cell line. The assessed polyurethanes are
suggested as possible candidate biomaterials for wound dressings due to their improved mechanical
properties and biocompatibility.
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1. Introduction
Polyurethanes (PUs) are widely used in the preparation of medical devices due to their
biocompatibility, degradability, and non-toxicity when compared to polymers such as polylactic
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acid (PLA), polycarbonate, polycaprolactone, among others [1–4]. Examples of PU applications in
the biomedical field are implants, artificial heart valves, sutures, catheters, artificial heart, vascular
prostheses, wound coatings, blood compatible coatings, drug delivery systems, porous supports for
tissue regeneration, among others [5–9].
Since the mechanical, thermal, chemical and biological properties of PUs can be varied during
the synthesis process [10–14], the addition of polymers, such as polycaprolactone diol (PCL) or
chitosan (Ch) can modify the properties of PUs such as biocompatibility [15] and the antimicrobial
activity. PCL is an attractive polymer for the development of biomaterials due to its properties such
as biocompatibility, biodegradability, ease in the processing of biomaterials, among others [16]. Ch is
a polysaccharide that is obtained from renewable sources because it is part of the structure of some
crustaceans. Ch is mainly characterized by being biocompatible, biodegradable, bioadhesive, non-the
toxic, and has antimicrobial properties, among others [15,17,18]. These properties have allowed PCL
and Ch to be used in some applications such as wound dressings, surgical sutures, scaffolds in tissue
engineering, among others [19]. The use of Ch and PCL is expected to increase the biocompatibility of
the PUs synthesized with polyols derived from castor oil. Additionally, the filler effect is expected to
increase the mechanical properties such as tensile strength. And when using the mixture of chitosan
with polycaprolactone, it is sought to evaluate if there is a possible synergistic effect or not to obtain
biocompatible materials with antimicrobial properties, or if both mechanical and biological properties
are affected.
Biocompatibility is interpreted as a series of interactions that occur at the tissue/material interface,
allowing the identification of those materials with surface characteristics and/or more biocompatible
polymer chemistry; these interactions are influenced by the intrinsic characteristics of the material.
Some biocompatibility tests involve analytical tests or observations of physiological phenomena,
reactions or surface properties attributable to a specific application [12].
Cell cultures are ideal systems for the study and observation of a specific cell type under specific
conditions since these systems do not have the complexity that an in vivo system entails, due to a
large number of variables that interact. In vitro tests assess the morphology, cytotoxicity and secretory
functions of different cell types. The tests can be by direct contact of the cells and the material or
indirect, adding an extract of the material to the cell culture [20,21].
Monocytes and macrophages are part of the innate immune system because they are cells
that are involved in inflammatory processes with the ability to synthesize and secrete pro and
anti-inflammatory cytokines [22]. Cytokines correspond to a diverse group of extracellular,
water-soluble proteins, which influence the production and activity of other cytokines by increasing
(proinflammatory) or decreasing (anti-inflammatory) the inflammatory response [23].
The human monocyte cell line THP-1 is widely used in research thanks to the ability of monocytes
to differentiate into macrophages [24]. THP-1 monocytes have a round shape in suspension; when they
differentiate upon stimulation by phorbol 12-myristate-13-acetate (PMA), the cells adhere to the culture
plates, gaining phenotypic and functional characteristics similar to primary human macrophages [25,26].
The immune response is assessed by measuring cytokines in the cell culture medium [22].
The inflammatory response of macrophages is activated by invading pathogens, particles,
lipopolysaccharides (LPSs), and other stimuli [27]. LPSs are part of the outer membrane of
Gram-negative bacteria and can cause tissue damage and the release of multiple pro-inflammatory
cytokines [27]. Therefore, when an inflammatory response is induced, pro-inflammatory cytokines,
such as interleukin-1 beta (IL-1β), tumor necrosis factor alpha (TNF-α), and interleukin-6 (IL-6),
can be released. Likewise, anti-inflammatory cytokines, such as interleukin-10 (IL-10) [28], can be
released. Biomaterials, such as high molecular weight polyethylene, can activate macrophages to
secrete pro-inflammatory cytokines, including TNF-α and IL-1β, among others, as a response to
material implantation [29].
PU applications in biomedicine are diverse due to Pus’ various properties. Using aliphatic
chains derived from vegetable oils creates flexible PUs, and cyclic diisocyanates provide greater
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mechanical strength [30]. Therefore, it is necessary to specifically characterize each synthesized
material to determine its functionality and suitability for biomedical devices. The aim of this research
was to determine the physicochemical, mechanical, morphological, biodegradability, and in vitro
biocompatibility characteristics of the PUs, in addition to the possible inflammatory effects of the
materials synthesized with castor oil polyols, depending on segment structure and PU cross-linking
density. In this study, different PUs were synthesized with castor oil (chemically modified or not) and
isophorone diisocyanate (IPDI) by adding polycaprolactone diol (PCL) (15% w/w) and chitosan (Ch)
(3% w/w). In vitro degradation was determined in acidic and basic media, and enzymatic degradation
was carried out with pig liver esterase. The in vitro cell viability was determined using L929 mouse
fibroblasts (ATCC® CCL-1), human fibroblasts (MRC-5) (ATCC® CCL-171™), and adult human dermal
fibroblasts (HDFa) (ATCC® PCS-201-012™) with the PUs. The viability was also determined by a
live/dead kit for the L929 mouse fibroblasts. Pro- and anti-inflammatory responses were evaluated by
cytokine expression (IFN-γ, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, and TNF-α) of the THP-1 cells with
and without stimulation by LPS. The present paper serves as a screening of the immunomodulatory
effects of PU materials synthesized with castor oil.
2. Results and Discussion
2.1. Obtaining Polyols
The reaction to obtaining polyols derived from the castor oil is presented in Scheme 1. The
hydroxyl number of the polyols transesterified with pentaerythritol was determined. The values of
the hydroxyl index for each polyol (P.1, P.2 and P.3) were 160, 191 and 236 mg KOH per g of castor
oil sample, respectively. According to the results of the hydroxyl index, it is noted that the chemical
modification of the castor oil increases as the pentaerythritol content increases. The increment of
the hydroxyl index can be related to the increase of the crosslinking reactions and to the gain of the
bulk density of the polymeric materials. An increase in the crosslink density would generate an
improvement in the mechanical properties of the polymer matrices.
 
Scheme 1. Reaction scheme for obtaining polyols.
2.2. Mechanical Properties of PUs
Aromatic diisocyanates are the most commonly used in the synthesis of PUs due to
their mechanical properties, but they can produce carcinogenic and mutagenic diamines upon
degradation [31], therefore, an aliphatic diisocyanate was used in this research to avoid the side
effects of the raw materials on living tissues.
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Mechanical testing is essential to establish the use of a biomaterial because it allows obtaining the
load parameters required for a tissue of interest [32]. The mechanical properties of 12 PU matrices were
evaluated by determining the stress-strain curves from which the tensile strength and the elongation
at the break were obtained. Figure 1 shows the results of the mechanical properties depending on the
polyol used in the synthesis.
Figure 1. Mechanical properties of the synthesized PUs. (a) Maximum stress of PUs; (b) Percent
elongation of PUs. The data are expressed as the mean ± SD (n = 3). Bars with different letters (a–h)
indicate significant differences (p < 0.05) between the polyols.
Physical and mechanical properties depend on the atomic and molecular structure of the
materials used in the synthesis. The nature of the bonds and subunits of the structure affects
the mechanical properties and therefore the stress-strain properties, which are of interest for the
evaluation of biomaterials [32]. The highest tensile strength (16.86 MPa) was obtained with polyol P.3
(P.3-0%Ch-0%PCL). Figure 1a shows an increase in the tensile strength of all the materials synthesized
with polyol P.3, which has the highest cross-linking. This is how the chemical modification of the
polyols increases the maximum stress—via the increase of physical cross-linking of the polymer
matrix [33].
The mechanical properties of PUs are attributed to presence of hard and soft segment domains [34].
The hard segment generally refers to the combination of the chain extender and the diisocyanate
components, while the soft segments refer to polymeric diols. Depending on the structure of the hard
and soft segments, crystalline and amorphous domains can be formed, which determine the stiffness
and stability of the material [35]. Hydrogen bond cause strong interactions, so the polar nature of the
hard segment causes a strong attraction, forming the domains [36]. Therefore, when using polyol P.3 in
the synthesis, the values of the mechanical properties increased because the soft segments had a higher
number of hydroxyl groups, increasing the cross-linking density, and the hard segments formed a ring,
providing greater resistance.
Regarding the percent elongation at break (Figure 1b), the analysis showed significant differences
(p < 0.05) of polyol P.1 compared with the other polyols (P.2 and P.3), with the percentage increasing
as the polyol was modified. The mechanical properties of PUs depend on many factors, including
molecular weight, chemical bonds, cross-linking, crystallinity of the polymer, and the size, shape,
and interactions of the hard segment present in the structure [37]. Thus, PUs with a higher degree
of cross-linking have higher values of tensile strength and percent elongation at break. Increased
cross-linking produces a more compact structure [37]. An increase in strength is attributed to the
content of intermolecular hydrogen bonds and cross-linking density [38].
When analyzing the influence of the additives used in the synthesis on the mechanical properties,
significant differences are found when 3% Ch was added to polyol P.2 (P.2-3%Ch-0%PCL), obtaining
a higher value than the other materials synthesized with P.1 and P.3. For polyol P.3, the additives
decreased the maximum stress compared with the material without additives.
Chen et al. (2018) synthesized PUs with PCL as a polyol, IPDI, and polylactic acid (PLA), obtaining
tensile strength values between 41 and 60 MPa when using PLA- and PCL-based PU ratios in the
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range of 80/20 to 95/5. The authors attributed the decrease in tensile strength as the ratio of PCL
increased to the plasticizing effect of certain non-cross-linked PCL polyols and to a possible decrease
in compatibility as the PCL content increased [39].
A similar effect was observed for percent elongation at break because it decreased when PCL and
Ch were added to polyol P.3 (P.3-3%Ch-15%PCL). The other materials did not differ with the additives
used from the material without additives. The flexibility of PU may be due to the long oil hydrocarbon
chain present in the polymer chain [37]. This agrees with the results reported by Park et al. (2013),
who synthesized PUs with polycaprolactone, hexamethylene diisocyanate, and isosorbide, with silk
added, and determined that a higher silk content increased the stiffness and decreased the maximum
stress. The authors stated that the design of flexible and soft polymers allows for the production of a
wide range of biomaterials to regenerate soft tissues such as muscles and ligaments [6]. Additionally,
Vannozzi et al. reported that in general, soft and deformable substrates are key features for skeletal
muscle tissue engineering [33].
2.3. Fourier-Transform Infrared Spectroscopy (FTIR)
FTIR was used to determine the efficiency of the synthesis process by the identification of
characteristic functional groups of PU and the absence of characteristic peaks of the monomers














Figure 2. FTIR spectra of the synthesized PUs.
Figure 2 shows that all of the FTIR spectra had similar peaks, independent of the polyol or additive
used in the synthesis, and the peaks observed corresponded to the expected PU matrices. The absence
of the stretching peak of the −N=C=O bond of the diisocyanates at 2250 cm−1 [31], indicates there
were no unreacted free isocyanate groups in the synthesized PU matrices, showing that the reaction
was complete.
Spectral peaks characteristic of PUs can be seen in the spectra. Thus, around 3330 cm−1, the
characteristic bands for the stretching vibrations of the −N–H bonds are observed [40] from which it
can be inferred that they correspond to the urethane bonds present in the matrices. Near 2923 cm−1,
the stretching peak of the methyl group can be observed, and at around 2855 cm−1, the symmetric
stretching of the C–H bond is present. At around 1700 cm−1, an intense band is present due to the
C=O bond stretching [40] thus indicating the formation of the urethane group. Around 1250 cm−1,
the C–N bond stretching is observed; at about 1140 cm−1, the stretching vibrations of the C–O bond
appear [37].
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2.4. Thermal Analysis
2.4.1. Thermogravimetric Analysis
Thermogravimetric analysis was performed by producing thermograms of the PUs. Figure 3
shows the results for the synthesized matrices.
Figure 3. Thermograms of the synthesized PUs. (a) Thermogravimetric (TG) curve of PUs;
(b) Derivative of the thermogravimetric (DTG) curve of PUs.
Figure 3 shows a trend regarding thermal behavior of the synthesized PUs, showing no
displacements of the degradation temperatures with the use of modified polyols. When obtaining
the curves derived from thermogravimetry, several peaks were observed, which agrees with other
authors stating that the mechanism of degradation of PUs is complex due to the formation of various
compounds in the process [41].
For each polymer matrix a thermogram was obtained from which the stability of the synthesized
PUs in this study were determined. It was observed that the polyol type and additives did not
affect the thermal stability of the materials when compared with the synthesized material without
additives. The thermograms showed that all PUs were stable at temperatures below 300 ◦C and showed
complete degradation at temperatures near 600 ◦C, which coincides with the research conducted by
Jutrzenka et al. (2018), who synthesized PUs based on a glycerin derivative, polyethylene-butylene,
and diphenylmethane diisocyanate. They determined that the materials were stable up to 300 ◦C [36].
In a study on PUs synthesized with castor oil and isophorone diisocyanate that were proposed as
surgical adhesives, the PUs had the same degradation values, and the authors stated that the values
related to the degradation temperatures do not affect the biomedical application since physiological
temperature is lower (≈37 ◦C) [42].
Three degradation regions were detected for the polymer matrices. This is consistent with the
study performed with polymeric matrices synthesized with castor oil and isophorone diisocyanate by
adding different concentrations of PCL and Ch [43]. The first stage of degradation was observed in
the range of 250–370 ◦C and corresponds to the thermal degradation of the urethane bonds formed
in the hard segments, characterized by being technically unstable [2]. The second stage was between
375–430 ◦C and corresponds to the degradation of the soft segments [36]. The last stage was in the
range of 425–500 ◦C and corresponds to the thermal degradation of the double bonds of remaining
fatty acids from castor oil [44,45].
2.4.2. Differential Scanning Calorimetry (DSC)
Table 1 shows the glass transition temperature (Tg) values for the synthesized materials, as
determined by the DSC curves of the materials. Table 1 shows that the polyol type and the additives
significantly influence the Tg value. This agrees with what is understood from the mechanical
properties of the molecular structure produced by modifying the polyol derived from castor oil.
The values of Tg for P.1, P.2, and P.3 without additives were −14.8 ◦C, −12.8 ◦C and 14 ◦C, respectively.
P.1 had the lowest values of Tg (between −14 ◦C and −25 ◦C, approximately).
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0%Ch-0%PCL −14.8 −12.8 14.8
3%Ch-0%PCL −13.3 −1.0 13.7
0%Ch-15%PCL −25.3 −10.2 4.7
3%Ch-15%PCL −25.4 −14.8 2.8
The observed trend is a decrease in Tg as the hydroxyl index decreases, which agrees with the
cross-linking of the synthesized PUs, indicating that greater energy is needed for reordering the
structure by a change in intermolecular forces. This may be due to secondary interactions resulting
from the hyperbranched structure [46]. The thermal properties of PUs depend on the number of
urethane bonds present in the structure because they can tolerate a considerable amount of heat [47].
Saénz-Pérez et al. (2016) synthesized PUs with polytetramethylene glycol and diphenylmethane or
toluene diisocyanates, and butanediol. In the determination of Tg, they found that the values increased
as the amount of chain extender increased. Therefore, the authors state that the increase in Tg was
caused by the reduction in the mobility of chain segments due to the increase of hard segments [48].
The ricinoleic acid triglyceride from castor oil used as a polyol contains an ordered structure
in which hydroxyl groups are uniformly distributed within the chain, helping to obtain a PU with
a uniform cross-linked structure, achieving high mechanical properties and thermal stability [30].
In general, all of the synthesized matrices had a single value of Tg, indicating that all the materials
showed homogeneous segment dispersion. The Tg values were similar to those reported for PUs
based on polyethylene glycol, poly (ε-caprolactone-co-D,L-lactide), and diurethane diisocyanate (with
hexamethylene diisocyanate and butanediol), where the authors found values near −33 ◦C. Likewise,
the authors did not find exothermic peaks because the materials were amorphous [49]. With the above
information, it can be generalized that Pus are thermally stable and that they can be used in various
biomedical applications, for example, as materials for non-absorbable sutures.
2.5. Hydrophilic Character
2.5.1. Contact Angle
To evaluate the hydrophilic nature of PUs, the water contact angle on their surfaces was



























Figure 4. Contact angle of the synthesized PUs. The data are expressed as the mean ± SD (n = 10).
Bars with different letters (a–c) indicate significant differences (p < 0.05).
According to the statistical analysis in Figure 4, it is observed that for polyols P.2 and P.3, there
are no significant differences in contact angle values. For P.1, significant differences are observed by
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using additives because there is a reduction of angle values, indicating a decrease in the hydrophilic
character. Values near 100 degrees were found, so it can be deduced that the materials tend to be
hydrophobic. Mi et al. determined the contact angles of PCL-based thermoplastic PUs and different
chain extenders; the values were near 90 degrees. They attributed the results of the contact angle to the
hydrophilic functional groups present in the chain extenders that were used. The authors state that
although PUs maintain the same chemical structure, monomer variation in the synthesis can affect the
wettability and therefore vary the degradation behavior [50].
Likewise, Gossart et al. evaluated the contact angle of PUs synthesized with L-lysine diisocyanate,
hydroxyethyl methacrylate, and poly (hexamethylene-carbamate) and found values above 80 degrees.
The authors state that the common values reported for PU matrices were in the range of 80 to 90
degrees depending on the structure of the PU and interactions with the surfaces [51]. The results of
the contact angle shown in Figure 4 are greater than those reported; this possibly results from the
cross-linked network generated by the monomers used in the synthesis, as the materials tended to
be hydrophobic.
2.5.2. Water Absorption Rate

































Figure 5. Water absorption rate over 72 h. Absorption results are expressed as the mean ± SD (n = 3).
Bars with different letters (a–d) indicate significant differences (p < 0.05).
The weights of the materials were monitored until constant weight over 24, 48, 72, and 144 h, but
the data are not shown because no significant differences were found after 48 h. The results show
that the water absorption rates range between 0.5 and 1.5%. As seen in Figure 5, adding PCL and Ch
increases the rate of absorption compared to the material without additives, although the difference in
rates was not greater than one. It is likely that by increasing the amount of additive more functional
groups became available to interact with the medium, which is also polar. However, by increasing the
functionality of the polyol, the effect generated is inverse, showing a reduction in the rate of absorption
compared to PUs without the additive. Internal interactions (hydrogen bonds) increase the barrier
effect by preventing fluid diffusion. In addition, the additive function causes the chains to reorganize,
showing a reduction of volumetric defects or voids in which the water can be deposited [32].
Marques et al. evaluated a bioadhesive synthesized from lactic acid in which the water absorption
was 10%. The authors noted that moderate rates of water absorption improved the hemostatic character
of the materials [52].
The contact angle and the rate of absorption provide information about
hydrophobicity/hydrophilicity and could be an indirect indicator of surface molecular mobility.
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Surface wettability can affect protein adsorption on the surface and biocompatibility [53]. This is one
reason why it is indispensable to perform a study of material biocompatibility to determine its possible
acceptance by the human body. Therefore, the PUs synthesized in this study can be considered
suitable for biomedical applications, such as materials for non-absorbable sutures, considering the
water absorption rates under the test conditions.
2.6. Density Determination






























Figure 6. Density of the synthesized PUs. The data are expressed as the mean ± SD (n = 3). Bars with
different letters (a–d) indicate significant differences (p < 0.05).
As seen in Figure 6, the density of PUs depends on the type of polyol, which agrees with the
results shown for the mechanical and thermal properties. As the cross-linking density increased, the
density of the resulting polymeric material significantly increased, although the difference between the
highest and lowest values was less than 5%. This agrees with the results of Conejero-García et al. who
synthesized polyglycerol sebacate, with a different degree of cross-linking, as a material for various
applications in tissue engineering. The density values reported by the authors ranged between 1.13
and 1.14 g mL−1 [54].
The high densities of polymeric materials can be related to a higher hydroxyl (OH) content due to
increased cross-linking reactions [55]. In a study conducted by Carriço et al. they found that increasing
the castor oil content in the formulation of foam increased the apparent density, suggesting that the
polymer chains were more packed, with less free volume and smaller cells, increasing the stiffness of
these materials [55].
2.7. Dynamo-Mechanical Thermal Analysis (DMTA)
Figure 7 shows the dynamic behavior, DMTA, in a tension mode of PUs corresponding to the
evolution of the modulus and the loss factor versus temperature. With the variation of the storage
modulus and the loss factor, it was possible to observe the displacements suffered by Tg for the
evaluated materials. It can be seen that Tg increases when polyols P.2 and P.3 are used; this is probably
due to the stiffness of the structure and greater generation of hydrogen bonds because of the high
hydroxyl index present in the polyol [38,39]. According to the above results, it can be inferred that
material compatibility decreases when the polyol without modifications, and therefore with less
cross-linking, is used.
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Figure 7. DMTA thermograms of the synthesized PUs. (a) Loss factor; (b) Storage modulus.
Results with a similar trend were found by Chen et al. on PU matrices synthesized with PCL as a
polyol, IPDI, and PLA. The authors reported that when the mobility of the chain decreased, the value
of Tg increased. Therefore, they observed that phase compatibility decreased when the PCL content
increased due to a possible plasticizing effect of non-cross-linked material [39].
A similar behavior occurred with the modulus results. The lowest values corresponded to the
materials synthesized with P.1 (polyol without modification) compared with polyols P.2 and P.3, which
have a higher content of hydroxyl groups. An increase in hydroxyl groups results in an increase
in cross-linking, hindering polymer chain mobility and thereby increasing the storage modulus. A
decrease in polymer chain mobility can limit energy transfer and diffusion, which could decrease the
absorption capacity of impact resistance and deformation [39].
The relationship between hard and soft segments is important as they simultaneously act as
a physical cross-linking agent and as a high-modulus filler. When there is an organization of the
hard and soft segments in the respective domains, pre-polymers tend to have two Tg values. One
temperature will be negative corresponding to the soft segments, while the other will be positive,
corresponding to the hard segments [38]. When a single event of Tg occurs, it could be inferred that
there is a homogeneous phase distribution [38]. According to the results obtained by DSC, it can be
observed that the trend of Tg is similar, that is, a single value of Tg is present, increasing as the polyol
is modified. The presence of a single transition can be related to the existence of a dominant phase,
so it can be inferred that there is a uniform distribution of the components [56]. The differences in Tg
between the polyols used may be due to the cross-linking density because this would cause a greater
compatibility between hard and soft segments [38].
2.8. Field-Emission Scanning Electron Microscopy (FESEM)
Figure 8 shows the morphology of PUs synthesized with IPDI as a function of the polyol. The
FESEM micrographs showed a uniform distribution of PUs, but it was not possible to differentiate
the hard segments from the soft segments. Similarly, no differences were observed related to the
type of polyol used for the polymeric matrix. These results can be correlated with the calorimetric
results because if there is only a single Tg, it is probable that there is a homogeneous phase distribution.
This agrees with the results reported by Thakur et al. on PUs synthesized with castor oil and toluene
diisocyanate for the coating of materials [47].
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Figure 8. FESEM micrographs of PUs synthesized at 100×. (a) P.1; (b) P.2; (c) P.3.
2.9. In Vitro Biodegradability Assays
The biodegradability of PUs was evaluated in the presence of different media (HCl, NaOH, and
enzymatic) over a specific period of time, the results are shown in Figure 9.
 
Figure 9. Degradation rate of PUs in different media. (a) Acidic medium (0.1 M HCl) for 90 days; (b)
Basic medium (0.1 M NaOH) for 90 days; (c) Enzyme medium (esterase) for 21 days. The data are
expressed as the mean ± SD (n = 3). Bars with different letters (a–f) indicate significant differences (p <
0.05) between the polyols.
PCL was used as a positive control in enzymatic degradation, showing a degradation of 9.08
± 0.30% after 21 days. It can be inferred that the linear structure of PCL facilitates the diffusion of
the cleaved chains throughout the polymer and their release into the medium, producing a higher
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degradation rate. For the synthesized PUs, characterized by being cross-linked materials, the chain
mobility is lower, thus hindering the diffusion of the cleaved chains.
The highest value of the degradation rate after 90 days of testing (acidic and basic media) was
obtained with the acidic medium under the test conditions for the material synthesized with polyol P.1
by adding the additives (3%Ch-15%PCL). FTIR of the degraded materials (Figure 10) helped determine












Degradation in acidic medium Degradation in basic medium
Figure 10. FTIR spectra of PUs degraded in acidic, basic, and enzymatic media.
Figure 10 shows that the functional groups characteristic of PUs are conserved compared with
the undegraded material, therefore, it can be inferred that degradation occurs at the surface level.
Surface images of the degraded materials were also taken using FESEM, observing a possible surface
degradation of the materials (Figure 11). When observing that the degradation rate is less than 4% in
the evaluated media, it can be said this is due to the hydrophobic character of PUs, which agrees with
the results found for the rate of water absorption and contact angle.
Figure 11. FESEM micrographs of the PU synthesized with P.2-3%Ch-15%PCL after the degradation
process in different media (10,000×). (a) Undegraded material; (b) Acidic medium (0.1 M HCl) after 90
days; (c) Basic medium (0.1 M NaOH) after 90 days; (d) Enzyme medium (esterase) after 21 days.
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The results obtained in this research show a similar trend with those reported by Thakur et
al., who evaluated the chemical resistance of PUs in acidic and basic media, finding that in general,
PUs show chemical resistance, and PUs based on castor oil showed higher resistance to the basic
medium because the oil contains hydrolyzable functional groups [37]. This may be the reason why the
biodegradation of the PUs in basic medium was lower than in acidic medium.
The degradation of poly (ester-urethane) occurs mainly by a hydrolytic attack of the ester and
urethane bond [31]. Das et al. attributed the degradation in acidic and basic media to different types of
strong interactions in the structures of PUs [57]. The authors stated that low resistance to alkalis is due
to the hydrolyzable ester bonds in the monoglyceride residues and PCL of polymers [57]. After 90 days
of testing, it was observed that the highest values of the degradation rate under the test conditions
were relatively low (3.9% in acidic medium and 2.3% in basic medium). These results indicate that the
polymeric materials are resistant to degradation due to the structure of PUs, that is, to the cross-linked
matrix with high mechanical properties and a hydrophobic character.
Regarding enzymatic degradation (Figure 12c), the highest rate observed was 1.6% after 21 days.
This degradation process was greater than those obtained with the other treatments evaluated. This
behavior can be attributed to an increase of hydroxyl groups in the polyols, producing an increase
in the physical cross-linking of the polymer, and therefore, an increase in urethane groups. Urethane
bonds are similar to amides and may be hydrolyzed by enzymes such as the esterase used in this
research [58,59]. This agrees with what was stated by Gogoi et al. who reported that amide and urea
bonds present in the branched polymer structure facilitate degradation [60]. According to Cherng et
al., the degradation of PUs is due to cleavage of the hydrolytically weak bonds that are characteristic
of the soft segments; therefore, they concluded that the in vitro degradation rate depends mainly on
the type of polyol used in the synthesis due to the ester bonds in the structure [58].
 
Figure 12. Percentage of cell viability at 24 h. (a) L929 Mouse fibroblasts; (b) Human fibroblasts
(MRC-5); (c) Human dermal fibroblasts (HDFa). The data are expressed as the mean ± SD (n = 3). Bars
with different letters (a–d) indicate significant differences (p < 0.05) between the polyols.
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2.10. In Vitro Cell Viability Assay by the MTT Method
As part of the in vitro biological evaluation of PUs, the percentage of cell viability was determined
on three fibroblast cell lines. The results are shown in Figure 12.
Figure 12 shows that all polymers had a cell viability of greater than 70% for the three cell types
evaluated. According to the ISO/CD 10993-5 standard, values greater than 70% can be considered
suitable for biomaterials since they would be non-cytotoxic. As a control material, polypropylene
(PP) was used because it is a biocompatible and non-absorbable biomaterial. As a negative control,
doxorubicin (Doxo) was used. Figure 12a shows the cell viability results of the PUs on L929 fibroblasts.
The percent viability of all matrices, except for the PU synthesized with P.3 without additive, did not
show significant differences (p < 0.05) compared to PP. For the PU synthesized with P.3, significant
differences were observed with the polymer synthesized with P.1 and with the control, but the cell
viabilities are suitable to propose the synthesized materials as possible biomaterials. For the L929
fibroblasts, as the cross-linking of PU increased, the percentage of cell viability decreased. It is likely
that the high degree of cross-linking produces a low availability of functional groups, such as −OH
groups, in the cross-linked polymer. These groups would decrease the cell adhesion to the surface [33]
mediated by proteins from the medium.
Bakhshi et al. evaluated PUs synthesized by adding quaternary ammonium salts in the
epoxidation of soybean oil and found that PUs show a cell viability between 78–108% with L929
mouse fibroblasts, indicating that there was no toxicity of the synthesized polymers, coinciding with
the results of this study [2].
Similar results were found by Calvo-Correas et al. in a preliminary study of in vitro cytotoxicity
with murine L929 cells. These authors determined that PUs synthesized from castor oil and lysine
diisocyanate had a cell viability greater than 100% in the first 24 h of the assay when following the ISO
10993-12 standard, indicating that the synthesized PUs were non-toxic and could have a potential use
in biomedical applications [61]. Likewise, the results from the current study agree with those reported
by Reddy et al., who synthesized a PU from lysine diisocyanate, PCL, and 1,4-butane-diamide and
found that the polymers did not show toxicity when in contact with NIH/3T3 mouse fibroblasts [62].
Figure 12b shows the cell viability results of the polymers on human fibroblasts (MRC-5). For
this cell line, no trend was observed related to the polyol type used in the synthesis of the PUs. The
viability was decreased compared to that of the control material (PP); nevertheless, the materials are
suitable for use in the design of biomaterials because they show a cell viability of greater than 80%.
Figure 12c shows the cell viability results of PUs on human fibroblasts (HDFa), and the materials
show greater than 80% cell viability. Here, there were no statistically significant differences (p < 0.05)
between the polyols used in the synthesis of PUs. Similarly, there were no significant differences
between the synthesized materials and the PP control material; therefore, it can be inferred that the
synthesized PUs can be considered suitable for the design of biomaterials for non-absorbable sutures.
The above results are in accordance with those reported by Coakley et al., who evaluated HDFa
cells in vitro from a construct derived from porcine urinary bladder as a potential scaffold in tissue
engineering. The study demonstrated the viability of the human dermal fibroblasts. The results
showed cell viability values of greater than 90% [63].
Cytotoxicity may be related to the relative cell viability of controls, where values lower than 30%
indicate severe toxicity of the materials, values between 30 and 60% indicate moderate toxicity, values
between 60 and 90% indicate slight toxicity, and values above 90% indicate that the materials are
non-toxic [64]. Therefore, the fibroblast cell viability results shown in Figure 12 demonstrate that the
PUs are non-toxic for all of the lines evaluated.
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2.11. Immunocytochemical Techniques
2.11.1. In Vitro Cell Viability Assay by a Live/Dead Kit
L929 cells that were cultured directly on the material and evaluated by the MTT method showed
no toxic effects. When evaluating the cells by a live/dead viability kit, it was possible to observe that
the cells adhered to the material, showed viability, and proliferated during the exposure time with
the material. This kit allows determination of the number of live and dead cells during the test. In
this experiment, viable cells were determined. Figure 13 shows the fluorescence units of the viability
results as evaluated by the live/dead kit.
 
Figure 13. Fluorescence unit results of the in vitro cell viability test after 48 h with the live/dead kit.
Polystyrene (PS) positive control; Latex negative control. The data are expressed as the mean ± SD
(n = 3). Bars with different letters (a–f) indicate significant differences (p < 0.05) between polyols.
The results shown in Figure 13 indicate that PUs synthesized with modified polyols by
transesterification with and without the addition of Ch show values of living cells similar to and higher
than the material used as a positive control, PS. The materials synthesized with modified polyols by
adding Ch showed statistically significant differences compared to the other PUs after 48 h of testing.
Likewise, all the materials showed higher values than the negative control used in the test.
All the materials showed statistically significant differences compared to the negative control
(latex). When comparing to the results of the positive control (PS), no significant differences were
observed between the materials synthesized with P.3 without additive and by adding 3% Ch. This
indicated that these materials had a similar cell viability behavior to that obtained with the PS reference
material, which is widely used to grow and proliferate cells in vitro. Similarly, it was observed that
one material evaluated showed significant differences compared to PS, with the viability values being
higher than the positive control. This PU corresponds to the one synthesized with polyol P.2 with 3%
Ch. These results indicate that Ch has a positive effect because it improves the biocompatibility of
the PU.
Chitosan has a primary amino group and two free hydroxyl groups for each glucose unit, which is
beneficial for biomedical applications [15]. The presence of free amino groups causes an increase in the
positive charge of the polymer; therefore, there is a greater interaction between Ch and the cells [65].
These results agree with those reported by Laube et al., who performed a live/dead staining
assay of NIH/3T3 fibroblasts grown on PU foams that were synthesized with lysine diisocyanate.
They found that the cells were viable and proliferated, showing an increased cell density over time.
Therefore, the authors proposed these materials as possible substitutes for soft tissue fillers [31].
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2.11.2. Fixation and Morphological Analysis with Phalloidin and DAPI
In this assay, the adhesion and proliferation of L929 cells were observed by morphological analysis
and were compared to the latex negative control. PS was used as a positive control, which is a common
biomaterial used for cell culturing. Figure 14 shows the images obtained from the cells fixed and
stained after 24 h of contact with the PUs by polyol type.
Figure 14. Optical microscopy images of phalloidin (green) and DAPI (blue) staining for representative
PUs evaluated on L929 fibroblasts for 24 h. C(+) polystyrene positive control, C(−) latex negative
control. Images were analyzed by ImageJ software.
This technique stains the F-actin fibers (a main component of the cytoskeleton) with phalloidin,
producing a green color [66], and DAPI staining produces a blue color for the fibroblast nuclei. As
observed in the images, the structure of the L929 fibroblasts was conserved when compared with the
positive control. Likewise, varying type of polyol or additive did not produce conformational changes
in cell structure. As seen in the images, fibroblasts could adhere to the polymeric material, as evaluated
after 24 h of contact. Cell morphology can indicate substrate-cell interactions. Flat and extended cell
forms indicate strong adhesion from cell to substrate, while a rounded morphology generally means
that the cells have difficulty in adhering to the substrate [67]. With the above, it can be inferred that the
PUs evaluated in direct contact with cells allow cell proliferation and do not affect the cell morphology
after 24 h of testing. Therefore, the synthesized PUs in this research may be suitable as materials for
the design of non-absorbable sutures.
2.12. Evaluation of Inflammatory Processes
Twelve materials synthesized with castor oil polyols and IPDI with 3% Ch and 15% PCL were
evaluated to determine the in vitro inflammation processes produced after contact with the materials.
Inflammation was evaluated by the release of different cytokines to the medium of THP-1 cells that
were differentiated into macrophages, with and without LPS stimulation, and in contact with the
PUs. Nine inflammatory markers were analyzed, including pro- and anti-inflammatory cytokines
(IFN-γ, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, and TNF-α). The first test group (group A) was used to
determine the possible effect of PUs on the inflammatory process of macrophages.
Figure 15 shows the concentrations of anti-inflammatory cytokines expressed by the macrophages
after 24 h of exposure to the PUs. Figure 16 shows the concentration of pro-inflammatory cytokines
expressed in the culture medium. The reference material was a polypropylene (PP) biomaterial used in
non-absorbable biomedical sutures. The control was the culture medium without polymer. Figures 15
and 16 show cytokine expression in the monocytes (the cells not treated with PMA). The second test
group (group B) was formed to determine if the synthesized materials had anti-inflammatory activity
against cells in which inflammation had been stimulated by LPS before direct contact with the PUs.
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Figure 15. Anti-inflammatory cytokines without LPS stimulation. (a) IL-10; (b) IL-5; (c) IL-4. PP:
polypropylene as a reference material; Control: culture medium without PUs; THP-1: monocyte cell
line. The concentration of cytokines is expressed as the mean ± SD (n = 3).
 
Figure 16. Pro-inflammatory cytokines without LPS stimulation. (a) INF-γ; (b) TNF-α; (c) IL-1β;
(d) IL-8; (e) IL-6; (f) IL-2. PP: polypropylene as a reference material; Control: culture medium without
PUs; THP-1: monocyte cell line. The concentration of cytokines is expressed as the mean ± SD (n = 3).
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The results of the concentration of pro- and anti-inflammatory cytokines from test B are shown in
Figures 17 and 18, respectively. PP was tested as a reference material, and culture medium without
polymer was used as a control.
As observed in the results of groups A and B, there were no significant differences between the
concentrations of the cytokines expressed by the cells that were stimulated with LPS and those that
were not stimulated. This may be related to the protocol that was used. A standardized protocol to
differentiate THP-1 monocytes into macrophages with PMA is not yet available. Therefore, a wide
variation of PMA concentrations is found—between 6 and 600 nM. The time of stimulation with PMA
can vary from 3 to 72 h, and the recovery periods vary between 0 and 10 days [25,68]. It is probable
that high concentrations of PMA (higher than 100 ng mL−1) increase the levels of expression of genes
associated with inflammation and cause an increase in the secretion of pro-inflammatory cytokines,
such as TNF or IL-8 [25].
As stated by Park et al. (2007), high concentrations of PMA can induce the expression of some
genes during the differentiation process, which can mask the effect of post-differentiation stimuli [69].
The above results indicate that the concentrations of PMA used during the differentiation process of
THP-1 monocytes into macrophages triggered the release of pro- and anti-inflammatory cytokines,
and this process was prior to exposing the cells to LPS stimulation.
The results obtained for group A (Figures 15 and 16) show that the PUs do not produce an
inflammatory process in THP-1 macrophages. This is based on the control results (medium without
PU) and the PP reference material, which showed higher values (although not always significant) in
the concentrations of the evaluated pro- and anti-inflammatory cytokines.
An acute inflammation in an organism occurs due to a protective response against tissue
damage caused by infectious or foreign agents. The first cytokines formed in response to bacterial
lipopolysaccharides, tissue injury or infection are TNF-α and IL-1β, which act directly on specific
receptors to trigger a cascade of other effectors, such as cytokines and chemokines, among
others [23,25,70]. TNF-α and IL-1β have a synergic effect on inflammation, also promoted by IFN-γ
through the increase of TNF-α [70]. Tumor necrosis factor (TNF-α) is a pro-inflammatory cytokine that
is stimulated early in the inflammatory response [23].
One cytokine evaluated was interleukin-4 (IL-4), characterized by having a potent
anti-inflammatory activity and the capacity to inhibit the synthesis of pro-inflammatory cytokines [71].
It acts on activated macrophages to reduce the effects of cytokines IL-1, TNF-α, IL-6, and IL-8 [23].
Therefore, by expressing a pro- or anti-inflammatory cytokine, the expression of its opposite is
inhibited. Figure 17 shows IL-4 values near 5 pg mL−1, and its opposites such as TNF-α, IL-6,
and IL-8 show values over 20,000 pg mL−1, as observed in Figure 15. Interleukin-10 (IL-10), which
exerts anti-inflammatory actions on monocytes or macrophages, was also evaluated [71]. It inhibits
the pro-inflammatory cytokines IL-1, TNF-α, and IL-6, stimulating the endogenous production of
anti-inflammatory cytokines [23].
TNF-α plays an important role in the inflammatory response of an organism, as previously
mentioned. Upon LPS stimulation, a systemic inflammatory state occurs that is characterized
by increased levels of the pro-inflammatory cytokines TNF-α and IL-1β, and decreased levels of
anti-inflammatory cytokines, such as IL-10 [26]. This behavior was observed in the values obtained
from group B because in Figure 18a, the values obtained for TNF-α showed concentrations near
30,000 pg mL−1 and IL-1β had values of 25,000 pg mL−1, but for IL-10, mean values of 80 pg mL−1
were found.
Other evaluated cytokines were interleukins 2 and 6. Interleukin-2 (IL-2) is a pro-inflammatory
cytokine characterized by the generation and propagation of the antigen-specific immune response [23].
Interleukin-6 (IL-6) is a cytokine with pro-inflammatory properties, and high levels are associated with
severity in septic processes. IL-6 is sometimes considered an anti-inflammatory cytokine because it
can induce beneficial proteins in septic shock [71].
64
Molecules 2019, 24, 237
For the two groups (A and B), the cytokines of the THP-1 monocytes that were not transformed to
macrophages were evaluated to observe the basal expression levels of each cytokine. According to
Chanput et al., the basal levels of cytokines of THP-1 monocytes and macrophages have values near 20
and 30 pg mL−1 [22]. For the study performed with PUs, cytokines IFN GAMA, IL-2, IL-5, and IL-6
had values that were within the range mentioned by the study of Chanput et al. for THP-1 monocytes,
as observed in Figures 15–18. After the differentiation of monocytes into macrophages, it was observed
(Figures 17 and 18) that the expression levels of all cytokines increased compared to the basal levels of
the monocytes. Anti-inflammatory cytokines IL-4, IL-5, and IL-10 had increases of 55, 65, and 35%,
respectively. Pro-inflammatory cytokines IL-2, IL-6, IL-8, IL-1β, IFN-γ, and TNF-α had increases of 65,
122, 29, 100, 70, and 97%, respectively. Regarding the results of the macrophages stimulated with LPS,
the percent increases in the concentrations of the cytokines were similar to these.
According to the results from the reference biomaterial (PP) and the medium without PU, the
behavior does not show statistically significant differences of the PUs evaluated in group B. Therefore,
it can be inferred that the PUs do not have anti-inflammatory activity.
The results show that, for the differentiation of THP-1 monocytes into macrophages, in vitro
standardization and optimization is necessary to achieve adequate cytokine expression results. THP-1
monocytes and macrophages could be an adequate and reliable model to evaluate the inflammatory
response before conducting a more detailed study with human-derived cells [22].
 
Figure 17. Anti-inflammatory cytokines with LPS stimulation. (a) IL-10; (b) IL-5; (c) IL-4. PP:
polypropylene as a reference material; Control: culture medium without PUs; THP-1: monocyte
cell line. The concentration of cytokines is expressed as the mean ± SD (n = 3).
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Figure 18. Pro-inflammatory cytokines with LPS stimulation. (a) INF-γ; (b) TNF-α; (c) IL-1β; (d) IL-8;
(e) IL-6; (f) IL-2. PP: polypropylene as a reference material; Control: culture medium without PUs;
THP-1: monocyte cell line. The concentration of cytokines is expressed as the mean ± SD (n = 3).
3. Materials and Methods
3.1. Reagents
Castor (Ricinus communis) oil was purchased from Químicos Campota and Co. Ltd. (Bogotá,
Colombia). Isophorone diisocyanate (IPDI), polycaprolactone diol (PCL) (average molecular weight
of 2000 g mol−1), low molecular weight chitosan (Ch) (with a percentage of deacetylation between
75–85%), n-octane, 0.1 M hydrochloric acid (HCl), 0.1 M NaOH, porcine liver esterase (18 units mg−1),
4′,6-diamidino-2-phenylindole dihydrochloride (DAPI), and phorbol 12-myristate-13-acetate (PMA)
were acquired from Sigma-Aldrich Chemical Co. (St. Louis, MO, USA). Pentaerythritol was from
Merck KGaA (Darmstadt, Germany). Phosphate-buffered saline (PBS: Dulbecco’s phosphate-buffered
saline), 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT), 2.5% trypsin (10×),
penicillin-streptomycin (10,000 units of penicillin and 10,000 μg of streptomycin per milliliter),
Dulbecco’s modified Eagle medium (DMEM, 1×), Roswell Park Memorial Institute (RPMI) 1640,
Live/dead® Viability/Cytotoxicity Kit, Alexa Flour™ 488 phalloidin, and lipopolysaccharide (LPS,
Escherichia coli 026:B6) were obtained from Gibco/Invitrogen (Paisley, UK). Fetal bovine serum (FBS)
was from Eurobio (Les Ulis, France).
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3.2. Biological Material
Human acute monocytic leukemia cell line, THP-1 (ATCC® TIB-202™). Mouse subcutaneous
connective tissue fibroblasts L929 (ATCC® CCL-1). Human lung fibroblasts MRC-5 (ATCC®
CCL-171™). Adult human dermal fibroblast HDFa (ATCC® PCS-201-012™). All biological materials
were acquired from the strain library of the Universidad de La Sabana (Chía, Colombia).
3.3. Obtaining Polyols
The polyols were derived from castor oil (P.1, P.2, and P.3). P.1 corresponded to commercial
unmodified castor oil. Polyols P.2 and P.3 were obtained by transesterification with pentaerythritol [72].
For the reaction, the castor oil temperature was raised to 120 ◦C for 10 min. The temperature was then
further increased to 210 ◦C, adding pentaerythritol (1.32% and 2.64% mol pentaerythritol/mol castor
oil for P.2 and P.3, respectively) and 0.05% lead oxide as a catalyst. The mixture was maintained at
210 ◦C for 2 h. After the reaction time, the catalyst was removed by decantation for 24 h and filtration.
The hydroxyl number of the polyols were determined according to ASTM D1957-86 [73].
3.4. Synthesis of Polyurethanes
The PUs were synthesized by the pre-polymer method. The polyol was brought to 60 ◦C, and
the diisocyanate was added the reactor at a constant NCO:OH ratio (1:1) [74], and maintained at 300
rpm for 5 min. Them the PCL (15% w/w of oil polyol weight) and Ch (3% w/w of oil polyol weight)
were then added and maintained at 300 rpm for 5 min additional. The formation of the PU sheets
was carried out by pouring the prepolymer into a steel mold. Twelve PU matrices were synthesized
in sheets (15 cm × 9 cm × 0.3 cm (length × width × height)). Curing was performed at 110 ◦C for
12 h [72]. The synthesized PUs are identified with the following nomenclature: Pn-xCh-yPCL, where n
represents the polyol used (1 for unmodified castor oil, 2 for castor oil with 1.32% pentaerythritol/mol,
and 3 for the castor oil with 2.64% pentaerythritol/mol), and x and y represent the percentage of Ch
and PCL, respectively.
3.5. Mechanical Tests
A universal testing machine EZ-LX (Shimadzu, Kyoto, Japan) was used to determine maximum
stress, percent elongation, and Young’s modulus of the polyurethanes (following the ASTM D638-10
standard). A load cell of 5 kN with a crosshead speed of 25 mm min−1 was used [75,76]. Three samples
of 40 mm × 6 mm × 3 mm (length × width × thickness) were tested.
3.6. Fourier-Transform Infrared Spectroscopy (FTIR)
Chemical structures were evaluated by an ATR-FTIR spectrometer (Bruker Alpha, Billerica, MA,
USA), in the range from 400 to 4000 cm−1. The spectrum corresponds to the average of 24 scans at a
spectral resolution of 4 cm−1 [40,77].
3.7. Thermal Analysis
3.7.1. Thermogravimetric Analysis
Thermal behavior was evaluated in a TGA/DCS1 thermogravimetric analyzer coupled to DSC
(Mettler-Toledo Inc., Schwerzenbach, Switzerland). According to ASTM D6370, the conditions used
were as follows: heating speed of 25 ◦C min−1, a temperature range of 25–600 ◦C, nitrogen atmosphere,
and samples of 15 ± 2 mg [48].
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3.7.2. Differential Scanning Calorimetry
Glass transition temperatures were determined by a DSC 3+ analyzer (Mettler-Toledo, Columbus,
OH, USA). The conditions were as follows: temperature range from −70 ◦C to 150 ◦C, nitrogen
atmosphere with 20 mL min−1 flow, and sample weights of 10 ± 2 mg [78].
3.8. Hydrophilic Character
3.8.1. Contact Angle
A “Drop Shape Analysis—DSA” device (GH11, Krüss, Hamburg, Germany) was used to measure
the contact angle. According to ASTM-D7334-08 (2013), it was measured with the sessile drop method
using 10 μL of distilled water at 20 ◦C [79]. Ten measurements of each material were performed.
3.8.2. Water Absorption Rate
To remove uncross-linked chains and monomer residues after synthesis, the PU materials were
washed with ethanol for two days, renewing the ethanol every day. The solvent was then replaced by
deionized water for two more days. The materials were dried in a vacuum chamber (0.01 mm Hg) at
37 ◦C for 24 h [54]. The rate of water absorption was determined by immersing the sample in distilled
water until constant weight. The residual water was then removed from the samples with dry filter
paper, and the samples were weighed [80]. All tests were performed in triplicate. The rate of water
absorption at equilibrium was calculated by comparing the mass of the sample (mt) after obtaining
constant weight with the initial mass (mi) of the sample using Equation (1):
% Water absortion of PUs = (mi − mt)/mi (1)
3.9. Determination of Density
The material density was determined using the Archimedes immersion technique using a Mettler
AX 205 balance (Mettler-Toledo Inc.) with a sensitivity of 0.01 mg and a Mettler ME-33360 density
determination kit. Dry samples of 5 mm × 5 mm × 3 mm were used to calculate the density in
triplicate. The PUs were weighed in the air (mair) and then immersed in n-octane with a known density
(ρn-octane), and the immersion weight (mn-octane) was obtained at 20 ◦C. The density was calculated by
the following Equation (2) [54]:
Density of PUs = (maire × ρn−octano)/(maire − mn−octano) (2)
3.10. Dynamic Mechanical Thermal Analysis (DMTA)
The effect of temperature on the mechanical properties was evaluated by a DMTA test. A DMA
8000 thermomechanical analyzer (Perkin-Elmer, Waltham, MA, USA) was used at a frequency of 1 Hz,
a deformation of 0.1%, and a temperature program between −90 ◦C and 150 ◦C, with a heating rate of
5 ◦C min−1. The storage modulus and the loss factor, tanδ [38], were determined.
3.11. Field Emission Scanning Electron Microscopy (FESEM)
Morphological characterization of the PUs was performed with a field-emission scanning electron
microscope (FESEM, ZEISS ULTRA 55 from Oxford Instruments (Abingdon, UK). The PUs were
washed with ethanol for two days, renewing the ethanol every day. The solvent was then replaced by
deionized water for two more days. The materials were dried in a vacuum chamber (0.01 mm Hg) at
37 ◦C for 24 h [54]. The samples were coated with platinum to observe the morphology of the materials
with an accelerating voltage of 5 kV [81].
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3.12. In Vitro Biodegradability Tests
Biodegradability tests were performed in independent tests in triplicate following ASTM F1635-11.
To remove uncross-linked chains and monomer residues, the PUs were washed with ethanol for two
days, renewing the ethanol each day. The solvent was then replaced by deionized water for two more
days. The materials were dried in a vacuum chamber at 37 ◦C for 24 h [54]. Samples of 5 mm × 5 mm
× 3 mm were placed in the biodegradation media and incubated at 37 ◦C for three months, except
for the enzyme medium (10 units mg−1 solid), which was for 21 days. After this time, the samples
were washed with distilled water, dried in a vacuum chamber, and weighed. The reagents used
were: 0.1 M HCl medium, 0.1 M NaOH medium, and porcine liver esterase enzymatic medium. The
biodegradation rate was calculated by comparing the dry weight (wf) of the sample after degradation
during the predetermined time with the initial dry weight (wi) of the sample using Equation (3) [81,82]:
% Degradation of PUs = (wi − wt)/wi (3)
3.13. In Vitro Cell Viability Assay by the MTT Method
L929 mouse fibroblasts and MRC-5 and HDFa human fibroblasts were cultured in DMEM
supplemented with 10% FBS and 1% penicillin-streptomycin in T-75 cell culture flasks. They were
grown at 37 ◦C and 5% CO2. The cell culture medium was changed every 48 h [83]. At 100% confluence,
the cells were trypsinized (trypsin-EDTA) for viability analysis.
The effect of polyurethanes on cell viability was evaluated by the MTT method defined by
ISO/CD 10993-5. Cells were seeded in 96-well plates at a concentration of 4.0 × 104 cells per well
in supplemented medium and cultured at 37 ◦C and 5% CO2 for 24 h. Subsequently, PU cylinders
of 3 mm × 2 mm (diameter × height) (previously sterilized under ultraviolet UV light (260 nm) for
30 min on each side [33]) were placed in 100 μL of supplemented medium. The materials were left
in contact with the polymers for 24 h at 37 ◦C and 5% CO2. The supernatant and polymers were
then removed, and the MTT solution (12 mM in PBS) was added to a total volume of 100 μL and
incubated for 4 h at 37 ◦C. The supernatant was removed, and 100 μL of dimethyl sulfoxide was
added and incubated for 15 min at 37 ◦C. The optical density was then determined in a plate reader
(Bio-Tek ELx800 Microplate Reader, Highland Park, Winooski, VT, USA) at 570 nm. A polypropylene
biomaterial (PP) was used as a positive control for cell viability, and doxorubicin (DOXO) was used as
a negative control. All tests were performed in triplicate. Cell viability was determined according to
Equation (4):
% Cell viability of PUs = Abssample/Abscontrol (4)
where Abssample corresponds to the absorbance value of the cells after treatment with the PU, and
Abscontrol corresponds to the cells without treatment.
3.14. Immunocytochemical Techniques
In vitro cell viability assay by the live/dead kit. Cell viability was also evaluated by the live/dead
kit based on plasmatic membrane integrity and intracellular esterase activity [84]. L929 mouse
fibroblasts were cultured in RPMI supplemented with 10% FBS and 1% penicillin-streptomycin in T-75
cell culture flasks at 37 ◦C and 5% CO2. The cell culture medium was changed every 48 h [83]. At 100%
confluence, the cells were trypsinized (trypsin-EDTA) for viability analysis.
Prior to the assay, the PUs were washed with ethanol and water for 3 days and dried in a vacuum
chamber at 37 ◦C for 24 h [54]. PU sheets with a diameter of 4 mm (previously sterilized under UV
light (260 nm) for 30 min on each side) were placed in 96-well plates [33]. Five microliters of cells,
at a concentration of 1.0 × 104 cells mL−1, were then seeded onto each material using supplemented
medium and incubated at 37 ◦C and 5% CO2 for 30 min. Next, 95 μL of supplemented medium was
added and incubated for 24 h at 37 ◦C and 5% CO2 [54]. The supernatant was removed, and 2 μL of
calcein AM (live cell marker) staining solution and 4 μL of ethidium homodimer (dead cell marker)
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were added and incubated for 20 min in the dark with stirring [84]. Fluorescence measurement was
performed for calcein in a Victor 1420 Multilabel Counter spectrophotometer (Perkin-Elmer, Waltham,
MA, USA) at 485 nm to determine the concentration of living cells. PS was used as a positive control
and latex as a negative control. All tests were performed in triplicate.
Fixation and morphological analysis with phalloidin and DAPI. L929 fibroblasts in contact with the
material after 24 h of incubation were washed with PBS and fixed for 20 min with paraformaldehyde
4% w/v at 20 ◦C. They were then washed twice with PBS at 4 ◦C. Phalloidin (Alexa Flour™ 488
phalloidin) was added and incubated for 20 min to reveal F-actin. The samples were then washed
twice with PBS. The cell nuclei were stained for 5 min with DAPI at a 1/5000 dilution in PBS, followed
by washing twice with PBS. Next, 0.05% sodium azide was added. The cell structure was observed
using an Eclipse 80i optical microscope (Nikon, Tokyo, Japan) equipped with a Nikon Intensilight
Illuminator [54]. The images were analyzed by ImageJ software version 1.45k (Bethesda, MD, USA).
3.15. Differentiation into Macrophages and Inflammation Stimulation
A human acute monocytic leukemia cell line, THP-1, was used. The cells were cultured at 37 ◦C
and 5% CO2 in RPMI medium supplemented with 10% FBS and 1% penicillin-streptomycin in T-75
cell culture flasks. For cell differentiation into macrophages, the cells were centrifuged at 2000 rpm for
10 min, resuspended in 3 mL of RPMI culture medium and seeded into 24-well plates [69] by adding
200 mM of PMA and incubating for 48 h [27]. The differentiated cells (macrophages) were washed
twice with PBS to remove undifferentiated cells [26]. The macrophages that had been differentiated
with PMA were stimulated with 700 ng mL−1 of LPS for 3 h [22].
3.16. Evaluation of Inflammatory Processes
With the THP-1 cell line and PUs, two independent tests were performed to evaluate the
inflammatory processes of the materials in contact with the cells. The first test (group A) consisted in
the direct contact of PUs on the cells differentiated into macrophages with PMA, for 24 h, to determine
whether the PUs caused inflammation after contact with the cell line. The next test group (group B)
consisted of PUs in contact for 24 h with macrophages differentiated with PMA and stimulated with
LPS to determine whether the materials had anti-inflammatory activity.
3.17. Immunoassay
The MILLIPLEX® MAP kit for flow cytometry was used to evaluate cytokine production (IFN-γ,
IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, and TNF-α) and release to the supernatant of the macrophages
cultured in contact with PUs for 24 h, following the instructions provided by the manufacturers.
A mixture of beads with different fluorescence intensities, coated with antibodies for the mentioned
cytokines, was pre-incubated in the dark for one hour on an orbital shaker. Concentration standards
of 3.2, 16, 80, 400, 2000 and 10,000 pg mL−1 were used to determine the concentration curve of each
analyte. In a 96-well plate, 200 μL of wash buffer was added, the plate was shaken for 10 min, and
the supernatant was discarded. Twenty-five microliters of the standards, 25 μL of running buffer,
25 μL of the stock solution, 25 μL of supernatant from cells in the appropriate wells, and 25 μL of the
bead mixture were added. The plate was incubated overnight with shaking at 4 ◦C. The supernatant
was then removed, and the samples were washed twice with 200 μL of wash buffer. Next, 25 μL
of antibody was added for detection, and the samples were incubated for 1 h in the dark and with
shaking. Twenty-five microliters of the streptavidin phycoerythrin binding protein was then added
and incubated for 30 min with shaking in the dark. The supernatant was discarded, and the wells were
washed twice with 200 μL of wash buffer. One hundred and fifty microliters of the coating liquid were
then added, and the plate was read on a MAGPIX flow cytometer from MILLIPLEX MAP (Darmstadt,
Germany). The results of the samples were analyzed using the xPONENT MAGPIX software (Madison,
WI, USA).
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3.18. Statistical Analysis
The results were expressed as mean values ± standard deviation (SD). The data were analyzed
by means of an analysis of variance (ANOVA) and the significant differences were determined for
p < 0.05. For the comparison between samples the t-Student test was used with the SPSS Statistics
Software v.23 (IBM, Armonk, NY, USA).
4. Conclusions
PUs synthesized with castor oil polyols, isophorone diisocyanate, 15% w/w polycaprolactone
and 3% w/w chitosan were used to evaluate their mechanical, physicochemical, morphological,
biodegradability, and biocompatibility characteristics, along with their possible inflammatory effects.
The type of polyol and additive showed a significant impact on the maximum stress, percent elongation,
and contact angle of the material. Chemical modification of the polyols improves the evaluated
properties due to the increased cross-linking of the resulting materials. The resulting mechanical
properties of the PUs verified their dependence on the presence of hydrogen bonds, the number
of hydroxyl groups in the polyols, and the interactions between the hard and soft segments of the
matrix. The polyol with the highest hydroxyl index showed the highest values for the mechanical
and thermal properties. The percent elongation, with a maximum of 265%, can be used to obtain
resistant materials with flexibility, which allows designing biomaterials that do not cause injuries to
soft tissues. The degradation rates under the study conditions showed values of less than 4%, so it
can be inferred that cross-linking of the synthesized PUs hinders the degradation process. In vitro
cell viability was determined using L929 mouse fibroblasts, human fibroblasts (MRC-5) and adult
human dermal fibroblast (HDFa). The cell viability results of the PUs in contact with the three cell lines
demonstrated that there was no effect on cell viability; therefore, it is likely that these materials could
be used for direct contact with the skin without causing damage to surrounding cells. Cell viability
was also determined by the live/dead kit for the L929 mouse fibroblasts. Due to the biocompatible
properties of the PUs evaluated in this study, it can be inferred that they are suitable for use in
biomedical applications as materials for non-absorbable biomedical sutures.
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Abstract: Traditional ionic liquids (ILs) catalysts suffer from the difficulty of product
purification and can only be used in homogeneous catalytic systems. In this work,
by reacting ILs with co-catalyst (ZnBr2), we successfully converted three polyether
imidazole ionic liquids (PIILs), i.e., HO-[Poly-epichlorohydrin-methimidazole]Cl
(HO-[PECH-MIM]Cl), HOOC-[Poly-epichlorohydrin-methimidazole]Cl (HOOC-[PECH-MIM]Cl),
and H2N-[Poly-epichlorohydrin-methimidazole]Cl (H2N-[PECH-MIM]Cl), to three composite
PIIL materials, which were further immobilized on ZSM-5 zeolite by chemical bonding
to result in three immobilized catalysts, namely ZSM-5-HO-[PECH-MIM]Cl/[ZnBr2],
ZSM-5-HOOC-[PECH-MIM]Cl/[ZnBr2], and ZSM-5-H2N-[PECH-MIM]Cl/[ZnBr2]. Their structures,
thermal stabilities, and morphologies were fully characterized by Fourier-transform infrared
spectroscopy (FT-IR), X-ray diffractometry (XRD), thermogravimetric analysis (TGA), and scanning
electron microscopy (SEM). The amount of composite PIIL immobilized on ZSM-5 was determined
by elemental analysis. Catalytic performance of the immobilized catalysts was evaluated through the
catalytic synthesis of propylene carbonate (PC) from CO2 and propylene oxide (PO). Influences of
reaction temperature, time, and pressure on catalytic performance were investigated through the
orthogonal test, and the effect of catalyst circulation was also studied. Under an optimal reaction
condition (130 ◦C, 2.5 MPa, 0.75 h), the composite catalyst, ZSM-5-HOOC- [PECH-MIM]Cl/[ZnBr2],
exhibited the best catalytic activity with a conversion rate of 98.3% and selectivity of 97.4%.
Significantly, the immobilized catalyst could still maintain high heterogeneous catalytic activity even
after being reused for eight cycles.
Keywords: catalyst; CO2; heterogeneous catalysis; molecular sieve; polyether imidazole ionic liquid
1. Introduction
Carbon dioxide (CO2) is a rich carbon resource in nature. Over the years, experts and scholars
around the world have been working on the catalytic conversion and utilization of CO2 [1–5]. Although
research results have shown that the chemically speaking CO2 is extremely inactive, careful selection
of proper catalysts could make CO2 become a low-cost and widely used resource. Therefore,
the development of efficient catalysts is the key to achieve chemical fixation and conversion of CO2
under mild conditions.
Ionic liquids (ILs), as environmentally friendly chemical materials, have been widely used in
various fields including organic synthesis, biomass dissolution, catalysis, and composite materials
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preparation due to their unique properties [6–10]. In recent years, studies on the conversion of CO2
to cyclic carbonate using ILs as catalysts have been widely reported [11–13], demonstrating that
the catalytic performance of ILs as a single component in catalysts is unfavorable, and the addition
of Lewis acids or other co-catalysts in the catalysts is necessary to achieve better catalytic activity.
However, these studies are still associated with several disadvantages including limitation of the
intermittent tank reaction system, catalyst separation, and product purification [14]. These defects
make ILs difficult to be applied in industrial processes. To solve these problems, a structural design
concept based on ILs-immobilized catalysts has gained considerable attention. Yin and coworkers [15]
immobilized 3-(2-hydroxyethyl)-1-propylimidazolium bromide ILs on SBA-15, Al-SBA-15, and SiO2,
but the yield declined obviously after three cycles of catalysis. Zhang’s group [16] and Xiong‘s
group [17] immobilized ILs on chitosan and coconut shell activated carbon supporter, respectively.
However, gradual loss of active components in the immobilized catalysts also occurred in the catalytic
process. Therefore the utilization of chemical bonding between ILs and supporters is key to realize
the resource transformation of CO2. Compared with other catalytic systems, such as metal [18],
metal complexes [19], and imidazolium salt [20], ILs with the advantages of low energy consumption,
high recycling efficiency, and less corrosion to equipment have become a hotspot [16]. Polyether
polymer catalysts contain macromolecular chains that can form a synergistic and base barrier effect to
enhance catalytic activity [21].
In this work, three polyether imidazole ionic liquids (PIILs) were selected to react with co-catalyst
(ZnBr2) to obtain three composite PIILs, followed by further immobilization on ZSM-5 zeolite to result
in three immobilized PIILs catalysts (Figure 1 and Supplementary Materials). The chemical bonding
between the composite PIILs and ZSM-5 was determined and the phase transitions of PIILs were also
achieved. The immobilization is stable, so that the prepared catalyst can still maintain high catalytic
activity after eight cycles.
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Figure 1. (a) The diagram for the preparation of immobilized catalysts for the synthesis of propylene
carbonates from carbon dioxide; (b) the photos of the synthesized materials showing the color change
and phase transition; and (c) the chemical structure of the catalyst and its synthesis process, taking
ZSM-5-HO-[PECH-MIM]Cl/[ZnBr2] as an example.
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2. Results and Discussion
2.1. Fourier-Transform Infrared Spectroscopy (FT-IR)
FT-IR studies on zeolite ZSM-5 and its immobilized catalysts were carried out (Figure 2). As in
pattern (a), the peak at 1066 cm−1 corresponds to the Si–O characteristic peak of ZSM-5 [22]. Patterns
(b, c, d) contain all the characteristic absorption peaks of pattern (a), and meanwhile, the characteristic
peaks at ca. 1655 cm−1 and 626 cm−1, which are associated with the stretching frequency of the
imidazole ring, were also found. The peaks at ca. 1275 cm−1 in patterns (b, c, d) could be assigned to
the enhanced stretching vibration of C–O–C. The strong absorption peak at 3386 cm−1 of pattern (b)
corresponds to the stretching vibration of the hydroxyl group. When polyether imidazole molecular
chains are linked to ZSM-5, hydrogen chloride is released [15,23,24]. However, a small portion
of HOOC-[PECH-MIM]Cl/[ZnBr2] still exists as deduced from the peak at 1720 cm−1 with low
intensity in pattern (c), which is due to the physical adsorption on the surface of ZSM-5. In the
immobilization process of H2N-[PECH-MIM]Cl/[ZnBr2], there are hydrogen atoms on the surface
and inside of the molecular sieve [25]. A part of hydrogen on ZSM-5 reacted with the chloride ions of
H2N-[PECH-MIM]Cl/[ZnBr2] thus releasing hydrogen chloride, and the other part of the hydrogen
easily forms a hydrogen bond with oxygen in the polyether chain [15,23]. The hydrogen bonds caused
the appearance of a wide and strong hydroxyl peak at 3396 cm−1 in pattern (d), thus the low amino
peak was covered. The above results indicated the successful anchorage of composite PIILs on ZSM-5.
Figure 2. FT-IR spectra of zeolite ZSM-5 and its immobilized catalysts: (a) ZSM-5;
(b) ZSM-5-HO-[PECH-MIM]Cl/[ZnBr2]; (c) ZSM-5-HOOC-[PECH-MIM]Cl/[ZnBr2]; and
(d) ZSM-5-H2N-[PECH-MIM]Cl/[ZnBr2].
2.2. Scanning Electron Microscopy (SEM)
SEM images of ZSM-5 and its immobilized catalysts are provided in Figure 3. After the
immobilization, the surfaces of the catalysts (b, c, d) were covered with a white translucent substance,
and the surfaces became smoother. The particles became larger in size and their profiles became clearer,
indicating that a part of the PIILs was immobilized on the surface of ZSM-5. SEM results further
suggest the successful immobilization of PIILs catalysts on ZSM-5 and the solid state of the obtained
immobilized catalysts. See Figure 1b for ordinary photos of the phase transition.
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Figure 3. SEM images of zeolite ZSM-5 and its immobilized catalysts: (a) ZSM-5;
(b) ZSM-5-HO-[PECH-MIM]Cl/[ZnBr2]; (c) ZSM-5-HOOC-[PECH-MIM]Cl/[ZnBr2]; and
(d) SM-5-H2N-[PECH-MIM]Cl/[ZnBr2].
2.3. X-Ray Diffractometry (XRD)
The XRD patterns of ZSM-5 and its immobilized catalysts are shown in Figure 4. In pattern (a),
the peaks of high intensity at 23.1◦, 23.9◦, and 24.4◦ are the characteristic diffraction peaks of ZSM-5,
indicating good crystallinity of our synthesized ZSM-5. Compared with pattern (a), patterns (b, c, d)
exhibit all the diffraction peaks of ZSM-5, and the shape and intensity of the diffraction peaks have
negligible changes, indicating that the prepared catalysts maintained the good crystallinity of ZSM-5
after immobilization of the three composite PIILs onto ZSM-5.
Figure 4. XRD patterns of zeolite ZSM-5 and its immobilized catalysts: (a) ZSM-5;
(b) ZSM-5-HO-[PECH-MIM]Cl/[ZnBr2]; (c) ZSM-5-HOOC-[PECH-MIM]Cl/[ZnBr2]; and
(d) ZSM-5-H2N-[PECH-MIM]Cl/[ZnBr2].
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2.4. Thermogravimetry (TG) and Derivative Thermogravimetry (DTG)
Molecular sieve ZSM-5 and its immobilized catalysts were further characterized by
thermogravimetric analyzer (TGA) to explore their thermal stability with a heating rate of 10 ◦C/min.
TG and DTG results are shown in Figure 5. As seen in Figure 5a, ZSM-5 and the three catalysts have
slight weight loss before 150 ◦C, which is caused by the evaporation of water. As the temperature
rises, the curve of ZSM-5 in Figure 5b approximates to a straight line, where the weight loss rate does
not change and ZSM-5 does not break down. From Figure 5a, the three immobilized catalysts were
broken down in two steps. The first loss (230–550 ◦C) is attributed to the loss of grafted composite
PIILs [26–28], and the second slight loss (550–700 ◦C) is due to the decomposition of some molecular
sieve [29–31]. The three catalysts with functional groups of –OH, –COOH, and –NH2 have maximum
decomposition rate at 490 ◦C, 460 ◦C, and 475 ◦C, respectively, and their residual rates are maintained
above 50%. The decomposition speed and thermal stability of the three immobilized catalysts with
different functional groups are different, and among them, ZSM-5-HOOC-[PECH-MIM]Cl/[ZnBr2]
possesses the fastest decomposition and the highest residual rate. The thermal stability of the other two
immobilized catalysts shows little difference, and the weight loss processes are similar. TG and DTG
results suggest that the immobilized catalysts have good thermal stability, and that the immobilized
catalysts would not decompose under 230 ◦C.
Figure 5. (a) TG and (b) DTG of zeolite ZSM-5 and its immobilized catalysts:
ZSM-5-HO-[PECH-MIM]Cl/[ZnBr2]; ZSM-5-HOOC-[PECH-MIM]Cl/[ZnBr2]; and
ZSM-5-H2N-[PECH-MIM]Cl/[ZnBr2].
2.5. Effects of Different Catalysts on the Catalytic Performance
The catalytic performance of the above mentioned three PIILs, three composite PIILs, ZSM-5,
and three immobilized catalysts for the synthesis of propylene carbonate (PC) from CO2 and propylene
oxide (PO) was investigated (Table 1). Three PIILs showed catalytic activity (entries 1–3), among
them, HOOC-[PECH-MIM]Cl has the best catalytic performance because the terminal carboxyl group
has acidity and can also act as donor of a hydrogen bond, which could add a synergistic effect
with the anion. The synergistic effect contributes to the activation and ring opening of PO and
improves the catalytic activity [15,24]. Zinc bromide has a catalytic effect when used alone as a
co-catalyst (entry 4). The catalytic performance of PIILs were further improved after addition of
zinc bromide (entries 5–7) [26,27], where the conversion rate reached 100%, and the selectivity and
yield both reached above 97%. The improvement of the catalytic performance can be attributed
to the addition of zinc bromide that increased the amount of bromide ions. The Br− attacked the
β-carbon atom of PO, and therefore increased the conversion rate. The polyether macromolecular
chain has a basic isolation effect and an infinite dilution effect, which could not only inhibit the
formation of by-products but also improve the selectivity [32,33]. The catalytic activity of ZSM-5
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is poor (entry 8). The excellent catalytic performance of the three immobilized catalysts is very
promising, although there is no big difference between them (entries 9–11). This is because the
structures of the immobilized catalysts were similar after three composite PIILs were immobilized
on the molecular sieve by chemical bonding. The chemical bonding occurs through the covalent
bond formation by condensation between the chlorine of PIILs and the hydrogen on ZSM-5 [25].
All of the three immobilized catalysts have polyether macromolecular chains as the main chains
and imidazole rings as the branched chains. ZSM-5-HOOC-[PECH-MIM]Cl/[ZnBr2] has better
catalytic activity than the other two immobilized catalysts, because there is still a small amount
of HOOC-[PECH-MIM]Cl/[ZnBr2] physically adsorbed on the surface of ZSM-5. It still has acidity,
which is good for ring opening [15,24], consistent with the FT-IR study. The catalytic activity of the
immobilized catalysts is slightly lower than that of the composite PIILs since the amount of composite
PIILs is reduced after immobilization. However, the conversion rate and selectivity both reached 95%.
Experimental results showed an excellent catalytic performance of the three immobilized catalysts,
among which ZSM-5-HOOC-[PECH-MIM]Cl/[ZnBr2] represents the best.




Selectivity (%) Yield (%) Purity (%)
1 HO-[PECH-MIM]Cl 90.4 96.4 87.1 99.1
2 HOOC-[PECH-MIM]Cl 95.1 96.8 92.1 99.4
3 H2N-[PECH-MIM]Cl 93.3 95.3 88.9 98.9
4 ZnBr2 40.8 68.2 27.8 95.2
5 HO-[PECH-MIM]Cl/[ZnBr2] 100 97.1 97.1 99.5
6 HOOC-[PECH-MIM]Cl/[ZnBr2] 100 98.9 98.9 99.7
7 H2N-[PECH-MIM]Cl/[ZnBr2] 100 97.6 97.6 99.4
8 ZSM-5 9.4 41.2 3.87 96.4
9 ZSM-5-HO-[PECH-MIM]Cl/[ZnBr2] 95.8 96.5 92.4 98.3
10 ZSM-5-HOOC-[PECH-MIM]Cl/[ZnBr2] 96.3 96.8 93.2 99.2
11 ZSM-5-H2N-[PECH-MIM]Cl/[ZnBr2] 96.1 96.4 92.6 99.0
1 Reaction condition: catalyst, 2.5 wt%, temperature, 120 ◦C; pressure, 2.5 MPa; time, 1 h.
2.6. Effects of Reaction Conditions on the Catalytic Performance
The effect of reaction conditions on the catalytic performance of ZSM-5-HOOC-[PECH-MIM]
Cl/[ZnBr2] was studied. To define the optimal reaction conditions, the orthogonal test of L9 (34) was
used to investigate the effects of reaction pressure, temperature, and time on the conversion rate and
selectivity (Table 2). Knj (n = 1,2,3) indicated the sums of three conversion rates or selectivity when the
values of the corresponding factors were the same for each time. R was the range. The results show
that reaction pressure has the greatest effect on conversion rate and selectivity, followed by reaction
temperature and time. When the reaction pressure is 2.5 MPa, the temperature is 130 ◦C, and the time
is 0.75 h, the immobilized catalyst exhibited the best catalytic performance with a conversion rate of
98.3% and a selectivity of 97.4%. When the reaction pressure is increased, more CO2 can be dissolved
in PO, therefore, the conversion rate and selectivity can be increased. If the pressure was too high or
the reaction time prolonged, the selectivity declined, which is consistent with the previous literature
reports [16,34–36]. Excessive temperature could cause a decrease in selectivity due to the exothermic
nature of the cycloaddition reaction that could lead to the production of some byproduct such as from
the polymerization of PC [15,37].
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Table 2. Orthogonal test-effects of reaction conditions on catalytic performance.
Factor
Conversion Rate (%) Selectivity (%)
Pressure (MPa) Temperature (◦C) Time (h)
1 2.0 110 0.75 82.3 92.4
2 2.0 120 1.0 90.6 90.1
3 2.0 130 1.25 95.4 85.2
4 2.5 110 1.0 95.9 98.2
5 2.5 120 1.25 97.6 97.5
6 2.5 130 0.75 98.3 97.4
7 3.0 110 1.25 92.1 94.6
8 3.0 120 0.75 97.9 90.3
9 3.0 130 1.0 99.5 84.2
K1j 268.3/267.7 270.3/285.2 278.5/280.1 — —
K2j 291.8/293.1 286.1/277.9 286.0/272.5 — —
K3j 289.5/269.1 293.2/266.8 285.1/277.3 — —
R 23.5/25.4 22.9/18.4 7.5/7.6 — —
2.7. Effect of the Catalyst Circulation on the Catalytic Performance
The effect of catalyst circulation on catalytic performance was investigated under an optimized
reaction condition (2.5 MPa, 130 ◦C, 0.75 h), with ZSM-5-HOOC-[PECH-MIM]Cl/[ZnBr2] as the
catalyst. As in Figure 6, the experimental results suggest an excellent reusability of the immobilized
catalyst. The conversion rate and yield are 98.3% and 97.4%, respectively, in the first use. In the next
two cycles, the catalytic performance decreased. Elemental analysis was used to measure the fresh
catalyst, three and eight cycle catalysts, respectively (Table 3). The results showed that the grafted rate
of composite PIILs catalyst decreased over 1 to 3 cycles, and there was negligible change after three
cycles. The reason is that a small amount of physically adsorbed PIILs is easily falls off from ZSM-5
zeolite during the 1st to 3rd cycles. From the 4th cycle, the grafted rate of PIILs, conversion rate and
yield showed small changes, which indicate that the chemical bonding between the composite PIILs
and the zeolite is steady, and therefore the catalytic performance of the immobilized catalyst remains
stable. The conversion rate is 86.7% and the yield is 77.9% after the 8th cycle. The results in Figure 6
are consistent with those in Table 3. The amount of the grafted PIIL is 1.121 mmol/g, the chemical
graft is about 0.803 mmol/g, and physical graft is about 0.318 mmol/g.
Figure 6. Effect of the catalyst circulation on catalytic performance.
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ZSM-5-HOOC-[PECH-MIM]Cl/[ZnBr2] 1 3.149 7.744 2.000 1.121 1.780 × 10−3
ZSM-5-HOOC-[PECH-MIM]Cl/[ZnBr2] 2 2.275 7.131 1.694 0.810 1.472 × 10−3
ZSM-5-HOOC-[PECH-MIM]Cl/[ZnBr2] 3 2.256 7.059 1.681 0.803 1.633 × 10−3
1 Fresh catalyst; 2 Catalyst reused 2 times; 3 Catalyst reused 8 times.
3. Materials and Methods
3.1. Reagents and Instruments
Three PIILs, i.e., HO-[PECH-MIM]Cl, HOOC-[PECH-MIM]Cl, and H2N-[PECH-MIM]Cl,
were prepared according to our published procedures [26–28]. Zinc bromide was purchased from
Tianjin Guangfu chemical reagents factory (Tianjin, China). Acetonitrile was received from Tianjin
Guangfu Fine Chemical Research Institute and used without further purification. PO was obtained
from Jiangsu Yonghua fine chemicals Research Company (Suzhou, China). ZSM-5 zeolite, CO2,
and nitrogen were supplied by Liaoyang Petrochemical Industries Company (Liaoning, China).
Instruments used in this study included a MAGNA-IR750 Fourier Transform Infrared
Spectrometer (FT-IR, Thermo Nicolet Corporation, Markham, ON, Canada); TM3000 Scanning Electron
Microscope (SEM, Keyence, Osaka, Japan); D/max-2400 Automatic X-ray Diffractometer (XRD,
RKC Instrument Inc., Tokyo, Japan); TGA4000 Thermogravimetric Analyzer (TGA, PerkinElmer,
Waltham, MA, USA); PerkinElmer-2400 Element Analyzer (EA, PerkinElmer, Waltham, MA, USA);
PARR4523 Catalytic Device (PARR, Moline, IL, USA); 1790F Gas Chromatograph (GC) (Agilent
Technologies, Inc., Santa Clara, CA, USA); D08-8C Carbon Dioxide Flowmeter (Beijing Sevenstar
Electronics Co., Ltd., Beijing, China); DF-101S Magnetic Stirrer (Gongyi Yuhua Instrument Co., Ltd.,
Gongyi, China); SFX-2L Rotary Evaporator (Taiwan Xinyue Instrument and Meter Co., Ltd., Xiamen,
China); DZF-6050 Vacuum Drying box (Gongyi Yuhua Instrument Co., Ltd., Gongyi, China); 2-XZ-4
rotary vane vacuum pump (Wenling City Yangan Electromechanical Co., Ltd., Wenling, China).
3.2. Preparation of Immobilized Catalysts
Three PIILs, i.e., HO-[PECH-MIM]Cl, HOOC-[PECH-MIM]Cl, and H2N-[PECH-MIM]Cl,
were prepared according to our published procedures [26–28]. Briefly, epichlorohydrin (ECH) was
polymerized to form poly-epichlorohydrin (PECH) possessing –OH groups, then chloroacetic acid
and ammonia were used to react with PECH to obtain products with –COOH and –NH2 groups,
respectively. Then three types of PECH samples with –OH, –COOH, and –NH2 were reacted
with imidazole to obtain three PIILs. Next, a given amount of ZnBr2 was added into the three
PIILs, respectively, and the resulting mixtures were heated at reflux under stirring for 24 h. As the
reaction proceeded, the mixtures became more viscous with a dark color change. When the reactions
were complete, three reddish brown liquids were obtained, namely three composite PIILs, i.e.,
HO-[PECH-MIM]Cl/[ZnBr2], HOOC-[PECH-MIM]Cl/[ZnBr2], and H2N-[PECH-MIM]Cl/[ZnBr2].
Then, the composite PIILs were added, respectively, to the suspension of ZSM-5 in acetonitrile, and the
resulting mixtures were stirred at 70 ◦C for 24–36 h to obtain milk-white liquids. Acetonitrile was
removed from the obtained liquids by rotary evaporation at 65 ◦C. The afforded three samples of white
powder were then dried in vacuum at 65 ◦C for 24 h under 0.08 MPa to remove residual acetonitrile,
leading to the final products of immobilized PIILs catalysts, i.e., ZSM-5-HO-[PECH-MIM]Cl/[ZnBr2],
ZSM-5-HOOC-[PECH-MIM]Cl/[ZnBr2] and, ZSM-5-H2N-[PECH-MIM]Cl/[ZnBr2] ( Figure 1c).
3.3. Typical Procedure for the Synthesis of PC from PO and CO2
The immobilized catalyst (2.5% mass fraction of PO) was added in the stainless-steel autoclave.
After the atmosphere was replaced by nitrogen, PO and CO2 were filled into the autoclave. When the
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flow of CO2 was 0, the reaction was complete. The crude product was purified to obtain the refined
PC, and its purity was determined by gas chromatography. Specific steps refer to our reported
papers [26,27].
4. Conclusions
Three immobilized PIILs catalysts were newly developed, and their catalytic performance
studied. The results showed that the immobilization of composite PIILs on ZSM-5 was
mainly based on chemical bonding, while a small amount of physical adsorption also existed.
ZSM-5-HOOC-[PECH-MIM]Cl/[ZnBr2] exhibited the highest catalytic activity in the synthesis of
PC under the optimized condition: reaction temperature of 130 ◦C, pressure of 2.5 MPa, and time of
0.75 h, where the conversion rate reached 98.3% and the selectivity 97.4%. Significantly, the catalyst still
maintained a good catalytic activity after eight cycles. We envisage that the newly prepared catalysts
can solve the problems of traditional ILs catalysts including the difficulty in production purification
and short service life in the catalytic process. We believe that our research can provide industrial
continuous conversion of CO2 in a packed bed reactor with acceptable performance.
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Abstract: Saffron, a kind of rare medicinal herb with antioxidant, antitumor, and anti-inflammatory
activities, is the dry stigma of Crocus sativus L. A new water-soluble endophytic exopolysaccharide
(EPS-2) was isolated from saffron by anion exchange chromatography and gel filtration. The chemical
structure was characterized by FT-IR, GC-MS, and 1D and 2D-NMR spectra, indicating that EPS-2
has a main backbone of (1→2)-linked α-D-Manp, (1→2, 4)-linked α-D-Manp, (1→4)-linked α-D-Xylp,
(1→2, 3, 5)-linked β-D-Araf, (1→6)- linked α-D-Glcp with α-D-Glcp-(1→ and α-D-Galp-(1→ as
sidegroups. Furthermore, EPS-2 significantly attenuated gentamicin-induced cell damage in cultured
HEI-OC1 cells and increased cell survival in zebrafish model. The results suggested that EPS-2
could protect cochlear hair cells from ototoxicity exposure. This study could provide new insights
for studies on the pharmacological mechanisms of endophytic exopolysaccharides from saffron as
otoprotective agents
Keywords: hearing loss; saffron; endophytic exopolysaccharide; gentamicin; cochlear hair cell
1. Introduction
Hearing loss is a global problem. To date, more than 466 million people have moderate to severe
or greater hearing loss, and one-third of them are over 65 years old. As the world’s population ages,
it is estimated that approximately 900 million people (or one in every 10 people) will suffer hearing loss
by 2050. World Health Organization (WHO) estimates that an annual global cost of hearing loss will be
US $750 billion, including health sector costs (excluding hearing equipment), education support costs,
productivity losses and social costs [1]. Unfortunately, hearing loss has not received sufficient attention
by the pharmaceutical industry, and until now there have been few Food and Drug Administration
(FDA)-approved drugs to treat or prevent different types of hearing loss [2]. Most hearing loss is
caused by permanent loss of hair cells in the inner ear. One of the most likely causes of hair cell death
is exposure to ototoxic agents, including aminoglycoside antibiotics such as gentamicin (GM) and
neomycin, and cisplatin anticancer agents [3,4]. Additionally, it is estimated that aminoglycoside
antibiotics generate hearing thresholds of almost 50% [5]. However, these aminoglycoside drugs
also continue to be used in view of their cost and effectiveness, and their ototoxicity usually limits
the dose range of drugs [4,6]. GM is a cationic aminoglycoside that enters cells via endocytosis and
forms a complex with iron, which drives the formation of free radicals and directly promotes the
formation of ROS [7]. Recent reports show that antioxidant drugs can benefit patients with hearing
loss, because hearing loss is produced by excessive generation of reactive oxygen species (ROS) in cells
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of the cochlea [8,9]. Therefore, it is highly possible to find potential drugs in antioxidants to prevent
hair cell loss due to ototoxicity exposure and attenuate hearing loss.
With today’s interest in new renewable sources of polymers, polysaccharides are macromolecular
carbohydrates that play a vital role in the growth and development of living organisms, and serve
as important biological response modifiers. Furthermore, it is well known that the polysaccharides
can be used in various pharmaceutical formulations due to their sustainability, biodegradability,
and biosafety [10–12]. Polysaccharides are widely distributed in plants, animals, and microorganisms.
Endophytic fungi symbiotically live in plant tissues and all or part of their entire life cycles is spent
in and/or between plant cells, often without causing apparent symptoms of diseases. Moreover,
these microorganisms play important roles as components of plant ecosystems [13]. Endophytic
fungi benefit their hosts by enhancing resistance to disease, abiotic stress and plant growth, and they
have been widely recognized as a rich, potential and novel source of natural bioactive substances in
agricultural, pharmaceutical and food industries [14]. Nowadays, endophytic fungi, as a renewable
resource, are of growing interest. They often produce exopolysaccharides with unique structures and
diverse biological activities, which have become the most promising group of antioxidants [15,16].
Saffron (Crocus sativus L.) is a perennial stemless herb of the Iridaceae family grown in
Turkey, Iran, and China, and it has a variety of biological activities, such as antitumor, antioxidant,
and anti-inflammatory effects [17,18]. As the main medicinal part of saffron, the stigma extract has
antioxidant properties, which can scavenge oxygen radicals and effectively inhibit the activity of oxygen
radicals [19]. Our previous studies have shown that crude exopolysaccharide extracted from fermentation
mycelia of saffron exhibited excellent scavenging activities against 1, 1-diphenyl-2-picrylhydrazyl,
hydroxyl and superoxide anion radicals [20]. However, the purification of exopolysaccharide and
its further activity have not been researched. The present research describes the purification and
characterization of a water-soluble exopolysaccharide (EPS-2) from the fermentation culture of endophytic
fungus Penicillium citreonigrum CSL-27 of saffron and investigates its protective role in the damaged
cochlear hair cells.
2. Results and Discussion
2.1. Isolation and Purification of Exopolysaccharide
The main exopolysaccharide fraction EPS-2 was collected according to the detection curve of
phenol-sulphuric acid colorimetry. After purification with a DEAE-52 cellulose column (Figure 1a),
one major fractional peak was obtained. According to Figure 1b, the fraction appeared as a single
and symmetrical peak after being further purified by Sephadex G-75 column chromatography. EPS-2
appeared as a single and symmetrical peak in the high performance gel permeation chromatography
(HPGPC) (Figure 1c), indicating homogeneity. By comparison of the retention times of EPS-2 with the
molecular standards, the molecular weight of EPS-2 was estimated to be 40.4 kDa. The colorimetric
analysis has shown that EPS-2 contains 88.9% total carbohydrate, and no sulfate ester, protein, or uronic
acid is detected. Monosaccharide composition analysis indicated that EPS-2 was mainly composed
of mannose, glucose, galactose, xylose, and arabinose with a molar ratio of 51.77:36.76:5.76:3.16:6.94.
The results of SEM have shown that EPS-2 has a frizzy shape, and the surface has a scaly texture.
The irregular aggregation has determined that EPS-2 is an amorphous solid. The molecular aggregation
may be attributed to a repulsive force between the polysaccharides and the side chains.
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Figure 1. Chromatograms of EPS-2 from P. citreonigrum CSL-27 from (a) DEAE-52 cellulose column
chromatography, (b) Sephadex G-75 chromatography, (c) HPGPC, and (d) FT-IR spectrum.
2.2. Fourier Transformed Infrared (FT-IR) Spectroscopy Analysis
The IR spectrum of EPS-2 displayed the characteristic peaks of polysaccharide (Figure 1d).
The strong and broad absorption peak at 3367 cm−1 was related to the stretch vibration of O–H
(hydroxyl group) bond existing in all polymers. The strong peak at 2939 cm−1 was due to the C–H
stretching vibration in the sugar ring and the strong absorption peak at 1657 cm−1 represented the
stretching vibration of C=O and carboxyl group. Another peak at 1418 cm−1 could be attributed to
the symmetric stretching of the COO-group [21]. The presence of strong absorbance in the region
1200–950 cm−1 indicated the polysaccharide nature of EPS-2. The strong absorption at 1131 and
1056 cm−1 in the range of 1200–1000 cm−1, which is anomeric region, was attributed to C–O–C and
C–O groups in the polysaccharide, suggesting that the monosaccharide in the EPS-2 has a pyranose
ring [22]. Moreover, the band at 912 cm−1 indicated the pyranose form of the glucosyl residue and
absorption peak at 817 cm−1 as well as the existence of glycosidic linkages of the EPS-2. Moreover,
the weak absorption at 912 and 817 cm−1 was assigned to the coexistence of α and β glycosidic
bonds [23].
2.3. Methylation Analysis
Methylation is an essential method to analyze linkages that form methoxyl groups
on the free hydroxyl groups of polysaccharides [24]. After methylation of EPS-2, a series
of methylated derivatives were identified based on a gas chromatography coupled with
mass spectrometry (GC-MS) analysis. According to the retention time and the ion fragment
characteristics in the GC-MS spectra, 1,2,5-tri-O-acetyl-3,4,6-tri-O-methyl-mannitol (residue A),
1,2,4,5-tri-O-acetyl-3,6-tri-O-methyl-mannitol (residue B), 1,5-di-O-acetyl-2,3,4,6-tetra-O-methyl-D-
glucitol (residue C), 1,5,6-tri-O-acetyl-2,3, 4-tri-O-methyl-D-glucitol (residue D), 1, 5-di-O-acetyl-2, 3,
4, 6-tetra-O-methyl-galactitol (residue E), 1,4,5-tri-O-acetyl-2, 3-di-O-methyl-D-xylitol (residue F),
and 2,3,4,5-tetra-O-acetyl-D-arabinitol (residue G) were detected (summarized in Table 1),
indicating the presence of →2)–Manp-(1→, →2, 4)–Manp-(1→, Glc-(1→, →6)-Glcp-(1→, Gal-(1→,
→4)–α-D-Xyl-(1→ and →2, 3, 5)–Ara-(1→, respectively. The molar ratio was 7.2:2.3:3.3:1.2:1.0:1.1:1.1,
which was in agreement with the results of the GC analysis of monosaccharide components.
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Table 1. Glycosidic linkage composition of methylated EPS-2.
PMAA Mass Fragments (m/z) Molar Ratio Linkage Type
3,4,6-Me3-Manp a 87, 101, 117, 129, 161, 189, 233 7.2 →2)-D-Manp-(1→
3,6-Me2-Manp 43, 71, 87, 129, 173, 189, 233 2.3 →2, 4)-D-Manp-(1→
2,3,4,6-Me4-Glcp 45, 71, 87, 101, 117, 129, 145, 161, 205 3.3 D-Glcp-(1→
2,3,4-Me3-Glcp 58, 71, 87, 99, 101, 117, 129, 161, 189, 233 1.2 →6)-D-Glcp-(1→
2,3,4,6-Me4-Galp 87, 101, 117, 129, 189, 233 1.0 D-Galp-(1→
2,3-Me2-Xylp 43, 87, 101, 117, 129, 189 1.1 →4)-D-Xylp-(1→
Araf 73, 85, 115, 145, 158, 187, 217 1.1 →2, 3, 5)-D-Araf-(1→
a 3, 4, 6-Me3-Manp = 1, 2, 5-Tri-O-acetyl-3,4,6-tri-O-methyl-mannitol.
2.4. Nuclear Magnetic Resonance (NMR) Spectroscopy Analysis
The structure of EPS-2 was further analyzed by NMR spectroscopy. The 1H, 13C, HSQC,
and HMBC spectra of EPS-2 are shown in Figure 2. Several anomeric proton signals (5.31–5.03 ppm)
appeared in the 1H-NMR spectrum. Other proton signals were located in the region of about
4.25–3.36 ppm, which were attributed to the protons of the C-2–C-6 of hexosyl glycosidic ring.
The corresponding anomeric carbon signals (102.4–98.2 ppm) were identified in the 13C-NMR and
HSQC spectra of EPS-2. These signals corresponded to seven types of residues (residue A–G,
respectively), and this result was consistent with the GC-MS result.
The carbon and proton signals of residues A-G were grouped by comprehensive analysis,
comparison of the NMR spectra, GC-MS data of EPS-2 and published literature [25–28]. The α/β
configurations of residues were judged by the chemical shift and coupling constant of the
anomeric proton [29,30]. In the HSQC spectrum, the anomeric signals at 100.5/5.30, 98.2/5.16,
98.3/5.07,102.4/5.10, 102.1/5.06, 102.0/5.03, and 102.3/5.07 ppm corresponded to residues A–G,
respectively, which belonged to →2)–α-D-Manp-(1→, →2, 4)–α-D-Manp-(1→, α-D-Glcp-(1→,
→6)-α-D-Glcp-(1→, α-Galp-(1→, →4)–α-D-Xylp-(1→, and →2, 3, 5)–β-D-Araf-(1→, respectively.
Additionally, the adjacent carbon and hydrogen signals of each residue were assigned according to the
HMBC spectrum. The data on carbon and hydrogen for EPS-2 are shown in Table 2.
Figure 2. Cont.
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Figure 2. 1H-NMR (a), 13C-NMR (b), HSQC (c), HMBC spectrum (d), and predicted repetitive structural
unit (e) of EPS-2.
Table 2. Assignment of 13C-NMR and1H-NMR chemical shifts of EPS-2.
No. Glycosyl Residues
Chemical Shifts, δ (ppm)










































































Some points existed in HSQC and also showed in HMBC were removed, and the remained linkage
sites between the residues were determined by analyzing the HMBC spectrum of EPS-2. In the HMBC
spectrum, the peak at δ 78.5/5.30 ppm (AC2/AH1) suggested that there is a recurring C-2 linked O-1
of residue A structure in EPS-2. The signal at δ 78.3/5.16 ppm (B C2/B H1) has shown that C-2 is
linked to O-1 of residue B, and the signal at δ 100.5/3.96 ppm (A C1/B H2) has indicated that C-2 of
residue B is linked to O-1 of recurring residue A. Likewise, the linkages of residue F O-1 with residue
A C-2, residue C O-1 with residue B C-4, and residue B O-1 with residue D C-6 were deduced by
the signals at δ 102.0/4.11 ppm (FC1/AH2), 70.3/5.07 ppm (BC4/CH1), 66.2/5.16 ppm (DC6/BH1),
respectively. In addition, signals at δ δ98.3/4.25 ppm (CC1/GH2), δ 82.8/5.10 ppm (GC3/DH1), δ
66.6/5.06 ppm (GC5/EH1), and δ 78.4/5.07 ppm (FC4/GH1) illustrate that O-1, C-2, C-3 and C-5 of
residue G were linked to the C-4 of residue F, O-1 of residue C, O-1 of residue D, O-1 of residue E,
respectively. The possible repetitive structure unit of EPS-2 was inferred and is shown in Figure 2e.
2.5. Effects of EPS-2 on the Viability of House Ear Institute-Organ of Corti 1 (HEI-OC1) Cells Treated with GM
As evidenced by the MTT assay, the exposure to GM for 24 h decreased the cell viability
in a dose-dependent manner. Cell viability was reduced by ca. 50% by 10 mM GM (Figure 3a).
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Thus, 10 mM GM was used subsequently. Cells were pretreated with 50, 100, 200, 400, and 800 μg/mL
EPS-2 for 1 h before adding 10 mM GM. Control cells were treated with a vehicle (0.1% DMSO).
Cell survival was determined after 24 h. In the control group, no cytotoxicity was observed at 0.1%
DMSO. The exposure of HEI-OC1 cells to GM resulted in a significant reduction of cell viability, but cell
pretreatment with EPS-2 significantly inhibited GM-mediated cytotoxicity in a dose-dependent manner,
as shown in Figure 3b. In cells treated with GM only, EPS-2 at 50 μg/mL increased cell viability by
50% EDA (40 μM), a positive control also significantly increased cell survival.
Figure 3. Effect of EPS-2 on GM-mediated decrease in viability of HEI-OC1 cells. (a) GM decreased
cell viability dose dependently. GM (10 mM) treatment for 24 h decreased the cell viability by ca. 50%.
(b) EPS-2 protected HEI-OC1 cells following GM (10 mM) treatment. * p < 0.05, *** p < 0.001 vs. control
group. Results are shown as the mean ± SD (n = 6).
2.6. Protective Effect of EPS-2 on Hair Cells in Neuromasts
Using the zebrafish lateral line as a model of hair cell death, we tested EPS-2 prevented
GM-induced hair cell death. DASPEI was performed to stain mitochondria, and the mean number of
hair cells in the four neuromasts (SO1, SO2, O1, and OC1) of the zebrafish larvae was calculated to
quantitatively assess the changes. Aminoglycoside treatment caused nuclear fragmentation and
reduced neuromast fluorescence, while protective compound could prevent fragmentation and
preserve labeling intensity.
From two independent screens, we found that EPS-2 protected hair cells from GM (Figure 4).
We first determined whether 1 h of exposure to EPS-2 alone caused hair cell death, and the
400 μg/mL concentration of EPS-2 was revealed to have toxicity for hair cells compared to negative
control, whereas 200 μg/mL EPS-2 had no toxicity for hair cells compared to the negative control
group. Therefore, EPS-2 at a concentration of 200 μg/mL was expected to be applied as a maximal
concentration in the following study. Pretreatment with 25, 50, 100, and 200 μg/mL EPS-2 resulted in
significant protection of hair cells exposed to 100 μM GM compared to GM alone. The mean (± SD)
number of hair cells in the neuromasts in the negative control group was 36.62 ± 1.85, and the viability
of hair cells was set to 100%. In the model group (100 μM GM), the viability of hair cells was 50%;
in the positive control group (0.5 μM EDA), the viability of hair cells was 82%; the protective effect of
pre-treated EPS-2 increased in a dose-dependent manner until 200 μg/mL (the viability of hair cells
was up to 72%) of concentration with a significantly large number of viable hair cells than that in the
model group.
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Figure 4. Analysis of hair cell damage by DASPEI assay (×10). (a) negative control: 36.62 ± 1.85
cells; (b) GM 100 μM treatment: 18.37 ± 2.26 cells; (c) EPS-2 25 μg/mL + GM 100 μM treatment:
19.37 ± 1.41 cells; (d) EPS-2 50 μg/mL + GM 100 μM treatment: 21.00 ± 1.85cells; (e) EPS-2 100 μg/mL
+ GM 100 μM treatment: 21.87 ± 1.55 cells; (f) EPS-2 200 μg/mL + GM 100 μM treatment: 26.25 ± 3.01
cells; (g) positive control: 30.00 ± 3.16 cells; and (h) EPS-2 protected hair cells following GM (100 μM)
treatment. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. control group). Results are shown as the mean ± SD
(n = 8 fish per treatment). Scale bar = 10 μm.
3. Experimental
3.1. Chemicals and Reagents
3-Aminobenzoic acid ethyl ester methanesulfonate (MS-222, CAS no. 886-86-2), 3-methy-1-
pheny-2-pyrazoline-5-one (EDA, CAS no. 89-25-8), 2-(4-(dimethylamino)styryl)-N- ethylpyridinium
iodide (DASPEI, CAS no. 3785-01-1) and 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium
bromide (MTT, CAS no. 298-93-1) were obtained from Sigma-Aldrich (St Louis, MO, USA). Gentamycin
(GM, CAS no.1405-41-0) was purchased from Dalilan Meilun Biotechnology Co., Ltd. (Dalian,
China). The Hepes-buffered DMEM solution (pH 7.4, Gibco, 1×, sterile, CAS no. 21063-029)
used in this study contained neither phenol red nor sodium pyruvate was purchased from Life
Technologies Co. (Grand Island, NY, USA). High-glucose Dulbecco’s modified Eagle medium
(DMEM) and Fetal bovine serum (FBS) were purchased from Thermo Fisher Scientific (Waltham,
MA, USA). DEAE-cellulose 52 was purchased from Beijing Dingguo Changsheng Biotechnology Co.,
Ltd. (Beijing, China). Sephadex G-75 gel filtration medium was purchased from Shanghai Lanji
Biotechnology Co., Ltd. (Shanghai, China). Trifluoroacetic acid (TFA), 1-phenyl-3-methyl-5-pyrazolone
(PMP), standard monosaccharides (D-mannose, L-rhamnose, D-glucuronic acid, D-galacturonic acid,
D-glucose, D-galactose, D-xylose, L-arabinose, and D-fucose), T-series dextrans of different molecular
weights (T-5.2, T-11.6, T-23.8, T-48.6, T-148, T-273, T-410, T-668, and T-1400) and dialysis tubing
(molecular weight cut off, 8000–14,000 Da) were obtained from Sigma-Aldrich (St. Louis, MO,
USA). The reagents used in high-performance liquid chromatography (HPLC) and GC-MS were
of chromatograph grade, and all other chemicals and reagents used were of analytical grade (AR).
3.2. Fungal Material Microbial Strain and Culture Conditions
The strain CSL-27 was isolated from the corm of saffron and identified as Penicillium citreonigrum
by Beijing Dingguo Changsheng Biotechnology Co. Ltd. The strain was stored at China Center for
Type Culture Collection (CCTCC) (Wuhan, China). The strain was activated on potato dextrose agar
(PDA) slants, and then cultivated on a rotary shaker (TCYQ, Taicang Laboratory Equipment Factory,
Jiangsu Province, China) constantly at 120 rpm and 28 ◦C for 14 days. The liquid culture medium
contained 10 g/L glucose, 2 g/L peptone, 1 g/L yeast extract and 1 g/L NaCl with a pH of 6.5.
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3.3. Cell Culture
HEI-OC1 cell line, derived from the organ of Corti was obtained from the House Ear Institute
(Los Angeles, CA, USA). Cells were cultured in high-glucose DMEM, supplemented with 10% FBS
at 33 ◦C and 10% CO2 in a humidified atmosphere without antibiotics. The cell incubator (HERAcell
150i) was derived from Thermo Fisher Scientific (Waltham, MA, USA).
3.4. Zebrafish Husbandry
Zebrafish (Danio rerio) embryos were produced by paired matings of AB wild-type adult fish from
School of Pharmaceutical Sciences, Sun Yat-sen University and maintained in zebrafish facilities at
School of Pharmacy, Guangdong Pharmaceutical University. Experiments were performed on 5–6 day
old larval zebrafish maintained at 28 ◦C in a defined embryo medium (EM) containing 1 mM MgSO4,
120 μM KH2PO4, 74 μM Na2HPO4, 1 mM CaCl2, 500 μM KCl, 15 mM NaCl, and 500 μM NaHCO3 in
distilled water at pH 7.2. This age range was selected due to the fact that hair cells in 5 day-old fish
show mature responses to ototoxic insult, and the small fish size allows for high throughput screening
of compounds in small volumes [31]. All procedures were approved by the appropriate Institutional
Animal Care and Use Committee at Guangdong Pharmaceutical University.
3.5. Isolation and Purification of EPS-2
The supernatant from the culture of strain CSL-27 was collected and concentrated by a vacuum
rotary evaporator (EYELA, Japan). The concentrated solution was treated with four volumes of cold
95% EtOH and kept overnight at 4 ◦C. The precipitate was separated and collected by centrifugation
at 3000 rpm for 20 min and dissolved in distilled water and deproteinated by the Sevag method [32].
Finally, the precipitate was dialyzed in distilled water for 48 h at 4 ◦C and then freeze-dried to obtain
a crude polysaccharide. The sugar content in the EPS was analyzed using phenol-sulfuric acid method
with glucose as the standard [33].
The crude exopolysaccharide was purified using a column (2.6 × 95 cm) packed with Macroporous
resin AB-8. Distilled water was employed as the mobile phase. The flow rate was 2 mL/min. Each
fraction (10 mL) was collected and analyzed with the phenol-sulfuric acid reagent at 490 nm using
a spectrophotometer [33]. The fractions, which coincided with the major peak, were collected together,
concentrated at 60 ◦C with a rotary evaporator under vacuum, dialyzed (Mw cut off: 8000 Da) and
lyophilized. The exopolysaccharide samples obtained by lyophilizing were dissolved in distilled water
and fractionated on a pre-equilibrated DEAE-52 cellulose column (2.6 × 60 cm) equilibrated with
distilled water and then eluted with aqueous NaCl solution (0.1 mol/L) at a flow rate of 1 mL/min.
All the fractions were assayed for carbohydrate content by the phenol-sulfuric acid method and the
fraction representing only one sharp peak was collected, dialyzed, concentrated and further purified
using a Sephadex G-75 gel-filtration column (1.6 × 70 cm) by eluting with distilled water at a flow
rate of 0.2 mL/min. Consequently, a fine exopolysaccharide, named EPS-2, was obtained. After
freeze-drying, EPS-2 was available for use in the subsequent experiments.
3.6. Analysis of Physicochemical Characteristics
The molecular weight of EPS-2 was assessed by HPGPC on TSK-5000PWXL and TSK G-3000
PWXL gel columns (1.8 × 300 mm) in series (Tosoh Biosep, Tokyo, Japan). The columns were
calibrated with dextran standards and a refractive index detector (Waters 2414, Milford, MA, USA),
and eluted with 0.02 M KH2PO4 solution at a flow rate of 0.6 mL/min and column temperature
of 35 ◦C. The molecular weight was estimated by reference to a calibration curve made by a set
of standards dextran (Mw: 1400, 668, 410, 273, 148, 48.6, 23.8, and 5.2 kDa) [34]. The sample was
dissolved in 1 mL of distilled water and mixed with an equal volume of 4.0 M TFA. The sample
was allowed to stand still for 4 h at 100 ◦C and the acid-hydrolyzed sample was filtered through
a 0.45 μm syringe filter and the residual acid was removed through decompression and distillation
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with methanol for thrice [35]. The resulting monosaccharide compositions were determined by HPLC
after precolumn derivatization with PMP using a Shimadzu HPLC system fitted with Phenomenex
GEMINI-NX C18 HPLC column (4.6 nm × 250 mm) and Shimadzu prominence diode array detector.
The sugar was identified by comparison with reference sugars (L-rhamnose, L-arabinose, D-fucose,
D-xylose, D-mannose, D-galactose, D-glucose, D-glucuronic acid, and D-galacturonic acid). Calculation
of the molar ratio of the monosaccharide was carried out on the basis of the peak area of the
monosaccharide [24].
The morphology of EPS-2 was observed under a low vacuum scanning electron microscope (SEM,
Philips Quanta-400, Netherlands). The dried exopolysaccharide powder was placed on a specimen
holder with the help of double-sided adhesive tapes and then sputtered with the gold powder using
a sputter coater. The sample was observed at magnifications of 800× and 1600× at an accelerating
potential of 20 kV under low vacuum conditions.
3.7. FT-IR Analysis
FT-IR spectroscopy was used to determine the functional groups of the purified EPS. Infrared
spectra of the purified EPS fraction were recorded in the 4000–400 cm−1 region using a FT-IR system
(Perkin Elmer Spectrometer 100, Wellesley, MA, USA). The sample (10 mg) was mixed with 100 mg
of dried potassium bromide (KBr) and compressed to prepare as a salt disc (10 mm diameter) for
reading the spectrum further. The determinations were performed in two independent replicates and
are reported as the mean with standard deviations.
3.8. Methylation Analysis
A methylation analysis was performed by the method of Hakomori with some modifications [15].
In brief, polysaccharide in dimethyl sulfoxide (DMSO) was methylated using NaH and iodomethane.
After 6 h total hydrolysis with 2 M TFA at 105 ◦C, the methylated sugar residues were converted to
partially methylated alditol acetates by reduction with NaBH4, followed by acetylation with acetic
anhydride. The derived sugar residues were dissolved in 100 μL chloroform. Subsequently, partial
methylated alditol acetates (PMAAs) were analyzed by GC-MS on the Shimadzu NTST system
equipped with a TG WAXMS capillary column (30.0 m × 0.25 mm × 0.25 μm) (ThermoFinnigan,
Silicon valley, CA, USA). The temperature was set to 50 ◦C, maintained for 3 min, then increased to
240 ◦C at a rate of 15 ◦C/min, and maintained at 240 ◦C for 20 min. Helium acted as the carrier gas,
with the flow rate maintained at 1.0 mL/min. PMAAs were identified by the retention times and
fragmentation patterns.
3.9. NMR Spectroscopy Analysis
1H-NMR and 13C-NMR spectra were recorded using a Bruker AVANCE IIIT600 NMR
spectrometer at 25 ◦C. The sample (35 mg) was deuterium-exchanged by lyophilization two times
with 99.97% D2O, and then was dissolved in 1.0 mL of 99.97% D2O. Acetone was taken as the
internal standard (2.225 ppm for 1H and 31.07 ppm for 13C). 1H-NMR, 13C-NMR, 1H-1H COSY, HSQC,
and HMBC were performed using the standard Agilent software.
3.10. Protection Assay
Hair cells act as sensory receptors for the auditory and vestibular systems in all vertebrates.
Conventional vertebrate experimental animal models are well suited to detect and solve problems
related to hair cell death and survival, but they are not suitable for drug screening. This is mainly
because the inner ear is inaccessible and the alive time of inner ear cochlear tissue is very short
in vitro [36]. As present, HEI-OC1 cell line is a mature and immortalized cell lines derived from the
cochlea and vestibular tissue that has been shown to be sensitive to some known ototoxins, such as
GM and cisplatin [37]. In addition, Hair cells in the inner ear of mammals are similarity with the
pathway activated by ototoxicity exposure in zebrafish lateral line, but hair cells in zebrafish regenerate
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following ototoxicity exposure unlike mammals. Therefore, the zebrafish lateral line is an excellent
model for drug screening that modulates hair cell survival, an intractable approach in mammalian
systems [3]. In this experiment, HEI-OC1 cell line and zebrafish model were effectively combined for
the activity assay of EPS-2.
3.10.1. Cell Viability Assay
Cell viability was measured using the MTT assay as described previously [38]. HEI-OC1 cells
were seeded at a density of 1 × 104 cells/well in a 96-well plate and cultured overnight. To investigate
the effect of EPS-2 on cell viability, HEI-OC1 cells were treated with 50, 100, 200, 400, and 800 μg/mL
EPS-2 for 1 h, before being exposed to GM. When the cells were confluent, the culture medium was
replaced with medium containing GM, which was the calculated half-maximal inhibitory concentration
(IC50). After one day of incubation, 100 μL MTT was added to each culture well and the 96-well plate
was incubated at 33 ◦C in an atmosphere of 10% CO2 for 4 h. EDA (40 μM) was used as a positive
control. The effect of EPS-2 on viability at each concentration was calculated as a percentage of the
control activity from the absorbance values. Absorbance at 490 nm was measured using a Microplate
spectrophotometer (RT-2100C, Shenzhen Rayto Life Science Co., Ltd., China) for cell viability and the
average OD in control cells was taken as 100% of viability. A final concentration of 10 mM GM was
selected to damage the HEI-OC1 cells in the following experiments.
Cell relative viability (%) = ODexperiment/ODcontrol × 100% (ODblank was used to zero)
Six wells were used for each EPS-2 concentration and three independent experiments
were performed.
3.10.2. Assay of Zebrafish Neuromast Hair Cell Protection
At 5–6 days post-fertilization (dpf) AB zebrafish larvae were raised at 28.5 ◦C in Petri dishes and
transferred to cell culture baskets placed in 96-well culture plates in groups of 3–4 fish per basket.
The larvae were exposed to EPS-2 at the following concentrations: 25, 50, 100, 200, and 400 μg/mL
for 1 h for the experimental group. A negative control group with no additional sample was also
established. The larvae were then washed with the EM three times and anesthetized using 40 μg/mL
MS-222 for 5 min as described in previous publications [39]. The mean count of hair cells was calculated
within four neuromasts (SO1, SO2, O1, and OC1) on one side of each fish at a 10× magnification
using a Zeiss inverted fluorescence microscope (Carl ZEISS AG, Germany) for each group (n = 8).
All zebrafish were alive and no abnormal developments were observed.
Then the 5–6 dpf zebrafish larvae were pretreated with EPS-2 for 1 h at concentrations of 25, 50,
100, and 200 μg/mL followed by treatment with 100 μM GM, respectively. Following 1 h GM exposure,
the larvae were rinsed briefly with EM, and incubated in a staining agent (0.005% DASPEI) for 15min,
rinsed three times with fresh EM and anesthetized in 40 μg/mL MS-222 for 5 min. The hair cells within
the above-mentioned four neuromasts were examined. Each neuromast was scored for presence of
a normal compliment of hair cells, with reduced or absent DASPEI staining indicating a reduction in
the number of hair cells. Composite scores were calculated for the larvae in each treatment group,
normalized to the control group and expressed as % hair cell survival. Negative controls were treated
with GM while positive controls were treated with 0.5 μM EDA.
3.10.3. Statistical Analysis
All data were presented as the mean ± standard deviation. One-way analysis of variance
(ANOVA) was used for multiple comparisons; p < 0.05 was considered statistically significant.
Statistical analysis was performed with IBM SPSS 21.0 for Windows (IBM, Armonk, NY, USA).
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4. Conclusions
Hearing loss is the one of the most common sensory disorders in humans, and a large number
of cases are due to hair cell damage caused by ototoxicity drugs such as GM. Therefore, it is great
significance to identify agents and their mechanisms that protect hair cells from ototoxicity damage [40].
Saffron has strong biological activities, and the active part is concentrated in the stigma, and the amount
is too small to be detrimental to further research. Thus, endophytic fungus is a good substitute for
studying saffron. Moreover, many literatures have reported that endophytic exopolysaccharides
have unique charms and effective activities. We previously reported the antioxidant activity of
crude exopolysaccharide extracted from fermentation mycelia of saffron. The characterization of
polysaccharides of the endophytic fungus had great significance for the further structure-function
relationship study, and the development and application of the endophytic polysaccharide. Therefore,
we purified the polysaccharide with DEAE-52 cellulose and Sephadex G-75 columns, and a new
water-soluble endophytic polysaccharide EPS-2 with a molecular weight of 40.4 kDa was obtained.
The results of monosaccharide composition, FT-IR spectroscopy, GC-MS and NMR analyses suggested
that EPS-2 is composed of →2)–Manp-(1→, →2, 4)–Manp-(1→, Glc-(1→, →6)- Glcp-(1→, Gal-(1→,
→4)–α-D-Xyl-(1→, and →2, 3, 5)–Ara-(1→. The possible repetitive structural unit of EPS-2 was
inferred. The most effective concentration of EPS-2 for attenuating GM-induced HEI-OC1 cell damage
was 200 μg/mL (50% cell viability), and EPS-2 protected hair cells from a concentration of 25 μg/mL
(50% hair cell number) in a zebrafish model. In conclusion, the study reports the systematic purification,
structural identification, and the in-vitro testing of its protective effects on hair cells against GM toxicity
of EPS-2 and notes its potential as a natural candidate lead for new drugs to combat hearing loss that
can be utilized in the pharmaceutical and healthcare industries.
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Abstract: In recent years, rare earth doped upconversion nanocrystals have been widely used in
different fields owing to their unique merits. Although rare earth chlorides and trifluoroacetates
are commonly used precursors for the synthesis of nanocrystals, they have certain disadvantages.
For example, rare earth chlorides are expensive and rare earth trifluoroacetates produce toxic gases
during the reaction. To overcome these drawbacks, we use the less expensive rare earth hydroxide
as a precursor to synthesize β-NaYF4 nanoparticles with multiform shapes and sizes. Small-sized
nanocrystals (15 nm) can be obtained by precisely controlling the synthesis conditions. Compared with
the previous methods, the current method is more facile and has lower cost. In addition, the defects of
the nanocrystal surface are reduced through constructing core–shell structures, resulting in enhanced
upconversion luminescence intensity.
Keywords: β-NaYF4; rare earth upconversion nanoparticles; core–shell structure
1. Introduction
In recent years, Lanthanide (Ln3+)-doped upconversion nanoparticles (UCNPs) that convert low
energy photons into high energy photons through a two- or multi-photon absorption mechanism
have extensively attracted researchers’ attention due to their potential applications in a variety of
fields, such as bioimaging [1–8], biosensing [9,10], drug delivery [11,12], and cancer therapy [13–16].
Compared with traditional fluorescent probes, such as organic fluorescent dyes and semiconductor
quantum dots, UCNPs possess some unique advantages, including weak background fluorescence,
large anti-Stokes shift, high photochemical stability, narrow emission bandwidth, long luminescent
lifetime, high penetration depth, and low toxicity, among others [17–24]. Among reported UCNPs,
hexagonal phase (β-) sodium yttrium fluoride has been shown to be one of most efficient host materials
owing to its low photon cutoff energy (~350 cm−1) and high chemical stability, which are able to
effectively reduce non-radiative energy losses at the intermediate states of lanthanide ions [25]. So far,
several methods have been reported to synthesize lanthanide-doped β-NaYF4 nanoparticles with
controlled crystalline phase, shape, and size. Solvothermal method and thermal decomposition
methods are two of the most frequently used techniques to synthesize monodisperse lanthanide-doped
β-NaYF4 nanoparticles. For example, Haase reported the synthesis of β-NaYF4 by using expensive
rare earth chlorides as precursors [26]. Capobianco and co-workers synthesized β-NaYF4 nanocrystals
co-doped with Yb3+/Er3+ or Yb3+/Tm3+ via the thermal decomposition of rare earth trifluoroacetate
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precursors where octadecene (ODE) and oleic acid (OA) were chosen as a solvent and ligand,
respectively [27]. However, there are disadvantages in this method, such as the high synthetic
temperature, the complicated decomposition process, and the uncontrollable experimental conditions.
More importantly, the heating of trifluoroacetate would produce toxic fluorinated and oxyfluorinated
carbon gases.
In this paper, we developed a novel method by using cheap rare earth hydroxide as a precursor to
synthesize monodisperse hexagonal NaYF4:Yb3+/Ln3+ core and NaYF4:Yb3+/Ln3+@NaGdF4 (Ln = Er,
Tm, and Ho) core–shell nanoparticles with well-defined shapes. Compared with the previous methods,
this method is low-cost and more facile. Moreover, during the reaction process no toxic gases are
produced. In addition, the size of nanocrystals can be tuned by controlling the reaction conditions,
such as the molar ratio of Na+/Ln3+/F−, the volume ratio of OA and ODE, and the amount of
sodium oleate (NaOA). Under 980 nm laser excitation, these core–shell nanoparticles showed intense
upconversion emissions relative to NaYF4:Yb/Ln (Ln = Er, Tm, and Ho) core nanoparticles.
2. Results and Discussion
It is well known that for the synthesis of nanomaterials, sodium sources and fluorine sources are two
important factors in affecting the morphology and size of nanocrystals. In our experiments, we explored
the effects of sodium hydroxide (NaOH), sodium oleate (NaOA), sodium trifluoroacetate (CF3COONa),
and sodium fluoride (NaF) on the morphology and size of nanocrystals. It can be easily seen that the
particle size was uneven when CF3COONa (Figure 1A) and NaF (Figure 1B) were used as sodium
sources. Moreover, their powder X-ray diffraction (XRD) patterns were in line with the standard cubic
one of JCPDS 06-0342 (Figure 1E). The broader width (red pentagram) of the XRD was ascribed to the
peak of silica from the slide. However, NaYF4:Yb3+/Er3+ nanoparticles obtained with NaOH (Figure 1C)
or NaOA (Figure 1D) as sodium sources had a uniform size and a crystal phase that matched well the
standard JCPDS 16-0334 of β-NaYF4 (Figure 1E). In addition, the size of the upconverting nanoparticles
synthesized with NaOA was smaller than that of NaOH. This means NaOA can effectively inhibit the
growth of NaYF4 because of extra OA–ligands from NaOA. Taken together, the sodium source has
a great influence on the size and crystal phase of the nanocrystals.
Figure 1. TEM images of NaYF4:Yb3+/Er3+ nanocrystals synthesized with NaOH (A), NaOA (B),
CF3COONa (C), and NaF (D) as well as the corresponding XRD patterns (E). The red pentagram
represents the peak of silica from the slide. The standard diffraction patterns of the α-NaYF4 (JCPDS
06-0342) and the β-NaYF4 (JCPDS 16-0334) are displayed at the bottom for reference. Scale bars, 100 nm.
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Based on the above results, we firstly used NaOH as sodium sources to explore the effect of
Na+/Ln3+/F− on the size and morphology of nanocrystals. A series of NaYF4:Yb3+/Er3+ nanocrystals
were synthesized with different ratios of Na+/Ln3+/F− when the volume ratio of OA/ODE was fixed.
Figure 2 presents the TEM images and size distributions of the NaYF4:Yb3+/Er3+ nanocrystals.
It can be clearly seen that when the molar ratio Na+/Ln3+/F− increased, the particle size of the
products decreased accompanied by the shape evolution from rod to sphere. When the molar ratio of
Na+/Ln3+/F− was 2.5:1:4, the nanoparticles are regular rods with good monodispersity. Their lengths
and widths are 32 nm and 27 nm (Figure 2A,B and Figure S1, Supporting Information), which are
obtained by randomly measuring more than 150 particles. When the ratio of Na+/Ln3+/F− was
increased from 2.5:1:4 to 4:1:4, the size of the nanocrystals was reduced from 32.7 to 27.7 nm. It has
been reported that the simultaneous addition of Na+ and F− in the solution can produce small
β-phase seeds, thereby the final growth of small-sized nanocrystals can be controlled easily [28].
Moreover, the size of the nanocrystals was decreased from 25 to 23 nm when the molar ratio of
Na+/Ln3+/F− was increased to be 6:1:6 (Figure 2G,H). When the molar ratio was further increased to
8:1:8 (Figure 2I,J), the size of the nanocrystals was reduced to 22 nm.
 
Figure 2. TEM images and size histograms of NaYF4:Yb3+/Er3+ nanocrystals synthesized with NaOH
by using Na+/Ln3+/F− with a molar ratio of 2.5:1:4 (A,B), 4:1:4 (C,D), 6:1:6 (E,F), 8:1:6 (G,H), and 8:1:8
(I,J), respectively, as well as the corresponding XRD patterns (K); the standard diffraction pattern of
the β-NaYF4 (JCPDS 16-0334) is depicted at the bottom for reference. Scale bars, 100 nm.
To clarify the role of NaOA, we further studied the effect of its amount on the synthesis of
NaYF4:Yb3+/Er3+ nanocrystals. Herein, we used NaOA substitute for NaOH to synthesize diverse
nanoparticles with different molar ratios of Na+/Ln3+/F−. Figure 3 shows the TEM images of
as-synthesized NaYF4:Yb3+/Er3+ nanocrystals, which exhibited the morphology and size evolution.
As expected, the morphology of the nanocrystals changed from rods to spheres. Meanwhile, the size
was reduced from about 24 to 16 nm. As the amount of NaOA increased from 1.5 to 2.5 mmol, the size
of the nanocrystals decreased to 20 nm (Figure 3A–D). Then the size of NaYF4:Yb3+/Er3+ nanocrystals
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was further decreased to about 17 nm when the amount of NaOA increased to 6 mmol (Figure 3E,F)
and 8 mmol (Figure 3G,H), respectively. It was possible that oxygen moiety in the OA–ligands had
a much stronger binding affinity to Y3+ ions when there were adequate OA–ligands with the increased
of NaOA.
 
Figure 3. TEM images and size histograms of NaYF4:Yb3+/Er3+ nanocrystals synthesized with NaOA
by using Na+/Ln3+/F− withmolar ratios of 1.5:1:4 (A,B), 2.5:1:4 (C,D), 6:1:4 (E,F), and 8:1:4 (G,H),
respectively. Scale bars, 100 nm.
The OA–ligands can effectively induce the orderly arrangement of Y3+ ions during the formation
process of NaYF4 [29]. Additionally, when the amount of OA–ligands was adequate, they would cover
the surface of the nanoparticles to inhibit the growth of nanocrystals, which is an effective method
to obtain the nanocrystals with a smaller size. Figure S2 (Supporting Information) shows the XRD
patterns of the as-prepared NaYF4:Yb3+/Er3+ core nanoparticles. All the XRD patterns of samples
could be matched with the pure hexagonal-phases NaYF4 (JCPDS 16-0334), and no trace of other
phases or impurities were observed, which clearly suggests the high crystallinities of these as-prepared
nanoparticles. It has been reported that the presence of oleic acid in the solvent plays an important
role in tuning the size and morphology of NaYF4:Yb3+/Er3+ nanocrystals [30]. Figure 4 shows the
TEM images and size distributions of NaYF4:Yb3+/Er3+ nanoparticles prepared at different ratios of
OA/ODE of 4/15 (Figure 4A,B), 8/15 (Figure 4C,D), 10/15 (Figure 4E,F), and 15/15 (Figure 4H,I).
As can be seen, the resulting NaYF4:Yb3+/Er3+ nanoparticles with the ratio of OA/ODE (4/15) were
hexagonal in shape with an average diameter of about 26 nm. With the increased volume ratio of
OA/ODE, the particle size of NaYF4:Yb3+/Er3+ nanoparticles gradually increased, and the average
diameter of nanoparticles was found to be approximately 40 nm at 8/15 of OA/ODE. The XRD of
all as-prepared samples are shown in Figure S3 (Supporting Information). The same procedure was
used to further synthesize NaYF4 nanoparticles doped with other lanthanide elements such as 40%
Yb3+/0.5%Tm3+ (Figure S3A,B) and 18% Yb3+/2% Ho3+ (Figure S3C,D, Supporting Information),
respectively. It was observed that the size and morphology of the nanoparticles closely resembled
those of the Yb3+/Er3+ co-doped NaYF4 counterpart (Figure S1, Supporting Information). These results
indicate that the change of dopant ions in low doping concentrations does not alter the particle growth
process [31].
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Figure 4. TEM images and size histograms of NaYF4:Yb3+/Er3+ nanocrystals synthesized at varied
amounts of oleic acid (OA). The volume ratios of OA and octadecene (ODE) are 4:15 (A,B), 8:15 (C,D),
10:15 (E,F), and 15:15 (G,H), respectively. Scale bars, 100 nm.
More importantly, the emission intensity of Ln3+ doped UCNPs depends on dopant–host combination,
particle size, shape, and phase [32–38]. The emission intensity of NaYF4 core was relatively weak due to
the surface defects. However, in recent years, the construction of core–shell structure has been one of
the effective ways to improve the efficiency of upconversion luminescence [26,39–42]. This is because
the inert shell coating can protect the luminescent activators in the core nanoparticles from the surface
quenching of excitation energy [42]. In this paper, we prepared NaYF4:Yb3+/Ln3+@NaGdF4 and studied
their upconversion optical properties. Figure 5A–F displays the TEM images and the corresponding size
distribution of NaYF4:Yb3+/Ln3+@NaGdF4 core–shell nanoparticles. The NaYF4:Yb3+/Er3+ core-only
nanoparticles with an average diameter of about 27 nm are shown in Figure S1. After coating an inert
shell layer of NaGdF4, the average diameter of NaYF4:Yb3+/Er3+@NaGdF4 core–shell was determined
to be about 42 nm, which means a thick shell layer (thickness ~7.5 nm) was coated around the
NaYF4:Yb3+/Er3+ core nanoparticles (Figure 5A,B). Similar TEM image and size distribution were
obtained for NaYF4:Yb3+/Tm3+@NaGdF4 (Figure 5C,D) and NaYF4:Yb3+/Ho3+@NaGdF4 (Figure 5E,F)
core–shell nanoparticles. The corresponding shell thickness was determined to be about 11 nm and
9 nm, respectively. Figure 5G depicts the upconversion emission spectra for the NaYF4:Yb3+/Er3+ core
nanoparticles and the NaYF4:Yb3+/Er3+@NaGdF4 core–shell nanoparticles. As can be seen, there were
two green emission bands centered at 520 nm and 540 nm, which were attributed to the electronic
transition of 2H11/2 → 4I15/2, 4S3/2 → 4I15/2 of Er3+. In addition, there was a red emission at 654 nm,
which corresponded to the 4F9/2 → 4I15/2 transition of Er3+. For the NaYF4:Yb3+/Er3+ core, after coating
7.5 nm NaGdF4 shell, the fluorescence intensity of NaYF4:Yb3+/Er3+@NaGdF4 core–shell nanoparticles
was about 100 times higher than that of NaYF4:Yb3+/Er3+ core nanoparticles at 540 nm. In contrast,
for the NaYF4:Yb3+/Tm3+ core nanoparticles, the blue emissions, the ultraviolet emission, and red
emission corresponded to the (1I6 → 3F4, 342 nm, 1D2 → 3H6, 360 nm), (1D2 → 3F4, 450 nm, 1G4 → 3H6,
475 nm), (1G4 → 3F4, 647 nm) transitions of Tm3+ ions, respectively. Due to the NaGdF4 (~11 nm) shell
coating, the emission intensity was remarkably enhanced to about 120 times at 475 nm (Figure 5G).
Figure 5H shows the upconversion emission spectra of the NaYF4:Yb3+/Ho3+ core nanoparticles and the
NaYF4:Yb3+/Ho3+@NaGdF4 core–shell nanoparticles. When excited at 980 nm, three upconversion
fluorescence bands with maxima at green (540 nm), red (645 nm), and 750 nm regions could be
observed from optimized NaYF4:Yb3+/Ho3+ nanophosphors, which corresponded to 5S2 → 5I8, 5F3 → 5I8,
and 5S2 → 5I7 transitions of Ho3+ ions. Similarly, when the ~9 nm NaGdF4 shell was covered on the surface
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of the NaYF4:Yb3+/Ho3+ core, the luminescence intensity was also significantly improved. The emission
intensity of NaYF4:Yb3+/Ho3+@NaGdF4 core–shell nanoparticles was determined to be about 80 times as
strong as that of NaYF4:Yb3+/Ho3+ core nanoparticles.
 
Figure 5. TEM images, size histograms, and the corresponding upconversion spectra of
core–shell structured NaYF4:Yb3+/Er3+@NaGdF4 (A,D,G), NaYF4: Yb3+/Tm3+@NaGdF4 (B,E,H),
and NaYF4:Yb3+/Ho3+@NaGdF4 (C,F,I), respectively. Scale bars, 100 nm.
3. Materials and Methods
3.1. Materials
Materials Y2O3 (99.99%), Yb2O3 (99.99%), Er2O3 (99.99%), Tm2O3 (99.99%), Ho2O3 (99.99%), Y2O3
(99.99%), GdCl3·6H2O (99.99%), NH4F (98%), NaF (98%), and CF3COONa (97%) were purchased
from Aladdin (Shanghai, China). Oleic acid (OA, 90%), 1-octadecene (ODE, 90%), and sodium oleate
(Na-OA, >97%) were purchased from Sigma-Aldrich (Darmstadt, Germany). Other chemical reagents,
such as NaOH (90%), ethyl alcohol (99.7%), methanol (99.5%), and n-hexane (97%), were obtained
from Shanghai Lingfeng Chemical Reagent Co., Ltd. All chemicals were used as received without
further purification.
Rare earth chloride (LnCl3) stock solutions of 1 M (Ln = Y, Yb) and 0.1 M (Ln = Er, Tm, and Ho) were
prepared by dissolving the corresponding metal oxides in hydrochloric acid at elevated temperature.
The final solutions were adjusted to pH ~6.
3.2. Synthesis of β-NaYF4:Yb3+/Ln3+ (Ln = Er, Tm and Ho) Core Nanoparticles
First, Ln(OH)3 (Ln = Y3+, Yb3+, and Er3+/Tm3+/Ho3+) complexes were prepared by adding NaOH
of 2 M to the rare earth chloride solution, and then the obtained product was washed twice. Rare earth
hydroxide was added to a 100 mL flask containing 10 mL of OA and 15 mL of ODE. The mixture was
heated at 140 ◦C for 1 h under stirring in order to form the lanthanide–oleate complexes. After cooling
down to 40 ◦C naturally, 8 mL of methanol solution containing NH4F (4 mmol) and NaOH (2.5 mmol)
was added. Subsequently, the resulting mixture solution was heated at 70 ◦C for 10 min to evaporate
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the methanol under magnetic stirring. After the temperature was raised up to 110 ◦C under vacuum
for 30 min, the reaction mixture was heated to 300 ◦C under argon for 1 h and then cooled down to
room temperature. The resulting nanoparticles were precipitated by adding excess ethanol, separated
by centrifugation at 4000 rpm for 4 min, washed with a mixture of n-hexane and ethanol several times,
and finally dispersed in n-hexane for further use.
3.3. Synthesis of β-NaYF4:Yb/Ln@NaGdF4 (Ln = Er, Tm, and Ho) Core–Shell Nanoparticles
In a typical procedure for the synthesis of NaYF4:Yb3+/Er3+ (17/3%)@NaGdF4 nanoparticles,
the NaGdF4 inert shell precursor was prepared by mixing 0.5 mmol of GdCl3 with 6 mL of OA and
15 mL of ODE in a 100 mL flask followed by heating at 150 ◦C for 40 min. Then, the obtained NaGdF4
inert shell precursor was cooled down to room temperature. Subsequently, the NaYF4:Yb3+/Er3+
(17/3%) core-only nanoparticles dispersed in 3 mL of cyclohexane along with 8 mL of methanol
solution of NH4F (2 mmol) and NaOH (1.25 mmol) was added. Subsequently, the resulting mixture
solution was heated at 70 ◦C for 10 min under magnetic stirring to evaporate the methanol. After the
resulting solution for 30 min at 110 ◦C under vacuum, the reaction mixture was heated to 310 ◦C
under argon for 1.5 h and then cooled down to room temperature. Finally, the obtained core–shell
nanoparticle products were precipitated by the addition of ethanol, collected by centrifugation at
4000 rpm for 4 min, washed with a mixture of n-hexane and ethanol several times, and finally dispersed
in n-hexane.
3.4. Instrumentation
Transmission electron microscopy (TEM) images (Hitachi, Tokyo, Japan) were acquired on
a HT7700 transmission electron microscopy at an acceleration voltage of 100 kV. X-ray diffraction (XRD)
patterns were recorded on an X-ray diffraction (RigakuSmartLab, Tokyo, Japan) with Cu Kαradiation
(λ = 0.15418 nm) at a voltage of 45 kV and a current of 20 mA. Upconversion luminescence spectra were
detected by a spectrophotometer (FluoroMax-4, Shanghai, China) equipped with a 980 nm diode laser.
4. Conclusions
In summary, we developed a novel, facile, and low-cost method to synthesize Yb3+/Ln3+
(Ln = Er, Tm, and Ho) co-doped β-NaYF4 nanocrystals. The size and morphology of the products
were manipulated through the precise tuning of the ratio of Na+/Ln3+/F−, the ratio of OA/ODE,
and the quantity of the NaOA. As the ratio of Na+/Ln3+/F− and the amount of NaOA increased,
the size of the nanocrystals gradually decreased and the corresponding morphologies evolved from
nanospheres to nanorods. Finally, this method can also apply to the fabrication of core–shell structured
nanomaterials. The uniform NaYF4:Yb3+/Ln3+@NaGdF4 core–shell nanoparticles were prepared
successfully, and their emission intensity was remarkably enhanced, which could provide prospect
applications in the biomedical fields. Particularly, some photosensitizers or chemotherapy drugs could
be conjugated with these UCNPs to achieve NIR-triggered drug delivery and controlled release to
ameliorate the therapy efficiency of tumors.
Supplementary Materials: The following are available online, Figure S1: TEM image (A) and the corresponding
size histogram (B) of NaYF4:Yb3+/Er3+ nanocrystals synthesized with NaOH as sodium source, Figure S2:
XRD patterns of the as-synthesized NaYF4:Yb3+/Er3+ nanocrystals with NaOA at varied molar ratios of
Na+/Ln3+/F−. The standard diffraction patterns of the β-NaYF4 (JCPDS 16-0334) depicted at the bottom for
reference, Figure S3: XRD patterns of the as-synthesized NaYF4:Yb3+/Er3+ nanocrystals at varied amounts of oleic
acid. The volume ratios of oleic acid and octadecene are 15:15, 10:15, 8:15, and 4:15, respectively. The diffraction
pattern at the bottom is the literature reference for hexagonal NaYF4 nanocrystal (JCPDS 16-0334), Figure S4: TEM
images and size histograms of the NaYF4:Yb3+/Er3+ (A, B), and NaYF4: Yb3+/Ho3+ (C, D), respectively.
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Abstract: The preparation of highly ordered colloidal architectures has attracted significant attention
and is a rapidly growing field for various applications, e.g., sensors, absorbers, and membranes.
A promising technique for the preparation of elastomeric inverse opal films relies on tailored
core/shell particle architectures and application of the so-called melt-shear organization technique.
Within the present work, a convenient route for the preparation of core/shell particles featuring
highly fluorinated shell materials as building blocks is described. As particle core materials, both
organic or inorganic (SiO2) particles can be used as a template, followed by a semi-continuous
stepwise emulsion polymerization for the synthesis of the soft fluoropolymer shell material. The use
of functional monomers as shell-material offers the possibility to create opal and inverse opal
films with striking optical properties according to Bragg’s law of diffraction. Due to the presence
of fluorinated moieties, the chemical resistance of the final opals and inverse opals is increased.
The herein developed fluorine-containing particle-based films feature a low surface energy for the
matrix material leading to good hydrophobic properties. Moreover, the low refractive index of the
fluoropolymer shell compared to the core (or voids) led to excellent optical properties based on
structural colors. The herein described fluoropolymer opals and inverse opals are expected to pave
the way toward novel functional materials for application in fields of coatings and optical sensors.
Keywords: fluoropolymers; melt-shear organization; chemical resistance; solvent responsiveness;
hydrophobicity; core/shell particles; emulsion polymerization; particle processing
1. Introduction
Fluor-containing polymers represent a unique class of functional materials combining different
interesting properties, and such polymers have attracted significant attention in the recent past.
Some of these properties are their remarkable resistance toward chemicals, high thermal stability,
wetting behavior, and repellent capabilities, as well as their low refractive indices compared to
other polymer materials [1–3]. Therefore, the field of applications for fluoropolymers is widespread
and range over coatings, membranes, optical applications, and high performance elastomers [4–8].
Designing novel fluoropolymer and hierarchical architectures is relevant for the development of
improved and new applications, for instance, in the field of three-dimensionally ordered porous
coatings and photonic materials. In general, the control and understanding of surface properties
is crucial for the development of advanced materials with well-defined wetting properties. Such
so-called smart surfaces have already been used in applications such as self-cleaning surfaces, tunable
optical lenses, lab-on-chip systems, microfluidic devices, and many different textile applications [9–14].
Considerable effort has been carried out on understanding the influence of designed, rough surfaces
on the wetting properties, initiated by the pioneering works of Wenzel, Cassie, and Baxter long
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ago [15,16]. Hierarchical particle-based architectures, such as colloidal crystals and inverse opals
with adjustable dimensions, have gained considerable attention due to their tremendous potential for
various applications in catalysis, separation, sensors, optics, and biomedicine [17–27]. In the case of
porous materials, different templating approaches have been used for the design of the final materials
after removal of the template material [28–33]. Colloidal crystals can be prepared by various techniques
such as particle deposition or spin coating of respective particle dispersions [21,34]. For example,
Kim et al. developed omniphobic inverse opals for the preparation of omniphobic porous materials
some years ago [35]. Vogel et al. reported on the infiltration of inverse opals with lubricants for gaining
access to highly repellent surfaces toward many different liquids [36]. By this elegant approach,
the adsorption of liquid-borne contaminants could be prevented, and reduction of ice adhesion could
be accomplished. Single and dual inverse opal structures of fluoropolymer-containing materials
have been developed by Wu and co-workers [37]. All these materials were obtained by the vertical
deposition method or via spin-coating of particles. Another technique for the precise arrangement
of polymer-based particles can be accomplished in flow fields by, e.g., combinations of melting and
shear-ordering methods leading to so-called polymer opal films [27,38,39]. This so-called melt-shear
organization technique requires core-shell particles and features the major advantage of fully solvent-
and dispersion-free material processing. The hard core/soft shell particles are compressed between
the plates of a moderately hot press, and the hard core particles can merge into the colloidal crystal
structure yielding free-standing polymer opal films in one single step. Only recently, the feasibility of
this technique was shown for inorganic core particles featuring a polymer or hybrid soft and meltable
shell was reported [40–44]. This melt-shear organization technique allows for the facile preparation
of almost perfectly ordered core/shell particles embedded in an elastomeric polymer matrix, and it
can be applied on industrially relevant length scales [45]. The combination of fluoropolymers with
this technique has not been reported for the preparation of functional opal films or inverse opals films
yet. Within the present study, we report for the first time the incorporation of fluoropolymers into
core/shell particle architectures, which can be advantageously used for the melt-shear organization
technique. Both organic particle cores and inorganic silica core particles featuring a comparably
soft fluoropolymer shell are prepared. Application of the melt-shear organization technique yield
free-standing fluoropolymer opal and inverse films with remarkably distinct reflection colors and
hydrophobic properties. Moreover, these novel opal and inverse opal films were investigated with
respect to their optical properties, swelling capability in water, and chemical resistance toward acids
and bases.
2. Results and Discussion
The following chapter is divided into six sections, starting with the design of fluorine-containing
core/shell particles, followed by the preparation of opal and inverse opal films based on these particles
by application of the melt-shear organization technique. Finally, the feasibility of herein investigated
fluorine-containing opals and inverse opals will be elucidated with respect to their optical properties,
chemical resistance, and solvent-induced structural color changes.
2.1. Bottom-Up Fabrication of Fluorine-Containing Opal and Inverse Opal Films
For the preparation of fluorine-containing opal films as well as inverse opal films the tailored
design of monodisperse core interlayer shell particles is a basic prerequisite. For this purpose,
the complex particle architecture was developed by a step-wise emulsion polymerization as given in
Figure 1. In the case of filled opal films (Figure 1a), the hard organic core particles were generated by
the polymerization of styrene, combined with the cross-linker butandiol diacrylate (BDDA), followed
by a starved feed addition of an emulsion consisting of styrene and allylmethacrylate (ALMA).
The particle sizes were analyzed by means of dynamic light scattering (DLS) and transmission electron
microscopy (TEM), as described in detail in the following. For the next synthesis step, an additional
cross-linked interlayer consisting of n-butylacrylate (nBuA) and ALMA was introduced. Herein,
113
Molecules 2019, 24, 333
the residual allyl-moieties of ALMA were capable of acting as grafting anchors for the soft shell
material. As already mentioned in the introduction, this step is important to ensure preservation of
the spherical shape of the particle cores during processing and during the application of mechanical
stress during the melt-shear-organization [27,46,47]. The major part of the outer soft shell consisted
of poly(1H,1H,2H,2H-nonafluorohexylmethacrylate) (PNFHMA) (60 wt%) as a fluorine-containing
polymer. For maintaining a soft and processable polymer mass for the intended extrusion step,
a softer comonomer was additionally introduced as shell material. For this purpose, nBuA (20 wt%)
and trifluoroethylacrylate (TFEA) (20 wt%) as comonomers were copolymerized with an NFHMA
monomer. The intermediate glass transition temperature (Tg) decreased up to 14 ◦C for the copolymer,
compared to the respective Tg of the respective PNFHMA homopolymers (Tg = 25 ◦C) (Figure S1 of the
Supporting Information) [48]. These three monomers were used for the formation of the—compared to
the hard core material—soft and functional fluorine-containing particle shell material. The successful
formation of the core/interlayer/shell-particles was followed by DLS measurements (Figure S2a
of the Supporting Information), proving an increase in the diameter after every synthesis step.
In detail, the average hydrodynamic diameter of the particles were 206 ± 2 nm for the PS core
particles, 211 ± 2 nm for the core/interlayer, and 246 ± 1 nm for the final fluorine-containing
core/interlayer/shell particles. It can be concluded from these results that rather monodisperse
particles were accessible, which will be important for the optical properties of the opal films (see
next sections). The fluorine-containing particles were additionally investigated by using transmission
electron microscopy (TEM) (Figure S2b–d), confirming the monodisperse and spherical character of
the fluoropolymer-containing core/shell particles. These findings were essential for the fabrication
of soft colloid crystal films as described in the next section. Both the DLS and TEM measurements
revealed the successful formation of the core/interlayer/shell architecture and sizes of each particles
were found to be in excellent agreement with expectations based on monomer consumption and the
recipe for emulsion polymerization (cf. Experimental Section).
 
Figure 1. (a) Stepwise synthesis of organic fluorine-containing PS@P(NFHMA-co-TFEA-co-nBuA)
core/interlayer/shell particles; (b) stepwise synthesis of inorganic/organic fluorine-containing
SiO2@P(TFEA-co-NFHMA-co-iBuMa) core/interlayer/shell particles. Abbreviations:
polystyrene (PS), allylmethacrylate (ALMA), n-butylacrylate (nBuA), 1H,1H,2H,2H-
nonafluorohexylmethacrylate (NFHMA), trifluoroethylacrylate (TFEA), tetraethoxysilane (TEOS),
3-methacryloxypropyltrimethoxysilane (MEMO), and i-butylmethacrylate (iBuMA).
Core/interlayer/shell particles were also synthesized for the preparation of the corresponding
inverse opal films. For this purpose, silica (SiO2) particles were used as hard core particles. Pristine
SiO2-particles were synthesized according to the literature by van Blaaderen et al. [49], applying a
sol-gel process (Stöber process). For the preparation of monodisperse SiO2 particles, tetraethoxysilane
(TEOS) in ethanol was used as a precursor, followed by a functionalization of the particle surface with
3-methacryloxypropyltrimethoxysilane (MEMO) [39]. For transferring the particles into the emulsion
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polymerization, ethanol was substituted by deionized water by azeotropic distillation. In the next step,
the MEMO-functionalized SiO2-particles were used for the preparation of the interlayer, consisting of
poly(nBuA-co-ALMA). Finally, the polymerization of the outer shell was performed by copolymerizing
TFEA (60 wt%), NFHMA (20 wt%), and iso-butylmethacrylate (iBMA) (20 wt%) as monomers. These
inorganic core particles featuring an organic interlayer/shell polymer were examined with respect to
morphology and average size by DLS measurements and TEM (Figure 2). All data on the different
particles are compiled in Table 1.
Figure 2. (a) DLS measurements of SiO2 core particles, MEMO-functionalized SiO2 particles,
SiO2 core/P(nBuA-co-AMLA)-interlayer particles, and SiO2 core/P(nBuA-co-ALMA)interlayer/
P(TFEA-co-NFHMA-co-iBuMA)-shell particles; (b) TEM image of SiO2-core particles; (c) TEM image of
MEMO-functionalized SiO2 particles; (d) TEM image of SiO2 core/interlayer particles; (e) TEM image
of SiO2 core interlayer shell particles.
Table 1. Average hydrodynamic diameter of particles measured by means of DLS and average
diameters of the dried particle, as determined by TEM. In the case of TEM analysis, 50 particles
were measured with respect to their size.
Particle DLS (d/nm) TEM (d/nm)
PS 206 ± 2 192 ± 10
PS@P(nBuA-co-ALMA) 211 ± 2 202 ± 6
PS@P(NFHMA-co-TFEA-co-nBuA) 246 ± 1 238 ± 11
SiO2 240 ± 1 232 ± 6
SiO2@MEMO 249 ± 4 234 ± 11
SiO2@P(nBuA-co-ALMA) 271 ± 1 261 ± 8
SiO2@P(TFEA-co-NFHMA-co-iBuMa) 315 ± 9 303 ± 4
In summary, the DLS and TEM measurements again evidenced the successful preparation of
well-defined spherical particles and a continuously increasing particle size for each synthesis step.
While the particles in Figure 2b,c were still clearly separated from each other, the particles in Figure 2d,e
are obviously connected by a soft polymer shell. DLS measurements in general give a larger diameter
for particle systems compared to the TEM images, because the hydrodynamic diameters of the
particles is determined, which is larger compared to particles in the dried state. For gaining insights
into the composition and the thermal properties of the designed functional particles comprising the
PS core, the PS@P(NFHMA-co-TFEA-co-nBuA) as well as the SiO2@P(TFEA-co-NFHMA-co-iBuMA)
core/interlayer/shell particles, differential scanning calorimetry (DSC) measurements were performed.
The measured glass transition temperature of the (NFHMA-co-TFEA-co-nBuA)-polymer shell was
found to be 14 ◦C, which was significantly lower than the Tg value found for the PS core, i.e., 100 ◦C
(Figure S1). Moreover, the Tg value of the shell was found to be in between the Tgs of the pure
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components, i.e., 25 ◦C for PNFHMA [48], −54 ◦C for PnBuA [50], and −10 ◦C for PTFEA, confirming
the successful copolymerization of the corresponding monomers.
Compared to this organic particle system, the glass transition temperature for the
SiO2@P(TFEA-co-NFHMA-co-iBuMA) core/shell particles was found to be 27 ◦C (Figure S3) due to the
content of PiBuMA, which featured a glass transition temperature of 53 ◦C for the homopolymers [50].
Hence, successful copolymerization of the respective monomers was evidenced by the presence of the
intermediate glass transition temperature. Moreover, these moderate values for the glass transition
temperatures should enable processing by means of melt-shear organization of the core/shell particles,
which will be described in the following.
For preparation of the elastomeric opal films using the melt-shear organization technique,
the core/interlayer/shell particles were precipitated from their dispersion followed by drying at
40 ◦C. For homogenization of the obtained particle mass as well as for the addition of UV-cross-linking
reagents (Irgacure 184, benzophenone, and 1,4-butanedioldiacrylate (BDDA)), the sticky particle mass
was mixed using a microextruder at 90 ◦C (see Experimental Section). During this step, the addition of
cross-linking reagents is important for subsequent UV-induced cross-linking reaction of the opal film.
For this reason, cross-linking reagents that do not initiate chemical reactions during the melt-shear
organization process but can initiate a posteriori are necessary. A cross-linked network, generated by
the UV irradiation of the opal films, enhances the mechanical—and therefore the optical—properties
of the opal films [46,47,51]. In order to additionally enhance the reflection colors of the opal films,
0.05 wt% carbon black (special black 4, Degussa) powder as an absorber was added during the
extrusion. In general, carbon black powder has been found to dramatically enhance the perceived
reflection color due to spectrally resonant scattering inside the opal structure without affecting the
lattice quality [52]. Moreover, because of the small amount of added carbon black, it is not expected
that the refractive index of the fluoropolymer-containing matrix material will be significantly increased.
In the next step, the extruded polymer strands were subjected to the melt-shear organization process
(Figure 3), allowing the core/shell particles to merge into a colloid crystal structure.
Figure 3. Fabrication of opal films using the melt-shear organization technique and preparation of an
inverse opal by HF etching of the SiO2 core particles.
For this purpose, the particle mass was placed between the plates of a press followed by increasing
the temperature and applying a pressure up to 100 bar (cf. Experimental Section). Within this film
formation step, the soft shells generated a continuous matrix embedding the hexagonally arranged
hard core particles. The latter formed the final colloidal crystal structure. In order to gain elastomeric
properties and to maintain the stability upon etching for the preparation of an inverse opal film,
the opal film was irradiated with UV-light to initiate the cross-linking reaction inside the polymer
matrix. In this way, an elastomeric fluorine-containing opal film with iridescent reflection colors was
prepared as studied in detail in the next section.
2.2. Optical Properties and Morphology of the PS@P(NFHMA-co-TFEA-co-nBuA) Opal Film
For the preparation of the elastomeric fluorine-containing opal films, some basic requirements
must be fulfilled: (i) a periodic close-packed arrangement of the hard spheres, (ii) the monodispersity
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of the core particles, and (iii) a refractive index contrast between the hard core, respectively the voids,
and the matrix material.
According to Bragg´s law of diffraction combined with Snell´s law (Equation (1)), the perceived
wavelength of reflection (λ111) is influenced by the average refractive index neff, which can be calculated
by considering the refractive index ni and the volume fractions φi for all ingredients of the opal
(Equation (2)). The wavelength of reflection depends also on the periodicity α111 and the angle of
incident light θ [24].
λ111 = 2α111(n2e f f − sin2 θ)
1/2
(1)
ne f f = ∑ niφi (2)
For this purpose, an organic core-particle consisting of polystyrene (neff ∼= 1.59) [53] and a
shell material containing a high content of poly(NFHMA) (neff ∼= 1.35) [54] was used. Compared
to previously reported organic core/shell opal films, this combination featured a higher refractive
index contrast (Δneff ≤ 0.24). From the photographs obtained by scanning electron microscopy (SEM)
(Figure 4a), it can be concluded that the particle-based film consists of closely packed and hexagonally
aligned layers of particles. Additional to these findings, transmission electron microscopy (TEM)
images obtained for ultra-thin slices prepared from the opal film are shown in Figure 4b, revealing the
individual PS particles embedded in a lighter appearing matrix. The lighter matrix corresponded to the
fluoropolymer shell material, having less electron contrast compared to the aromatic PS core particles.
However, in the case of the TEM images, the core particles appeared to be more distorted. This can be
explained by the fact that the spherical domains having a size of 192 ± 10 nm are much larger than the
microtomed thin slices, which are approximately 50–70 nm in thickness. During ultramicrotoming
of the bulk polymer films with spherical domains inside a soft matrix, the probability for perfect
cutting of spherical objects is reduced, which is a known problem for spherical domains during sample
preparation by using ultramicrotomy [55].
 
Figure 4. (a) SEM image: surface of PS@P(NFHMA-co-TFEA-co-nBuA) opal film; (b) TEM image:
ultra-thin cut of the cross-section of a PS@P(NFHMA-co-TFEA-co-nBuA) opal film.
To determine the position of the Bragg peak and evidencing a good optical performance
based on the ordered particles, angle-dependent UV/Vis measurements were performed (Figure 5).
The measurements were recorded for angles of incident between 90◦ and 60◦. Within the corresponding
spectra, a distinct Bragg peak at a wavelength of 558 nm was observed. At lower angles of incidence,
the value for the reflected light, i.e., the Bragg peak was blue-shifted from 558 nm at 90◦ to 486 nm
at 60◦ according to Bragg´s law of diffraction. This finding proved the existence of a structural
color for the herein designed fluorine-containing opal films. Moreover, it can be concluded that the
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melt-shear organization of the PS@P(NFHMA-co-TFEA-co-nBuA) particles leads to a regularly ordered
particle-based film with brilliant reflection colors.
 
Figure 5. Angle-dependent UV/Vis reflection spectra of the opal film prepared from
PS@P(NFHMA-co-TFEA-co-nBuA) core/interlayer/shell particles and corresponding photographs of
the opal film at an angle of view of 90◦ and 60◦. The final opal discs featured a diameter of 8 cm.
2.3. Chemical Resistance of the PS@P(NFHMA-co-TFEA-co-nBuA) Opal Film
In general, polymers having a high content of fluorine-containing monomers feature a good
chemical resistance toward acids or bases [56]. In order to investigate the chemical resistance, the here
prepared opal films were exposed to a strong acid (hydrochloric acid pH = 1) and base (potassium
hydroxide pH = 13), followed by subsequent UV/Vis measurements of the samples. In Figure S4,
UV/Vis spectroscopy measurements of the opal films treated with potassium hydroxide solution
and hydrochloric acid are shown. The untreated film featured a reflection color maximum at a
wavelength of approximately 525 nm. When the fluorine-containing opal film was treated with
deionized water, the reflection peak of the opal film slightly shifted to 544 nm, which was due to
the swelling capability of the matrix material. However, treatment of the swollen opal films with
concentrated acid or concentrated base did not lead to a significant change of the optical properties.
In more detail, the reflection color of the opal film treated for 20 min with potassium hydroxide was
shifted only toward 6 nm and Bragg peak maximum was finally located at a wavelength of 550 nm at
an angle of view of 90◦. When the opal film was treated for 20 min with hydrochloric acid, the peak
was located at a wavelength of 540 nm, i.e., only with a shift of 4 nm. Therefore, UV/Vis measurements
proved the excellent order and resistance of the opal films under harsh conditions.
2.4. Hydrophobicity and Solvent Response of the PS@P(NFHMA-co-TFEA-co-nBuA) Opal Film
The hydrophobic character of the fluorine-containing opals was determined by contact angle
measurements. A contact angle between the opal film surface and a sessile drop of deionized water of
106 ± 3◦ was obtained, which categorized the surface hydrophobic (see Figure S5a). As described in
the introduction, fluoropolymers have already found an extensive application as a low surface energy
material for water repellency applications [37,57]. In general, the wettability of surfaces with liquid
depends on two factors: (i) the chemical factor based on the low surface energy and (ii) the geometrical
factors mainly given by roughness and tailored architecture of the surface. As can be concluded from
the SEM image in Figure 4a, the surface of the opal film is not exceptional rough or structured, and
the water repellency effect is therefore considered to stem from the chemical factor, i.e., the used
fluorine-containing polymers. Despite the high chemical resistance and water repellency, the domain
sizes of the opal film could be influenced upon treatment with various organic solvents. When the
distance between the spheres forming the colloidal crystal stack is in the range of half the wavelength
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of visible light, structural colors can be observed, as described by Bragg´s law of diffraction. Solvent
treatment caused a swelling-induced volume change of the matrix polymer, resulting in the increase
of surface plane spacing of the closely packed PS spheres embedded in the cross-linked opal film.
Moreover, the Bragg conditions for the respective colors was also influenced by the refractive index of
the solvent used for matrix swelling, which has been described in earlier works [23,24,58]. Typically,
the swelling behavior of the matrix materials leads to a shift of the reflection peak maximum toward a
higher wavelength. In other words, the volume expansion of the polymer matrix induced by solvent
treatment leads to a red-shift of the reflection peak maxima. Exemplarily, the peak maximum shifted
from 525 nm for the untreated opal film to 808 nm after treatment with THF (Figure 6). Depending
on the swelling capability, the used media (water, ethanol, acetonitrile, acetone, ethyl methyl ketone
(EMK), and THF) will lead to a more pronounced reflection peak maximum shift within this order.
Noteworthy, after complete evaporation of the used solvents, the fluorine-containing opals reached the
original peak maximum value after repeated solvent treatment-evaporation cycles, at least three times.
In summary, the convenient preparation of fluoropolymer-containing opal films featuring
angle-dependent reflection colors and solvent-responsive behavior were prepared. Moreover,
the reflection peak position of the fluorine-containing opal films were not altered by treatment with
concentrated acids and bases.
 
Figure 6. UV/Vis reflection spectra of a solvent-treated opal film based on PS@P(NFHMA-co-TFEA-
co-nBuA) core/interlayer/shell particles (left) and exemplary photographs of the opal film prior to
and after treatment with THF (right). Abbreviations: ethanol (EtOH), ethyl methyl-ketone (EMK), and
tetrahydrofurane (THF).
2.5. Optical and Structural Properties of the SiO2@P(TFEA-co-NFHMA-co-iBuMA) Inverse Opal Film
For the preparation of fluoropolymer inverse opal films, SiO2 core particles with a comparably
soft fluorine-copolymer shell were subjected to the melt-shear-organization technique. The silica-core
particles were etched by HF treatment in a subsequent step in order to gain access to the inverted opal
structure (see Experimental Section). The opal films prior to the etching process featured no bright
reflection color, since the refractive index contrast Δneff between the silica core particles (neff = 1.43) [59]
and the fluoropolymer matrix (neff ≤ 1.41) was rather low [57]. However, after removal of the silica core
particles, the ordered pores inside the fluoropolymer matrix led to a more pronounced refractive index
contrast and therefore to the appearance of iridescent structural colors. Figure 7a shows photographs
of the opal film filled with SiO2 cores featuring no reflection colors, while in Figure 7b the inverted
opal film is given showing structural colors.
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Figure 7. (a) Photographic picture of the filled opal film based on SiO2@P(TFEA-co-NFHMA-co-iBuMA)
core/interlayer/shell particles, without reflection colors; (b) photographic picture of the inverse opal
film based on SiO2@P(TFEA-co-NFHMA-co-iBuMA) core/interlayer/shell particles, with reflection
colors. The cutout of the inverse opal discs featured a diameter of 2 cm.
In order to obtain more intensive reflection colors, a higher content of pores was of utmost
importance. Therefore, the film was treated with hydrofluoric acid for full removal of the SiO2
cores after several days. Corresponding SEM studies revealed that the surface of the inverse
fluoropolymer opal film is open-porous with a uniform diameter of the pores of 175 ± 5 nm (Figure 8a).
The corresponding cross-section (Figure 8b) revealed that the SiO2 core particles were also removed in
the interior of the opal film. It has to be mentioned that the pore order and pore size distribution seemed
to be influenced with respect to their spherical shape within the SEM photographs for the cross-section
compared to the film topography. This might be caused by sample preparation using freeze-fracturing
for the comparably soft inverse opal films. Moreover, for the preparation of the fluoropolymer inverse
opal films, a slightly different polymer composition was chosen. In comparison to the opal films
described in Section 2.2, a lower fraction of NFHMA (20 wt%) and a higher amount of TFEA (60 wt%)
was used. The reason for changing the composition and for additionally introducing iBuMA (20 wt%)
instead of nBuA was the softness of the final inverse opal film leading to a pore collapse after the etching
process. While using a fluropolymer copolymer with PiBMA, the glass transition temperature could be
increased to 25 ◦C, suitable for convenient core/shell particle processing and for the preparation of a
free-standing inverse opal film. The Tg was determined to be 25 ◦C, as studied by DSC measurements
(Figure S3).
 
Figure 8. SEM photograph of the topography (a) and corresponding cross-section SEM photograph
(b) of an inverse opal film based on SiO2@P(TFEA-co-NFHMA-co-iBuMA) core/interlayer/shell
particles after melt-shear organization and subsequent HF etching.
To further investigate the pore order and to visualize influence on the morphology upon water
treatment, atomic force microscopy (AFM) studies were additionally carried out. Corresponding AFM
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measurements for the dried film and for the inverse opal film in water are given in Figure 9. In good
accordance with the SEM images in Figure 8, AFM studies confirmed the presence of well-ordered
hexagonally aligned pores. The average pore size in the dried state was determined to be 179 ± 8 nm,
which was in good agreement with the pore size determined in the corresponding SEM image
(175 ± 5 nm). Figure 9b give the results for AFM measurement of the same inverse opal film in
water. As a finding, the average pore size was found to 153 ± 10 nm in diameter, which reflects a slight
swelling capability of the water-treated inverse opal matrix material.
 
Figure 9. AFM image of the dried inverse opal film obtained after etching of the
SiO2@P(TFEA-co-NFHMA-co-iBuMA)-based particle films (a) and the same film measured in water
(b) Scale bars correspond to 1 μm (see text).
2.6. Chemical Resistance and Solvent-Responsivness of the Inverse Opal Film
As already mentioned in the previous section, the hydrophobic character of the
fluoropolymer-based opal materials was proven by contact angle measurements. Here, contact
angle measurements for the inverse opal film derived after etching of SiO2@P(TFEA-co-
NFHMA-co-iBuMA)-based particle films, resulted in a contact angle of 102 ± 2◦ (Figure S5b). Along
with the results obtained from the AFM measurements, a slight swelling of the inverse opal film upon
water treatment was observed, which also led to a shift of the maximum peak position during UV/Vis
spectroscopy measurements (Figure 10). In detail, the dried inverse opal film featured a reflection color
peak at a wavelength of 518 nm, while the peak shifted to a wavelength of 570 nm upon water treatment.
This was found to be a remarkable difference compared to the results obtained for the filled opals as
shown in Figure 6, revealing a peak maximum shift of only 16 nm. This finding underpins the more
pronounced sensing capability for water (and other media) for the inverse opal structures compared
to the filled opal films. This effect is even more pronounced while using organic solvents (Figure 10).
The peak maxima shifted in polar media, such as water (peak maximum at 570 nm) or ethanol (612 nm),
tetrahydrofuran (704 nm), and acetonitrile (836 nm), respectively. This observation can be explained by
the swelling capability induced by the different solvents for the fluorine-containing matrix. In contrast,
the appearance of the structural colors is only slightly affected by the change of the refractive index
contrast, since the different refractive indices of the used solvents are similar, i.e., 1.33 for water, 1.36 for
ethanol, 1.37 for ethyl methyl ketone, 1.40 for THF, and 1.34 for acetonitrile [60,61].
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Figure 10. UV/Vis reflection spectra of solvent-treated inverse opal film based on
P(TFEA-co-NFHMA-co-iBuMA). Abbreviations: ethanol (EtOH), ethyl methyl ketone (EMK), and
tetrahydrofuran (THF).
Finally, the chemical resistance of the inverse opal film caused by fluorine-containing matrix
was also examined by treatment with a strong acid (hydrochloric acid pH = 1) and base (potassium
hydroxide pH = 13) by UV/Vis spectroscopy measurements (Figure S6). Despite the slightly reduced
fluorine-content inside the inverse opal matrix, only a small shift of the reflection peak maximum
of approximately 10 nm was obtained from the corresponding spectra. This finding proved the
high chemical resistance also for the inverse opal films upon potassium hydroxide and hydrochloric
acid treatment.
3. Experimental
3.1. Materials and Methods
1H,1H,2H,2H-Nonafluorohxylmethacrylate (NFHMA, 95%) was obtained from ABCR (Karlsruhe,
Germany), trifluoroethylacrylat (TFEA, >98%) from TCI (Eschborn, Germany), Butandioldiacrylate
(BDDA), and Irgacure 184 from BASF (Ludwigshafen, Germany). Dowfax 2A1, a surfactant having
a dual polar head group and a non-polar alkyl chain was obtained from Dow Chemicals (Midland,
MI, USA), carbon black (Special Black 4) by Degussa GmbH (Essen, Germany), and benzophenon,
the UV-initiator, was donated by Merck Chemicals (Darmstadt, Germany). All other chemicals were
purchased from VWR (Radnor, PA, USA), Acros Organics, Fisher Scientific (Schwerte, Germany), and
Sigma Aldrich (St. Louis, MO, USA) and used as received, if not otherwise mentioned. Prior to use
for the polymerization, inhibitors were removed from the monomers nBuA, iBuMA, and styrene by
passing through an alumina column (basic, 50–200 μm, Acros Organics).
Dynamic light scattering (DLS) measurements of the particle dispersions were performed with a
Zetasizer ZS90 (Malvern Instruments, Malvern, UK). The measurements were carried out at 25 ◦C at an
angle of 90◦. For the evaluations, the z-weight average hydrodynamic diameter was used. Transmission
electron microscopy (TEM) was realized on a Zeiss EM 10 electron microscope (Oberkochen, Germany)
operating at 60 kV. The images were recorded in bright field mode with a slow scan CCD camera
obtained from TRS Tröndle (Morrenweis, Germany). The control of the camera was computer-assisted
using ImageSP from TRS. Scanning electron microscopy (SEM) was performed on a Philips XL30
FEG (Amsterdam, Netherlands) with an operating voltage of 5–10 kV. The samples were previously
coated for 100 s at 30 mA with a thin gold layer, using a Quorum Q300T D sputter coater (Lewes,
122
Molecules 2019, 24, 333
UK). Angle dependent reflection measurements were performed using a custom built goniometer
setup measured in steps of 10◦ of scattering angle. All other reflection spectra were recorded using a
Vis/-NIR fiber spectrometer USB 2000, Ocean Optics (Ostfildern, Germany). For the measurements,
a deuterium/tungsten halogen lamp DT mini 2, Ocean Optics was used. Measurements in water or
solvents were carried out at normal light incidence (90◦). Thermal properties of the core interlayer
shell particles were characterized using a differential scanning calorimeter (DSC) from Mettler Toledo
(Columbus, OH, USA) DSC-1 in the temperature range from −50 ◦C to 150 ◦C with a heating rate of
20 K min−1 in a nitrogen atmosphere. Atomic force microscopy measurements were accomplished in
the PeakForce Tapping mode with an Icon Dimension Bruker AXS (Santa Barbara, CA, USA). Images
with dimensions of 5 × 5 μm2 (512 × 512 pixel) were taken in air and deionized water at a scan
rate of 1 Hz using a maximum force of 2 nN. The inverse optical sensitivity of the laser detection
system was calibrated by pushing the cantilever with the tip onto a stiff substrate (sapphire) and
relating the deflection of the laser spot on the photosensitive diode with the movement of the z-piezo.
The cantilever spring constant was 0.8 nN/nm measured by the thermal noise method [62]. The contact
angle (CA) was measured using the sessile-drop-method with a Contact angle system DATAPhysics
OCA 15 EC (Filderstadt, Germany) using 2 μL droplets of deionized water. The measurements were
conduced in a controlled climatic chamber at a temperature of 23 ± 2 ◦C and a relative humidity of
40%. Contact angles were determined geometrically using the SCA20 software by aligning a tangent
from the surficial contact point along the droplet profile.
3.2. Synthesis of PS@PBuA@P(NFHMA-co-TFEA-co-nBuA) Core/Interlayer/Shell-Particles
The stepwise generation of fluorine-containing polymer based particles is illustrated in Figure 1a.
The corresponding monodisperse PS particles were synthesized according to starved feed emulsion
polymerization protocols. A 1 L reactor under an argon stream, equipped with a reflux condenser
and a stirrer, was heated up to 80 ◦C and filled with a dispersion of 3.6 g of styrene, 0.4 g of BDDA,
0.1 g of SDS, and 280 g of degassed water. The polymerization was initiated by adding solutions of
70 mg of sodiummetabisulfite (SBS) in 5 g of water and 500 mg of sodiumperoxodisulfate (SPS) in 5 g
of water. After 20 min, a monomer emulsion containing 3.5 g of ALMA, 31.5 g of styrene, 180 mg of
KOH, 164 mg of SDS 105 mg of Igepal, and 40.9 g of water was added continuously with a flow rate of
0.5 mL/min. After one hour of reaction time, the polystyrene particles with an average diameter of
206 nm were characterized and stored for further use.
The core-shell particle featuring a copolymer of PnBuA, PNFHMA, and PTFEA as a soft shell was
synthesized in a 100 mL double-wall reactor equipped with a stirrer and reflux condenser in an argon
atmosphere at 80 ◦C. For this purpose, 60 g of the PS-particle dispersion with a solid content of 8.4 wt%
was filled into the reactor, and the emulsion polymerization was initiated by the addition of 14 mg of
SBS and 77 mg of SPS dissolved in 2 mL of deionized water. After 20 min reaction time, a monomer
emulsion (ME1) consisting of 75 mg of ALMA, 425 mg of nBuA, 10 mg of Dowfax 2A1, 5 mg of SDS,
and 2.5 g of deionized water was added with a flow rate of 0.2 mL min−1 using a rotary piston pump.
After the complete addition of ME1, a solution of 12 mg of SPS in 2 g of water was added and a second
monomer emulsion (ME2) consisting of 2.7 g of NFHMA, 0.9 g of TFEA, 0.9 g of nBuA, 45 mg of KOH,
16 mg of SDS, 13 mg of Dowfax 2A1, and 5.22 g of water were continuously added with a flow rate of
0.2 mL min−1. After complete addition of the ME2, the temperature of polymerization was maintained
for an additional hour prior to cooling the vessel to room temperature. The average particle diameter
of the core shell particle was determined to be 246 ± 1 nm (DLS).
3.3. Synthesis of SiO2@PBuA@P(TFEA-co-NFHMA-co-iBuMA) Core/Interlayer/Shell-Particles
Silica particle dispersion with a solid content of 2.5 wt% in ethanol were prepared using a sol-gel
process (Stöber process) according to the protocol described by van Blaaderen [49]. A mixture of
1.3 L of ethanolic silica dispersion with 1.6 mL of 3-methacryloxypropyltrimethoxysilane (MEMO)
was heated to 60 ◦C and stirred for 2 h. After functionalization, ammonia was carefully removed
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by azeotropic distillation at 60 ◦C under reduced pressure, while the volume was kept constant by
tcontinuous addition of ethanol. When the dispersion was free of ammonia, the volume was reduced
to 300 mL at 60 ◦C. For transferring the silica particle dispersion into an aqueous medium for the
intended emulsion polymerization, a solution of 50 mg of SDS in 100 mL of deionized water was added,
and ethanol was removed by azeotropic distillation. The volume was kept constant by continuous
addition of water. The final MEMO-functionalized aqueous dispersion featured a silica solid content
of 8.83 wt%. The average particle diameter of the particles after functionalization was 249 ± 4 nm,
as determined by DLS measurements.
For synthesis of the hybrid core-shell particles, 70 g of the pristine SiO2 particle dispersion was
filled in a 100 mL double wall reactor. The emulsion polymerization was initiated at 80 ◦C by the
addition of a solution of 16 mg of SBS and 94 mg of SPS in 2 mL of deionized water. After 20 min, a
monomer emulsion (ME1) consisting of 83 mg of ALMA, 0.47 g of nBuA, 11 mg of Dowfax 2A1, 6 mg
of SDS, and 2.77 g of water were added by a rotary piston pump with a flow rate of 0.2 mL min−1.
After a 15 min reaction time, 15 mg of SPS in 2 mL of water was added and another monomer emulsion
(ME2) composed of 3.55 g of TFEA, 0.9 g of NFHMA, 0,9 g of iBuMA, 7 mg of KOH, 16 mg of SDS,
12 mg of Dowfax 2A1, and 5.2 g of water was continuously added with a flow rate of 0.2 mL min−1.
After an additional hour, the product was cooled to room temperature. The diameter of the core/shell
particle was 315 ± 9 nm, as determined by DLS measurements.
3.4. Particle Processing and Preparation of Opal and Inverse Opal Films
For the preparation of elastomeric opal films, the obtained PS@PnBuA@P(NFHMA-co-TFEA-co-
nBuA) particles were precipitated in methanol containing 20% of saturated sodium chloride solution.
The precipitate was filtered, washed with water, and dried under vacuum at 40 ◦C. For homogenization,
the precursor powder was mixed with 7.25 wt% BDDA, 1 wt% benzophenone, 1 wt% Irgacure 184,
and 0.05 wt% carbon black (special black 4, Degussa) in a microextruder (HAAKE Minilab II350,
Thermo Scientific, Waltham, MA, USA) at 90 ◦C. For opal film formation, a 2 g portion of the polymeric
mass was covered by two PET foils and heated between two steel-plates in a Collin laboratory press
(Dr. Collin GmbH, Ebersberg, Germany). The particle mass was transduced into an opal disc film
of approximately 8 cm in size by using the melt-shear organization technique at 90 ◦C and 100 bar.
Subsequently, the opal films were irradiated with a mercury lamb (UVA Cube 2000, Dr Hoenle AG,
Gräfelfing, Germany) with an output power of 1000 W at a distance of 10 cm for 3 min at both sides, for
cross-linking reactions. For conversion of the opal film containing SiO2 core particles into an inverse
opal film, the cores were removed by etching with hydrofluoric acid (HF, 10 wt% in water) for 4 days.
The films were washed with plenty of deionized water several times.
4. Conclusions
In conclusion, the current work demonstrated an efficient protocol for preparation of
fluorine-containing core/interlayer/shell particles. For the hard core particle preparation, inorganic
SiO2 or PS particles were used, whereas the soft shell was formed by a stepwise emulsion
polymerization of highly fluorinated monomers, i.e., 1H,1H,2H,2H-nonafluorohexylmethacrylate
(NFHMA) and trifluoroethylacrylate (TFEA), leading to well-defined fluorine-containing core/shell
particles. The melt-shear organization technique was applied for the preparation of easily scalable
fluoropolymer opal disc films. The opal film based on SiO2 core particles were subjected to an
etching protocol using hydrofluoric acid to gain access to fluoropolymer inverse opal structures.
Characterization of the particles, opal films, and inverse opal films was carried out using DLS,
TEM, SEM, AFM, DSC, UV/Vis spectroscopy, and contact angle measurements, evidencing the size,
uniformity, and order after the melt-shear organization and subsequent etching. The feasibility of
fluorine-containing polymers as functional matrix materials, leading to opal films featuring brilliant
reflection colors, was shown by the good refractive index contrast compared to the PS core material
(or air voids in the case of the inverse opals). Finally, swelling capability and stimuli-responsiveness
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upon treatment with different solvents were investigated, and the reversible switching behavior of the
optical properties was shown. Moreover, the inverse opals revealed good hydrophobic properties and
excellent chemical resistance toward strong acids and bases. Along with the good structural colors,
we envisage the herein investigated fluorine-containing opal and inverse opal films as promising
candidates in the field of robust coatings and switchable optical sensing devices.
Supplementary Materials: The following information are available online, Figure S1: DSC thermogram of PS
based core/shell particles; Figure S2: DLS measurements and TEM images of PS based core/shell particles;
Figure S3: DSC thermogram of SiO2 based core/shell particles; Figure S4: UV/Vis spectra of an opal film;
Figure S5: Photograph of drops of water on opal and invers opal films; Figure S6: UV/Vis spectra of an inverse
opal film.
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Abstract: Multi-drug resistance (MDR) presents a serious problem in cancer chemotherapy. In this
study, Vitamin E (VE)-Albumin core-shell nanoparticles were developed for paclitaxel (PTX) delivery
to improve the chemotherapy efficacy in an MDR breast cancer model. The PTX-loaded VE-Albumin
core-shell nanoparticles (PTX-VE NPs) had small particle sizes (about 100 nm), high drug entrapment
efficiency (95.7%) and loading capacity (12.5%), and showed sustained release profiles, in vitro.
Docking studies indicated that the hydrophobic interaction and hydrogen bonds play a significant
role in the formation of the PTX-VE NPs. The results of confocal laser scanning microscopy analysis
demonstrated that the cell uptake of PTX was significantly increased by the PTX-VE NPs, compared
with the NPs without VE (PTX NPs). The PTX-VE NPs also exhibited stronger cytotoxicity, compared
with PTX NPs with an increased accumulation of PTX in the MCF-7/ADR cells. Importantly, the
PTX-VE NPs showed a higher anti-cancer efficacy in MCF-7/ADR tumor xenograft model than
the PTX NPs and the PTX solutions. Overall, the VE-Albumin core-shell nanoparticles could be a
promising nanocarrier for PTX delivery to improve the chemotherapeutic efficacy of MDR cancer.
Keywords: Vitamin E; albumin; core-shell nanoparticles; paclitaxel; multi-drug resistance; breast cancer
1. Introduction
Multi-drug resistance (MDR) is a large obstacle to the success of cancer chemotherapy and is
crucial to cancer metastasis and recovery [1]. The well-known P-glucoprotein (P-gp), an ATP-binding
cassette transporter, which is over expressed on the surface membrane of cancer cells, is one of the
major reasons for the cancer MDR [2]. Many P-gp substrates, such as paclitaxel, were expelled out of
the cancer cells, resulting in the reduction of intracellular drug accumulation, thereby leading to the
treatment failure [3]. Therefore, it is urgent to explore a more effective strategy for overcoming the
cancer MDR.
Paclitaxel (PTX), a water-insoluble compound, is used widely as a fist-line drug in clinical
treatment against variety of cancers [4]. PTX is commonly formulated as Taxol®, which uses
Cremophor EL and dehydrated ethanol (50:50, V/V) as delivery vehicles to enhance its solubility.
But this formulation often causes side effects, such as hypersensitivity, neuropathy, and neurotoxicity,
which associate highly with Cremophor EL [5]. To mitigate these side effects, Abraxane®, a new
formulation, was developed by using the high affinity between paclitaxel and serum albumin to
prepare paclitaxel/albumin nanocomplex [5]. This formulation was approved by Food and Drug
Administration in 2005. However, its anticancer effect is still greatly affected by cancer MDR.
P-gp inhibitors have been studied for over P-gp mediated drug efflux, such as verapamil,
dexverapamil, and tariquidar [6]. These P-gp inhibitors have been evaluated in clinic, but have
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not exhibited a good improvement in the therapeutic efficiency. These failures were mainly ascribed to
the undesired toxicities, which have urged us to seek for new, more effective compounds with low
toxicity and fewer side effects. Vitamin E (VE) is a lipid-soluble antioxidant, which protects lipids and
membranes from oxidative damage [7]. It was reported that VE were not only able to overcome MDR
by inhibition of ATPase activity, but also did not consider the toxicity [8,9]. In addition, water insoluble
anticancer drugs, like PTX, can be loaded well in the VE-based emulsion for parental delivery [10].
Therefore, the use of VE as a P-gp inhibitor will be an attractive candidate to overcome the cancer
MDR. However, VE is water-insoluble, which affects its administration in clinic.
Nano-drug delivery systems have been extensively investigated for anti-cancer drug delivery [11–21].
The nanocarriers could not only increase the water solubility of drugs but circumvent the P-gp efflux
pump with entering the cancer cells by an endocytosis process [22]. Moreover, the nanoparticles
provided a promising strategy for co-delivery of multiple drugs, in a single carrier, to improve
the therapeutic efficiency of cancers [23–28]. Various nanocarriers have been developed for the
co-delivery of anti-cancer drugs and P-gp inhibitors, such as the co-delivery of paclitaxel and borneol in
lipid-albumin nanocomplex [29–31], docetaxel and verapamil in polymeric micelles [32], and paclitaxel
and curcumin in lipid-albumin hybrid nanoparticles [33]. Additionally, VE is a lipid-soluble oil, which
could be well encapsulated by the albumin to fabricate the VE-Albumin core-shell nanoparticles,
through a hydrophobic interaction; VE and albumin could also make interactions with PTX. These
interactions are beneficial for increasing the PTX-loading efficiency. Therefore, we speculate that
co-delivery of the PTX and the VE with the VE-Albumin core-shell nanoparticles could improve the
therapeutic efficiency of PTX against MDR cancers.
In this study, bovine serum albumin was used as a carrier to fabricate the VE-albumin core-shell
nanoparticles co-delivery of the PTX and the VE. VE as the oil core of nanoparticles, not only increases
the PTX-loading efficiency but also overcomes the P-gp-mediated drug efflux. The physicochemical
properties and in vitro release were characterized. The cytotoxicity and cellular uptake were also
investigated. Moreover, the anti-cancer effect was evaluated in breast cancer xenografts, in mice. It
was speculated that the VE-albumin core-shell nanoparticles would be a suitable drug delivery system
for anticancer drug delivery to over MDR, in cancer.
2. Materials and Methods
2.1. Materials and Animals
Paclitaxel was obtained from the Tianfeng Bioengineering Technology Co., Ltd. (Shenyang, China).
Vitamin E and bovine serum albumin was obtained from Sigma-Aldrich (St. Louis, MO, USA).
Cremophor EL was obtained from BASF Corporation (Ludwigshafen, Germany). 3-(4,5-Dimethyl-
thiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) was obtained from Sigma (St. Louis, MO,
USA). RPMI-1640 and fetal bovine serum were obtained from Gibco (BRL, Gaithersburg, MD, USA).
All other chemicals and solvents were of analytical or chromatographic grade and were used without
further purification.
The PTX solution was prepared according to the clinical formulation. In brief, PTX (0.012 g)
was dissolved in anhydrous ethanol (1 mL) and Cremophor EL (1 mL), under magnetic stirring.
PTX solution was diluted with saline, before the test.
Balb/c mice (16–18 g) were obtained from the Experimental Animal Center (Nantong University,
China). All animal experiments were approved by Nantong University Ethics Committee (20180512-001)
and conformed to the Guidelines for the Use of Laboratory Animals.
2.2. Preparation of PTX NPs and PTX-VE NPs
The PTX NPs and PTX-VE NPs were fabricated by a desolvation-ultrasonication technique, as
described in our previous report, with some modifications [29]. In brief, BSA (0.20 g) was dissolved
in 5 mL deionized water, with magnetic stirring. VE (0.01 g) and PTX (0.01 g) were dissolved in
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0.3 mL anhydrous ethanol. Then, the VE and PTX mixed solution were added dropwise to the BSA
solution, with magnetic stirring. The mixtures were dispersed by probe ultrasonication (JY92-II,
Ningbo Scientz Biotechnology Co., Ltd., Ningbo, China) at 400 W, for 4 min, in an ice bath with a
3 s pulse-on period and a 1 s pulse-off period. After sonication, anhydrous ethanol was evaporated
by a rotator RE-2000 (Ya Rong Biochemical Instrument Factory, Shanghai, China). Subsequently, the
samples were centrifuged at 3000 rpm, for 10 min, to remove the unloaded drug and impurities, and
passed through a 0.45 μm filter membrane for removing the larger particles. The obtained suspensions
were kept at 4 ◦C.
2.3. Characterization of PTX-VE NPs
2.3.1. Size Distribution and Morphology
The particle size and polydispersity index (P.I.) of the NPs was determined by dynamic light
scattering (PSS NICOMP 380, Santa Barbara, CA, USA). The morphology of NPs was evaluated by
transmission electron microscopy (TEM) (JEOL, Tokyo, Japan). In brief, the samples were diluted with
distilled water and dropped onto a copper grid. The excess sample was removed with filter paper.
Then, 2% phosphotungstic acid staining solution was dropped onto the grid. Finally, the sample was
air-dried and assessed with TEM.
2.3.2. Determination of Entrapment Efficiency (EE) and Loading Capacity (LC)
The EE and LC were determined by the method described in our previous research [29].
To separate PTX from the PTX-VE NPs, acetonitrile was added to precipitate BSA, via sonication,
for 5 min. After centrifugation at 12,000 rpm for 10 min, the PTX concentration in the supernatant











Geometry of VE was optimized in gas phase. The calculation was conducted using the GAMESS
suit of codes with the hybrid functional B3LYP. The 6-31G (dp) basis set was used for all the elements.
Docking studies were executed using Autodock Vina.9 [27]. BSA crystalline protein structure was
obtained from protein databank (Bovine serum albumin: 4OR0, http://www.rcsb.org). The structure
of VE used for docking studies was optimized with DFT calculations. Protein structures were altered to
include polar hydrogen atoms. During docking studies, the protein structure was kept rigid. Rotation
in the VE complex and the PTX complex was permitted for all single bonds.
2.5. In Vitro Drug Release
The release behavior of PTX from the PTX-VE NPs was evaluated by a dialysis method.
The phosphate buffered saline (PBS, pH 7.4) containing 0.5% w/v Tween 80 was used as the dissolution
medium. In brief, the samples were suspended in a flask and then immersed in the dissolution medium
at 37 ◦C under at 120 rpm. The amount of PTX released was determined by HPLC.
2.6. Cytotoxicity of PTX-VE NPs
The MCF-7 and MCF-7/ADR cell line were purchased from Nanjing Kaiji Biotech. Ltd. Co.
(Nanjing, China). The cells were cultured in RPMI medium, supplemented with 10% FBS and 1%
penicillin-streptomycin, at 37 ◦C, with 5% CO2 and 95% relative humidity. The Cells were seeded
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in 96-well plates, at a density of 5.0 × 103 cells/well. After 48 h incubation, the growth medium
was replaced with 200 μL medium containing VE, PTX solution, and PTX-VE NPs with different
concentrations, respectively. Then, each well was added with 20 μL MTT (5 mg/mL) solution and was
incubated for an additional 4 h. The culture medium was removed and 200 μL DMSO was added to
each well to dissolve the formazan. The absorbance at 492 nm was measured in a microplate reader
(Model 500, San Francisco, CA, USA). The results were expressed as % cell viability (OD of treated
group/OD of control group ×100).
2.7. Rhodamine 6G Accumulation in MCF-7/ADR Cells
MCF-7/Adr cells were seeded onto the cover glasses at 1 × 105 cells in 6-well plate, for 24 h.
The cells were washed and incubated with Rhodamine 6G solution (Rho solution), Rho NPs, and
Rho-VE NPs, at 37 ◦C, for 2 h. Then the cells were washed twice with 4 ◦C PBS and fixed with 4%
paraformaldehyde, for 20 min. The nuclei were counterstained by 4′,6-diamidino-2-phenylindole
(DAPI). The Rho 6G fluorescence was visualized by confocal laser scanning microscope (CLSM, TCS
SP2/AOBS, LEICA, Bensheim, Germany).
2.8. Therapeutic Efficacy in Resistant Breast Cancer Xenografts Mice
The anti-tumor effect was evaluated in MCF-7/ADR tumor bearing Balb/c mice model.
MCF-7/ADR cells were injected subcutaneously, at 2 × 107 cells, in the armpit of the right anterior limb.
When the tumor sizes reached about 100 mm3, the mice were randomly divided into four groups (n = 6),
and the formulations of PTX solution, PTX NPs, and PTX-VE NPs were intravenously administrated
at a dose of 10 mg/kg, at two-day intervals, for five times, with physiological saline as control. Tumor
volumes and Body weights were measured with a caliper every other day. Tumor volume (V) was





where a and b represent the long and short axis of tumor, respectively.
2.9. Statistical Analysis
Analysis of statistical significance was performed with the SPSS statistics software 16.0. The data
are presented as the mean ± SD. Student’s t-test was used to analyze the differences. The differences
were considered significant at p < 0.05.
3. Results and Discussion
3.1. Preparation and Characterization of PTX-VE NPs
The PTX-VE NPs were fabricated by the desolvation-ultrasonication method. The PTX and VE
mixed ethanol solution was added to the BSA solution, and the mixture was subjected to probe
sonication. Subsequently, the PTX-VE NPs was formed by the interaction among the PTX, VE, and
BSA. Both PTX and VE have high affinity with albumin [34,35], the PTX and VE can bound tightly
to BSA via hydrophobic interactions and hydrogen bond, which were in favor of the formation of
PTX-VE NPs.
The average size of the PTX NPs and PTX-VE NPs was approximately 100 nm (Table 1), which
was considered effective for the accumulation of nanoparticles, in tumor tissue, via passive targeting.
The PTX encapsulation in the PTX-VE NPs was increased significantly with a loading capacity > 12%,
which was five-fold more than that of PTX NPs, owing mainly to the solubility of PTX in the VE oil.
The NPs also have a higher drug encapsulation efficiency (>90%). The morphology of the NPs was
evaluated by TEM, which showed a uniform and spherical shape (Figure 1).
132
Molecules 2018, 23, 2760
Table 1. Physicochemical characteristics of PTX NPs and PTX-VE NPs (n = 3).
Formulation Size (nm) P.I. Zeta Potential (mV) EE (%) LC (%)
PTX NPs 101.2 ± 2.8 0.167 ± 0.03 −2.15 ± 0.6 91.2 ± 3.0 2.5 ± 0.08
PTX-VE NPs 106.9 ± 3.2 0.172 ± 0.02 −20.64 ± 0.8 95.7 ± 2.1 12.5 ± 0.15
  
(a) (b) 
Figure 1. TEM image of PTX NPs (a) and PTX-VE NPs (b).
3.2. Docking Studies
Docking studies were performed to investigate the interaction between PTX and BSA, VE
and BSA, respectively (Figure 2). The crystalline structure of BSA was obtained from the protein
databank. In thermodynamics, a negative binding affinity demonstrates a favorable interaction system.
The calculated binding affinity of PTX and VE with BSA were −8.3 kcal/mol and −7.5 kcal/mol,
respectively, indicating that PTX and VE have strong interaction with BSA. As shown in Figure 2,
there were hydrogen bonds between the Glu 424, Ser 109, Lys 114 of BSA and the nitrogen atom,
oxygen atom, oxygen atom of PTX, respectively. There also existed hydrogen bonds between the
Arg144, Asp108 and the hydroxy of the VE, respectively. Moreover, hydrophobic interactions were
another important interaction between the PTX/VE and the BSA. The hydrophobic interactions were
established between the Ile 522, Leu 189, Val 423, Ala 193, and PTX; these interactions also occurred
between the Ile 455, Val 425, Leu189, Ala 193, and VE. In addition, the hydrophobic interactions and
hydrogen bonds between the VE and the PTX cannot be ignored. In summary, the intermolecular
force, such as hydrophobic interactions and hydrogen bonds played significantly important role in the
formation of the PTX-VE NPs.
. 
Figure 2. The molecular docking BSA with PTX (a,b) and VE (c,d).
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3.3. In Vitro Drug Release
The profiles of the PTX release from the NPs are showed in Figure 3. Nearly 90% of the PTX was
released from the PTX solution, in 8 h. Both, PTX NPs and PTX-VE NPs exhibited a sustained release
profile, as compared with the PTX solution. After 24 h, the PTX release was about 76% and 60% for
the PTX NPs and PTX-VE NPs, respectively. The PTX release from the PTX-VE NPs was slower than
that of the PTX NPs. The release of PTX from the NPs might be affected by interactions among PTX,
VE, and albumin, such as Hydrogen bonds, π-π stacking, and hydrophobic interactions. In addition,
the relative rapid release of PTX from NPs, in the early stage, was likely due to the diffusion of drugs
absorbed at the outer shell, while the sustained release in the late stage was probably related to the
gradual diffusion of drugs in the inner core of NPs.
Figure 3. In vitro release profile of PTX from PTX solution, PTX NPs, and PTX-VE NPs, in phosphate
buffered saline (0.5% of Tween 80 in PBS, pH 7.4), at 37 ± 0.5 ◦C (n = 3).
3.4. Cytotoxicity of PTX-VE NPs
The cytotoxicity study of the PTX solution, PTX NPs, and the PTX-VE NPs was evaluated using
the MTT assay and the results are show in Figure 4. It is clear that cell viabilities for all the formulations
in MCF-7 cells were lower than that at concentration 1–100 μg/mL in MCF-7/ADR cells, due to
P-gp-mediated efflux, which could reduce the drug accumulation in the cells. The PTX-VE NPs
exhibited better cytotoxic effect than the PTX NPs, indicating that the PTX-VE NPs could exert stronger
MDR-overcoming effects on the MCF-7/ADR cells. In addition, the cytotoxicity of the PTX-VE NPs
showed no significant difference, as compared with the PTX solution. The reason was deduced that the
cytotoxicity of the PTX solution was partially attributed to the use of Cremophor EL/ethanol mixture,
which had 42.1% cytotoxicity on the MCF-7 cells [36]. However, in the case of the PTX-VE NPs, the
nanocarriers are biocompatible, and the cytotoxic effect was induced mainly by the PTX incorporated
in the nanoparticles [37].
Figure 4. In vitro cytotoxicity of PTX solution, PTX NPs, and PTX-VE NPs, against MCF cells (a) and
MCF-7/ADR cells (b). Data represented the mean ± S.D. (n = 3). * p < 0.05, significant difference.
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3.5. Rhodamine 6G Accumulation in MCF-7/ADR Cells
As a substrate of the P-gp efflux pump, the Rhodamine 6G (Rho) was often used as a fluorescent
probe to evaluate the whether the improved cytotoxicity of the PTX-VE NPs was due to the increased
intracellular drug delivery in MCF-7/ADR cells. Figure 5 shows the fluorescence images in the
MCF-7/ADR cells, after 1 h, following the different Rho-labeled formulation treatments. The cells
treated with Rho solution exhibited the least amounts of fluorescence signals, which could be attributed
to the uptake inhibition of Rho by the P-gp efflux transporter, overexpressed in the MCF-7/ADR cells.
Cells treated with the Rho NPs showed increased fluorescence signals, in comparison with the Rho
solution. This was consistent with the research that the nanocarriers were able to circumvent the P-gp
efflux pump by entering the cells through an endocytic process. However, the increased cell uptake
of the Rho NPs was still restricted. The reason inferred was that the rapid release of encapsulated
drugs in the cytoplasm was still probably shuttled out of cells, by the P-gp, which is overexpressed
on the MCF-7/ADR cell membranes. Furthermore, the strongest fluorescence signals were observed
in the cells treated with the Rho-VE NPs. This could be ascribed to the synergic combination of the
nanocarrier and the VE. The nanocarrier increased the intracellular drug delivery by circumventing
the P-gp efflux pump and the P-gp ATPase activity was probably inhibited by the released VE from
the nanoparticles in cells.
 
Figure 5. Confocal laser scanning microscope images of various Rhodamine 6G (Rho) labeled
formulations in the MCF-7/ADR cells. Original magnification: 10 × 20.
3.6. Anti-Tumor Effect and Safety in the Xenograft Model
The anti-tumor effect of the PTX-VE NPs was studied in the Balb/c mice bearing the MCF-7/ADR
tumor xenograft model. The changes of tumor value and body weight were shown in Figure 6a, the
tumor growth rates of different formulations, in ascending order, was PTX-VE NPs, PTX NPs, PTX
solution and Saline, respectively. The results indicated that the PTX-VE NPs were the most effective
formulation to treat MDR breast cancer. During the treatment, the relative body weight change of
mice was also measured, as shown in Figure 6b. No significant body weight loss was observed for
the PTX-VE NPs, PTX NPs, PTX solution and Saline, throughout the experiment, demonstrating good
safety and low systemic toxicity of these formulations.
Accordingly, PTX-VE NPs was a safe and efficient drug delivery system to overcome MDR.
The reasons could be deduced to the following aspects, as shown in Figure 7. First, the PTX-VE NPs
with particle size less than 200nm, which was able to avoid the rapid reticuloendothelial system uptake
and achieved a high accumulation in the tumor site by an enhanced permeability and retention (EPR)
effect [35]. Second, the NPs could utilize the albumin receptor (gp60) mediated endocytosis through
the blood vessel endothelial cells in the angiogenic tumor vasculature and an increased intratumoral
accumulation [10,26]. Finally, the combination of the PTX and the VE in the NPs, would significantly
enhance the intracellular drug uptake efficiency in MDR tumor cells and improve the therapeutic
efficiency of resistant cancers.
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Figure 6. Anti-tumor effect of PTX formulations on the Balb/c mice implanted with MCF-7/ADR cells.
Mice were injected through tail vein with Saline, PTX solution, PTX NPs and PTX-VE NPs, at a dosage
of 10 mg/kg. The changes of tumor volume (a) and body weight (b) during 16-day treatments. (n = 6).
* p < 0.05, significant difference when compared with Saline, # p < 0.05, significant difference when
compared with PTX solution. & p < 0.05, significant difference when compared with PTX NPs.
Figure 7. Schematic illustration of the PTX-VE NPs to reversal of MDR.
4. Conclusions
The present study fabricated the PTX loaded VE-Albumin core-shell nanoparticles to treat
MDR breast cancer. The fabricated nanoparticles showed satisfying particle size, drug loading, and
sustained-release profile, in vitro. Compared with PTX NPs, PTX-VE NPs exhibited higher cellular
uptake and stronger cytotoxic effect in MDR breast cancer cells. Therefore, the PTX loaded VE-Albumin
core-shell nanoparticles could be a potential strategy for the treatment of MDR breast cancer.
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Abstract: Novel pH responsive copolymers with tertiary amine groups were prepared by free
radical polymerization with 2-(dialkylamino)ethyl methacrylate monomers. These polymers were
pH sensitive with the ability to be responsively fine-tuned in aqueous solution, which was proven
through titration, transmittance measurements, and proton nuclear magnetic resonance spectroscopy.
The polymers were soluble in water at low pH values, induced by electrostatic repulsion between
amine groups, and aggregated above their pKa value due to the hydrophobic effect of the alkyls.
The pH responsive values were precisely tuned from 7.4 to 4.8 by increasing the hydrophobic
monomer ratio. Our work provides a novel approach for the development of ultrasensitive
pH-responsive polymers for application in biomedical materials.
Keywords: fine-tuning; pH responsive; poly(methacrylamide)s; phase transition
1. Introduction
The development of tumor-targeted drug delivery systems have attracted increasing interest
given their potential to address therapeutic issues in clinical practice [1–7]. Many studies have
focused on designing and improving specific transport and activation of intelligent materials that
have stimuli responsive properties [8–13]. An interesting aspect of the physiology of tumors is their
lower extra-cellular pH (6.5–7.2) compared to the surrounding normal tissues and blood, thus pH
can be considered as an ideal trigger for tumor tissues and tumor cells [14]. To target the acidic
bio-compartments, several smart materials with pH-responsive properties were designed to increase
target efficacy. For instance, the Kobayashi group developed a small molecule system to target the
tissue of the mice. This pH of this system can transition across two values of pH value, which
means a 200-fold proton concentration change [15–17]. Despite these remarkable advances, selective
targeting by pH-sensitive materials of different endocytic components is challenging owing to the
small pH differences in these compartments, such as early endosomes (5.9–6.2) versus lysosomes
(5.0–5.5) [18–20].
Various pH-responsive polymer systems have been studied, such as liposomes [21], micelles [22,23],
nanoparticles [24], and nanogels [25–27]. The pH-responsive polymers can undergo phase transition
at a specific pH values and direct spontaneous assemblies [28–31]. Polyelectrolytes, which
contain weak acidic or basic groups, have been exploited as pH responsive polymers, inspiring
advances in polymer research. Polybases, like poly(2-(diethylamino)ethyl methacrylate) (PDEAEMA),
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poly(4 or 2-vinylpyridine) (PVP), and poly(vinyl imidazole), were developed for biomedical
applications in gene transfer, bio-imaging, and controlled drug release, due to their excellent
physicochemical properties [32–34]. The amine group, pyridine, and imidazole group in polymer
chains can accept protons under acidic condition and release them in basic environments to induce
phase transition [35,36]. For instance, PDEAEMA dissolves in acidic aqueous solution due to the
electrostatic repulsions between the protonated amine groups, but undergoes a precipitation above
pH 7.5, caused by the hydrophobic effect of substituted ethyl group. However, a challenging issue
faced by these widely used polybases is that their phase transition values from the solution state to the
precipitation state are usually fixed. Therefore, they are less accurate when targeting cell organelles
with different pH microenvironments. The broad pH transition range of these polybases also limits
the increase in their responsive property. To develop responsive polymers with narrow transition
pH ranges, Armes et al. [37] reported a novel polybase system, poly(2-(diisopropylamino)ethyl
methacrylate) (PDPAEMA), with a phase transition at pH 6.3 and a sharp pH transition, providing a
method by which to prepare ultra-sensitive pH-responsive polymers.
In this work, we developed a series of novel reversible pH-responsive (co)polymers with
a fine-tunable pH transition value. These polymers were synthesized using a free radical
polymerization method with tertiary amine-based monomers, 2-(dibutylamino)ethyl methacrylate
and 2-(dimethylamino)ethyl methacrylate. At low pH, the (co)polymers were in the unimer state
due to the electrostatic interaction and hydrophilicity of the protonated tertiary amine units. At high
pH, the stronger hydrophobicity of the alkyl groups on the deprotonated amines led to (co)polymer
aggregation. All the (co)polymers showed rapid phase separation at their pKa, and the pH transition
range can be controlled within a very narrowly defined value.
2. Results
2.1. Synthesis of the (Co)polymers
A series of random copolymers poly(2-(dimethylamino)ethyl methacrylate)-co-2-(dibutylamino)
ethyl methacrylate (P(DMAEMA-co-DBAEMA)) were obtained by conventional free radical
polymerization with varying feed ratios of the monomers containing different tertiary amine groups.
Comparing the signal integrals of the proton peaks at 2.3 ppm and at 2.5 ppm (Figure 1, Figures S1–S4),
the compositions of the copolymers could be determined, as summarized in Table 1. The molar ratios
of the monomer units in the copolymers were relatively close to the feed ratios. Due to the methacrylic
acid ester structure of the two monomers, random sequences of two monomer units were expected in
the copolymer chains.
Figure 1. Proton nuclear magnetic resonance (1H-NMR) spectrum of poly(2-(dimethylamino)ethyl
methacrylate)-co-2-(dibutylamino)ethyl methacrylate (P(DMAEMA0.73-co-DBAEMA0.27)) in CDCl3.
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In Feed In Polymer a
PDMAEMA 100 100 73 1.21 1.85 1.53 7.4
P(DMAEMA0.73-co-DBAEMA0.27) 75 73 67 1.06 1.47 1.39 6.8
P(DMAEMA0.51-co-DBAEMA0.49) 50 51 62 1.01 1.84 1.82 6.3
P(DMAEMA0.29-co-DBAEMA0.71) 25 29 65 1.13 2.03 1.80 5.5
PDBAEMA 0 0 56 1.40 2.59 1.85 4.8
a Percent molar ratio determined by hydrogen nuclear magnetic resonance (1H-NMR); b Determined by gel
permeation chromatography (GPC) in tetrahydrofuran (THF) with polystyrene standards; c Determined by titration
during the heating process.
2.2. pH Titration of Different Copolymers and Measurement of pKa
For pH-responsive polymers, the pKa value is a critical parameter that can be evaluated through
titration experiments. Figure 2A shows the potentiometric titration curves for 0.5 mg/mL (co)polymer
solutions. NaOH solution was added to neutralize the protons. Potentiometric titration curves were
produced for (co)polymers by plotting the solution pH against the volume of added NaOH. Starting
from pH ~3, the addition of small aliquots of NaOH would neutralize the free protons and increase
the solution pH. The pH value of PDMAEMA increased continuously with higher NaOH content,
whereas for the other (co)polymers, especially PDBAEMA, titration curves were obtained with a
plateau at the polymer buffering region. This indicates that the added NaOH was consumed during
the deprotonation of the tertiary amine groups on the polymer pendent chain, which corresponds
to the phase transition of the polymer. With the completion of the process, further addition of base
increased the solution pH rapidly. For each sample, the pKa values were calculated as the pH halfway
between the two equivalence points in the titration curve. With increasing DBAEMA monomer
amounts from 0% to 100%, as shown in Figure 2B, the average pKa values of the polymers decreased
from 7.4 to 4.8, which was attributed to the hydrophobic property of butyl on amine. An approximately
linear relationship was observed between the pKa values and DBAEMA monomer molar ratios of the
(co)polymers, which indicates that the pKa of the pH sensitive polycations can be controlled easily and
precisely by adjusting the hydrophobic properties of the pendent group.
Figure 2. (A) pH titration curves of (co)polymers. The volumes of NaOH (VNaOH) were normalized to
the initial amount of amine ([R3N]0 in mmol); (B) pKa values of the tertiary amine-based polymers as a
function of DBAEMA ratio.
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2.3. Phase Transition Behaviors of the Fine-Tuning pH Responsive Polymers
The tenability of the (co)polymers’ pH-responsive properties were evaluated by transmittance
experiments. Figure 3A,B show the optical images and transmittance changes of the polymer solutions
as NaOH was added from initial acid solutions, where all of the polymers were completely dissolved.
Over the entire pH range in the measurements, the PDMAEMA solution remained clear with a
transmittance around 100%, which was likely due to the hydrophilicity of the dimethyl amino groups,
in good agreement with the titration experiment. However, with the incorporation of DBAEMA,
the turbidity of the polymer solutions increased sharply at critical pH values due to the aggregation of
the polymer chains. The phase transition pH range decreased with the increasing ratio of DBAEMA.
Compared to conventional pH responsive materials, the DBAEMA-based polymers displayed a much
sharper pH-dependent phase transition, where the transmittance from 100% to 0% was limited to
0.3 pH, indicating that only double the proton concentration could lead to complete turbidity of
the copolymers in aqueous solutions. Furthermore, the reversibility of the pH-responsive tertiary
amine-based polymers was confirmed by the PDBAEMA transmittance measurement. We also
analyzed the polymer solution during cyclic tests between pH 4.0 and pH 7.4. As shown in Figure 3C,
the dissolution and aggregation of the polymer solutions are fully reversible for at least five cycles,
which indicates the novel pH sensitive materials can be used repeatedly.
Figure 3. (A) Optical images of (co)polymer solutions at different pH. (B) The transmittance curves
of (co)polymer solutions with increasing pH values. (C) The pH reversibility study of PDBAEMA
solution with cycles between pH 4.0 and pH 7.4.
Proton nuclear magnetic resonance spectroscopy (1H-NMR) was also employed to investigate
the effect of pH on the phase transition behaviors of the polymers in aqueous solution. PDBAEMA
and P(DMAEMA0.73-co-DBAEMA0.27) were investigated as a function of pH in order to compare
the aggregation behavior of the polymers with different tertiary amine groups. 1,4-Dioxane, with
a single peak at 3.7 ppm, was used as the internal standard, as its intensity remained almost the
same before and after the polymer underwent a phase transition. The spectra of the PDBAEMA and
P(DMAEMA0.73-co-DBAEMA0.27) were recorded in the pH range of 4.1 to 8.5, and Figure 4 shows the
1H-NMR spectra of the polymers in D2O with the tertiary amines in different ionization states. At pH
4.1 and 5.3, the amine groups were protonated; both PDBAEMA and P(DMAEMA0.73-co-DBAEMA0.27)
were dissolved in the deuterated solution and proton resonance peaks for the segments of each
polymer were easily visualized. However, as pH increased from 5.5 to 6.6, the signal intensities
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of the PDBAEMA dramatically decreased and disappeared at pH 7.8, when PDBAEMA became
completely deprotonated. The suppressed resonances of the polymer were due to the limitation of
the motion of the polymer chain, which can be attributed to the phase transition behavior driven
by the hydrophobic effect. For P(DMAEMA0.73-co-DBAEMA0.27), although the signal integrations of
the polymer signals decreased gradually when the pH increased above 6.3, the peaks of DMAEMA
segments were still observable even at pH 8.5. This drastic difference between PDBAEMA and
P(DMAEMA0.73-co-DBAEMA0.27) spectra can be attributed to the dehydration behaviors of the
polymers upon neutralization. The hydrophobic effect involving the butyl groups on the PDBAEMA
pendent segments enabled the polymer chains to pack densely in aqueous solution, thus leading to
more efficient dehydration and a sharper phase transition.
Figure 4. 1H-NMR spectra of (A) P(DMAEMA0.73-co-DBAEMA0.27) and (B) PDBAEMA at different
pH in D2O.
3. Materials and Methods
3.1. Materials
2-(dibutylamino) ethanol was purchased from Alfa Aesar Company (Haverhill, MA, USA) and
2-(dimethylamino)ethyl methacrylate (DMAEMA) was purchased from Sigma-Aldrich (St. Louis,
MO, USA). CDCl3, D2O, and 1,4-Dioxane were purchased from Acros Co. (Beijing, China) and used
as received. Tetrahydrofuran (THF) was freshly purified by distillation over sodium prior to use.
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2,2-Azoisobutyronitrile (AIBN) was recrystallized three times from methanol. Other solvents and
reagents were purchased from Beijing Chemical Reagent Co. (Beijing, China) and used as received.
3.2. Synthesis of the DBA Monomer
The tertiary amine-based methacrylate monomer 2-(Dibutylamino)ethyl methacrylate (DBAEMA)
was synthesized by following a previously reported method [38]. 2-(dibutylamino)ethyl ethanol (17.3 g,
0.1 mol), triethylamine (10.1 g, 0.1 mol), and inhibitor hydroquinone (0.11 g, 0.001 mol) were dissolved
in 100 mL THF and placed in a three-neck flask. To this solution, methacryloyl chloride (10.4 g,
0.1 mol) was added dropwise with constant stirring. The resulting solution was refluxed in THF for
2 h and then filtered to remove the precipitated white triethylamine-HCl salts with completion of the
reaction. After removing THF solvent by rotary evaporator, the resulting residue was distilled in vacuo
(83–87 ◦C at 0.05 mm Hg) as a colorless liquid. The obtained DBAEMA monomer was characterized
by 1H-NMR. 1H-NMR (TMS, CDCl3, ppm): 6.09 (br, 1H, CHH=C(CH3)-), 5.55 (br, 1H, CHH=C(CH3)-),
4.19 (t, J = 6.3 Hz, 2H, -OCH2CH2N-), 2.73 (t, J = 6.3 Hz, 2H, -OCH2CH2N-), 2.46 (t, J = 7.6 Hz, 2H,
-N(CH2CH2CH2CH3)2), 1.93 (s, 3H, CH2=C(CH3)-), 1.41 (m, 4H, -N(CH2CH2CH2CH3)2), 1.29 (m, 4H,
-N(CH2CH2CH2CH3)2), 0.89 (t, J = 7.3 Hz, 6H, -N(CH2CH2CH2CH3)2), Yield: 56%.
3.3. Synthesis of the (Co)polymers
The P(DMAEMA-co-DBAEMA) copolymers, PDMAEMA, and PDBAEMA were prepared by free
radical polymerization in THF with varying DBAEMA to DMAEMA molar feed ratios of 0:4, 1:3, 2:2, 3:1,
and 4:0, respectively. Typical procedures employed for the polymerization were as follows. Monomers
were dissolved in THF at a total concentration of 0.10 g/mL, to which azodiisobutyronitrile (AIBN)
(1.0 mol% relative to monomers) was added as a free radical initiator. After three cycles of freeze-thaw
to thoroughly remove oxygen, the tube was sealed under reduced pressure and the polymerization
was performed at 60 ◦C for 24 h. The polymers were purified by precipitation from diethyl ether twice,
collected by filtration, and dried under vacuum to obtain white powders. The molecular weights and
the composition of the (co)polymers were determined by gel permeation chromatography (GPC) and
1H-NMR, respectively.
3.4. Characterization of the (Co)polymers
1H-NMR spectra of the monomers and (co)polymers were recorded in CDCl3 on a Varian-600
MHz spectrometer with tetramethylsilane (TMS) as the internal reference. The molecular weight
and molecular weight distributions of the (co)polymers were measured with gel permeation
chromatography (GPC) equipment consisting of WGE3010 pump, 3010 refractive index detector,
and WGE Styra gel columns. The temperature of the columns was 35 ◦C and THF was used as an
eluent at a flow rate of 1 mL/min. A series of narrowly dispersed polystyrene samples were used as
standards and Millennium 32 software was used to calculate the molecular weight and polydispersity.
3.5. pH Titration
The pKa values of different (co)polymers were detected by pH titration. When the prepared
polymer was dissolved in 0.1 N HCl to reach a final concentration of 5–10 mg/mL, the pH titration
experiment was performed by adding small volumes (50–100 μL increments) of 0.1 N NaOH solution
under stirring. The pH values of the solution were measured continuously using a Sartorius (Germany)
pH meter with a microelectrode.
3.6. Turbidity Measurements by UV/Vis Spectroscopy
The pH-dependent phase transition of the polymers was determined by the turbidity of the
polymer solutions as a function of pH. The transmittance of the 1 mg/mL (co)polymer solutions
in 0.1 N HCl were measured at 500 nm through a 1 cm quartz cell on a Shimadzu 2550 ultraviolet
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(UV)-vis spectrometer. To adjust the pH, 0.2 N NaOH was added, and the final volumes of the polymer
solutions increased about 10% compared with initial volumes. The pH values were monitored with a
digital internal pH meter. Polymer-free deionized (DI) water was used as a reference.
3.7. 1H-NMR Measurements of pH-Dependent Phase Transition
P(DMAEMA0.73-co-DBAEMA0.27) and PDBA were first dissolved in the deuterated buffers at a
concentration of 10 mg/mL, and 1,4-dioxane was used as an internal standard. To adjust the pH value,
0.1 N NaOD deuterated solution was added and the Varian Mercury Plu600 MHz NMR spectrometer
was used to record the 1H-NMR spectra at different pH.
4. Conclusions
A series of novel pH-responsive polymers based on tertiary amine functional groups were
developed by easy free radical copolymerization. The pKa values of the polymers were precisely tuned
by adjusting the feed ratio between the two monomers, DMAEMA and DBAEMA. The phase transition
of polymers occurred in narrow pH ranges, which was demonstrated by transmittance and 1H-NMR
detection. Below pKa, the positive charges of the protonated amine groups maintained the solubility
of the polymers in aqueous solution, whereas when pH was greater than pKa, the hydrophobic butyl
groups on neutralized PDBAEMA segments rapidly induced the aggregation and precipitation of
the polymers. Compared to widely used PDMAEMA and PDEAEMA, the developed polymers
with PDBAEMA segments displayed much sharper pH transition ranges. The finely tunable
transition pH values mean the polymers are a promising platform for drug delivery and biomedicine
applications, where the encapsulated drugs at physiological pH would be triggered to release in
acidic microenvironments.
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Abstract: Thermosensitive gels are commonly used as drug carriers in medical fields, mainly due
to their convenient processing and easy functionalization. However, their overall performance has
been severely affected by their unsatisfying biocompatibility and biodegradability. To this end,
we synthesized poly(L-alanine) (PLAla)-based thermosensitive hydrogels with different degrees
of polymerization by ring-opening polymerization. The obtained mPEG45−PLAla copolymers
showed distinct transition temperatures and degradation abilities. It was found that slight changes
in the length of hydrophobic side groups had a decisive effect on the gelation behavior of the
polypeptide hydrogel. Longer hydrophobic ends led to a lower gelation temperature of gel at the
same concentration, which implied better gelation capability. The hydrogels showed rapid gelling,
enhanced biocompatibility, and better degradability. Therefore, this thermosensitive hydrogel is a
promising material for biomedical application.
Keywords: amphiphilicity; phase change; polyamino acids; degradability
1. Introduction
The application of hydrogels in the biomedical field has rapidly increased over the past
decade, including use in three-dimensional (3D) cell culture [1–3], drug delivery [4–6], and tissue
engineering [7–9]. Polymer hydrogels can trap a large amount of moisture inside for easier cell
membrane penetration and drug transmission. They enjoy excellent physical properties and exhibit a
controllable degradation process. On account of the incomparable convenience, the in situ gelation
of biodegradable hydrogels has aroused great interest in many researchers. Among numerous
biodegradable hydrogels, thermosensitive hydrogels have specific advantages. On the one hand,
they are rather safe for clinical utilization because the common thermosensitive gel preparation process
does not involve the use of organic solvents. On the other hand, the gelling conditions of heat-sensitive
hydrogels are easy to control, making them applicable in the field of biomedicine [10–12].
Thermosensitive hydrogels can be generated from block copolymers consisting of hydrophilic
poly(ethylene glycol) (PEG) and hydrophobic moieties such as poly(lactic acid) (PLA) [13,14],
poly(lactic-co-glycolic acid) (PLGA) [15–17], poly(ε-caprolactone) (PCL) [18–20], polyamidoamine
(PAMAM) [21], and so on. Thermosensitive hydrogels are soluble at low temperatures, which facilitates
the introduction of chemotherapeutic drugs [22–24], functional proteins [25], and cells. Due to
the amorphous form of the hydrogel at low temperatures, it can be seamlessly filled into injury
sites [26,27]. At body temperature, the soluble hydrogels turn into a gel state and provide a depot for
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the encapsulated medical agents to achieve sustained release and long-term therapeutic effect [28].
For example, growth factors can be slowly and continuously released locally for the efficient repair
of bone and nerve tissues [29–31]. The hydrogels can also function as 3D scaffolds and as a nutrient
resource for cell growth in tissue engineering [32], aiming to help cells grow in a more uniform manner
and promote cell proliferation [33].
In 2012, Qian’s team prepared a bionic hydrogel composed of three components (i.e., triblock
PEG−PCL−PEG copolymer (PECE), nano-hydroxyapatite (n-HA), and collagen), which showed
satisfactory efficacy in skull repair [34]. In 2015, Chen’s team engineered a thermosensitive
PLGA−PEG−PLGA hydrogel loaded with 5-fluorouracil for the prevention of postoperative tendon
adhesion, and acquired a good histological score [35]. However, despite the wide application of
thermosensitive hydrogels in various diseases in clinical practice, they are not free from flaws.
Some hydrogels are difficult to gelatinize, and the degradation time is uncontrollable. Moreover,
hydrogels with poor biocompatibility always lead to severe tissue damages. Therefore, there is
an urgent need to develop thermosensitive polypeptide polymers with good biocompatibility and
biodegradability to avoid the above problems.
Towards this aim, peptide systems have been developed to avoid evoking the formation
of an acidic microenvironment during degradation, and thus reduce the damages to
surrounding tissues and minimize the adverse effects toward the bioactivity of the loaded
protein or cells. Apart from this, the gelation performance of the polypeptide copolymer
can be tuned by copolymerization with various hydrophobic or hydrophilic amino acid
monomers, which widens the clinical applications. In 2011, Jeong’s team reported the synthesis
of poly(alanine-co-leucine)−poloxamer−poly(alanine-co-leucine) (PAL−PLX−PAL) hydrogels,
which exhibited a sustained drug release pattern without producing evident inflammatory effects [22].
In 2017, methoxy poly(ethylene glycol)-block-poly(L-alanine-co-L-phenylalanine) mPEG-b-PLAF
hydrogel was synthesized by the ring-opening polymerization (ROP) reaction of L-alanine
N-carboxyanhydrides (L-Ala NCA) and L-phenylalanine NCA, with amino-terminated mPEG
(mPEG-NH2) as a macroinitiator. Encapsulated with combretastatin A4 (CA4) and doxorubicin
(DOX), mPEG−b−PLAF hydrogel had an excellent inhibitory effect on the proliferation of B16F10
melanoma cells [36].
In this work, mPEG−poly(L-alanine) (mPEG−PLAla) polymers with different degrees
of polymerization (DPs) were synthesized and named mPEG45−PLAla30, mPEG45−PLAla22,
and mPEG45−PLAla14. The influence of different DPs on the gelation properties of hydrogels was
studied. It was found that hydrogels with higher DP showed better gelation ability than those with
lower DP. In addition, the gelation behavior, tissue safety, and cytotoxicity of these polymers in vitro
and in vivo were also tested and evaluated. The study revealed that these hydrogels had notable
potential for employment in the biomedical field.
2. Results and Discussion
2.1. Material Synthesis and Structure Characterization
Triphosgene and L-alanine were synthesized into L-Ala NCA in dried tetrahydrofuran (THF)
solvent, as shown in Scheme 1. The polypeptide hydrogels were produced via the ROP of L-Ala NCA
initiated by mPEG45-NH2. The mPEG45−PLAla copolymers with different DPs were synthesized
by altering the feed amount. The DPs of PLAla were determined by contrasting the integral of the
methyl peaks of side chains (−CH3) with the methylene peak of PEG (−CH2CH2O−). The DPs of
mPEG45−PLAla30, mPEG45−PLAla22, and mPEG45−PLAla14 were 30, 22, and 14, respectively.
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Scheme 1. Synthetic routes of L-alanine N-carboxyanhydrides (l-Ala NCA) and methoxy poly(ethylene
glycol)−poly(l-alanine) (mPEG45−PLAla).
The typical proton nuclear magnetic resonance (1H NMR) spectrum of block copolymer is shown
in Figure 1a, and all peaks could be accurately assigned. The peaks at 1.47, 3.40, 3.50–3.80, and 4.64 ppm
stood for the protons of alanine methyl, mPEG terminal methoxy, mPEG backbone, and polymer




Figure 1. Structure characterization of mPEG45−PLAla. (a) 1H NMR spectra of mPEG45−PLAla30,
mPEG45−PLAla22, and mPEG45−PLAla14, where the subscripts indicate the degree of polymerization
(DP); (b) Fourier-transform infrared (FT-IR) spectra of mPEG45−PLAla30, mPEG45−PLAla22,
and mPEG45−PLAla14.
The secondary structure of the copolymer was studied by FT-IR. In Figure 1b, characteristic
peaks of amide bond at 1627 cm−1 and 1544 cm−1 were observed, indicating that all copolymers went
through the main β-sheet conformation.
2.2. Gelation Ability and Internal Appearance
The tube inversion method was used to determine the transition temperatures. Polypeptides
were solubilized in a phosphate-buffered saline (PBS) solution, and went through a solution–gel
transition with the change in temperature. The samples were defined as gel if they stayed still
when the vial was inverted for as long as 30 s. The phase diagrams of mPEG45−PLAla30 and
mPEG45−PLAla22 copolymers are shown in Figure 2a,b. Only copolymers with a DP of no less than
22 could undergo solution–gel transition at the concentration of 3.0–8.0 wt. %. It was noticeable that
mPEG45−PLAla22 showed a higher gel transition temperature than mPEG45−PLAla30. The critical
gelation temperatures (CGTs) of mPEG45−PLAla30 and mPEG45−PLAla22 were 5 ◦C and 15 ◦C,
respectively, at the concentration of 5.0 wt. %. The lower CGT of mPEG45−PLAla30 could be explained
by longer hydrophobic end than that of mPEG45−PLAla22 [37].
Solution phase behaviors of the three copolymers at different temperatures were investigated.
The images in Figure 2a,b showed the mPEG45−PLAla30 and mPEG45−PLAla22 solutions in
PBS (5.0 wt. %) at 4 ◦C and 37 ◦C. Although all copolymers were dispersed in PBS at 4 ◦C,
the mPEG45−PLAla14 formed a clear solution while mPEG45−PLAla30 and mPEG45−PLAla22 showed
a turbid state. When temperature rose to 37 ◦C, mPEG45−PLAla30 and mPEG45−PLAla22 were
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observed to be stably gelled within 5 min, while mPEG45−PLala14 remained in a viscous flow state.
This was because mPEG45−PLala14 had better water solubility. Further, the morphology of the
mPEG45−PLAla30 hydrogel (5.0 wt. %) was observed by scanning electron microscope (SEM). As can
be seen in Figure 2c, it was found that there were numerous tiny pores in the mPEG45−PLAla30 gel,
which was due to the 3D network structure of the gel. These pores showed a size of about 100 μm and
were evenly distributed within the hydrogel, making them suitable as a depot for therapeutic agents.
These findings prove that mPEG45−PLAla30 and mPEG45−PLAla22 hydrogels feature good stability








Figure 2. Gelatinization characteristics of mPEG45−PLAla. (a) Solution–gel phase diagrams of the
mPEG45−PLAla30 and (b) mPEG45−PLAla22 copolymer solutions; (c) Scanning electron microscope
(SEM) image of mPEG45−PLAla30 hydrogels formed at 40 ◦C; (d) G’ of the mPEG45−PLAla30 (PLAla30),
mPEG45−PLAla22 (PLAla22), and mPEG45−PLAla14 (PLAla14) at the concentration of 5.0 wt. %
in phosphate-buffered saline (PBS) solution; (e) Changes of G’ and G” of mPEG45−PLAla30 and
(f) mPEG45−PLAla22 in PBS solutions (5 wt. %).
2.3. Mechanical Performance Test
Thermally induced storage modulus (G′) and loss modulus (G”) changes of the three copolymers
were obtained by dynamic mechanical analysis. G′ represents the systematic gel-like behavior of
the elastic component of the complex modulus, and G” is an index of the viscous component of
the complex modulus and a measure of the sol-like behavior. The intersection of G′ and G” reflects
the sol–gel transition. As shown in Figure 2d, the G′ of mPEG45−PLAla30 and mPEG45−PLAla22
obviously increased along with rising temperatures. However, only a minor increment in G′ was
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seen in mPEG45−PLAla14, and no significant change in G′ was detected, even when the temperature
rose to about 50 ◦C, implying that there was no sol–gel modification of mPEG45−PLAla14 within
the experimental temperature range. The reason was that hydrophilic mPEG was longer than
the hydrophobic end made up of polypeptides. Therefore, with a longer hydrophilic segment,
mPEG45−PLAla14 showed better water solubility than mPEG45−PLAla30 and mPEG45−PLAla22,
thus featuring less obvious sol–gel change. Notably, the length of the hydrophobic side chain had a
remarkable effect on the gelation function of the mPEG−peptide block copolymer.
In Figure 2e,f, G′ was smaller than G” when the temperature was lower than CGTs (5 ◦C in
mPEG45−PLAla30 and 12 ◦C in mPEG45−PLAla22), which reflected the viscous state of hydrogels.
As the temperature increased above CGTs, G′ was sharply elevated and surpassed G”, confirming the
gel formation. This result was in accordance with the findings in Figure 2a,b.
2.4. Mechanism of Gelatinization
In order to study the mechanism of sol–gel transition, the nuclear magnetic peak changes, diameter
changes, and conformation evolution of polypeptides in response to temperature were tested by carbon
nuclear magnetic resonance (13C-NMR), dynamic light scattering (DLS), and circular dichroism (CD).
As shown in Figure 3a, when temperature rose from 20 to 60 ◦C, the characteristic peak of PEG
gradually moved from 69.7 to 70.3 ppm, which revealed continuous dehydration of the PEG block
during the heat-induced sol–gel transition process. Two main reasons accounted for the gelation of
polymers. First, the interaction between hydrophobic blocks became stronger as temperature increased.





Figure 3. Gelation mechanism of the hydrogels. (a) 13C-NMR spectra (in D2O) of 5.0 wt. %
mPEG45−PLAla30 solution as a function of temperature; (b) Average hydrodynamic diameter (Dh)
of micelles of mPEG45−PLAla30 as a function of temperature in water (5.0 μg mL−1); (c) Circular
dichroism (CD) spectra of mPEG45−PLAla30 (0.05 mg mL−1) in aqueous solution as a function
of temperature.
As seen in Figure 3b, the diameter changes of mPEG45−PLAla30 were determined at the
concentration of 5.0 μg mL−1. At 10 ◦C, the average hydrodynamic diameter (Dh) of mPEG45−PLAla30
was about 31.4 nm. When the temperature rose to 20 ◦C and 50 ◦C, the number swiftly increased to
95.9 nm and 356.2 nm, respectively. The dramatic changes in particle size could be explained by the
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interaction between the shell of PEG and core of polypeptides caused by the dehydration processof
PEG [38].
In Figure 3c, the CD spectrum illustrated the alteration of the secondary structure of the aqueous
mPEG45−PLAla30 during the sol–gel transition process. The two typical bands corresponding to
the β-sheet conformation, a positive Cotton band at 195 nm and a negative Cotton band at 226 nm,
were clearly shown. The above results revealed that the synthesized thermosensitive hydrogel had
good physicochemical properties and a clear solution−gel transformation mechanism.
2.5. Degradability Test and Pathological Analysis
Since hydrogels are often used in the biomedical field, biodegradability is a decisive factor for
clinical application. If the degradation rate of the hydrogel is too high, it will lead to a rapid release
of the payload. In contrast, if the hydrogel requires a long time to degrade, then it will probably
remain at the injection site even after all drugs are released, which is inconvenient for further treatment.
The in vitro degradation of mPEG45−PLAla30 hydrogel (5.0 wt. %) was evaluated in PBS and PBS
with elastase K or α-chymotrypsin. As shown in Figure 4a, there was a mass loss of over 70% and
67% hydrogel in the elastase K and α-chymotrypsin groups on day 15, respectively—considerably
higher than 20% in PBS. The results could be explained by the absence of elastase K or α-chymotrypsin,
where the mass loss of gels was merely attributed to the surface erosion of the hydrogels. However,
with elastase K or α-chymotrypsin, the polypeptide chains of the hydrogels were also fast degrading,






Figure 4. Degradation of hydrogel in vitro and in vivo, and histological analysis of skin. (a) Mass
loss curves of in vitro degradation of hydrogels in PBS, and PBS with elastase-K or α-chymotrypsin
(0.2 mg mL−1) groups; (b) Images of in vivo gel maintenance at 10 min, 7, 14, 21, and 28 days after the
injection of 5.0 wt. % mPEG45−PLAla30 hydrogels; (c) Hematoxylin and eosin (H&E) images of the
skin tissue near the hydrogels on day 7, 14, 21, and 28, respectively.
The degradation process of hydrogels in vivo was monitored for 28 days, and images were taken
at 10 min, 7, 14, 21, and 28 days after hydrogel treatment. At 4 ◦C, 500.0 μL of mPEG45−PLAla30
solution (5.0 wt. %) was subcutaneously injected into Sprague−Dawley (SD) rats through 21-gauge
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syringe needles. In Figure 4b, the solution rapidly turned into gel in 10 min after injection. Seven days
later, only a small portion of the hydrogel was degraded. On day 14, the size of the hydrogel shrank
to less than 50%, while on day 28, the hydrogel was completely degraded. This degradation rate of
hydrogel was suitable for application in biomedical fields requiring long-term treatment, such as tissue
repair. As shown in Figure 4c, at different time intervals, the tissue surrounding the gel was surgically
separated and processed by H&E staining to examine the condition of tissue damage. Basically,
no histological damage or immune response was found at any time point.
2.6. Safety Evaluation
The cytotoxicity of hydrogel mPEG45−PLAla30 in vitro was evaluated by methyl thiazolyl
tetrazolium (MTT) assay and hemolysis test. In Figure 5a, L929 cells treated with the highest
concentration of mPEG45−PLAla30 (100.0 ìg mL−1) for 24 h retained almost 100% viability, confirming
its excellent biocompatibility. Moreover, the effect of different concentrations of gel on hemolysis was
also investigated. In this part, hemolysis was measured spectroscopically according to previously
reported methods [39]. As shown in Figure 5b, no hemolysis was detected in blood samples
treated with all test concentrations of mPEG45−PLAla30, which further confirmed the outstanding
biocompatibility. Overall, the findings above revealed that the hydrogel showed little toxicity,
both in vitro and in vivo. Therefore, it is a promising material for usage in clinical practice.
  
(a) (b) 
Figure 5. Biological compatibility of mPEG45−PLAla30. (a) In vitro cytotoxicity of the
mPEG45−PLAla30 toward L929 cells. Data were presented as mean ± SD (n = 5); (b) Hemolysis
experiments of mPEG45−PLAla30. Data are presented as mean ± SD (n = 3).
3. Materials and Methods
3.1. Materials
mPEG−OH, number-average molecular weight (Mn) = 2000 g mol−1, was purchased from
Sigma-Aldrich (St. Louis, MO, USA). The mPEG45−NH2 was synthesized conforming to the previously
reported protocol in our work [40]. THF and toluene were refluxed with sodium and distilled under
nitrogen before usage. N,N-Dimethylformamide (DMF) was stored over calcium hydride (CaH2) and
purified by vacuum distillation. All the other reagents and solvents were bought from Sinopharm
Chemical Reagent Co. Ltd., Beijing, China, and used as obtained.
3.2. Phase Diagram
The sol–gel transition behavior of the copolymers in PBS (pH 7.4) was determined by inverting
test method with a temperature increment of 2 ◦C per step. Samples with concentrations ranging from
3.0−7.0 wt. % were dissolved in PBS and stirred at 0 ◦C for 12 h. The copolymer solution (0.2 mL) was
introduced into the test tube with an inner diameter of 10.0 mm. The sol–gel transition temperature
was recorded if no flow was observed within 30 s after inverting the test tube. Each data point was the
average of three measurements.
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3.3. Dynamic Mechanical Analysis
Rheological experiments were performed on a US 302 Rheometer (Anton Paar, Graz, Austria).
The copolymer solution was placed between parallel plates of 25.0 mm in diameter with a gap of
0.5 mm. To prevent the evaporation of water, the outer edge of the sandwiched sample was sealed by
a thin layer of silicon oil. The data were collected under a controlled strain γ of 1% and a frequency of
1 rad s−1. The heating rate was 1 ◦C min−1.
3.4. In Vitro Gel Degradation
For this, 0.5 mL of mPEG45−PLAla30 hydrogel was incubated in PBS (5.0 wt. %) in vials
(diameter = 16.0 mm) at 37 ◦C for 10 min. PBS solutions (pH 7.4) containing 0.2 mg mL−1 elastase K or
0.2 mg mL−1 α-chymotrypsin were used as degradation media, and hydrogels incubated in PBS were
only used as a control. Different solutions (2.0 mL) were added to the top of the gels at 37 ◦C and the
entire medium was changed daily. The weight of the remaining gel was measured daily.
3.5. In Vivo Gel Degradation
SD rats (about 180.0 g, provided by Beijing Vital River Laboratory Animal Technology Co.,
Ltd., Beijing, China) were used for the detection of gel degradation in vivo. Rats were anesthetized
by inhalation of ether before 0.5 mL of mPEG45−PLAla30 PBS solutions (5.0 wt. %) were injected
into the dorsal subcutaneous area of the rats using a 21-gauge needle. The rats were sacrificed on
day 7, day 14, day 21, and day 28, respectively, to monitor the degradation behavior of the gel.
The experiments on animals were carried out according to the guide for the care and use of laboratory
animals, provided by Jilin University, Changchun, China, and the procedure was approved by the
local Animal Ethics Committee.
3.6. Cytotoxicity Measurement
The relative cytotoxicity was assessed by MTT viability assay against L929 mouse fibroblasts cells.
L929 cells were cultured in complete Dulbecco’s modified Eagle’s medium (DMEM) supplemented
with 10.0% (v/v) FBS, penicillin (50.0 IU mL−1), and streptomycin (50.0 IU mL−1) at 37 ◦C in a 5.0%
(v/v) carbon dioxide atmosphere. L929 cells with a density of 6000 cells per well were planted in
96-well plates in 180.0 μL of DMEM. After incubation for 24 h, 20.0 μL of copolymer solutions at
different concentrations (31.3–1000.0 μg mL−1) were added. L929 cells were incubated with copolymers
for another 24 h before 20.0 ìL of PBS solution containing MTT (0.05 mg mL−1) was added and
incubated for a further 4 h. Then, the media was replaced with 160.0 μL of dimethyl sulfoxide (DMSO).
The absorbance of the solution was measured on a Bio-Rad 680 microplate reader (Hercules, CA, USA)
at 490 nm. Cell viability (%) was calculated according to the following Equation (1).
Measurements were done in five replicates.
Cell viability (%) = Asample/Acontrol × 100, (1)
where Asample and Acontrol denote the absorbances of sample and control, respectively.
4. Conclusions
In this work, thermosensitive hydrogels mPEG45−PLAla with three different DP (14, 22, and 30)
were synthesized by ROP of L-Ala NCA monomer initiated by mPEG45−NH2. The effect of different
DP on the solution−gel transition was investigated. It is worth noting that mPEG45−PLAla30 had a
lower sol–gel transition temperature than mPEG45−PLAla22, attributed to the longer hydrophobic
segment. In addition, mPEG−PLAla hydrogel had good stability and high mechanical strength
after gelation. Moreover, mPEG−PLAla hydrogel did not cause any tissue damage, inflammatory
reaction, or hemolysis reaction during degradation, confirming its good biocompatibility. In summary,
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the mPEG−PLAla hydrogel designed in our study had improved biocompatibility, appropriate
degradation, and gelation ability. Therefore, the polypeptide hydrogels showed promise for application
in tissue repair and regeneration, cell 3D culture, and treatment of cancer. Moreover, by loading
functional drugs, the hydrogels can also be used for postoperative recovery and anti-infection.
Based on the above findings, polypeptide thermosensitive hydrogels have broad prospects in the
biomedical field.
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Abstract: Electro-responsive smart electrorheological (ER) fluids consist of electrically polarizing
organic or inorganic particles and insulating oils in general. In this study, we focus on various
conducting polymers of polyaniline and its derivatives and copolymers, along with polypyrrole
and poly(ionic liquid), which are adopted as smart and functional materials in ER fluids. Their ER
characteristics, including viscoelastic behaviors of shear stress, yield stress, and dynamic moduli,
and dielectric properties are expounded and appraised using polarizability measurement, flow curve
testing, inductance-capacitance-resistance meter testing, and several rheological equations of state.
Furthermore, their potential industrial applications are also covered.
Keywords: conducting polymer; composite; electrorheological; smart fluid; viscoelastic
1. Introduction
Smart functional materials that can detect and identify external (or internal) stimuli, including
electricity, light, heat, magnetic fields, stress, strain, and chemicals [1], have gained attention due to
their various engineering applications, such as vibration controls [2], detection [3], electronics [4],
and drug delivery [5]. Among these smart functional materials, electrorheological (ER) suspensions
consisting of electro-responsive particles and an insulating fluid, such as silicone or mineral oil [6–8],
play a crucial role. By engaging an electric field, the electro-responsive functional particles begin
to polarize within milliseconds and the initially dispersed particles aggregate to build a chain form,
following an external electrical field direction because of an induced dipolar attractive force. Thus,
the microstructure of the ER suspension changes from a liquid-like to a solid-like form, as shown in
Figure 1. Therefore, their physical and rheological behaviors, such as steady shear viscosity, shear stress,
dynamic modulus, and yield stresses, and even stress relaxation changes according to the applied
electric fields; however, these changes can be reversed by removing the field. Most ER fluids suit the
Bingham fluid model, which illustrates that a fluid has its own yield stress, and the flow motion of the
fluid impedes when an input external shear stress is lower than the yield stress [9]. ER fluids with
this controllable and tunable phase change have a very good market prospect and wide applications,
such as dampers [10], ER haptic devices [11], shock absorbers, microfluidics [12–14], clutches [15],
ER finishing devices [16], and tactile displays [17].
ER fluids have been the subject of research and exploration since their discovery [18]. Furthermore,
research to find fibrillation structures between two applied electrodes with an apparent increase of
the viscosity of ER fluids have also been conducted. Klass and Martinek [19] introduced a dielectric
principle, and a water-associated electrical double-layer model, to explain that the critical factor of the
ER effect was the molecule in the wet-base ER fluids. The particles were polarized and distorted when
the extra electric field was applied and then the water molecules made an attractive bridge between
dispersed particles, thereby showing a higher surface tension.
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Figure 1. Schematic diagram of electrorheological (ER) behavior with an external electrical field.
Furthermore, ER materials cover a wide range of organics and inorganics particles, including
polymers and their organic or inorganic composites, with their particle size ranging from nanometers
to micrometers with multiple shapes, such as spherical, fibrous, sheet, and rod-like [20,21].
In this study, we focus on anhydrous ER materials with various conducting polymers and
their nanocomposites. Conducting polymers possess conjugated repeating units, which can be
appraised by some important variables, such as ionization potential, electron affinity, band gap,
and bandwidth [22–24]. By regulating these parameters the thermal, electrical, and optical properties
of polymers can be easily enhanced [25,26]. In particular, the electrical conductivity and thermal
or mechanical stability of nanocomposites, which have improved mechanical property, dispersion
stability, or physical characteristics, and can be easily controlled by various fabrication techniques [27].
Sundry conducting polymers have been employed as ER materials, including
polyaniline (PANI) [28,29], polypyrrole (PPy) [30], poly(p-phenylene) (PPP) [31–33],
poly(3,4-ethylenedioxythiophene) (PEDOT) [34], and so on. This study focuses on the ER
effect of conducting polymeric materials and their composites, including synthesis methods and
typical characteristics, using various rheological measurement methods. Furthermore, according to
the viscoelastic behaviors, such as flow curves, shear viscosity, yield stresses, and dynamic modulus,
the ER effect of polymeric materials dispersion is compared under an external electrical field with
various strengths.
2. Polymeric ER Materials
Oxides or non-oxide inorganic particles were introduced in ER fluids at the initial stages of study.
However, the dispersion stability was poor because of the large density variation between the dispersed
particles and the base oil. Therefore, organic particles gained attention, especially conducting polymers,
which are provided with conjugated π bonds along with a high dielectric constant, thereby exhibiting
excellent polarization capabilities under applied electric field strengths. Moreover, these types of
polymers can be comprehensive as ER materials because they have highly polarizable functional
groups on the molecular backbone.
2.1. PPy
Among the various conductive polymers, PPy is a research hotspot because of its high
electrical conductivity, simple method of preparation [35], ease of surface modification [36], excellent
environmental stability [37], and ion-exchange capacity [38]. In addition, it can be easily produced in
a large quantity at a room temperature using various solvents, including water. PPy is an excellent
conductive polymer; thus, it can be applied in ER fluids.
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Kim and Song [33] dispersed PPy in mineral oil as an ER fluid and controlled the amount of
oxidant and surfactant while synthesizing PPy particles to investigate the impacts on their ER effect.
They observed that as the amount of oxidant and surfactant increases the yield stress increases at the
initial stage but decreases after passing culmination because of the enhanced particle polarization.
Using thermo-oxidative treatment in air, Xia et al. [39] tuned the electrical conductivity of the PPy
nanofibers (shown in Figure 2b) to that of a nanofiber-based ER fluid. Its yield stress and shear
modulus were stronger compared to those from a typical granular-shaped PPy based ER suspension,
because the fiber-like particles can ameliorate the dispersion stability of the suspension. Many studies
have been conducted on preparing conducting PPy-based composite materials to surmount the poor
processability of PPy particles.
Moreover, while the morphology of the conducting polymers is well-known to be related
to their synthetic conditions, such as temperature, pH, oxidant species, oxidant/monomer ratio,
polymerization type, and so on, shape- or size-related morphology of the dispersed particles became
an important parameter in the rheological output of ER fluids. Specifically, regarding the effect of a
hierarchical form on ER properties, sea urchin-like conducting polymeric particles are known to exhibit
both better sedimentation stability than those with a smooth surface and better rheological behaviors.
They are expected to show larger drag forces and inter-particular frictions with their increased surface
area compared to that of the smooth-surfaced particles. Therefore, an improved ER efficiency with
larger yield stress can be expected in the same experimental conditions. Moreover, compared to the ER
fluid of spherically shaped particles, the systems with fiber-like particles were also observed to exhibit
better ER characteristics and enhanced suspension stability because the elongated shape possesses a
bigger induced-dipole moment and greater inter-particle interaction.
Concurrently, clays are widely used to compose polymer composites not only because of their
large specific surface area and good mechanical properties, but also because of their chemical, thermal,
and dimensional stability and low cost [40]. Halloysite (HNT) is a type of clay mined from natural
deposits and has a predominantly hollow tubular structure. HNT has been widely used in electronics,
catalysis, separation, and functional materials because of its uniquely versatile surface features.
Jang et al. [41] synthesized PPy/HNT nanocomposites (Figure 2c) and observed that adding HNT is
an effective method to improve PPy conductivity and properties of PPy-based ER fluids. Furthermore,
montmorillonite (MMT) clay is widely used in conducting polymer nanocomposites because their
particle size is smaller than 10 μm and they can be easily intercalated. Cations, such as Na+ and Ca2+,
in its lamellar surface enable interactions with monomers ensuring reasonable conductivity of the
associated electric signal. Following testing, Kim et al. [42] observed that PPy-dodecylbenzenesulfonic
acid (DBSA)/clay nanocomposites have better insulation and thermal stability. PPy was also inserted
into hexagonal channels of pore-expanded MCM-41 [43], whose insulating channel can improve the
ER response of the PPy suspension (Figure 2d).
Not only clay, but also conventional polymers were introduced in conducting polymer/clay
nanocomposites to overcome the limitation of poor processability, prepare conducting polymer-based
composite materials, and improve the sedimentation of ER suspensions. Kim et al. [44] assembled
PPy-polycaprolactone (PPy-PCL) composites (Figure 2e) to improve the mechanical and electrical
properties of PPy, along with enhancing their ER response. Furthermore, Kim and Park [45] reported
an ER response by coating PPy on polyethylene particles, thereby enhancing polarization by increasing
the particle surface conductivity.
Moreover, compared to single-component counterparts, core-shell structured particles often
exhibit better physical and chemical properties. A conducting shell can be polarized instantaneously;
thus, its ER response can be improved. In addition, an insulating core or an insulating shell in
the composite particles is designed to obtain a lower current density, by which the practicability
and environmental protection of the materials can be improved [46,47]. Kim et al. [48] synthesized
PPy-coated silica core-shell structured nanoparticles (Figure 2f), while Sedlačík et al. [49] synthesized
titanium oxide (TiO2)/PPy core-shell structured nanoparticles (Figure 2g) and analyzed the steady-state
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and oscillatory flow behaviors. Both sets of results showed that the novel core-shell structure possessed
predominant maneuverability and ER response.
 
Figure 2. SEM morphologies of polypyrrole (PPy) and its composites: (a) granular PPy and (b) PPy
nanofibers, reprinted with permission from [39]. Copyright Elsevier, 2011; (c) PPy-HNT particles,
reprinted with permission from [41]. Copyright Springer Nature, 2014; (d) PPy/MCM-41 particles,
reprinted with permission from [43]. Copyright Elsevier, 2010; (e) PPy-polycaprolactone (PPy-PCL)
composites, reprinted with permission from [44]. Copyright Springer Nature, 2007; and, core-shell
structures of (f) PPy-silica, reprinted with permission from [48]. Copyright RSC Publishing, 2016 and
(g) PPy-TiO2, reprinted with permission from [49]. Copyright Springer Nature, 2011.
2.2. PANI
Among various whole conductive polymers, PANI is considered an essential candidate
material for ER fluids because of its ease of synthesis, low price, chemical and thermal stabilities,
and sensitive response to easily controllable electrical conductivity, which can be steered by a reversible
doping/dedoping process [50]. Most morphologies of a synthesized PANI are irregular. However,
using some methods, such as interfacial polymerization [51] and rapid mixing method [52], and using
a surfactant or template [53] to direct PANI growth, we can obtain various shapes of fibers, tubes,
spheres, and even urchin-like particles (shown in Figure 3).
For ER fluid applications, the high conductivity of PANI is undesirable because of the high leakage
currents passing through the suspension with the electric field [54]. Thus, the protonated PANI needs
to be changed to a PANI base by treating it with an ammonium hydroxide solution. The electrical
properties of the protonated PANI and its corresponding bases can be controlled at a molecular level
162
Molecules 2018, 23, 2854
by partial protonation and acid selection of substitution of the PANI ring, or copolymerization of
aniline with substituted aniline or other monomers, as shown in Scheme 1. In addition to the powder,
PANI can be deposited on almost any object in the reaction mixture during aniline oxidation, or as a
colloid when the reaction mixture contains a stabilizer.
 
Figure 3. SEM images of synthesized polyaniline (PANI): (a) spheres, reprinted with permission
from [55]; Copyright Spring Nature, 2013; (b) fibers, reprinted with permission from [52]. Copyright
American Chemical Society, 2009; (c) urchin-like, reprinted with permission from [56]. Copyright John
Wiley and Sons, 2009; and (d) nanotubes, reprinted with permission from [57]. Copyright American
Chemical Society, 2006.
Scheme 1. Conductive protonated PANI is converted to a non-conducting PANI base by deprotonation
with ammonium hydroxide.
To improve the ER response of PANI particles and obtain an appropriate semiconducting regime
for an ER application, multifarious inorganics, such as clays, TiO2, silica, and BaTiO3, and even
magnetic materials, such as carbonyl iron or Fe3O4 (shown in Figure 4) were introduced. Furthermore,
some non-conducting core polymers form a core-shell structure with PANI as a shell (shown in
Figure 5). For example, as one type of clay, attapulgite (ATP) or palygorskite, which is a kind of
crystalline hydrated magnesium silicate with a fiber shape, has been introduced for PANI/clay
composites. It not only possesses a large specific surface area but also cation exchange capacity and a
reactive hydroxyl group on its surface [58]. Han et al. [59] synthesized PANI/ATP composite materials
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and then estimated their ER responses, observing that they were a feasible and efficacious method
for obtaining good mechanical strength, and easy processing of composite ER material. Furthermore,
sepiolite (SPL), another species of natural silicate clay with a fibrous morphology that has a large
surface area and porosity showing its mechanical reinforcing capability [60], has also been introduced.
Owing to that, Jang and Choi [61] used SPL synthetizing with PANI to obtain a neoteric ER material.
As a multi-functional physical cross-linker, laponite, a synthetic clay material, which was adopted to
stabilize emulsions because of its uniform and small dimensions, can lead to non-covalent cross-linking
on the clay/polymer interface [62]. Jun et al. [63] combined PANI and laponite confirming that this
composite displayed a typical ER behavior. Noh et al. [64] reported neoteric Fe3O4/SiO2/PANI
nanoparticles, which can be applied in both ER and magnetorheological (MR) fluids. In addition,
they observed that the ER and MR responses were significantly improved under both electric and
magnetic fields.
 
Figure 4. SEM and TEM photos of: (a) PANI/ATP, reprinted with permission from [59]. Copyright
Elsevier, 2017; (b) PANI/SPL, reprinted with permission from [61]. Copyright Elsevier, 2015;
(c) PANI/laponite, reprinted with permission from [63]. Copyright Elsevier, 2015; and (d)
Fe3O4/SiO2/PANI nanoparticles, reprinted with permission from [64]. Copyright Royal Society
of Chemistry, 2017.
Moreover, PANI has also been applied comprehensively with various polymeric shells. It is not
sufficiently sophisticated to form a PS/PANI nanosphere, due to π-π stacking attractive interactions
between an aniline monomer and sulfonating polystyrene (PS) using concentrated sulfuric acid.
Kim et al. [65] compared two types of PS/PANI-based ER fluids whose PANI shell was either smooth
or urchin-like. In Lee et al.’s work [66], the glycidyl methacrylate (GMA) was used to graft an
aniline monomer with poly(methyl methacrylate) PMMA to form a PANI/PMMA core-shell structure.
However, in Zhang et al.’s report [67], the core-shell PGMA/PANI composites were synthesized and
applied in ER fluids.
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Figure 5. SEM images of: (a) smooth PANI@PS and (b) urchin-like PANI@PS, reprinted with permission
from [65]. Copyright RSC Publishing, 2015; and (c) PGMA/PANI composite, reprinted with permission
from [67]. Copyright Elsevier, 2013.
2.3. Other Conducting Polymers
In addition to either PPy or PANI, various other conducting polymers and their derivatives were
applied in ER fluids. Although PANI has its own advantages in terms of controllable conductivity,
environmental stability, and simple synthesis, it also exhibits limitations, such as poor solubility
in various organic solvents. To overcome these defects, various derivatives were introduced [68].
Poly(diphenylamine) (PDPA) as a derivative of PANI, possesses not only a relatively low conductivity,
which helps avoid cause short-circuiting and can be directly applied in an ER fluid, but also produces
improved solubility in organic solvents with better thermal stability [69]. Kim et al. [70,71] at
first synthesized normal PDPA nanoparticles for an ER fluid, and then further fabricated a novel
core-shell-type PDPA/PS structure (shown in Figure 6), thereby observing that both these materials
were suitable for ER fluids.
 
Figure 6. SEM images of (a) Poly(diphenylamine) (PDPA), reprinted with permission from [70].
Copyright Elsevier, 2017 and (b) PDPA/PS core/shell structure, reprinted with permission from [71].
Copyright Elsevier, 2017.
The chemical formula of a p-phenylenediamine (PDA) is similar that of an aniline. It inspires
its ER application with its polymeric form [72] along with its versatile synthetic methods to prepare
poly(p-phenylenediamine) (PPDA, whose schematic diagram is shown in Scheme 2) particles as
compared to PANI. Plachy et al. [73] tried to modify PPDA by heat treatment to achieve appropriate
conductivity; however, they observed that the ER efficiency decreased as the carbonization temperature
increased. Cao et al. [74] fabricated poly(p-phenylenediamine)/graphene oxide (PPDA/GO) composite
particles, and observed that both PPDA/GO particles and PPDA-based ER fluids exhibited significant
ER characteristics.
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Scheme 2. Schematic diagram of PDPA synthesis via an oxidative polymerization.
It can be also noted that by introducing proper substituents on polymeric backbones,
functionalized PANI could be fabricated, providing extra tuning capability of their chemical and
electrical characteristics [75,76].
Recently, poly(N-methylaniline), as a derivative of PANI, has piqued the interest of many
researchers as, compared to PANI, it possesses much lower electrical conductivity. Thereby, it could
be directly applied to the ER fluid without further treatment. Moon et al. [77] used a simple method
to fabricate a core-shell typed poly(methyl methacrylate)/poly(N-methylaniline) (PMMA-PNMA).
Figure 7 shows the synthetic fabrication of the PMMA-PNMA particles. Initially, the surface of the
PMMA microspheres, which were fabricated through a dispersion polymerization process, was treated
with glycidyl methacrylate, ethylene glycol dimethacrylate, and oxydianiline as swelling, crosslinking,
and chemical-grafting agents, respectively. Further, the PNMA shell was coated by chemical oxidation
polymerization. Their ER suspension based on the PMMA-PNMA particles demonstrated conventional
ER behaviors in both simple shear flow and dynamic oscillation measurements for several different
electric field strengths applied.
Figure 7. Schematic diagram of fabrication of poly(methyl methacrylate)/poly(N-methylaniline)
(PMMA–PNMA) core-shell particles, reprinted with permission from [77]. Copyright Elsevier, 2015.
Polyindole (PIN) has attracted huge attention due to its good thermal stability and high redox
activity [78]. Indole is composed of a benzene ring connected to the heterocyclic pyrolytic ring; thus,
it was anticipated that it would show the properties of both PPy and PPP. Park et al. [79] synthesized
emulsion-polymerized PIN nanoparticles and used these as an ER material. Sari et al. [80] synthesized
PIN/polyethylene composites and observed that they were thermally more stable than PIN, and the
ER suspensions was observed to be increasing with increases in the electric field.
Poly(O-anisidine) (POA), with a methoxy functional group (−OCH3) at an ortho position, lowers
the mobility of electric charge carriers following the polymeric backbone, thereby lowering the electrical
conductivity. Recently, POA was adopted as an ER material. Cheng et al. [81] used chemical oxidation
polymerization to synthesize hollow POA microspheres with 1 μm diameter in a sphere-like form.
The hollow POA particles had low density, which is an advantage for a high-stability dispersed
phase ER fluid. Furthermore, Lee et al. [82] fabricated a core-shell structure of POA-silica particles
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using N-[(3-trimethoxylsilyl)-propyl] aniline (PTMSPA) grafting agent and defined their ER properties
(as shown in Figure 8).
 
Figure 8. TEM images of (a) hollow poly(O-anisidine) (POA), reprinted with permission from [81].
Copyright IOP Publishing, 2011 and (b) POA/silica core/shell structure, reprinted with permission
from [82]. Copyright IOP Publishing, 2017.
Polyacene quinone radicals (PAQRs) are also a type of semi-conductive polymers, which possess
the p-conjugated structure. They have been widely used and studied because of their better thermal
stability, environmental stability, and the characteristic that their conductivity can be controlled by
polymerization conditions (such as temperature, acenes, and anhydrides). Wang et al. [83] synthesized
hollow PAQR sub-microspheres by a modified solvo-thermal method and then observed that their ER
fluid exhibited conventional ER properties. Poly(naphthalene quinone) (PNQR) has a similar chemical
p-conjugated structure as PAQR, and so also has an electrical conductivity and can be applied as an
ER fluid material. Cho et al. [84] synthesized PNQR from the Friedel–Craft acylation and its flow
behaviors when suspended in the silicone oil were analyzed using rheological equations of state from
Bingham, De Kee-Turcotte, and Cho-Choi-Jhon (CCJ) equations.
Meanwhile poly(3,4-ethylenedioxythiophene)(PEDOT):poly-(styrenesulfonic acid) as a derivative
of polythiophene, has attracted considerable attention because of its several advantages as a conducting
polymer, such as processability in aqueous solutions, and better thermal and structural stability [85].
An et al. [86] fabricated core/shell typed polystyrene (PS)/PEDOT microspheres and reported their
ER behaviors under an electrical field. On the other hand, Erol et al. [87] synthesized core/shell
typed nano-rods with a titania core and conducting polymeric PEDOT shell. They were fabricated
via covalent bonding to obtain a thin polymeric shell, making the interfacial interactions between
the two components stronger. They found that the nanorod-shaped TiO2/PEDOT particles exhibited
improved ER performance and storage moduli, as well as larger creep-recovery after stress loading,
when compared to their particulate morphology.
Furthermore, to solve problems such as high conductivity and low thermal stability of
PANI, aniline is often copolymerized with other conductive polymer monomers to form a more
functional conductive polymer. Cho et al. [88] synthesized poly(aniline-co-pyrrole) (PAPP) particles
(aniline:pyrrole = 1:1) via a chemical oxidation polymerization technique. It was proved that the
copolymer has better thermal stability and more suitable conductivity than PANI as the dispersed
phase in ER fluid. Pandey et al. [89] fabricated poly(aniline-co-O-anisidine) with a lower value
of electrical conductivity by explaining the incorporated O-anisidine moieties in PANI backbones.
Trlica et al. [90] also reported a poly(aniline-co-1,4-phenylenediamine) particles-based ER suspension
with an applied external electric field, along with electrical characteristics of an ER suspension.
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2.4. Composites
Various inorganic-conducting polymers have been introduced for their ER applications, and
among these, recently graphene has attracted great interest in the fields of capacitors, electronic devices,
sensors, and composites due to its unique structure and electrical characteristics, even in ER fluids [91].
Although graphene oxide (GO) which is the oxidized form of graphene has many defects during
its preparation process, it contains functional components such as an hydroxyl group, epoxy group,
and carboxyl group, making it more easily dispersed in water [92]. By simply compounding with
other polymers, it can be modified to have multiple functions. Zhang et al. [93] synthesized PANI/GO
composites by an in-situ oxidation polymerization method with a stable GO and reported its composite
particle-based ER suspension showed a general ER property. On the other hand, Min et al. [94]
fabricated core-shell typed PMMA/GO microspheres via a Pickering emulsion polymerization method
with the GO as the solid surfactant, and studied their ER response. Cao et al. [74] synthesized
poly(p-phenylenediamine)(PPDA)/GO composite particles via an in-situ oxidation polymerization
technique of p-phenylenediamine in GO suspension, observing improved typical ER behavior when
compared to PPDA particle-based ER fluid.
Furthermore, carbon nanotubes as another candidate for ER fluids have received a lot of
consideration [95–97], although compared with single-walled carbon nanotubes (SWNT), multi-walled
carbon nanotubes (MWNT) have been more widely used in the ER field due to their lower electrical
conductivity. Jin et al. [98] produced MWNT-adsorbed PS and PMMA particles using different
surfactants, such as anionic sodium dodecyl sulfate and sodium dodecylbenzene sulfonate, and cationic
cetyl trimethylammonium bromide. Not only conductive carbon materials, but also many metal oxides,
can be compounded with conductive polymers to form multifunctional materials showing remarkable
ER effects. Fang et al. [99] synthesized magnetic nanoparticles (Fe3O4) together with a conductive PPy
using a simple fabrication method, and applied it to both ER and MR fluids.
2.5. Poly(Ionic Liquid)s
Poly(ionic liquid)s (PILs), initially evaluated as ion conductive polymers, refer to a new type of
polymers in which ionic liquids (ILs) are linked through polymeric backbones to form macromolecular
structures. They have attracted huge scientific interest not only because they have the suitable
electrical conductivity and thermal stability from the ILs, but also because, like polymers, they have the
advantages of good solid morphology, simple processing and good mechanical properties [100,101].
To activate the ER effect, classical polyelectrolytes need to adsorb a tiny amount of water to
boost the local ion movement which will cause chemical corrosion, dielectric breakdown, and
limited operation at higher temperatures. Nevertheless, because of fluoric counter-ions including
tetrafluoroborate (BF4−), hexafluorophosphate (PF6−), and fluorinated imide ((CnF2n+1SO2)2N−),
PILs are generally organophilic and insoluble in water. Using a microwave-assisted dispersion
polymerization technique, Dong et al. [102] synthesized mono-dispersed PIL particles possessing
a styrenic backbone and different sizes of cationic/anionic parts (shown in Figure 9) and reported
their enhanced anhydrous ER characteristics. Then they further synthesized several mono-dispersed
poly[p-vinylbenzyl trimethylammonium] PIL microspheres possessing a similar diameter but different
counter-anions. This showed that PILs with a smaller volume or counter-ion size exhibited higher ER
behavior compared to PILs possessing organic counter-ions or inorganic counter-ions alone [103].
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Figure 9. SEM photos of poly(ionic liquid)s (PIL) particles: (a) poly((p-vinylbenzyl
trimethylammonium) (VBTMA)+CF3SO3); (b) poly(VBTMA+ (CF3SO2)2N−); and (c)
poly((p-vinylbenzyltriethylammonium bis(trifluoromethane sulfonimide) (VBTEA)+ (CF3SO2)2N−),
reprinted with permission from [102]. Copyright Elsevier, 2016.
3. ER Characteristics
3.1. Direct Observation
The electrical stimuli response characteristics of ER fluids can be directly detected by an optical
microscope (OM) with an external electric field [84]. The polarization measuring device is presented
in Figure 10a. The ER suspension was placed in the center of a transparent substrate connected to a
DC high voltage power supply, and micro-structural changes were captured by the OM. Sever and
Unal [104] prepared an ER fluid by dispersing nanocube-TiO2/poly(3-octhlthiophene) in silicone oil
and observing its polarizability and potential ER performance with this OM device technique. The
particles were suspended randomly similar to a liquid state when E = 0 kV/mm, while they were
electrically polarized and migrated to organize a columnar structure parallel to a field direction when
E = 0 kV/mm (Figure 10b). The formation of this chain like-columnar structure caused ER fluid to
exhibit a solid-like behavior, which was attributed to the polarization of the particles [8]. Furthermore,
this columnar structure was found to be stronger and thicker, in accordance with the increment in
applied E range from 0.5–2.5 kV/mm and could be maintained as long as an external electrical field
applied, indicating that the increased E caused a tighter columnar structure. These results are consistent
with OM studies carried out for various ER fluid materials [105–107].
Figure 10. (a) Schematic illustration of polarizability measuring device; (b) optical microscope (OM)
images showing the polarization of nanocube-TiO2/poly(3-octhlthiophene)-based ER fluid, reprinted
with permission from [104]. Copyright John Wiley and Sons, 2016.
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3.2. Flow Curve Behaviors
Stable steady shear flow curves in ER fluids can be established via a typical rotation rheometer test,
like the controlled shear rate (CSR) method, which provides a basis for observing the yield stress of ER
suspensions and electrical stimulus response behavior [21,108]. The flow curve of ER fluid produced





In general, two types of interactions occur between dispersed ER particles in a steady shear flow;
the electrostatic interaction caused by an external electrical field and a hydrodynamic interaction
induced by a steady shearing flow [109]. The shear flow field results in shear deformation of the
chain structures formed under an electric field; however, the broken structure tends to rebuild the
chain simultaneously under an applied external electrical field. These phenomena of destruction
and reorganization depend on the applied shear stresses and the electric field strengths. At a low
shear rate regime, the electro-static attractive interaction becomes prominent, allowing the chain
structure to reduce the effect from shear deformation [110]. As a shear rate increases, the breaking
rate exceeds the recombination rate, so that the chain structure will eventually be destroyed and will
exhibit a liquid-like behavior. However, a stronger electric field can result in a stronger electrostatic
interaction which is sufficient to resist shear deformation, allowing the solid-like behavior of the ER
fluid to re-emerge.
Based on the electrical stimuli-response behaviors of ER fluids in a shear flow field, many models
have been introduced to qualitatively explain the flow curve. The Bingham model (Equation (1)),
the simplest equation with two parameters, has been extensively employed as a viscoelastic equation
to fit steady shear behaviors exhibited in ER fluids along with various suspensions and MR fluids [111]:
τ = τy + η
.
γ τ ≥ τy
.




γ is a shear rate; η is a shear viscosity; τ and τy are shear and yield stresses,
respectively. Piao et al. [112] explained shear stress behaviors of PS/PANI-based ER suspension
using this Bingham fluid model, in which the flow curve, as shown in Figure 11a, was fitted by this
model quite well. Its shear stress was observed to increase linearly with increased shear rate when
E = 0 kV/mm, which is similar to that of Newtonian fluids. Under an applied electrical field, the ER
suspension demonstrated increments in shear stresses and exhibited a plateau behavior because of the
formation of the columnar structure.
However, in the case of Figure 11b [59], shear stresses of the PANI@ATP-based ER suspension
presented a weak concave shape in a low shear rate area, passed through a minimum value, and once
again increased. This behavior could be explained by the fact that the reconstituted structure is not
as complete as the structure formed before the steady shearing flow applied. Thus, they adopted the
Cho-Choi-Jhon (CCJ) equation [84], which is an empirical formula with six parameters to express the



















The first term corresponds to the decrease in the shear stress at the low shear rate area, and the
next term depicts a shear-thinning property at the high shear rate area. The t1 and t2 parameters are
time constant, and η∞ is a shear viscosity at the infinite shear rate. The exponent α represents the shear
stress decrease, and b is located between 0 and 1. This model was observed to be a good indication of
the overall behavior of various ER fluids [61,87,113], including the reduced shear stress phenomenon.
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In addition, the De Kee-Turcotte equation (Equation (3)) and Herschel-Bulkley equation
(Equation (4)), as a modified version of the Bingham equation, have also been applied for various ER
suspensions [114,115]:









where t1 is a time constant, m is a consistency index, and n is a flow index. Cho et al. [84] constructed the
flow curve of a poly(naphthalene quinone)-based ER suspension for different particle concentration
and electric field strengths, and interpreted its steady-state flow properties using three different
equations from the Bingham, De Kee-Turcotte, and CCJ models. As presented in Figure 11c, the CCJ
equation fitted the decrement of shear stress better for a shear rate range from 0.01–100 s−1; however,
significant deviation was found at a low shear rate region compared to other two equations, especially
for a lower volume fraction of poly(naphthalene quinone)-based ER fluid.
Based on the above models, Seo and colleagues [116] proposed a new rheological model














⎠+ η .γ (5)
Figure 11. Shear stress vs. shear rate for: (a) PS/PANI-based ER suspension (solid lines for Bingham
equation), reprinted with permission from [112]. Copyright Elsevier, 2017; (b) PANI@ATP-based ER
suspension (solid lines for CCJ equation), reprinted with permission from [59]. Copyright Elsevier,
2017; (c) poly(naphthalene quinone)-based ER fluid (dashed lines for Bingham equation, solid lines for
De Kee-Turcotte equation, and bold solid lines for CCJ equation), reprinted with permission from [84].
Copyright American Chemical Society, 2012; and (d) PMMA/PANI-based ER fluid (dotted and solid
lines for CCJ equation and four-parameter equation), reprinted with permission from [117]. Copyright
Elsevier, 2005.
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This four-parameter model was introduced to predict static yield stress, while the CCJ and
Bingham models were based on dynamic yield stress. In Equation (5), a is a time constant, τsy represents
a static yield stress, and α is a power-law index relating to the shear thinning. In Figure 11d, Seo and
Seo [117] analyzed the flow curves of PMMA/PANI-based ER suspension using the CCJ equation and
their proposed equation. At a low shear rate regime, the shear stresses predicted by the new model
converged to yield stress, while the prediction of the CCJ model continued to increase as the shear rate
decreased. Moreover, at the high shear rate area, the prediction of the CCJ equation deviated from
the experimental data, while the new equation prediction was considered to match the experimental
data better.
3.3. Yield Stress
Yield stress, as a key parameter of rheological properties in suspensions, can provide information
about the performance of the ER fluids depending on electrical field strength, volume fraction,
and dielectric properties of the particles. Many test methodologies have been applied to study
yield stress characteristics, corresponding to different yield stress values including dynamic, elastic,
and static yield stresses [118].
As shown in Figure 12, Lim et al. [119] studied dynamic, static, and elastic yield stresses vs.
electrical field strength for a PANI-nanotube-based ER suspension, estimated from controlled shear
rate, controlled shear stress, and dynamic oscillatory frequency tests, respectively. The results showed
that the static yield stress had the highest value because the static state that included more aggregate
without shear rate control, as compared to the ER fluid under the dynamic condition. The elastic yield
stress is obtained from the maximum shear stress required to achieve full recovery after the shear
stress is removed, which is the lowest. Nonetheless, these three types of yield stress as a function of
electric field strength presented equivalent behaviors.
Figure 12. Static, dynamic, and elastic yield stresses as a function of electrical field strength for
PANI-nanotube-based ER suspension, reprinted with permission from [119]. Copyright Elsevier, 2017.
As mentioned above, the electric field strength dependent yield stress has been the focus of many
studies on ER characteristics. Klingenberg et al. [6] introduced an electrostatic polarization model and
calculated the functional relation between yield stress and electrical field strength as follows:
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where ϕ represents a volume fraction and L represents the electrode separation. fm and θm are the
maximum dimensionless restoring force and angle, respectively. This expression means that the
dynamic yield stress is essentially proportional to the squared electrical field strength. However,
although some experiments confirmed this result [120,121], the effects of the particular material,
concentration, shape, and electric field strength will cause the index to deviate from 2.0 [122,123].
As shown in Figure 13, Sung et al. [124] observed that the yield stress of a highly substituted
potato starch phosphate (HPSP)-based ER fluid was not proportional to E2, which deviated from
the polarization model because of the non-spherical shape of HPSP.
Figure 13. Yield stress vs. electrical field strength for highly substituted potato starch phosphate
(HPSP)-based ER suspension with different molar ratios, reprinted with permission from [124].
Copyright American Chemical Society, 2005.
Concurrently for conducting suspensions under a high electric field strength, the ER characteristic
would be affected by a conductivity mismatch and an interaction between dispersed particles and
dispersing oil, rather than by their dielectric constant mismatch. Davis et al. [125] investigated the
effect of field-dependent fluid conductivity and proposed that the yield stress appeared to approach
E3/2 under high electric field strength (consistent with Figure 12) [126].
Moreover, as shown in Figure 14, the yield stresses of PANI/mSiO2-based ER suspensions can
be separated into two different areas in the entire electric field strength ranges [127]. Choi et al. [128]
proposed a critical electrical field strength (Ec) and developed the following simplified equation to









Ec could be obtained from an intersection between two power-law slopes for a low and a high
electrical field area. The parameter α is dependent on a particle volume concentration and a dielectric
constant of the ER suspension. Equation (7) contains two limiting behaviors of yield stress: E2 for
E  Ec and E1.5 for E  Ec. As presented in Figure 14, the ER characteristics of PANI/mSiO2
corresponded to the non-linear conductivity model where the indices are 2 below Ec and 1.5 above Ec.
Many other studies have proved the rationality of this equation [129,130].
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Figure 14. Yield stress of PANI/mSiO2-based ER suspension as a function of electrical field strength,
reprinted with permission from [127]. Copyright Elsevier, 2016.
4. Dielectric Analysis
A high dielectric constant shows a useful effect on the ER response because of the more effectively
achievable polarizability. In general, the dielectric property is measured by an inductance capacitance
resistance (LCR) tester. Figure 15 represents both the dielectric spectrum and the Cole–Cole curve
of POA-silica composites [82]. The permittivity is frequency-dependent and can be expressed in its
complex form involving permittivity (ε′) and the loss factor (ε′′ ): ε∗ = ε′ + ε′′ . The polarizability is
described as the permittivity difference of Δε = ε0 − ε∞ and relaxation time (λ = 12π fmax), which are
obtained by fitting the dielectric spectra with the Cole–Cole formula.




Figure 15. (a) Dielectric spectrum and (b) Cole–Cole plot of silica/POA based ER suspension, reprinted
with permission from [82]. Copyright IOP Publishing, 2017.
In Equation (8), ω is a frequency and (1 − α) expresses the relaxation time distribution for a whole
frequency area. It has been observed that a large ER efficiency is related to a large Δε and a dielectric
loss peak is placed between 102 and 105 Hz. When α is zero, Equation (8) is reduced to the Debye’s
single relaxation time model. In Dong ’s report [103], Equation (8) was used to compare different sizes
of poly[p-vinylbenzyl trimethylammonium] based PILs possessing a similar diameter but different
counter-anions. The results are shown in Table 1, with the counteranions of TfO, Δε having the largest
value. Furthermore, in the subsequent ER response experiment, the PILs with TfO also exhibited the
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best ER effect, thereby showing that PILs with a smaller volume or size of counter-ions demonstrated
a higher ER response.
Table 1. Dielectric properties of PIL suspensions [103].
Sample ε0 Δε λ
P[VBTMA][PF6] 4.70 1.70 0.002
P[VBTMA][BF4] 5.01 1.88 0.0061
P[VBTMA][TFSI] 5.14 1.96 0.0009
P[VBTMA][TfO] 5.11 2.01 0.00049
5. Engineering Applications
With yield stress generated under external electrical field strengths applied, ER fluids have the
advantages of reversible continuous control and fast response and so have been widely adopted in
vibration control, tactile display, sensor, and other applications for different modes. In a flow mode,
two electrodes are set, and the vibrational control is realized by tuning the fluid motion between the
two electrodes. In a shear mode, one electrode rotates freely relative to the other, thereby controlling
the vibration by tuning the shear force. In a squeeze mode, the electrode gap becomes larger and the
ER suspension is extruded by the normal force.
Further detailed applications using ER fluids include the torsional vibration clutch, brake, damper,
optical material polishing, tactile devices, and so on. The controllable ER characteristics can be used as
power transfer agents with functions similar to friction in conventional clutches; thus, much research
has been devoted to the application of this special object in automotive clutches. Madeja et al. [131]
investigated the practical ranges of a hydrodynamic clutch by applying an electric field,. To control
braking force distribution, Choi et al. [132] introduced a vehicle ER valve-based anti-block brake
system (ABS). Until now, ER fluids have relatively low yield stress under 8 kPa; thus, they are not used
as hydraulic actuators. However, with the development of giant ER fluids [133], because the yield
stress of the ER actuator can reach 130 kPa, it is expected to produce ER actuator.
An ER fluid can be precisely controlled by tuning the electrical field intensity; thus, it can also be
used in polishing the tactile devices of optical materials. Kuriyagawa et al. [16] used an ER solution for
the first time in the fabrication of optical lenses. Compared with MR polishing, ER polishing has the
advantages of a uniform electric field and simple electrode structure. Su et al. [134] used an ER fluid to
fabricate wheeled integrated electrodes for micro-optical components.
Moreover, Taylor et al. [135] developed a force display device using a 1-degree of freedom (1-DOF)
ER brake. Recently, Han et al. [136] reported a 4-DOF haptic device using ER fluids for a minimally
invasive surgery.
6. Conclusions
In this study, we discussed various modified and unmodified conductive polymers,
their composites with special structural properties (fiber, core-shell spherical or non-spherical particles,
and so on), and their ER responses. Considerable progress has been made in the introduction of new
and synthetic methods, and in their corresponding ER characteristics. ER materials with ideal chemical
and physical characteristics can be prepared by interfacial oxidation, micro-emulsion, Pickering
emulsion, polymer grafting, the co-precipitation hydrothermal method, the sol-gel method, and other
methods. Among these, the study of PANI and PPy is the most extensive and comprehensive, not only
in terms of the morphology and properties of the polymers themselves, but also in terms of the results of
their combination with other organic or inorganic compounds. In recent years, many new conductive
polymers, such as PDA, PDPA, PIN, and POA, and their composites with different conductivity
properties, have been widely used in ER fluids.
The power law between yield stresses and electric field strengths of various conducting polymer-
based ER fluids, with its exponent between 1.5 and 2.0, is explained based on both a polarization
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model with an exponent of 2.0 and a conduction model with an exponent of 1.5. Nonetheless, to cover
various conducting polymer-based ER suspensions in which the exponents do not follow one of
the two mechanisms mentioned above, a universal yield stress equation was designed to properly
correlate their dependence. In addition, both the CCJ and four-parameter models exhibited better
fitting performance for the shear stress curve of the ER suspensions under applied electrical fields
in the range of shear rate as compared with that of the traditional Bingham fluid model. Finally,
recent applications of ER fluids, such as in damper systems, control systems, haptic devices, polishing
systems, and so on, were summarized for potential commercialization of various engineering devices.
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Abstract: The field of controlled polymerization is growing and evolving at unprecedented rates,
facilitating polymer scientists to engineer the structure and property of polymer materials for a
variety of applications. However, the lack of degradability, particularly in vinyl polymers, is a general
concern not only for environmental sustainability, but also for biomedical applications. In recent
years, there has been a significant effort to develop reversible polymerization approaches in those
well-established controlled polymerization systems. Reversible polymerization typically involves
two steps, including (i) forward polymerization, which converts small monomers into macromolecule;
and (ii) depolymerization, which is capable of regenerating original monomers. Furthermore,
recycled monomers can be repolymerized into new polymers. In this perspective, we highlight
recent developments of reversible polymerization in those controlled polymerization systems and
offer insight into the promise and utility of reversible polymerization systems. More importantly,
the current challenges and future directions to solve those problems are discussed. We hope this
perspective can serve as an “initiator” to promote continuing innovations in this fairly new area.
Keywords: controlled polymerization; reversible polymerization; sustainable polymers
1. Introduction
The fundamental concept of reversibility has been widely utilized to drive the development of
new polymeric materials, which can display distinct but reversible change in properties upon receiving
a stimulus [1,2]. In light of this, a library of reversible materials based on polymers have recently
been achieved, including self-healing materials bearing reversible-covalent linkages [3–8], recyclable
materials such as vitrimers [9–11], polymer networks enabling reversible sol-gel transitions [12–14],
architecture-transformable polymers [15], and covalent or metal organic frameworks harnessing
reversible bonds [16–21]. Despite the tremendous success in the aforementioned polymer systems,
little attention has been paid to achieving reversible polymerizations. Compared with self-immolative
polymers, which can only undergo one-way depolymerization, a reversible polymerization
typically features reversible transformations between polymers and original monomers [22]. Indeed,
step-growth polymerizations relying on reversible-covalent chemistry, particularly Diels–Alder
chemistry, have provided an approach to reversible polymers that favors forward polymerization
at room temperature and tends to depolymerize at high temperatures (i.e., 120 ◦C) [23]. However,
those polymers prepared by step-growth polymerizations typically have very broad molecular weight
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distributions and small molecular weights, limiting their potentials in certain applications that require
precise polymer chain length, complicated architectures, and high molecular weights [24–29].
In the last two decades, the rapid advent of controlled and living polymerizations has
offered polymer scientists a powerful synthetic toolbox for accessing polymers with predetermined
molecular weights, well-defined architectures, and narrow distributions in molecular weights [30–35].
In addition, the excellent tolerance of functional groups in controlled polymerization systems has
enabled us to achieve advanced polymer materials with desired functions and properties [36–41].
In general, controlled polymerization techniques can be categorized into three common classes.
The first one involves ring-opening polymerization (ROP) of cyclized monomers (e.g., caprolactones,
lactides, and N-carboxyanhydrides) in the presence of a nucleophilic initiator and a catalyst
(metal or organic) [42–47]. The second category highlights the well-developed applications of
controlled anionic/cationic polymerizations, which have led to industrial production of thermoplastic
elastomers [30]. The last class focuses on reversible-deactivation radical polymerization (RDRP)
methodologies, which are capable of polymerizing vinyl monomers, such as acrylates, methacrylates,
and styrene in a controlled manner [48–51]. To date, three mainstream RDRP techniques, including
atom-transfer radical polymerization (ATRP) [52,53], reversible addition–fragmentation transfer
(RAFT) polymerization [54–57], and nitroxide-mediated polymerization have been developed [58].
Among them, ATRP and RAFT are receiving the most attention, due to their unique advantages, such as
mild polymerization conditions, broad monomer scope, and ease of end-group functionalization [59].
These controlled polymerization systems are enjoying tremendous success in producing polymers
that accommodate both industrial use (supported by ROP and anionic/cationic polymerizations)
and academic research. However, the studies related to depolymerization are scarce, because
depolymerization was typically considered as a side reaction that would lessen the performance—
e.g., the mechanical properties of polymer materials [60]. While this is true in the pursuit of
maximizing lifetime or long-term stability of polymer materials, serious pollution problems have
arisen from the lack of degradability in commercial polymer plastics under common conditions [61].
Sustainable polymers, such as degradable polyesters deriving from biomass resources, represent
a promising platform for environmental remedy. However, those polymers currently suffer from
high manufacturing cost and low mechanical properties compared to vinyl polymer-based materials
from petroleum resources. Moreover, the degradation of these sustainable polyesters is typically
one-way, resulting in non-polymerizable fragments that are not useful for the regeneration of new
materials. To fully achieve sustainability in polymer materials, recent attentions have been shifted
to the development of new methods for depolymerizing polymers back into original monomers
under accessible conditions [60,62–71]. These regenerated monomers can be recycled and further
repolymerized to obtain new polymer materials. From this perspective, we aim to first critically
assess the state-of-the-art toolbox for achieving reversible polymerization in controlled polymerization
systems (Scheme 1). Recent examples on reversible polymerizations will be classified according to
their controlled polymerization mechanisms, i.e., ROP and RDRP (Scheme 1 and Table 1). In addition,
we believe it is important to assess the current challenges of reversible polymerizations that can trigger
polymer chemists to solve this issue. Finally, potential applications deriving from this fairly new
concept will be predicted and discussed.
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Scheme 1. Various mechanisms of reversible polymerization approaches in controlled polymerization
systems; (a) ring-opening polymerization (ROP) and ring-closing depolymerization (RCDP);
(b) atom transfer radical polymerization (ATRP) and β-alkyl elimination-induced depolymerization;
(c) reversible addition–fragmentation transfer (RAFT) mediated polymerization and depolymerization.









Polyester ROP RCDP ≥99% Albertsson [64]
Polyester ROP RCDP ≥99% Chen [68]
Polyester ROP RCDP ≥99% Chen [71]
Polyester ROP RCDP ≥99% Chen [69]
Polyester ROP RCDP ≥99% Chen [70]
Polyester ROP RCDP ≥99% Chen [67]
Polyester ROP RCDP ≥99% Hoye [66]
Vinyl polymer ATRP β-alkyl elimination 24–34% Zhu [62]
Vinyl polymer ATRP Not identified 43–71% Haddleton [65]
Vinyl polymer RAFT RAFT 28% Gramlich [60]
2. Reversible Polymerization in Ring-Opening Polymerization Systems
We begin our exploration of reversible polymerization approaches in ROP systems [63,64,66–71].
As one of the most popular controlled polymerization strategies, ROP of cyclic monomers has
emerged as a useful synthetic route to prepare technologically interesting polymers with desirable
architectures and specific properties. In particular, nucleophile-initiated ROP in the presence of
metallic or organocatalysts allows the polymerization to proceed in a controlled manner, affording
polymers with pre-determinable molecular weights and narrow molecular weight distributions.
Applicable monomers include lactones, lactides, cyclic carbonates, N- or O-carboxyanhydrides,
and cyclooligosiloxanes, among others [43]. To date, well-defined polymers produced from those
monomers have attracted significant interest in both academic research and industry [43,72,73]
Although many of the ROP polymers are comprised of hydrolysable ester linkages in their
backbones, which can cause the polymers to degrade into oligomers or possibly small molecules, it is
still challenging to completely convert the polymers back to the original cyclized monomers. In 2014,
Albertsson and coworkers demonstrated their pioneering work on ring-closing depolymerization to
obtain a functional six-membered cyclic carbonate monomer, 2-allyloxylmethyl-2-ethyltrimethlene
carbonate (AOMEC), from its oligomeric form [63]. The synthesis of AOMEC was performed in a
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one-pot reaction, involving the oligomerization of trimethylolpropane allyl ether, diethyl carbonate,
and NaH, followed by an in-situ anionic depolymerization. It was observed that the depolymerization
can occur beyond the ceiling temperature of the polyester at a certain polymer/monomer concentration,
suggesting the reversible nature of the polymerization of AOMEC. However, there was still room
to improve, since the oligomers were synthesized simply by condensation reaction rather than ROP,
and the degree of polymerization was only from 1 to 7.
Inspired by this pioneering work, Albertsson’s team continued the study on AOMEC and first
demonstrated the reversible ROP of this six-membered cyclic carbonate monomer in 2016 [64]. It was
concluded that the equilibrium between controlled ROP of AOMEC and controlled ring-closing
depolymerization (RCDP) of poly(AOMEC) were dictated by various reaction parameters, such as
monomer concentration, reaction temperature, and even solvents. In their approach, AOMEC was
polymerized by ROP in the presence of an organocatalyst—that is, 1,8-diazabicyclo(5.4.0)undec-7-ene
(DBU) either in bulk or in different solvents (Figure 1a). Various temperatures were used to evaluate
the equilibrium conversion for calculating the ceiling temperature at certain polymerization conditions.
According to the thermodynamic principle, ROP of AOMEC was favored at a temperature lower than
the ceiling temperature. As the reaction temperature was higher than the ceiling temperature, RCDP of
poly(AOMEC) dominated. It is worth noting that the molecular weights increased/decreased linearly
as a function of monomer conversion in the cases of both ROP and RCDP (Figure 1b). Moreover,
the molecular weight distribution of all the evolving polymers remained as low as 1.1, which further
verified the exceptional control over the course of both polymerization and depolymerization.
Figure 1. Reversible polymerization in ring-opening polymerization systems. (a) Reversible
ROP of 2-allyloxylmethyl-2-ethyltrimethlene carbonate (AOMEC) at various reaction conditions;
(b) Correlations of molecular weights, polydispersity index, and monomer conversions under two
different polymerization conditions. Reproduced with permission from [64].
As one of the best suitable biomass-derived compounds to replace petroleum-derived chemicals,
γ-butyrolactone (γ-BL) and its polymer PγBL have great potential as sustainable materials [68,70].
However, γ-BL has been commonly considered to be “non-polymerizable” due to its low strain
energy, which has thereby rendered the ROP of γ-BL extremely challenging. Starting from 2016,
Chen et al. has conducted extensive research on ROP of γ-BL, and have now developed several
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exciting synthetic methodologies to achieving PγBL by ROP. In agreement with Albertsson’s viewpoint
on the thermodynamic basis, Chen anticipated that reaction conditions should be modulated to achieve
successful ROP, including a much lower reaction temperature than the ceiling temperature, a high
initial monomer concentration, and most importantly, a robust catalyst. In their first work associated
with γ-BL, the ROP of γ-BL was carried out at −40 ◦C in the presence of a lanthanide (Ln)-based
coordination polymerization catalyst [68]. The polymerization was capable of affording PγBL with
Mn as high as 30,000 g mol−1 and up to 90% monomer conversion. In addition, the polymer topology
(e.g., linear or cyclic) can also be controlled by varying the initiator structure and the feeding ratio of
raw materials (Figure 2). From the sustainable perspective, a quantitative depolymerization of PγBL
was realized by heating the purified polymers for 1 h at higher temperatures (i.e., 220 or 300 ◦C) than the
ceiling temperature. Interestingly, the PγBL that was dissolved in appropriate solvents depolymerized
much more rapidly in the presence of an organocatalyst (e.g., 1,5,7-triazabicyclo[4.4.0]dec-5-ene) or
metal catalyst (e.g., La[N(SiMe3)2]3), even at room temperature.
Figure 2. Reversible polymerization in ring-opening polymerization systems. (a) Proposed mechanism
for lanthanide-catalyzed ROP of γ-BL in the preparation of both linear and cyclic PγBL; (b) Chemical
structure of lanthanide catalyst. Reproduced with permission from [68].
In parallel, Chen and coworkers also discovered a metal-free ROP strategy to produce PγBL,
using a super-basic organocatalyst with abbreviation tert-Bu-P4 (Figure 3a) [71]. It should be noted that
the catalyst itself was able to initiate the ROP of γ-BL at −40 ◦C, by abstracting protons from γ-BL to
form highly reactive enolate species (Figure 3b). However, the monomer conversion was limited up to
30.4%, due to the possible interference of [tert-Bu-P4H]+ and an anionic dimer. Furthermore, the ROP
performance was greatly enhanced when tert-Bu-P4 was added, along with a suitable alcohol serving
as the initiator (e.g., BnOH). With the help of the alcoholic initiator, the monomer conversion reached as
high as ca. 90%, and the corresponding PγBL possessed a molecular weight of 26,700 g mol−1. Notably,
the PγBL prepared by this organocatalyzed ROP was completely recyclable, and can depolymerize
back to γ-BL upon heating at 260 ◦C for 1 h.
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Figure 3. Reversible polymerization in ring-opening polymerization systems. (a) Structure and basicity
of tert-Bu-P4; (b) proposed mechanism for the tert-Bu-P4-catalyzed ROP of γ-BL (i) with and (ii)
without alcohol as an initiator. Reproduced with permission from [71].
Encouraged by the success of preparing fully-recyclable PγBL via ROP with either metal (La,
Y) or organocatalysts, Chen’s group proceeded to apply this unique polymerization process to an
enriched variety of monomers. ROP of α-Methylene-γ-butyrolactone (MBL), a small molecule derived
from biomass and regarded as a potential alternative to the petroleum-based MMA, was subsequently
investigated (Figure 4) [69]. Since the monomer comprises a non-strained five-membered lactone and
a highly reactive exocyclic C=C double bond, many knee-jerk studies were exclusively focused on
traditional vinyl addition polymerization (VAP) [74,75]. In Chen’s work, the lanthanide (Ln)-based
coordination polymerization catalyst was utilized, leading to an unsaturated polyester P(MBL)
with Mn up to 21,000 g mol−1 through the ROP process. Remarkably, by adjusting the reaction
conditions, such as the catalyst (La)/initiator (ROH) ratio and temperature, three pathways of the MBL
polymerization can be realized independently, including conventional VAP, ROP, and crosslinking
polymerization. As was foreseeable, only the polymers resulted from the ROP pathway were
fully recyclable.
Figure 4. Reversible polymerization in ring-opening polymerization systems. Polymerization
of α-Methylene-γ-butyrolactone (MBL) following three distinct mechanisms. Reproduced with
permission from [69].
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Despite the notable achievement in lanthanide (La, Y) or superbase (tert-Bu-P4) catalyzed ROP of
γ-BL and its derivatives, the undesirable low temperature (i.e., −40 ◦C) to implement the process still
remained as one of biggest hurdles for industry use. Moreover, the as-synthesized polymers suffered
from limited thermostability and crystallinity. Hence, the exploration of new materials with both
superior properties and energy economy are still in demand. Recently, Chen’s group proposed a γ-BL
derivative (abbreviated as 3,4-T6GBL), with a cyclohexyl ring transfused to the five-membered lactone
at the α and β positions [70]. This monomer can be polymerized by using the coordinative insertion
ROP catalysts, producing linear or cyclic polymers with high molecular weights at room temperature
(Figure 5a). Following this finding, Chen et al. extended the scope of ROP of another γ-BL derivative
(4,5-T6GBL), where the cyclohexyl ring was fused at the β and γ (or 4,5) positions of the BL ring,
giving rise to linear/cyclic polymers at room temperature (Figure 5b) [67]. A controlled polymerization
behavior was observed as the molecular weights of evolving polymers, which increased linearly with
the monomer conversions. As expected, in both studies the resulting polymers possess enhanced
thermostability and could be quantitatively recycled back to their original building monomers by
either thermolysis or chemolysis.
Figure 5. Reversible polymerization in ring-opening polymerization systems. (a) Metal catalyzed ROP
of 3,4-T6GBL (M1) to linear and cyclic polymers; (b) Proposed pathways for metal catalyzed ROP of
4,5-T6GBL (M2) to linear and cyclic polymers. Reproduced with permission from [67,70].
Very recently, Hoye et al. described the synthesis of a novel substituted polyvalerolactone
from a malic acid derived monomer, 4-carbomethoxyvalerolactone (CMVL) [66]. In their work,
this six-membered ring monomer was blended with a diol (1,4-benzenedimethanol) and an organic
acid (diphenyl phosphate) at an ambient temperature, finally forming a semicrystalline material with
a molar mass up to 71,000 g mol−1. Notably, the resulting polymer can be either depolymerized back
into its original precursor monomer or degraded into acrylate-type analogues (Figure 6a). The former
process was catalyzed by tin octanoate (Sn(Oct)2), providing 87% monomer recovery; while the latter
was promoted by DBU with a comparable yield. In particular, a substantial kinetics study showed
that CMVL was polymerized smoothly and reached ca. 90% conversion after 15 h (Figure 6b). It also
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revealed that nearly all of the initiator was consumed within 20 min. This “fast initiation” can be
regarded as one of the characteristic behaviors of controlled polymerization systems.
Figure 6. Reversible polymerization in ring-opening polymerization systems. (a) Acid-catalyzed ROP
of 4-carbomethoxyvalerolactone (CMVL) and the divergent chemical recycling; (b) kinetics of the ROP
of CMVL in the presence of BnOH as an initiator. Reproduced with permission from [66].
3. Reversible Polymerization in Reversible-Deactivation Radical Polymerization Systems
Although reversible polymerizations in ROP systems have shown great promise in
next-generation sustainable polymer materials, the major market for commodity polymers is still
occupied by vinyl polymers, due to their low cost in manufacturing. Vinyl polymers are derived
from petroleum, a non-renewable resource. Therefore, the recycling of used vinyl polymer materials
such as plastics has immense merits, not only in global waste reduction, but also for petroleum
sustainability [76]. In this section, recent examples in depolymerization of vinyl polymers derived from
RDRP systems will be discussed. We hope those timely developments will prompt more innovative
thinking with regard to plastic recycling via a reversible polymerization approach.
In 2012, Zhu et al. reported the first example of reversible polymerizations in an RDRP
system [62]. In their pioneering work, vinyl polymerizations of several acrylamide monomers,
including N-isopropylacrylamide (NIPAM) and N,N-dimethylacrylamide (DMA), were successfully
achieved in the presence of CuCl and tris(2-dimethylaminoethyl)amine (Me6TREN) (Figure 7a).
Very intriguingly, they unexpectedly observed a phenomenon of depolymerization when radical
inhibitors like 2,2,6,6-tetramethylpiperidinooxy (TEMPO) or 1,4-benzoquinone (BQ) were added to
the ongoing polymerization system, with the initial purpose of terminating radical polymerizations.
To further elucidate the role of the copper catalyst in the depolymerization process, a control experiment
with regard to a conventional radical polymerization, using 2,2′-azobisisobutyronitrile (AIBN) as
radical initiator, was carried out in the absence of a copper catalyst and ligands. TEMPO was added
during the conventional radical polymerization, resulting in only the termination of polymerization,
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without any noticeable depolymerization. Those results unequivocally verified that a copper catalyst is
essential in depolymerization. Therefore, a depolymerization mechanism based on β-alkyl elimination
from the copper (II) coordination center was proposed (Figure 7b).
 
Figure 7. Reversible polymerization in copper-mediated polymerization systems. (a) Proposed
mechanism of CuCl/ tris(2-dimethylaminoethyl)amine (Me6TREN)-based radical polymerization
of N-isopropylacrylamide (NIPAM); (b) 2,2,6,6-tetramethylpiperidinooxy (TEMPO)-induced
depolymerization mechanism via β-alkyl elimination. Reproduced with permission from [67].
In a similar demonstration of reversible polymerization mediated by a copper catalyst, Haddleton
and coworkers were able to prepare well-defined polyacrylamides and polyacrylates through aqueous
copper-mediated radical polymerization in the presence of dissolved CO2 (Figure 8a) [65]. In the case
of a NIPAM monomer, the forward polymerization adopted rapid reaction kinetics, achieving full
monomer conversion within 10 min. Thereafter, a significant in-situ depolymerization occurred to an
extent of 52%, and thereby led to the regeneration of the NIPAM monomer, which was systemically
confirmed by proton nuclear magnetic resonance (NMR), gel permeation chromatography (GPC),
and electron ionization-mass spectroscopy. Importantly, this recycled NIPAM can be repolymerized
upon deoxygenation of the resulting solutions, illustrating the reversibility of the polymerization
(Figure 8b). Furthermore, the scope of reversible copper-mediated polymerization was extended to
N-hydroxyethyl acrylamide (HEAm) and 2-hydroxyethyl acrylate (HEA), demonstrating the versatility
of this system. However, it should be noted that the mechanism of depolymerization, as well as the
role of CO2 in the depolymerization process, was not identified in their study.
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Figure 8. Reversible polymerization in copper-mediated controlled polymerization system.
(a) A schematic illustration of aqueous reversible polymerizations mediated by a copper catalyst
and CO2; (b) Gel permeation chromatography GPC traces of original poly (N-isopropylacrylamide)
(PNIPAM) (blue), depolymerized PNIPAM (red), and repolymerized PNIPAM (green). Reproduced
with permission from [65].
In the aforementioned RDRP systems (Vide supra), the depolymerization phenomenon was
only observed during the course of the polymerization. However, it is arguably more interesting
from the materials point of view if one can depolymerize a polymer post-synthesis or after the
manufacturing process. In very recent work described by Gramlich, a set of brush polymers consisting
of oligo-ethylene glycol or oligo-dimethylsiloxane side chains were prepared by traditional RAFT
polymerization in the presence of AIBN at 70 ◦C (Figure 9a) [60]. After polymerization, those polymers
were thoroughly purified by repeated precipitations, to ensure the removal of residual monomers and
initiators. Upon purification, thermally-induced depolymerization of the as-synthesized polymer was
conducted in dilute dioxane solutions, leading to the regeneration of vinyl monomers until reaching
the monomer’s inherent equilibrium monomer concentration. Importantly, the residual polymers
exhibited high chain-end fidelity by retaining the trithiocarbonate moiety after depolymerization,
allowing for further reinitiation and repolymerization via a RAFT mechanism (Figure 9b,c).
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Figure 9. Reversible polymerization in a RAFT system. (a) Preparation of brush-type polymers via
RAFT polymerizations of methacrylate monomers; (b) depolymerization and repolymerization of
RAFT polymers; (c) GPC trance of original RAFT polymer (red solid line), depolymerized polymer
(blue dotted line), and repolymerized polymer (green dotted line). Reproduced with permission
from [60].
4. Closing Remarks
The current success in reversible polymerizations has enabled us to think about many new
possibilities in future polymer science. However, many challenges still remained to be addressed,
hampering the further translation of this new concept into real-world applications. One apparent
hurdle is how to achieve good control over the depolymerization process. While all the examples
covered in this perspective are related to controlled polymerizations, allowing for a predictable
degree of forward polymerizations, little information was provided to reveal the kinetics of the
depolymerization process, especially those involved in controlled radical polymerization. Indeed,
previous literature has placed much focus on the start and endpoint of depolymerization (in other
word, the highest degree of depolymerization). Notwithstanding, kinetic study will shed more
light on the fundamental mechanisms of reversible polymerizations, and if one can predetermine
and control the degree of depolymerization by changing several reaction parameters, such as time,
temperature, catalyst/initiator loading, polymer/monomer concentrations, among others. Moreover,
the ability to tune the depolymerization rate under normal conditions is expected to open the door
to many interesting applications (in addition to sustainable materials)—for example, self-healable
materials, and sustained release systems, which require slow and controllable depolymerization.
It is worth noting that the concurrent depolymerization approaches are typically associated with
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harsh conditions (e.g., high temperatures, metal catalysts), significantly impeding the translation of
this concept into biomedical uses. In light of this, the continuing pursuit of new depolymerization
methodologies that can be implemented under mild and physiological conditions will be important
towards bio-related applications.
Another challenge stems from the relatively low efficiency in depolymerizations, particularly those
in RDRP systems. In comparison with ROP-based depolymerization systems, which mainly rely on
breaking weak polyester backbones, the energy input necessary for reversing vinyl polymer backbones
(i.e., carbon–carbon single bonds) back to vinyl monomers is considerably higher. To our best
knowledge, the highest reported depolymerization conversion in RDRP systems was only 71% when
N-hydroxyethyl acrylamide was involved in copper(0)-mediated reversible polymerizations [65]. In the
RAFT mediated depolymerization approach, only 30% of monomers can be regenerated after heating
the diluted RAFT polymer solutions at 70 ◦C under a vacuum for several days [60]. From the viewpoint
of potential industrial applications, insufficient depolymerization could dramatically increase the cost
deriving from separating regenerated monomers from residual polymers. Therefore, we envision that
more attention will be paid to detailed mechanism study and the rational design of depolymerization
systems, with the goal of achieving high depolymerization efficiency (such as the effort for lowering
equilibrium monomer concentration). Moreover, we believe that mathematical tools, such as modeling
and simulations of reversible polymerizations, should play a key role in prediction of the dynamics,
final products, and optimal conditions in reversible polymerizations [77]. While the concept of
reversible polymerizations is still in its infant stage, it is anticipated that the future development in this
area will not only deepen our understanding of fundamental depolymerization mechanisms, but also
promote many new opportunities and applications in polymer science and engineering.
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Abstract: Multiple factors are involved in the development of cancers and their effects on survival
rate. Many are related to chemo-resistance of tumor cells. Thus, treatment with a single therapeutic
agent is often inadequate for successful cancer therapy. Ideally, combination therapy inhibits tumor
growth through multiple pathways by enhancing the performance of each individual therapy,
often resulting in a synergistic effect. Polymeric nanoparticles prepared from block co-polymers
have been a popular platform for co-delivery of combinations of drugs associated with the multiple
functional compartments within such nanoparticles. Various polymeric nanoparticles have been
applied to achieve enhanced therapeutic efficacy in cancer therapy. However, reported drug ratios
used in such systems often vary widely. Thus, the same combination of drugs may result in very
different therapeutic outcomes. In this review, we investigated polymeric co-delivery systems used
in cancer treatment and the drug combinations used in these systems for synergistic anti-cancer
effect. Development of polymeric co-delivery systems for a maximized therapeutic effect requires a
deeper understanding of the optimal ratio among therapeutic agents and the natural heterogenicity
of tumors.
Keywords: polymeric nanoparticles; stimuli-sensitive polymers; co-delivery systems; synergistic
effect; nucleic acid delivery; chemotherapy
1. Introduction
Cancer, next to heart disease, ranks as the second leading illness-related cause of death worldwide
with a growing incidence and mortality. It is one of the most challenging-to-treat diseases due mainly
to inefficient pharmacologically active agents and the complexity of cancer. To date, chemotherapy has
been widely used and has been the most efficient and successful treatment method in clinical practice.
However, there are three major issues limiting the therapeutic efficacy of chemotherapy. First, most of
chemotherapeutic agents have poor solubility that leads to deficiencies like low bioavailability, rapid
blood/renal clearance, and nonspecific targeting, with significant undesirable side effects on healthy
tissues. Second, non-uniform biodistribution limits the localization of drugs at the tumor site and leads
to consequent demands for higher doses that have unacceptable toxicity. Above all, genetic variations
that control survival and apoptotic pathways are involved in the development of cancers. Targeting an
individual pathway with conventional chemotherapy is often unsuccessful in eradicating all cancer
cells and results in multidrug resistance (MDR) over the course of treatment.
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Several alternative approaches to overcome these problems associated with traditional
chemotherapy have been established. Much attention has been focused directly on drug combination
approaches with the aims of more effective treatment and decreased side effects [1–3]. In general,
combination chemotherapy involves the simultaneous administration of two or more drugs with
non-overlapping toxicities and dissimilar mechanisms of action so as to inhibit multidrug resistance.
Combination therapy can overcome the toxicity of single drug therapy by targeting various signaling
pathways. Lately, combination therapy regimens have been intensively studied, and the results of
clinical practice have demonstrated synergistic effects that are greater than the sum of the individual
drug effects and less systemic toxicity associated with the delivery of lower drug doses.
However, combination regimens are still limited by a low rate of successful outcomes and
significant side effects due to low bioavailability of drugs and their nonuniform biodistribution.
To take advantage of possible synergy between drugs, they must attain effective molar ratios at the
tumor sites that are often hard to reach by conventional administration methods due to differences in
injection schedules, pharmacokinetic properties, metabolism, and non-uniform biodistribution.
One strategy for delivery of drugs to the tumor site at the desired molar ratio involves the merging
of nanotechnology with pharmacology and thereby take advantage of the nanoscale structures that
carry multiple drugs, allow tuning of drug release, and modify biodistribution and pharmacokinetic
characteristics of chemotherapeutic agents [4,5]. Such co-delivery systems may be used to not only
regulate the dosages and the ratio of chemotherapeutic agents at the tumor site. They may also
improve the efficacy of anticancer drugs through enhanced water solubility of hydrophobic molecules,
lower toxicity, and higher stability, which prolongs blood circulation time to enhance accumulation in
tumor tissues. Further enhancement of therapeutic efficacy can be achieved by taking the advantage of
stimuli-responsive drug delivery systems equipped with target-activated moieties [6,7].
Co-delivery systems ideally possess the potential for encapsulation of both hydrophobic and
hydrophilic drugs. Platforms for co-delivery systems should be designed to carry both traditional
chemotherapeutics and cell regulatory molecules, such as nucleic acids [6]. Although much progress
has been made with nanotechnology-based co-delivery systems, there are several problems to be
considered in formulating an ideal drug delivery system including those associated with encapsulating
drugs with a variety of solubilities and physicochemical properties, elevating drug concentrations
within tumor tissues and regulating their sequential drug release.
To date, considerable efforts have been made to develop nano-particulate co-delivery systems
for combination chemotherapy [6,8]. Various nanocarriers have been investigated, including lipid
nanoparticles [9], liposomes [10–12], dendrimers [13] and polymeric nanoparticles [14]. More attention
has been paid to polymeric nanoparticles mainly because of their potential to carry both hydrophobic
and hydrophilic drugs, favorable controlled drug release characteristics, low toxicity, high stability
and a prolonged circulation time which ultimately enhances accumulation in tumor targets.
Many research and review papers involving co-delivery of therapeutic agents by polymeric
nanoparticles in cancer therapy have been published [15–17]. However, therapeutic agents are
often administered separately instead of simultaneously using a polymeric nanoparticle capable
of delivering both agents [18]. Additionally, to the best of our knowledge, there is no comprehensive
review addressing the effects of the drug ratio in co-delivery systems, a likely significant parameter
promoting a synergistic therapeutic effect. The scope of this review is distinct from generalizations
of about polymeric co-delivery systems for chemotherapy. Our aim is to address the dosage,
cell type, mechanism, and their efficacy relationships that need to be considered in designing
co-delivery systems.
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2. Polymer Types Used in Preparing Co-Delivery Systems
2.1. Block Co-Polymer Conjugates
Amphiphilic polymers self-assemble into nanoparticles that are ideal co-delivery systems for both
hydrophilic and hydrophobic drugs (Table 1). These polymers are usually obtained by conjugating
together polymers with diverse properties. The block co-polymers formed inherit the properties of
each block, thus integrating advantages of various blocks into a single system. Depending on the
chemical composition, block co-polymers are prepared by conjugating hydrophobic and hydrophilic
polymers together through physical/chemical interactions or by modifying hydrophilic polymers
with hydrophobic lipid moieties. These synthetic block co-polymers self-assemble into polymeric
nanoparticles or micellar nanoparticles for co-delivery purposes. In order to minimize toxicity
and side effects, the major materials used are biodegradable polymers: chitosan [19], poly(lactic
acid) [20], gelatin [21], poly[N-(2-hydroxypropyl) methacrylamide] (HPMA) [22] and their copolymers,
poly(lactide-co-glycolide-co-caprolactone) [23] and poly(lactic-co-glycolic acid) [24]. Their total
degradation can occur in the body and can reach the kidney threshold for excretion [25].
Six classic methods for obtaining polymeric nanoparticles have been described: nanoprecipitation [26],
emulsion-diffusion [27], emulsification-coacervation [28], double emulsification [29], surface
polymerization [30], and layer-by-layer methods [31]. In addition, multifunctional polymeric
structures with precisely defined morphology can be obtained by a controlled atom transfer radical
polymerization (ATRP) method [32].
Polymeric systems are grouped below by sensitivity to changes in temperature, pH, light, redox
potential, and other special factors in their environment. Stimuli-sensitive polymers have become
one of the most prominent solutions for anti-cancer therapy. The unique properties of polymers
allow them to change their accumulation and drug release profile depending on the surrounding
conditions. They are used to target drugs, bioactive substances and genes. These systems selectively
deliver therapeutic agents to target tissues, cells and cell compartments to release their cargos [33–35].
By doing so, the pharmacological properties, release profile and therapeutic outcomes are improved
compared to delivery as free drugs.
2.2. Thermo-Sensitive Polymers
Polymeric nanoparticles formulated with thermo-sensitive polymers has been applied to activate
and control the release of active ingredients after reaching the target site. For example, overheating a
cancer by activating magnetic cargo-loaded polymeric nanoparticles with a local magnetic field [36].
Thermos-sensitivity has been one of the most commonly used stimulating features for biomedical
applications [37]. There are two types of polymers distinguished by their phase distribution.
The first type, called UCST (upper temperature of the critical solution), passes between phases
during cooling. In the second type LCST (lower critical temperature of the solution), this transition
occurs with increasing temperature. Systems with UCST are more prevalent for polymers soluble
in an organic solvent, while systems with LCST exist mainly for polymers dissolved in aqueous
solvents. The solubility of polymers in organic solvents is due to short-range van der Waals interaction.
The solubility of polymers in water is related to hydrophobic and hydrophilic interactions and the
formation of hydrogen bonds. For polymeric drug delivery systems, mainly aqueous solvents are
used [38–40].
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2.3. pH-Sensitive Polymers
The sensitivity of polymers to pH has been utilized in polymeric nanoparticles designed for drug
administration via the gastrointestinal tract (pH ranges from 2–4 in the stomach to about 6.8 in the
gut), in solid tumors where the interstitial space is more acidic due to hypoxia, with a pH of about 6.5
compared to a blood plasma pH of about 7.4. These pH-sensitive polymers can be weak bases (more
polar in an acid environment in a protonated form) or weak acids (more polar in a basic environment
in deprotonated form). Polymers abundant with primary amines are sensitive to low pH (pH 5.0)
and can facilitate the endosomal escape of drugs. Additionally, pH differences between normal tissue
and tumor tissue can create conditions for use of pH-sensitive polymeric drug delivery systems with
enhanced targeting and reduced side effects [63,64].
2.4. Redox-Sensitive Polymers
The redox potential differences in the tumor microenvironment inspired the idea of building
a redox reaction-sensitive polymeric system for cancer treatment. Redox sensitivity is usually used
in cases where changes of redox potential occur in inflamed tissues compared to healthy tissues.
Changes in redox potential in cancer tissues are due to the production of reactive oxygen species by
activated macrophages. Oxidatively degradable polymers, such as arylborone based on acid esters
(which after oxidation become phenols and boric acid), or dialkyl sulphide-based polymers (which
after oxidation become more hydrophilic), have been used as delivery systems for drugs to inflamed
tissues [65]. The disadvantage of these polymers is that the level of reactive oxygen species is often not
enough to fully oxidize the polymer so that the drug/gene cannot be released [66,67]. Drug delivery
systems also use polymers that react to light exposure and the presence of certain ions or organic
molecules including sodium alginate [68]. These types of polymer are applied mainly for diagnostic
purposes [69].
It can be said that designing a polymeric drug system with micro-environmentally sensitive
polymers is a “smart” strategy. Combining multiple therapeutic agents that inhibit tumor growth
through different pathways into one system is also a “smart” strategy. Many polymeric systems have
shown promising effects in cancer therapy based on these two ideas.
3. Application of Polymeric Nanoparticles as Co-Delivery Systems
3.1. Polymeric Nanoparticles for Co-Delivery of Chemotherapeutics
The aim of combining chemotherapeutics is to achieve an additive or even a synergistic effect.
By targeting different pathways, combination therapy delivered by polymeric nanoparticles makes
cancer cells more susceptible to the delivered therapeutic agents. Four commonly used approaches for
co-delivery of therapeutic agents using polymeric nanoparticles are shown in Figure 1. Most drugs are
passively loaded in polymeric nanoparticles according to their hydrophilicity. Hydrophobic molecules
can be loaded in the hydrophobic moieties of micelles or polymersomes, and hydrophilic molecules
are trapped in the hydrophilic compartments. Some drugs, such as nucleic acids, are co-loaded on
the surface of the polymeric nanoparticles by electrostatic forces or chemical conjugations. Another
approach is to directly conjugate drugs with the polymer through ester, amide or disulfide bonds [70].
Different types of polymeric nanoparticles can be further modified with targeting moieties.
Doxorubicin (DOX), a chemotherapeutic anthracycline, has been used clinically for treatment of
several hematologic malignancies and solid tumors including breast cancer [71]. However, using DOX
alone usually causes serious side effects in normal tissues, especially cardiotoxicity [72]. The molecular
mechanism of DOX-induced cardiotoxicity is still unclear [73,74]. However, it has been postulated that
it is caused by conversion of quinone into free radicals of half quinone, which in turn initiates cascading
reactions leading to production of reactive oxygen and nitrogen in the body [75,76]. To increase the
antitumor effect of DOX by overcoming cells resistance and, at the same time toning down the
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cardiotoxicity, DOX is often used in combination with other chemotherapeutics, nucleic acids and
antibodies in cancer therapy [77,78].
 
Figure 1. Drug loading in polymeric nanoparticles used as co-delivery systems in cancer treatment.
The combination of DOX with other anticancer drugs aims to achieve a synergistic effect of the
combined drugs or improve their biodistribution. Doxorubicin is often combined with Paclitaxel (PCT).
The hydrophobic delivery systems containing PCT are based on the entrapment of the drug in their
hydrophobic core. The combination of DOX and PCT in mPEG-PLGA polymeric nanoparticles made
by a dual emulsion method has allowed a better anti-cancer effect in vivo and a much faster release of
the drug from the carrier in an acidic environment [79]. A similar formulation was also used to destroy
tumor stem cells [80]. The double-reacting nanoparticles built of four polymers approved by the Food
and Drug Administration (FDA) for medical use were composed of poly (D-, L-lactide-co-glycolide)
(PLGA), Pluronic F127 (PF127), chitosan, and hyaluronic acid (HA). Combining PLGA and PF127
forms a more stable and homogeneous nanoparticles than with PLGA or PF127 alone. HA was used as
a targeting moiety towards cancer stem cells to reduce drug resistance associated with the dormant
metabolic state. As a result of the combination of both drugs, the anti-cancer effect was amplified ~500
times compared with a simple mix of the two drugs [80]. Similar polymeric co-delivery systems were
also used that enclosed the hydrophobic irinotecan (CPT) and hydrophilic DOX HCl, which inhibited
the activity of topoisomerase I and II and exhibited an enhanced therapeutic effect on breast and brain
tumors [81].
Another strategy, used to deliver camptothecin (CPT) and doxorubicin, was to form a graft
copolymer with side drug segments that form nanostructures using a protein folding pathway [82].
The graft copolymer was constructed by direct polymerization of g-camptothecin-glutamate
N-carboxyhydride (Glu (CPT)-NCA) at multiple sites on the PEG-based main chain via open ring
polymerization (ORP). Only the conjugated CPT is hydrophobic and served as the main driving force
during the assembly process. When exposed to water, the copolymer, together with DOX, curls to form
monodisperse nanolayers for the delivery of the two drugs. PEG coated nanocarriers exhibit good
stability and are internalized by various cancer cell lines through the lipid raft and clathrin-mediated
endocytosis pathways without premature leakage. These nanolayers generated high synergistic activity
of the CPT and DOX in various tumor cell lines. The in vivo study confirmed that the nanolayers can
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show strong accumulation at tumor sites and result in significant anti-tumor activity in a lung cancer
xenograft model compared to free drugs [82].
To overcome the drug resistance of tumors, redox-sensitive polymeric nanogels (<100 nm)
based on poly(acrylic acid) were designed. Doxorubicin and cisplatin were enclosed in the
nanogels by chelation, electrostatic interaction and π-π stacking interaction. Compare to free drugs,
nanogels delivered more drugs to MCF-7/ADR cells. Considerable accumulation in cancerous
tissues was observed in biodistribution experiments. In vitro anticancer studies showed better
cell killing activity of the nano drug delivery system. All the data indicated that the combination
therapy was more effective with reduced side effects [50]. Combinational delivery of DOX and
verapamil in pH-sensitive polymeric nanoparticles based on co-polymer methoxy-poly(ethylene
glycol)2k-poly(e-caprolactone)4k-poly(glutamic acid)1k (mPEG2k-PCL4k-PGA1k-FA) demonstrated a
high drug release efficiency in tumor environment. The system was reported to overcome the multidrug
resistance and improve the anti-cancer effect in MCF7/ADR cells (Figure 2) [83]. Other strategies
to overcome the drug resistance of a tumor include regulation of the level of multidrug resistant
protein [84]. Combining chemotherapeutics with gene therapy in polymeric nanoparticles for cancer
treatment has received extensive attention [85,86].
 
Figure 2. Folate-modified pH-sensitive co-delivery system of FA-poly(DOX+VER) polymer assembly
exhibits obvious pH-sensitivity, high active targeting ability, strong multidrug resistance reversal and
the enhanced therapeutic effect. Reproduced with permission from Li et al., Journal of Colloid and
Interface; Elsevier, 2016 [83].
3.2. Polymeric Nanoparticles for Co-Delivery of Nucleic Acid Therapeutics and Chemotherapeutics
Multiple genetic targets have been established for cancer treatment over the past several
decades. Based on the genetic links associated with tumor progression and development, nucleic
acid therapeutics, such as siRNA, plasmid DNA (pDNA), miRNA, and antisense oligonucleotides,
have provided highly attractive approaches to downregulate tumor-associated proteins or to recover
the function of tumor-suppressing pathways. However, because of their high molecular weight,
large amounts of negative charge, and enzyme-induced degradation, nucleic acids are very unstable
in the systemic circulation and can barely penetrate the cellular membrane. Thus, intensive efforts
have been made to develop delivery systems for nucleic acid therapy [87]. Here, combinations of
chemotherapeutics together with siRNA, pDNA, and miRNA delivered by polymeric nanoparticles
for cancer treatment are discussed.
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3.2.1. Co-Delivery of siRNA and Chemotherapeutics with Polymeric Nanoparticles
One of the most widely used nucleic acid molecules used in preclinical and clinical studies
has been small interfering RNA (siRNA). Cationic charged polymers, including chitosan [88,89],
poly(ethylenimine) [90], poly(amidoamine) (PAMAM) dendrimer [13,91], and poly [2-(N,N-dimethyl
aminoethyl) methacrylate] (PDMAEMA) [92,93], are capable of complexing with siRNA through
electrostatic interaction, preventing degradation of siRNA and enhancing delivery of siRNA
across the cell membrane. These polymers can be further modified by conjugating with other
polymeric compartments to form an amphiphilic polymer with the ability to deliver siRNA and
chemotherapeutics simultaneously.
Chitosan is a non-toxic and efficient vector for siRNA delivery. Surface modification with
cationic chitosan by either absorption or covalent binding is a good strategy to enable the traditional
drug delivery system to deliver siRNA as well [94]. Wang et al. coated chitosan on PLGA (50:50)
nanoparticles loaded with DOX and grafted with a co-delivery system for both DOX and siRNA for an
epidermal growth factor receptor [95]. Targeted with angiopep-2, the co-delivery system induced a
13% higher cell apoptosis rate than a PLGA nanoparticle loaded with DOX alone.
Cao et al. conjugated low molecular weight PEI with poly(ε-caprolactone) (PCL) through disulfide
or ester covalent linkages [96]. This amphiphilic PEI-PCL self-assembled into a micellar structure.
Doxorubicin was loaded into the PEI-PCL micelles using a chloroform/water mixture with sonication.
Bcl-2 siRNA was complexed with PEI-PCL micelles followed by further modification with PEG chains
to decrease the cytotoxicity of the nanoparticles. This DOX and siBcl-2 co-delivery system induced
a 60% decrease in cell viability 96 h after treatment in a Bel7402 cell line. However, the cell viability
decreased by only 40% when siScramble was used instead of siBcl-2, indicating a synergistic effect
with the co-delivery of DOX and siBcl-2. With further modification of the DOX plus siBcl-2 loaded
nanocarrier using folic acid, the cell viability decreased to 5%.
Another co-delivery system for siRNA and chemotherapy based on PEI was reported
by Navarro et al. [97]. To prepare the amphiphilic molecule, PEI was conjugated with a
dioleoylphosphatidylethanolamine (DOPE) moiety. Micellar nanoparticles formed by PEI-DOPE
reversed the multidrug resistance in MCF7/ADR cells with delivery of P-glycoprotein siRNA (siP-gp)
with DOX. Similarly, stearic acid was attached to PEI (1.8 kDa and 10 kDa) as a hydrophobic
compartment by Huang et al. [98]. The combination of DOX and VEGF siRNA (siVEGF)
co-delivered by PEI-SA micelles produced a promising in vivo Huh-7 tumor growth inhibition
effect over 30 days. Tang et al. constructed an amphiphilic polymer, polyethyleneimine-block-
poly((1,4-butanediol)-diacrylate-b-5-hydroxyamylamine) (PEI-PDHA), based on PEI 1.8 kDa [46].
Together with PEG-PDHA, this polymer self-assembled into nanoparticles co-loaded with siSnail,
siTwist, and PCT. Significantly, an enhanced cytotoxic effect was observed at a PCT concentration of
50 μg/mL. The IC50 of the nanoparticles loaded with the three agents was 54.7-fold lower than that of
free PCT.
PAMAM dendrimer is another candidate for siRNA delivery. The siRNA molecules are complexed
via the primary amines on the surface of PAMAM dendrimers. Hydrophobic compartments used
to load hydrophobic drugs can also be attached on the molecules through chemical conjugation.
Biswas et al. prepared a tri-block co-polymer PAMAM-PEG2k-DOPE by conjugation between
G4 PAMAM and DOPE-modified PEG [99]. PAMAM-PEG2k-DOPE self-assembled into micellar
nanoparticles that complexed siRNA on the surface via the PAMAM moiety and encapsulated DOX
base into the hydrophobic core. This co-delivery system efficiently delivered siRNA and DOX into
cells and downregulated green fluorescent proteins (GFP) used to monitor the transfection efficacy in
C166-GFP cells.
Another promising polymer for siRNA and chemotherapeutics co-delivery is PDMAEMA.
Modification in the backbone of PDMAEMA not only decreased the cytotoxicity of the polymer,
but also gave it the ability to load both siRNA and hydrophobic drugs [93,100]. Zhu et al. synthesized
the block co-polymer PDMAEMA-PCL-PDMAEMA by free radical reversible addition-fragmentation
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chain transfer polymerization and assembled it into cationic micelles. PCT and siBcl-2 were delivered
simultaneously using this system to PC3 cells, resulting in a 20% increased cytotoxicity than with
free PCT after 24 h’ treatment [100]. Wang et al. also delivered siBcl-2 together with DOX using a
PEG-PDEA-PDMA-DDAT triblock co-polymer. Nanoparticles loaded with both DOX and siBcl-2
increased the cytotoxicity by 27.5% and 19.8% compared to nanoparticles loaded only with Dox or
only siBcl-2, respectively [41].
3.2.2. Co-Delivery of pDNA and Chemotherapeutics with Polymeric Nanoparticles
Plasmid DNA (pDNA) was also delivered into cells after forming complexes with cationic
polymers such as PEI, chitosan and PDMAEMA [101]. After modifying polymers with hydrophobic
moieties, these polymers were widely applied for co-delivery of pDNA and hydrophobic
chemotherapeutic agents. In 2006, Wang et al. developed PCT and interleukin-12 encoding
pDNA co-delivery systems based on p(MDS-co-CES), which is poly{(N-methyldietheneamine
sebacate)-co-[(cholesteryl oxocarbonylamido ethyl) methyl bis(ethylene) amoonium bromide] sebacate}.
PCT was loaded inside the hydrophobic core during self-assembly, and pDNA was complexed with
the cationic moieties. P(MDS-co-CES) micelles co-loaded with PCT and pDNA resulted in a greater
tumor reduction than treatment with the gene or drug alone in a 4T1 mouse breast cancer model [102].
An abundance of primary amines makes branched PEI an ideal candidate for interaction with the
large number of phosphate groups found on pDNA. Similar to the PEI-PCL used for co-delivery of
siRNA and DOX, PEI1.8k-PCL was also reported as a co-delivery system for pDNA and hydrophobic
drug by Qiu et al. [103]. After loading with both DOX and pDNA encoding luciferase reporter
gene, PEI-PCL self-assembled into nanoparticles. Higher gene transfection efficacy than PEI25k
and enhanced cytotoxicity compared to DOX alone were achieved in HepG2 [103]. Based on this
structure, Shi et al. crafted a triblock co-polymer which consisted of mPEG5k-PCL2k-PEI2k for
the delivery of DOX and Msurvivin T34A encoding pDNA [104]. By reducing the proliferation of
tumor cells through Msurvivin T34A-induced caspase-mediated apoptosis, the author showed a
higher anti-tumor effect compared to micelles loaded with DOX or pDNA alone. The author also
suggested that treatment with dual-loaded micelles may allow lower doses of chemotherapeutics
while maintaining a similar therapeutic outcome and help mitigate the toxic effect associated with
high dose chemotherapeutics [104].
3.2.3. Co-Delivery of miRNA and Chemotherapeutics with Polymeric Nanoparticles
MiRNAs regulate the multiple molecular pathways associated with cancer development
with a high degree of biochemical specificity and potency [85]. Combination of miRNA with
small molecule therapeutics has provided an unprecedented opportunity to improve therapeutic
efficacy in a broad range of human cancers [105–108]. Using vectors identical for siRNA delivery,
modified cationic polymers have been widely applied for co-delivery of miRNA and small
molecule drugs. Mitall et al. conjugated gemcitabine (GEM) and complexed miR-205 mimics on
a mPEG-b-PCC-g-GEM-g-DC-g-CAT co-polymer, which self-assembled into polymeric micelles.
GEM and miR-205 mimics were co-delivered at concentrations of 500 nM and 100 nM in vitro.
Co-delivery of both drugs in polymeric micelles reduced tumor cell migration and restored
chemosensitivity to gemcitabine in resistant MIA PaCa-2R pancreatic cancer cells. Intratumor injection
of miR-205 (1 mg/kg)/gemcitabine (40 mg/kg) micelles to mice bearing MIA PaCa-2R xenografts
potently arrested tumor growth, whereas free gemcitabine or gemcitabine micelles had only a modest
effect [109].
Hyaluronic acid-chitosan nanoparticles used to co-encapsulate DOX and miR-34a were reported
by Deng et al. for treatment of triple negative breast cancer. Combinations of 100 nM of
miR-34a and 0.1/0.5/2.5 μM of DOX were investigated for their cytotoxic effect on MDA-MD-231
cells. Nanoparticles loaded with both drugs significantly increased cytotoxicity at all three DOX
concentrations. A superior in vivo efficacy of the combination therapy with 5 mg/kg of DOX and
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2 mg/kg of miR-34a was further demonstrated in mice bearing MDA-MB-231 subcutaneous xenografts
following intravenous administration of the co-delivery nanoparticles every two days [110]. Similarly,
Wang et al. prepared hyaluronic acid coated PEI-PLGA nanoparticles as a polymeric co-delivery
system for miR-542-3p and DOX. A range of DOX concentrations from 0.25 μg/mL to 2 μg/mL was
investigated for their therapeutic efficacy with 100 nM of miR-542-3p. The highest cytotoxicity increase,
compared to nanoparticles loaded with DOX only, was at a combination of 2 μg/mL of DOX and
100 nM of miR-542-3p in triple negative breast cancer cell lines [111].
In addition to nanoparticles composed of cationic polymers, neutral nanoparticles have also been
used to co-encapsulate miRNA and chemotherapeutics. As reported by Salzano et al., miRNA-34a
was conjugated with phospholipids through a disulfide bond, and DOX was conjugated with PEG
through a metalloproteinase 2 (MMP-2)-sensitive peptide (Figure 3). Conjugates were formulated into
dual-stimuli sensitive micellar nanoparticles that can simultaneously deliver DOX and miRNA-34a.
The combination of both drugs reduced HT1080 cell viability to 40% and 50% in monolayer and
3D spheroids tumor models, respectively [48]. Liu et al. incorporated miR-200c and docetaxel
(DTX) into the PEG-gelatinase cleavable peptide-poly(ε-caprolactone) (PEG-pep-PCL) nanoparticles.
The concurrent delivery of 10 mg/kg of DTX and 10 mg/kg of miR-200c markedly potentiated the
anti-tumor efficacy of DTX in vivo [112].
Figure 3. MMP-2 and glutathione sensitive polymeric nanoparticles used for co-delivery of DOX and
miRNA-34a. Reproduced with permission from Salzano et al., Small; John Wiley and sons, 2016 [48].
* p ≤ 0.05, **** p ≤ 0.0001, n = 3, error bars represent mean ± SD.
4. Dose/Efficacy Relationship within Co-Delivery Systems
Different combination delivery systems of anti-cancer drugs within a single polymeric vesicle
have been discussed in previous sections. The aim of these polymeric system is to leverage the
different mechanisms of the individual therapeutic agent for additive or synergistic therapeutic effects.
However, eventual success is determined by several other important factors that deserve consideration
in designing polymeric co-delivery systems. First, binding of pDNA onto polymeric nanoparticles
affects the DOX loading and vice versa. Xu et al. reported that co-encapsulation of p53 pDNA and DOX
within PLA coated PLGA microsphere resulted in significantly reduced encapsulation efficiency of
DOX [113]. However, similar hurdles were less obvious in carriers loaded with RNA and DOX. Second,
another factor that influences the therapeutic outcome can be ascribed to the drug release profiles of
different payloads. Depending on the interaction between drugs and polymers, drug delivered by
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hydrophobic interaction may be released much faster than those conjugated with polymers under
physiological conditions [114]. Thus, the drug release profile of polymeric nanoparticles is one of the
most crucial factors to consider when designing polymeric co-delivery systems [79,115]. Third, due to
different mechanisms of therapeutic agents, the therapeutic efficacy of one drug may disguise the effect
of others. Zhang et al. screened the IC50 of DOX and curcumin (CUR) at different ratios using SMMC
7721 cells after 48 h treatments. The IC50 value for DOX and CUR in cells treated with a combination
of DOX/CUR at ratio of 1:10 decreased to 0.46 μM and 4.65 μM, respectively, compared to IC50′s of
free DOX at 1.30 μM and free CUR at 25.7 μM [115]. Much research requires a focus on optimizing the
drug ratio for the optimal synergistic effect prior to co-loading multiple drugs into nanoparticles.
We would like to further elaborate on how drug combinations co-delivered are related to their
therapeutic outcomes by concentrating on the dosing ratios between different therapeutic agents
loaded in polymeric nanoparticles. Among the research published within the past decade, certain
drug combinations have been widely used as models for developing co-delivery systems, including
DOX, PCT, CUR, siBcl-2, siMDR-1. Although identical in drug combination, the therapeutic outcomes
of polymeric co-delivery systems vary between cells and types of polymers. Here, we reviewed the
factors that influence the therapeutic outcomes, with the aim of providing guidance in the design of
polymeric co-delivery systems.
4.1. Dose Combinations of Chemotherapeutics in Polymeric Co-Delivery Systems
4.1.1. Doxorubicin and Paclitaxel Combinations
Combining two chemotherapeutics in a single carrier has been a popular approach in designing
polymeric co-delivery systems. To validate the efficacy of these systems, a lot of work has to been
done to characterize the relationship between the therapeutic outcome with two agents and the ratio
of the two agents. In Table 2, drug combinations, at which synergistic anti-cancer effect was achieved,
were listed. DOX and PCT are two classic chemotherapeutic agents that have been applied extensively
in various polymeric systems. Combination delivery of both DOX and PCT are attractive for their
achievement of a higher therapeutic outcome. Wang et al. loaded hydrophilic DOX and hydrophobic
PCT in methoxyl PEG-PLGA co-polymer nanoparticles. The mPEG-PLGA co-loaded with both DOX
and PCT produced greater tumor growth inhibition in vitro than mPEG-PLGA loaded with either
DOX or PCT at the same concentrations. Moreover, the highest anti-tumor efficacy was achieved when
DOX and PCT were loaded at a concentration ratio of 2:1 using three different types of tumor cell
line [79].
Xu et al. prepared an amphiphilic poly(ethylene glycol)-poly(L-lactic acid) (PEG-PLA)
diblock co-polymer and incorporated DOX and PCT into the ultrafine PEG-PLA fibers by an
“emulsion-electronspinning” method [116]. The authors showed a lower cell viability and higher
percentage of cell cycle arrest when DOX and PCT were delivered at a concentration ratio of 1:1
to rat glioma C6 cells 72 h after treatment. Chen et al. conjugated Pluronic P105 with DOX and
encapsulated PCT into the hydrophobic core formed by P105-DOX and Pluronic F127 as a co-delivery
system for hydrophobic DOX and PCT (Figure 4). The ratio between DOX and PCT was 2:3, when
a higher in vitro cytotoxicity was observed in both MCF7/ADR and KBv cell lines. An increased
apoptotic event, S phase cell cycle arrest and enhanced spheroid growth inhibition were observed in
MCF7/ADR cells. The in vivo study also effected an efficient tumor growth inhibition over 14 days
at this drug ratio [117]. Similarly, Ma et al. investigated the performance of pH-sensitive Pluronic
F127-grafted chitosan for delivery of DOX together with PCT in vivo. In their study, 25 mg/kg of DOX
and 20 mg/kg of PCT were used. All these studies used a concentration ratio between DOX and PCT
of about 1:1 [118].
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Figure 4. Co-delivery of DOX and PCT in polymeric nanoparticles consist of P105 and Pluronic
F127 into MCF7/ADR cells. Reproduced with permission from Chen et al., International Journal of
Pharmaceutics; Elsevier, 2015 [117].
However, other groups have held a different opinion on the optimal drug ratio between
DOX and PCT loaded in polymeric vehicles. Duong et al. also prepared a PEG-PLGA based
co-polymer system for delivery of hydrophobic DOX base and PCT. In addition, folic acid and
TAT peptide were included to enhance the cellular interaction between PEG-PLGA micelles and a
human oral cavity carcinoma KB cell line. After screening several different combinations of DOX
and PCT and calculated their effectiveness using Calcusyn software, they demonstrated a better
synergistic effect of DOX and PCT at a concentration ratio of 1:0.2 than of a concentration ratio of
1:1 [119]. This ratio is supported by Lv et al.’s study. In their case, an amphiphilic deoxycholate
decorated methoxy poly(ethylene glycol)-b-poly(l-glutamic acid)-b-poly(l-lysine) triblock co-polymer
(mPEG-b-PLG-b-PLL) was synthesized and developed as a nano-vehicle for co-delivery of DOX and
PCT. The DOX and PCT co-loaded nanoparticles at a concentration ratio of 4:1 showed an obvious
synergistic effect. The CI50 value was approximately 0.57, indicating co-delivery of DOX and PCT had
evident superiority in tumor growth inhibition as compared with free drug combinations [120]. In an
animal study, 4 mg/kg of DOX and 1 mg/kg of PCT loaded in nanoparticles were given to animals
every four days. An efficient tumor growth inhibition was observed over 18 days in a A549 xenograft
tumor model. The tumor volume of the co-loaded nanoparticles-treated group was only 9.0% of the
control group at the 18th day, which was 3.2-fold, 6.3-fold, and 2.4-fold smaller than when treated with
free DOX, free PCT and free DOX + PCT, respectively [120].
Although various drug combinations were used among these different cases to achieve a
synergistic effect, one conclusion shared by these results is that control of the amount of DOX used is a
prominent factor. DOX has a faster release rate than PCT, and the release of DOX facilitates the release
of PCT. No significant synergistic effect was observed when PCT was used in excess [119]. Additionally,
PCT inhibited the tumor growth by stabilizing the microtubule during cell mitosis. Cells were arrested
rather than entering an apoptotic pathway when treated with DOX. Thus, synergistic effects can hardly
be observed 24–48 h after treatment because the effect of DOX overrode the effect of PCT [79].
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4.1.2. Doxorubicin and Curcumin Combinations
Another classis combination is DOX and CUR. CUR was believed to inhibit the tumor growth
by causing cell cycle arrest [133,134], inducing an apoptotic signal [135,136], reversing multidrug
resistance [137] and inhibiting the activation of NF-κB [138,139]. The exact molecular mechanisms of
curcumin-induced apoptosis in cancer cells varied and depended on the cell type and dose used [140].
Application of CUR as an adjuvant in co-delivery systems has aroused great interest [141].
Zhang et al. combined pro-apoptotic, anti-angiogenic activities in pH-sensitive nanoparticles
prepared with D-α-tocopherol poly(ethylene glycol)1k-block-poly (β-amino ester) (TPGS-PAE)
polymers. The authors optimized the concentration of DOX and CUR at a 1:10 ratio. When exposed to
0.25 μM of DOX together with 2.5 μM of CUR, a 45% increased cytotoxicity occurred over that treated
with DOX alone after 48 h in human SMMS 7721 liver cancer cells. The same ratio was also used in
an in vivo study, where 1 mg/kg of DOX and 10 mg/kg of CUR were delivered within TPGS-PAE
nanoparticles given intravenously once every other day. The CUR + DOX loaded nanoparticles induced
a tumor weight suppression of 73.4%, compared to the 32.6% in a free CUR + DOX group [115].
Yan et al. also investigated the performance of a DOX CUR co-delivery system in a human
liver cancer cell line, Hep G2. They came to a contradictory conclusion from Zhang’s. regarding
the drug ratio between DOX and CUR needed to reach a synergistic effect [142]. They prepared
a redox-responsive micelle composed of a glycyrrhetinic acid-modified chitosan-cystamine-
poly(ε-caprolactone) co-polymer (PCL-SS-CTS-GA). DOX and CUR were loaded in the PCL-SS-CTS-GA
nanoparticles at mole ratios of DOX:CUR = 1:1, 2:1 and 3:1. A synergistic effect was observed only at
ratio of 2:1 and 3:1 in a Hep G2 cell line [142]. This result was similar to that reported by Zhang et al.,
who conjugated DOX with methoxy-poly(ethylene glycol)-aldehyde (mPEG-CHO) and encapsulated
CUR into the hydrophobic core formed within the mPEG-DOX micelles. They used a 2.5-fold higher
concentration of DOX compared to CUR corresponding to a mole ratio of DOX:CUR = 1.6:1. In both
Hep G2 and HeLa cell lines, an enhanced cytotoxic effect was observed in the mPEG-DOX-CUR
nanoparticle-treated group compared to cells treated with DOX or CUR alone [143].
In other studies where CUR was utilized in an attempt to overcome multidrug resistance,
Wang et al. studied the effect of co-delivery of DOX and CUR in mice bearing MCF7/ADR or 4T1
tumors. The polymeric micelles for DOX and CUR co-delivery were based on two diblock co-polymers,
D-α-tocopherol polyethylene glycol succinate (TPGS) and PEG2k-DSPE. Cells were incubated with
polymeric micelles containing both drugs at a 1:1 ratio (mole ratio: DOX:CUR = 1:1.6) for 48 h. Over a
concentration range of DOX of 0.5 μg/mL to 40 μg/mL, the maximum cytotoxicity increase was
observed at 10 μg/mL. An 18.3-fold increase of apoptotic events was also observed at 10 μg/mL
of DOX in the group treated with polymeric micelles loaded with DOX and CUR compared with
the one treated with DOX only. A formulation co-loaded with 5 mg/kg of DOX and 5 mg/kg of
CUR injected intravenously every two days resulted in a significantly lower tumor volume after a
10-day treatment than those treated with either DOX or CUR alone [144]. Duan et al. co-encapsulated
0.12 μg/mL of DOX and 0.2 μg/mL of CUR (mole ratio: DOX: CUR = 1:2.6) in chitosan/poly(butyl
cyanoacrylate) nanoparticles to reverse the multidrug resistance in MCF7 ADR cell lines. They reported
that polymeric nanoparticles loaded with both drugs induced a higher cell growth inhibition and a
significantly greater downregulation of MDR-1 protein at 48 h after treatment [145].
Overall, the mole ratio of CUR and DOX reported for these polymeric delivery systems had
a broad range, suggesting that in the presence of multiple tumor inhibiting pathways, CUR acts
differently depending on the cell line. Thus, it’s hard to predict an effective universal ratio for
combination treatment with CUR plus DOX. Additionally, the release profile of CUR differs markedly
between polymeric delivery systems [146,147]. In some cases, DOX is directly conjugated with the
polymer, while in other cases, DOX and CUR are both passively encapsulated. The release profile and
types of tumor are key points to be taken into consideration during the design of polymeric co-delivery
systems using CUR.
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4.1.3. Paclitaxel and Cisplatin Combination
The use of a combination of PCT and cisplatin (CDDP) is another classic and popular co-delivery
strategy. Cisplatin, a member of the platinum-containing anticancer drugs, has been used intensively
for the treatment of various solid tumors, particularly in advanced stages. There are different
mechanisms that account for the effect of CDDP. It is well-known as a non-specific DNA-modifying
agent that induces cell apoptosis by interaction with nuclear DNA to inhibit the transcription and
replication of DNA. The clinical application of CDDP is limited because of its high dose-dependent
toxicity, drug resistance, and low bioavailability. PCT, on the other hand, a number of the taxane
family, works as a microtubule-stabilizing chemotherapeutic agent. It is known that PCT can also
inhibit platinum−DNA adduct repair and enhance apoptosis of cisplatin-resistant tumor cells [148].
However, it enhances the nephrotoxicity of CDDP. Nowadays, the combination therapy including
CDDP and PCT is still a popular clinical regimen used as a the first-line chemotherapeutic agent for
advanced cancer treatment.
To date, few works have dwelt on the study of co-delivery of the CDDP/PCT, due mainly to
the hydrophilic nature of CDDP and hydrophobicity of PCT, which has made the loading step very
challenging [149,150]. One strategy to overcome this problem is to use different cisplatin prodrugs
to facilitate drug loading [151,152]. Polymeric nanoparticles, particularly micelles with the ability to
carry both hydrophilic and hydrophobic drugs represent a promising candidate for the co-delivery of
CDDP and PCT. Mi et al. used a D-α-tocopherol-co-poly(ethylene glycol)1k succinate (TPGS)-cisplatin
prodrug (TPGS-CDDP) along with docetaxel to improve CDDP loading into Herceptin-decorated
PLA-TPGS nanoparticles. The highest drug loadings achievable for CDDP, PCT, and Herceptin using
this approach were 3.5 ± 0.1, 9.0 ± 0.5, and 73.1 ± 5.8 μg/mg, respectively [151]. The presence of
polymers with the ability to form a chelate with CDDP, such as PEG or poly-glutamic acid in the
copolymer structure, can also enhance drug loading capacity [125,129,130]. In He et al.’s work, the drug
loading capacity of PCT and CDDP attainable with FA-PLGA-PEG micelles has been reported to be
5.83 ± 0.04%, 4.68 ± 0.07%, respectively, at a polymer/drug ratio of 40:2:4 (polymer:CDDP:PCT) [153].
It is important to note that, the ratio of drug loading in the carrier plays a determinant role in
achieving the highest therapeutic efficacy for combination therapy. According to Wan et al., the actual
drug ratios in the tumor did not differ significantly from the drug ratios in the initial co-loaded drug
formulations [129]. Thus, assuring the drugs loading for polymeric nanoparticles in an appropriate
ratio would be of great importance in formulating a treatment. He et al. showed that in A549 and
M109 cells, the effectiveness of co-delivery of NPs, with a CDDP/PCT concentration ratio of 1:2,
was approximately twice that of CDDP [153]. Moreover, co-delivery of NPs, with a CDDP/PCT
concentration ratio of 1:2, exhibited the greatest anti-tumor activity among the two varieties of lung
cancer cell. Although in general, dual drug-loaded nanoparticles with a higher ratio of PCT exhibited
the greatest response, there are some reports indicating the best response corresponds to an equal drug
ratio [152].
Time-dependency is another factor affecting the synergism of CDDP/PCT co-delivery
systems [125]. This phenomenon was related to the release behavior of CDDP and PCT from the
carrier. In single drug-loaded nanoparticles, drug is quickly released, while in a dual drug-loaded
carrier system, chelation of PCT with CDDP prevented an initial burst release and resulted in a lower
growth inhibition effect. However, over time, more PCT was released, and the combination effect
became manifest. The in vivo studies on co-delivery systems for CDDP and PCT also clearly revealed
improved pharmacokinetics and biodistribution in the blood and tumor of either one or both drugs
compared to single drug micelles [129].
4.2. Dose Combinations of Nucleic Acid Therapeutics and Chemotherapeutics in Polymeric
Co-Delivery Systems
The rationale for combination of nucleic acid therapy with chemotherapeutics in a single platform
to ensure that cells will be simultaneously exposed to two types of damage has been discussed
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previously. The dose combination between nucleic acids and chemotherapeutics delivered has large
effects on the synergistic anti-cancer efficacy of such co-delivery systems (Table 3). Nucleic acid therapy
induces tumor inhibitory effects via different molecular pathways than traditional chemotherapeutics.
Plasmid DNA requires delivery into the nucleus followed by translation into therapeutic proteins and
the oligonucleotide requires interference with the mRNA or proteins in various pathways to generate
their effect. Thus, nucleic acid therapy takes a longer time than chemotherapeutics before the tumor
growth inhibition effect can be observed. The effect of chemotherapeutic agents can also disguise the
one from nucleic acid therapy. Therefore, controlling the ratio between nucleic acid molecules and
chemotherapeutics involving different mechanisms and types of pathways in polymeric systems is
critical for an ideal synergistic effect.
4.2.1. Inducing Apoptosis through Delivery of TRAIL
Interfering with the apoptotic pathway by either enhancing the pro-apoptotic effect or inhibiting
the anti-apoptotic effect with nucleic acid therapies is a promising cancer treatment. One of the
most attractive pro-apoptotic pathways for the treatment of cancer is through the tumor necrosis
factor (TNF)-related apoptosis-inducing ligand (TRAIL). TRAIL is a potent stimulator of apoptosis,
and tumor cells are significantly more sensitive to TRAIL-induced apoptosis than normal cells [154].
However, numerous cancer cells exhibit a certain amount of resistance to TRAIL-induced apoptosis.
Thus, combining TRAIL protein with traditional chemotherapeutics could increase the therapeutic
efficacy in TRAIL-resistant cancer cells [155,156]. Lee et al. co-loaded both TRAIL protein and DOX in
polymeric nanoparticles self-assembled from a biodegradable cationic co-polymer P(MDS-co-CES) to
achieve a synergistic cytotoxic effect in cancer cells. A synergistic effect of a 40% enhanced cytotoxicity
was observed with nanoparticles loaded with 10 nM of TRAIL and 0.8 μM of DOX compared to
nanoparticles loaded with each drug alone in TRAIL-resistant SW480 colorectal carcinoma cells [157].
The same group also used P(MDS-co-CES) for co-delivery of TRAIL and PCT. In the study, various
human breast cancer cell lines were exposed to 10 nM of TRAIL and 1.67 μM of PCT co-loaded in
P(MDS-co-CES) polymeric nanoparticles. A 25% enhanced cytotoxic effect was achieved compared to
single drug-loaded treatments [158].
In addition to delivering TRAIL in polymeric nanoparticles, Fan et al. delivered plasmid DNA
encoded for TRAIL together with DOX in β-cyclodextrin-polyethyleneimine (PEI-CD) supramolecular
nanoparticles (SNP). The PEI-CD SNP loaded with 0.5 μg/mL of DOX and 2.5 μg/mL of TRAIL pDNA
(pTRAIL) induced many more apoptotic events than individual drug treatment in SKOV-3 cells after
48 h treatment. At the same drug ratio, SKOV-3 ovarian tumor-bearing mice received a combination
treatment of 6 μg of DOX and 30 μg of pTRAIL twice per week. After 18 days, a significantly higher
tumor growth inhibition was observed in those mice [47]. In another study, DOX was complexed with
pORF-hTRAIL, which was then complexed with polyamidoamine-PEG-T7 (PAMAM-PEG-T7) through
electrostatic interaction. A significant synergistic effect occurred both in vitro and in vivo when
12.5-fold more DNA than DOX by weight was loaded into this platform. Each Bel-7402 tumor-bearing
mouse was treated with 50 μg of DNA in combination with 4 μg of DOX [159].
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4.2.2. Increasing Apoptosis by Restoring p53
A similar combination was also used to restore the function of the tumor suppressor, p53. Xu et al.
treated Hep G2 cells with a combination of 2 μg/mL of p53 gene and 0.9 μg/mL of DOX. Chitosan-p53
nanoparticles and DOX molecules were co-loaded in double-walled microspheres that consisted of
a PLGA core surrounded by a poly(L-lactic acid) (PLA) shell. Overall, the combined DOX and p53
treatment enhanced cytotoxicity and increased activation of caspase-3 compared to either DOX or p53
treatment alone [160].
Li et al. used a combination of DOX and p53 plasmid at 3 μg/mL and 4 μg/mL, respectively,
to induce a synergistic anti-cancer effect in breast cancer. Both drugs were loaded in micelles formed
from a star-shaped polymer consisting of a cationic poly[2-(dimethylamino) ethyl methacrylate]
(PDMAEMA) shell and a zwitterionic poly{N-[3-(methacryloylamino) propyl]-N,N-dimethyl-N
-(3-sulfopropyl) ammonium hydroxide} (PMPD) corona that was grafted from a polyhedral oligomeric
silsesquioxane (POSS)-based initiator. A high tumor cell apoptosis in MCF7 cells occurred in vitro and
extensive tumor growth inhibition was observed over 28 days with 1.5 mg/kg of DOX and 2 mg/kg of
p53 plasmid administrated every five days [161].
Usually, 2–4 μg/mL of plasmid DNA was used in co-delivery with chemotherapeutics to achieve
a synergistic effect. But the ratio between chemotherapeutics and pDNA ranged from 1–10. Chen et al.
investigated the response of cell viability in MCF7 cells to DOX-loaded polymeric nanoparticles
complexed with different ratios of p53 pDNA (Figure 5) [173]. An enhanced cell growth inhibition
was observed at weight ratios between DOX-NP and p53 pDNA from 5–10. This enhanced effect was
not observed at weight ratios higher than 10 or lower than 5. These results suggested that the ratio
between chemotherapy and pDNA for a synergistic effect could be affected by a diversity of cell lines
and types of cationic polymers. Especially because that, as previously discussed, the complexation of
pDNA with polymeric nanoparticles could affect the loading of chemotherapeutics [113]. Investigating
the pDNA complexation effect on drug loading, drug release profile is essential in evaluating the
anti-cancer performance of pDNA and chemotherapeutics-loaded polymeric co-delivery systems.
Figure 5. Co-delivery of DOX and pDNA in cationic polymeric nanoparticles with co-localization of
cargos and enhanced tumor cell growth inhibition. Reproduced with permission from Chen et al.,
Polymers; MDPI, 2019 under the license CC BY 4.0 [173].
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4.2.3. Decreasing Anti-Apoptotic Effect through Downregulation of Bcl-2
Another popular candidate used within co-delivery systems with pro-apoptotic effects has
been siBcl-2. Overexpression of Bcl-2 family proteins suppresses the cell death induced by
chemotherapeutics [174]. Thus, it’s particularly interesting to pursue possible synergistic effects
derived from the downregulation of Bcl-2 and administration of chemotherapeutics. Cao et al.
proposed loading DOX and siBcl-2 into PEI-PCL micelles using a chloroform/water mixture
under sonication. The micelles were then coated with folic acid-conjugated poly(ethylene
glycol)-block-poly(glutamic acid) (FA-PEG-PGA) after complexation of siBcl-2. Together with 20 nM
of siBcl-2, 0.05 μM of DOX was delivered to Bel-7402 liver cancer cells. The PEI-PCL/FA-PEG-PGA
micelles co-loaded with DOX and siBcl-2 induced a 60% increased cytotoxicity 96 h after treatment [96].
From the same group, Cheng et al. investigated the therapeutic efficacy of PEI-PCL/FA-PEG-PGA
micelles loaded with siBcl-2 and DOX using C6 glioma cells. They demonstrated that 25 nM of siBcl-2
achieved a higher knockdown effect than that at 12.5 nM. Most importantly, the knockdown effect of
Bcl-2 became saturated at concentrations higher than 25 nM. The combined therapeutic outcome of
DOX (22.5 μg/kg) and siBcl-2 (1.6 μg/kg) treatment in vivo highlighted the importance of combined
therapy of DOX and siRNA for tumor growth inhibition [162].
Wang et al. also investigated the combination of DOX and siBcl-2 in another human liver cancer
cell line, Hep G2, using a PDEA-PDMA-PEG co-polymer. They also used 20 nM of siBcl-2 but
increased the DOX concentration to 1.69 μM. Under this circumstance, co-delivery of both drugs
increased the cytotoxicity by 27.5% and 19.8% compared to nanoparticles loaded with DOX and siBcl-2,
respectively [41]. Instead of DOX, PCT has also been delivered together with siBcl-2. Wang et al.
studied the synergistic effect between siBcl-2 and PCT in triple negative breast adenocarcinoma
MDA-MB-231 cells. In the presence of 20 nM siBcl-2, cell viability decreased from 78% to 59% and
from 58% to 39% at PCT concentrations of 100 nM and 400 nM, respectively [102].
However, other groups have used a higher concentration of siBcl-2. For example, Zhu et al.
treated PC3 human prostate cancer cells with a combination of 188 nM of siBcl-2 and 0.58 μM of PCT.
The drugs were delivered using micellar nanoparticles composed of PDMAEMA-PCL-PDMAEMA
triblock co-polymer. They reported a synergistic effect of about 20% increased cytotoxicity compared
to free PCT at 24 h after treatment [100]. Such differences in the concentration of siBcl-2 used may
have resulted from the responses to siBcl-2 seen in different cell lines. Instead of screening for the
response of cells to siBcl-2, most groups have used a standard siRNA concentration of 100 nM in their
studies [42,175].
4.2.4. Decreasing the Anti-Apoptotic Effect through Downregulation of Survivin
Survivin is one of the most frequently occurring antiapoptotic proteins seen in cancerous tissues
(i.e., breast, colon, pancreas, and lung). Its main mechanism of action depends on inhibition of caspase
activation [176]. Through its action, survivin leads to increased proliferation of tumor cells [177].
Wang et al. developed a DOX, PCT, and survivin co-delivery system using a nano-emulsion composed
of a methoxy-poly (ethylene glycol) block copolymer (mPEG-PLGA) and e-polylysine (EPL). The core
of the nano-emulsion was DOX, and the PCT was enclosed in the hydrophobic layer. EPL on the
surface of the nano-emulsion complexed siRNA by electrostatic interaction. Experiments in mice
bearing a B16-F10 melanoma tumor showed a synergistic tumor growth inhibition effect from DOX
(8.6 mmol/kg), PCT (17.2 mmol/kg), and survivin-siRNA (1.5 mg/kg) [178].
In Shi et al.’s report where the block copolymer mPEG-PCL-g-PEI was used for co-delivery
of doxorubicin and Msurvivin T34A plasmid, a synergistic effect of DOX (4 mg/kg DOX) and
Msurvivin T34A plasmid (5 mg/kg) was demonstrated in mice bearing a B16-F10 melanoma, both
in subcutaneous and lung metastases models. Although they obtained only a slightly higher
antitumor activity when compared to free DOX, they effectively reduced systemic toxicity of
the treatment [104]. Survivin shRNA-encoding plasmid was also delivered to SKOV-3 cells by
self-assembled supramolecular micelles composed of b-cyclodextrin-polyethylenimine (PEI600-CyD)
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and 2-amineadamantine-conjugated PCT (Ada-PCT) by Hu et al. They proved that simultaneously
administrated PCT and shRNA at concentrations of 0.6 μg/mL, 2 μg/mL in vitro and 6 μg/animal,
20 μg/animal in vivo, respectively, induces significantly higher cell apoptosis and inhibits tumor
growth [163].
Another co-delivery pluronic system P85-PEI/TPGS/PCT/shSur containing survivin hairpin
RNA was developed to treat A549 human lung cancer. The purpose of this study was to overcome
paclitaxel resistance. Simultaneously administrated PCT (10 mg/kg) and shSur (2 mg/kg) showed
enhanced efficacy of anticancer activity including higher PTX-induced apoptosis and cells arrested
in G2/M phase [168]. A combination of DOX and survivin shRNA was also investigated by
Tang’s group for its effect in overcoming multidrug resistance. In their work, a pH-sensitive
polymer based on poly(b-amino ester), poly[(1,4-butanediol)-diacrylate-b-5-polyethylenimine]-
block-poly[(1,4-butanediol)-diacrylate-b-5-hydroxy amylamine] (PDP-PDHA) was synthesized.
Nanoparticles containing 6 mg/kg DOX and 2 mg/kg shRNA were administered to MCF7/ADR
tumor-bearing mice. The authors successfully raised the accumulation of DOX and shSur in the tumor
tissue, resulting in a tumor growth inhibition of 95.9% after 21 days [169].
4.2.5. Increasing Intracellular Drug Accumulation by Inhibiting Drug Efflux
P-glycoprotein (P-gp), encoded by the MDR-1 gene, overexpressed in many types of
human cancers, contributes to the multidrug resistant effect. Downregulation of P-gp has been
associated particularly with enhancing the therapeutic outcome of chemotherapeutics. Thus,
it is a popular inclusion in co-delivery systems for its synergistic effect. Xiong et al. reported
the co-delivery of siMDR-1 and DOX using polymeric micelles formed by poly(ethylene oxide)-
block-poly(ε-caprolactone) (PEO-b-PCL) amphiphilic block co-polymers to improve the anticancer
effect in the multidrug drug resistant human breast cancer cell line (MDA-MB-435/LCC6MDR1).
Micelles containing 5 μg/mL of DOX and 100 nM of siMDR-1 led to a maximum of ~70% cell growth
inhibition at 72 h after treatment [45]. Navarro et al. also demonstrated that the downregulation of
P-gp led to the inhibition of DOX efflux activity resulting in an enhanced cytotoxicity of DOX in the
MCF7/ADR cell line. The combination used in their study was 1 μg/mL of DOX and 100 nM of
siMDR-1. Drugs were delivered in polymeric nanoparticles consisting of PEI modified DOPE [97].
Zhang et al. prepared polymeric micelles based on N-succinyl chitosan-poly-L-lysine-palmitic
acid (NSC-PLL-PA) for co-delivery of DOX and siRNA targeting P-gp. The study revealed that
the therapeutic efficacy was close to the maximum when the siRNA concentration reached about
100 nM. This finding indicated that 100 nM was sufficient to downregulate P-gp expression, increase
intracellular DOX concentration, and maximize the therapeutic effects. The cytotoxicity results
at 48 h after treatment also indicated that a synergistic effect was achieved at 5 μg/mL of DOX
and 100 nM of siMDR-1. Increasing the concentration of DOX disguised the effect of siMDR-1,
leading to a more than 80% cytotoxic effect among all groups. Additionally, micelles loaded with
0.5 mg/kg of DOX and 0.2 mg/kg of siMDR-1 given to tumor-bearing mice every three days showed
a significant tumor growth inhibition over 24 days [164]. Other groups also reported synergistic
effects derived from co-delivery of siMDR-1 with DOX using polymeric nanoparticles at similar
concentration combinations. For example, Xu et al. co-delivered 3 μg/mL of DOX and 100 nM
of siP-gp in polymeric vehicles prepared from triblock copolymers, folate/methoxy-poly(ethylene
glycol)-block-poly(L-glutamate-hydrazide)-block-poly(N,N-dimethylaminopropyl methacrylamide)
(FA/m-PEG-b-P(LG-Hyd)-b-PDMAPMA) to MCF7 breast cancer cells [52]. And Misra et al. overcame
multidrug resistance in cells by co-delivering 11.6 μg/mL of DOX and 100 nM of siMDR-1 using
dimethyldidodecylammonium bromide (DMAB)-coated PLGA nanoparticles in the MCF7 ADR cell
line [165]. All these studies demonstrated the enhanced therapeutic efficacy against cancer using
polymeric co-delivery systems.
In our previous work, micellar nanoparticles consisting of PAMAM-PEG2k-DOPE and
PEG5k-DOPE were investigated as a co-delivery system for both hydrophobic drugs and siRNA
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(Figure 6). Combinations of DOX and siMDR-1 at different concentrations were applied to multidrug
resistant cell lines A2780/ADR and MCF7/ADR [91,99]. The synergistic effect of the co-delivery
system was observed in MCF7/ADR and A2780/ADR when treated with 125 nM of siMDR-1, 0.43 μM
of DOX, or 125 nM of siMDR-1, 1.7 μM of DOX, respectively. The cytotoxicity results also suggested
that co-delivery of siMDR-1 and DOX achieved an increased anti-cancer effect when delivery of
siMDR-1 was followed by DOX treatment separately. Since downregulation of P-gp alone does not
cause significant tumor growth inhibition, delivery of siMDR-1 together with intracellular delivery of
chemotherapeutics is required for an ideal therapeutic effect. However, inadequate downregulation
amount of P-gp or excess of chemotherapeutics could impair the performance of co-delivery systems
targeting inhibition of drug-efflux. An optimal concentration ratio should be established for desired
therapeutic outcomes.
Figure 6. Schematic structure of mixed dendrimer micelles composed of PAMAM-PEG2k-DOPE and
PEG5k-DOPE in co-delivery of DOX and siMDR-1. Reproduced with permission from Pan et al.,
European Journal of Pharmaceutics and Biopharmaceutics; Elsevier, 2019 [91].
4.2.6. Inhibiting Tumor Growth by Altering Immune Responses
Among many strategies for co-delivery systems, being able to modulate the natural immune
response against cancer cells is one of the most promising challenges. Chen et al. designed a co-delivery
system of DOX + IL-36γ/POEG-st-Pmor with an improved anti-metastatic effect in a mouse breast
cancer lung metastasis model with 4T1.2 cells. DOX 5 mg/kg and IL-36γ plasmid 50 μg per animal
synergistically enhanced the immune response (type I) by increasing the IFN-γ positive CD4+ and
CD8+ T cells [171]. Wu et al. also delivered the IL-2 immunoactivator together with DOX, but at a
much lower dose. N,N,N-Trimethyl chitosan-based polymeric nanoparticles loaded with 2 mg/kg of
DOX and 1.2 μg/animal of IL-2 were injected intravenously into SMMC 7721-bearing mice every two
days. When further modified with 8.45% w/w folic acid, the polymeric co-delivery system resulted in
a five-fold smaller tumor volume than those treated with DOX alone after 14 days [43].
Combination of IL-2 and PCT also has produced a synergistic effect in several reported studies.
Wang et al. delivered IL-2 at 5 μg in combination with 10 μg of PCT per animal using P(MDS)-co-CES
polymeric nanoparticles. Co-delivery of IL-2 and PCT resulted in a 2.5-fold lower tumor volume after
17 days of treatment than with individual drug loaded nanoparticles [102]. In another study, Zhao et al.
delivered an IL-2 and PCT combination of 2.5 μg/kg and 10 mg/kg, respectively, in PLGA/Pluronic
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F127-based nanoparticles. The in vivo study using a murine melanoma B16-F10 cell line showed
significant tumor growth and metastasis inhibition. Additionally, a prolonged overall survival rate
was demonstrated in tumor-bearing mice treated by co-delivery of IL-2 and PCT [172].
The release profile of ILs is critical in designing co-delivery systems for IL and chemotherapeutic
agents. Systemic administration of IL-2 may initiate an auto-immune response, resulting in side effects
from the therapy. Previously, combination of local administration of IL-2 and systemic administration
of PCT was used as a combination strategy [179]. IL-2 loaded in polymeric nanoparticles generated a
controlled release profile in the systemic circulation. Co-encapsulation of IL-2 with chemotherapeutic
agents not only induced a synergistic effect, but also minimized the auto-immune response. Although
the co-delivery approach using a single delivery system offers many advantages, pharmacokinetics
and cytotoxic side effect still need to be considered. The release profile of IL-2 is critical for the design
of co-delivery systems for IL-2 and chemotherapeutic agents.
5. Conclusions and Perspectives
In this review, we have discussed the different types of block co-polymers that have been
formulated into polymeric co-delivery systems for cancer treatment. We also focused on the
different drug combinations used in co-delivery systems and the influence of the combinations on
their therapeutic outcomes. As discussed earlier, targeting two multidrug resistance mechanisms
simultaneously with a single delivery platform is a promising strategy that can provide synchronized
pharmacokinetics and doses to the same cell population. Many co-delivery systems have been
developed that exhibit promising anti-tumor efficacy, especially in multidrug resistant tumors.
Nevertheless, it has been well-established that cancer cells have the inherent ability to avoid cell
death by activation of various anti-apoptotic pathways. These pathways seem to be cell type specific
and assault type specific. Therefore, it appears that the effectiveness of decreasing cell viability by
double sensitization is cell-specific. That means a certain combination of drugs may work perfectly
in one cell line, but may not work at all in another cell line without modification of the combination
of drugs. A “one type fit all” formulation seems unlikely for eradication of all types of tumors
clinically. Individualized therapy designed specifically for each type of cancer cell with different drug
combination may be more likely to be necessary for an effective therapeutic outcome [180].
Polymeric nanoparticles are ideal platforms for co-delivery because of the multicompartments
they contain. Amphiphilic co-polymers integrated with different properties have been synthesized
to encapsulate hydrophilic agents as well as hydrophobic agents. Cationic moieties in co-polymers
also provide the possibility for complexed nucleic acid molecules. Although there is much research
focusing on combination delivery using polymeric nanoparticles, little emphasis has been put on
the optimization of drug ratios to promote synergistic effects. The synergistic effect of polymeric
co-delivery systems depends on multiple factors. First of all, it is important to ensure that the
chemistries of delivery, carrier and therapeutic agents do not interact detrimentally with each other [86].
Another challenge is to ensure that the presence of one therapeutic agent does not interfere with the
action of others. Additionally, the ratio between two therapeutic agents can directly determine the
outcome of a co-delivery system. The release profile of small molecule drug and nucleic acid molecules
is another major challenge that requires considerable research.
Overall, a deeper understanding of the optimal ratio between therapeutic agents and the natural
heterogenicity of the tumor is necessary for development of polymeric co-delivery systems that
maximize therapeutic effects. Additionally, multifunctional polymeric nanoparticles, especially
stimuli-sensitive polymeric nanoparticles, allow high drug loading, optimized release profiles,
and enhanced in vivo stability for the co-delivery of distinctly different classes of therapeutic molecules.
There is a need to continue efforts at understanding the relationship between the mechanism of
action of encapsulated therapeutic agents and their pharmacological activities. Resolving these
challenges should result in multifunctional polymeric nanoparticles with significantly enhanced
therapeutic efficacy.
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Abstract: Cancer remains a leading cause of death worldwide with more than 10 million new
cases every year. Tumor-targeted nanomedicines have shown substantial improvements of the
therapeutic index of anticancer agents, addressing the deficiencies of conventional chemotherapy,
and have had a tremendous growth over past several decades. Due to the pathophysiological
characteristics that almost all tumor tissues have lower pH in comparison to normal healthy tissues,
among various tumor-targeted nanomaterials, pH-responsive polymeric materials have been one of
the most prevalent approaches for cancer diagnosis and treatment. In this review, we summarized the
types of pH-responsive polymers, describing their chemical structures and pH-response mechanisms;
we illustrated the structure-property relationships of pH-responsive polymers and introduced the
approaches to regulating their pH-responsive behaviors; we also highlighted the most representative
applications of pH-responsive polymers in cancer imaging and therapy. This review article aims to
provide general guidelines for the rational design of more effective pH-responsive nanomaterials for
cancer diagnosis and treatment.
Keywords: pH responsive polymers; nanomedicine; tumor imaging; drug delivery
1. Introduction
Many diseases originate from abnormal biological processes at the molecular level, such as
gene mutation, protein misfolding, and cell malfunctions as a result of infections [1]. Advances in
genomics, proteomics, and regenerative medicine have inspired development of numerous therapies
and technologies for the treatment of various diseases. With over 10 million new cases every year
globally, cancer remains a difficult disease to treat and one of the leading causes for death [2]. Cancer is
a prevalent disease that involves a series of genome mutations over time and results in both genetic
and phenotypic variations in different tumor cells [3,4]. Targeting cancer-specific biomarkers offers
great opportunities for precise tumor detection and efficacious drug delivery, and more importantly,
causes minimal side effects on normal cells [5]. However, it is impractical to apply a certain cell surface
receptor to a broader range of cancers due to their genetic or phenotypic heterogeneity. In contrast,
aerobic glycolysis, also known as the Warburg effect, represents a dysregulated energy metabolism in
many types of cancer, where glucose is preferentially taken up and converted into lactic acid [6]. As a
result, acidosis has occurred concurrently and evolved as a ubiquitous characteristic of cancer [7].
With comparable scales to biologic molecules, nanomaterials have been extensive investigated for
biomedical applications over past several decades [8,9]. The nanomaterials are present in small sizes
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ranging from 1 to 1000 nanometers with correspondingly large surface-to-volume ratio. A multitude
of targeting moieties can be incorporated to the surface of nanostructures via diverse engineering
procedures [10,11]. The physiochemical properties such as composition, size, and shape can be
sophisticatedly tailored for disease diagnosis, treatment, and prevention [12]. Different physiochemical
properties like optical, electrical, and magnetic responsiveness have been introduced to nanostructures
to facilitate biological diagnostics [13]. One extraordinary property of nanomaterials is that they
are generally multi-component systems. Different components or subunits of the nanostructures
can be delicately engineered to address the same specific challenge in medicine, resulting in strong
cooperative effect that is absent in monomolecular therapeutics [14]. A recent report revealed that
over 250 nanomaterial-based technologies or therapies have been approved by the Food and Drug
Administration (FDA) or are currently in different stage of clinical trials [15].
There has been explosive development of numerous nanotechnologies to diagnose and treat
cancer [16]. The tumor heterogeneity leads to the growing emphasis on customized nanomedicine [17].
Molecular imaging platforms are used to locate tumor and facilitate image-guided surgery [18]. Due to
enhanced permeability and retention (EPR) effect, nanoparticles are more likely to accumulate in
tumors and spare the surrounding benign tissues [19]. Since abnormal pH has been recognized as a
universally diagnostic hallmark of cancer, the design of pH responsive polymers that are capable of
altering their chemical or physical properties are of particular interest for cancer theranostics [20–23].
Moreover, nanoscale polymers with pH responsive segments can strengthen the targeting specificity
and hence promote the uptake of nanomedicine into tumor cells [24].
In this perspective, we will review the recent advances in the development of pH responsive
nanomaterials for cancer diagnosis and treatment. This article aims to provide general guidelines
for the rational design of pH-responsive nanomaterials for the diagnosis and treatment of cancer.
Main focus is placed on the polymer designing, mechanistic insights, and specific applications.
2. pH-Responsive Polymers
Fabricating pH responsive polymeric nanomaterials has been rapidly developed after the
emerging of advanced techniques in polymer synthesis, especially reversible-deactivation radical
polymerization such as ATRP and RAFT [25,26]. The technical state of the art allows for precise control
over molecular weights and molecular weight distributions, affording polymers with well-defined
topology structure [27–29]. The pH responsive polymers can be mainly classified into two categories:
(1) polymers with ionizable moieties and (2) polymers that contain acid-labile linkages [30]. The former
strategy employs a noncovalent transition to achieve pH responsivity. Typical ionizable moieties
include amines and carboxylic acids, which can be protonated or deprotonated at different pH values.
The alteration of solubility in aqueous medium serves as an amplified signal to represent the change of
environmental pH. For the latter, the backbone of polymers usually comprises acid-labile covalent
linkages. The decrease of pH is able to trigger the cleavage of these bonds, causing a degradation
of polymer chains or a dissociation of polymer aggregates. Compared to polymers with ionizable
moieties, polymers containing acid-labile linkages often present a slower internal structural transition
due to the nature of covalent bonding, which facilitate their applications in the drug delivery systems.
2.1. pH Responsive Polymers with Ionizable Groups
The pH response arises from the reversible protonation and deprotonation of ionizable groups at
the molecular level. The pKa of a polyelectrolyte, which is defined as the pH with equal concentration
of the protonated and deprotonated forms, can serve as a critical benchmark to reflect the polymer
ionization behaviors at various pH levels [31]. In general, there are two types of ionizable polymers:
basic polymers that accept protons at a relatively low pH and acidic polymers that release protons at
a relatively high pH. Consequently, these polybases or polyacids can form positively or negatively
charged polymer chains at different pH levels. Common basic moieties include amines, pyridines,
morpholines, piperazines; and common acidic groups include carboxylic acids, sulfonic acids,
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phosphoric acids, boronic acids, etc. [30]. Among them, amines, especially tertiary amines, have drawn
particular attention due to their ease to prepare and the feasibility to finely tune their pKa [32,33].
It was reported that the amines can present a marginally lower pKa when substituted with longer
hydrophobic chains [34].
Recently, Gao et al. designed a series of ultra-pH sensitive (UPS) polymers for real-time tumor
imaging [35–38]. These nanoprobes can sharply respond to and amplify in vivo pH signals in a
very narrow pH span. The UPS nanoparticles are comprised of an amphiphilic block copolymer:
PEG-b-PMA, where PEG stands for hydrophilic poly(ethylene glycol) and PMA is a hydrophobic
segment based on polymethacrylates with tertiary amine substituent. At physiological pH (7.4),
the block copolymers stay as core-shell micelles driven by self-assembly. If the environmental pH is
lower than the pKa of the pendent tertiary amines, the amines will get protonated and the micelles
will dissociate rapidly into unimers. It is worth noting that the process that comprises assembly and
dissociation is completely reversible, and fully determined by ambient pH. Acid-triggered dissociation
of micelles enable the increase of fluorescence intensity for molecular imaging and release of cargo for
drug delivery.
Yan et al. further expand the UPS polymer design based on biodegradable polypeptides
(Figure 1) [39]. They modified the peptides with ionizable tertiary amines for pH responsive behavior.
Hydrophilic and hydrophobic blocks were synthesized independently and covalently connected by
the copper(I)-catalyzed alkyne-azide cycloaddition (CuAAC) “click” chemistry [40]. The copolymer’s
pKa can be readily tuned by altering the ratio of amino substituents. Similar to aforementioned
UPS designing, a fluorescent cyanine dye (Cy5.5) was attached at the chain end of the amphiphilic
copolymer to convert the subtle pH variation into significant fluorescence intensity change. This study
suggested that the ultra-pH sensitivity resulted from the reversible protonation of ionizable amines
rather than the peptide backbone. It also inspired the design of degradable ultra-pH sensitive polymers.
Figure 1. Design of ultra-pH-sensitive polypeptide micelles. (a) Structure of amphiphilic copolymers
with ionizable tertiary amines and their transition at lower pH. (b) pH-triggered disassembly and
fluorescence. Reproduced with permission from Liyi Fu, Pan Yuan, Zheng Ruan, Le Liu, Tuanwei Li,
and Lifeng Yan, Polymer Chemistry; published by Royal Society of Chemistry, 2017.
Natural macromolecules with ionizable amino acid residues have also been investigated for
pH-triggered delivery of imaging and therapeutic agents [41–45]. Engelman and colleagues have
been working on the development of novel pH-responsive transmembrane peptides, pH low insertion
peptide (pHLIPs), for basic research and translational applications in membrane biophysics and
medicine (Figure 2) [46]. These pH-responsive peptides were derived from the C-helix of the protein
bacteriorhodopsin [47]. pHLIPs spontaneously self-assemble into a helix structure and insert across
the membrane upon exposure to acidic environment [48]. In physiological condition, where the pH
is around 7.4, the ionizable acid residues of the pHLIP (red circles) stay negatively charged and the
peptide will be weakly bound to the surface of membrane. Once encountering acidic condition like
tumor microenvironment, carboxyl group will be protonated and neutralized. Increased lipophilicity
(green circles) as a result of ionization drastically enhances the affinity of pHLIP to the hydrophobic
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inner core of the cellular membrane and triggers the formation of a helix and ensuing insertion across
the membrane. When the protonatable carboxyl groups are exposed to the normal intracellular pH,
pHLIP gets reversibly deprotonated and anchors in the membrane. The pH-responsive behavior
of pHLIP can be easily modified by replacing ionizable aspartic acid residues with glutamic acid
residues [43,49] or positively-charged lysine residues [41], or other protonatable amino acids [44].
Figure 2. Mechanism of pH (Low) Insertion Peptide (pHLIP) Insertion into the Cellular Membrane.
In healthy tissue where the pH is around 7.4, the ionizable residues of the pHLIP (red circles) remain
deprotonated and negatively charged, and the peptide resides at or near the hydrophilic surface of
the cellular membrane. Upon exposure to acidic tumor microenvironment, the ionizable residues and
negatively charged C-terminal carboxyl group of the pHLIP become neutrally charged (green circles).
The protonation results in an increase in the hydrophobicity of the pHLIP, triggering the pHLIP to
spontaneously fold into a helix and insert across the hydrophobic lipid bilayer of cell membrane,
resulting in the formation of a transmembrane helix. Following internalization and exposure to cytosol
with pH above 7, C-terminal ionizable residues are deprotonated again and anchor the pHLIP into
the membrane. Reproduced with permission from Linden C. Wyatt, Jason S. Lewis, Oleg A. Andreev,
Yana K. Reshetnyak, and Donald M. Engelman, Trends in Biotechnology; published by Elsevier, 2017.
Polyacids have also been extensively investigated for the design of pH-responsive nanoplatforms.
Hyaluronic acid (HA) is a key component of the extracellular matrix and is known to bind to
CD44 proteins as a surface receptor on cancer cells [50]. Kono and coworkers reported HA-based
pH-sensitive polymer-modified liposomes for tumor-targeted delivery of chemotherapeutics [51].
Instead of simply using HA as targeting moiety, these authors introduced 3-methyl glutarylated
(MGlu) units and 2-carboxycyclohexane-1-carboxylated (CHex) units for the design of a new
class of pH-responsive polymers with transition pH around 5.4–6.7. Carboxyl group-introduced
HA derivatives were prepared by reaction with various dicarboxylic anhydrides. Terminal alkyl
chains served as anchor units inserting into the hydrophobic lipid bilayers of liposomes (Figure 3).
Upon exposure to acidic endosome pH, both MGlu and CHex modified HA were protonated, enabling
lipid membrane disruption and intracellular release of chemotherapeutics. Mechanistic investigation
demonstrated that the Mglu/CHex significantly affected the pH-responsive behavior of HA derivatives.
Increased hydrophobicity led to a higher transition pH.
Figure 3. Structures of pH-sensitive modified hyaluronic acid derivatives. Reproduced with
permission from Maiko Miyazaki, Eiji Yuba, Hiroshi Hayashi, Atsushi Harada, and Kenji Kono,
Bioconjugate Chemistry; published by American Chemical Society, 2018.
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2.2. pH Responsive Dissociation Based on Acid-Labile Linkages
Polymers containing acid-labile or base-labile linkages can respond to the change of pH
by degradation. Since the tumor microenvironment is slightly acidic compared to normal physiological
environment, polymeric nanoparticles containing base-labile linkages have seldom been used for cancer
therapy and will not be covered in the perspective. In contrast, polymers with acid-labile linkages
have been extensively utilized for the designing of anticancer drug delivery systems [52]. The most
commonly used acid-labile linkages are listed in Table 1. The different degradation mechanisms of the
linkages and the products after cleavage are described [53,54].
Table 1. Summary of acid-labile linkages.










Hydrazone is one of the most explored acid-labile linkages used for acid-responsive dissociation
release due to its easy synthesis and moderate sensitivity [55]. Incorporation of hydrazine
into the backbone of polymers represents an ideal strategy for the design of tumor-targeted
drug delivery systems. Nie group designed a pH-sensitive drug-gold nanoparticle system for
tumor chemotherapy and surface enhanced Raman scattering (SERS) imaging (Figure 4) [56].
This multifunctional system comprised of poly(ethylene glycol), doxorubicin (Dox), hydrazone
linker, and gold nanoparticles (Au–Dox–PEG). 3-[2-pyridyldithio]propionyl hydrazide (PDPH) was
conjugated with Dox in methanol. PDPH acted as a pH-sensitive linker and introduced thiol
groups to ensure the anchoring of drug conjugates onto the surface of gold nanoparticles. Gao and
coworkers developed a pH-responsive polypeptide–drug nanoparticles for targeted cancer therapy
based on well-defined elastin-like polypeptides and acid-labile hydrazone linker [57]. Wang reported
a hydrazone-based multifunctional sericin nanoparticles for pH-sensitive subcellular delivery of
anti-tumor chemotherapeutics [58].
Acetal and ketal are also commonly used acid-labile linkages, which are very stable under
basic conditions, but can be readily hydrolyzed to corresponding carbonyl compound (aldehyde
and ketone) and alcohols through a caboxonium ion intermediate upon acidic cleavage [59]. Lu and
coworkers reported a novel envelop-like mesoporous silica nanoparticle platform [60]. This system
immobilized acetals on the surface of silica (yellow, left) before coupling to gate-keeper nanoparticle
(purple, right) (Figure 5). At acidic pH, the acetal was effectively hydrolyzed to remove the gate
keepers, allowing the escape of entrapped drug molecules. Liu et al. reported the facile fabrication of
acid-sensitive polymersomes for intracellular release of drug over several days [61]. The polymersomes
compromising cyclic benzylidene acetals in the hydrophobic bilayers were stable under neutral
pH, whereas were hydrolyzed into hydrophilic diol moieties upon exposure to acidic pH milieu.
The pH-triggered hydrolysis can be easily monitored by many experimental methods including
UV/Vis spectroscopy and TEM. A novel class of acid degradable poly(acetal urethane) was also
235
Molecules 2019, 24, 4
reported for the construction of acid-degradable micelles for delivery of hydrophobic anti-tumor
therapeutics [62]. More recently, Wang group designed a new hyperbranched amphiphilic acetal
polymers for pH-sensitive drug delivery [63]. Under neutral conditions, the block copolymers
self-assembled into well-defined core-shell micelles. This pH-induced acetal cleavage resulted in the
drastic decrease of hydrophobicity and dissociation of micelles. De Geest and coworkers synthesized
ketal-containing block copolymers as pH-responsive nanocarriers for the hydrophobic anticancer drug
paclitaxel (PTX) [64]. The hydrolysis of the ketal groups in the block copolymer side chains at pH < 5
lead to decomposition of the block copolymer nanoparticles and the PTX release.
 
Figure 4. A pH-sensitive drug-gold nanoparticle system. (a) Chemical synthesis of the
doxorubicin-hydrazone linker conjugate (dox–PDPH). (b) Schematic illustration for the synthesis
of the multifunctional drug delivery system and its pH-dependent doxorubicin release. Reproduced
with permission from Kate Y. J. Lee, Yiqing Wang, and Shuming Nie, RSC Advances; published by
Royal Society of Chemistry, 2015.
 
Figure 5. Schematic illustration of the envelope-type mesoporous silica nanoparticle for pH-responsive
drug delivery. Reproduced with permission from Yan Chen, Kelong Ai, Jianhua Liu, Guoying Sun,
Qi Yin, and Lehui Lu, Biomaterials; published by Elsevier, 2015.
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Boronate esters, formed between a boronic acid and an alcohol, are stable at neutral or alkaline pH
and readily dissociate to boronic acid and alcohol groups in a low-pH environment. Boronate esters
have been widely employed to exploit pH-sensitive polymeric carriers for anticancer drug delivery.
Messersmith et al. conjugated the boronic acid containing anticancer drug bortezomib (BTZ) to
catechol-containing polymers via the boronate ester (Figure 6) [65]. Under neutral or basic condition,
BTZ and catechol formed stable conjugates via boronate ester linkers, deactivating the cytotoxicity
of BTZ. Upon exposure to lower pH, the conjugates readily release free drugs. Levkin and coworkers
reported a dextran-based pH-sensitive nanoparticle system by modifying vicinal diol of dextran with
boronate esters [66]. pH-triggered hydrolysis of ester linkers resumed the hydrophilic hydroxyl groups
of dextran and destabilized the dug-encapsulated nanoparticles. Kim et al. reported a pH-sensitive
nanocomplex by grafting phenylboronic acid (PBA) onto the backbone of poly(maleic anhydride) [67].
Dox and PBA readily formed boronate esters following simple mixing.
 
Figure 6. Catechol-containing polymers conjugated the boronic acid containing anticancer drug
bortezomib via acid-labile boronate esters. Boronate esters are stable at neutral or alkaline pH
and readily dissociate to boronic acid and alcohol groups in acidic environments to release the free
active drug. Reproduced with permission from Jing Su, Feng Chen, Vincent L. Cryns, and Phillip B.
Messersmith, Journal of the American Chemical Society; published by American Chemical Society, 2011.
3. Tunable pH-Responsive Behavior
A fundamental challenge in nanomedicine is the specific delivery the therapeutic or diagnostic
agents to the targeted tissues or cells [68,69]. Targeted delivery has shown promise in reducing
off-target effect and lowering toxicity [70]. One major consideration in the design of pH-responsive
nanomaterials is choosing polymers with pKa values matching the desired pH range. The acidity of
gastrointestinal track is drastically different from that of blood [71]. Intracellular compartments such as
mitochondria, endosomes, and lysosomes also have slightly different pH values [72]. Even the level of
acidosis shows small variation among different types of tumors [6]. Therefore, a key consideration in
the design of tumor-targeted pH-responsive polymers is to ensure the polymers are able to differentiate
acidic tumor microenvironment from surrounding normal tissues. The variation in the potency of
diverse anti-tumor therapeutics also requires tunable release kinetics of payloads.
Reversible protonation of pH responsive polymers leads to the change of the hydrodynamic
volume, chain conformation, water solubility and maybe supramolecular self-assembly. Ionization also
allows us to modulate the pH-responsive behavior of these polymers. Mechanistic investigation
suggests that the acid-base equilibrium in the ionization process is controlled by the balance between
hydrophobic interaction and electrostatic repulsion [73]. The transition pH can be tuned by altering
the structural factors that affect the hydrophobic or electrostatic interactions. Environmental factors
that shift the transition pH such as ionic strength and species are beyond the scope of this review.
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3.1. Hydrophobic Modification
Hydrophobic modification is an important approach to modulate the transition pH of ionizable
polymers. Incorporating different hydrophobic groups or changing the length of hydrophobic chains
can lead to the shift of pKa. Li et al. systemically investigated key structural parameters that
affected the transition pH of a series of polymers containing ionizable tertiary amines (Figure 7a) [34].
The hydrophobic interactions can be strengthened by increasing the hydrophobicity of the amine
substituents. To accomplish this goal, they synthesized a series of pH sensitive block copolymers with
an identical poly(methacrylate) backbone and similar chain length but different linear terminal alkyl
groups on the side chain. The polymer with the most hydrophobic pentyl group yielded the lowest pKa
at 4.4. Meanwhile, the one with the least hydrophobic isopropyl group as an amine substituent showed
the highest pKa, close to 6.6. These results demonstrated that ionizable pH-sensitive copolymers with
more hydrophobic amine substituents have a lower pKa. They calculated the octanol–water partition
coefficients (LogP) of the repeating unit of hydrophobic segment and used them as a quantitative
measure of the strength of hydrophobic interactions. The plot of pKa values as a function of LogP
(Figure 7b) showed a linear correlation. To confirm the observation, they synthesized another series
of block copolymers with the same backbone and similar chain length, but different cyclic terminal
alkyl groups. A plot of transition pH as a function of LogP also showed a similar linear correlation.
 
Figure 7. Tunable pKa based on hydrophobic modification. (a) Structure of methacrylate-based block
copolymers with different alkyl substituents. (b) Increase of the hydrophobicity of the alkyl substituents
resulted in the linear decrease of pKa. (c) Increased hydrophobic chain length lead to decreased pKa in
a representative poly(ethylene glycol)-b-poly(2-(diisopropylamino)ethyl methacrylate) (PEG-b-PDPA)
polymer. Reproduced with permission from Yang Li, Zhaohui Wang, Qi Wei, Min Luo, Gang Huang,
Baran D. Sumer, and Jinming Gao. Biomaterials; published by Elsevier, 2016.
To prove the concept that hydrophobic chain length has a significant effect on the pKa value,
Li et al. synthesized a series of poly(methacrylate)-poly(ethylene oxide) block copolymers with
the fixed hydrophilic poly(ethylene oxide) chains but variable chain lengths of the hydrophobic
poly(methacrylate) block (x = 5, 10, 20, 60, and 100), and evaluated the pKa value shift caused by
the change of the hydrophobic chain length. Results indicated that the pKa values were inversely
proportional to the length of the hydrophobic chain. The transition pH of block copolymers, with
the longest hydrophobic segment, yielded the lowest pKa at 6.2 (Figure 7c). In contrast, polymers
with the shortest hydrophobic chain length, displayed the highest transition pH around 6.7. The plot
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of pKa values as a function of the hydrophobic chain length showed a dramatic hydrophobic chain
length-dependent transition pH shift.
Hydrophobic modification has also been demonstrated to be a practical strategy in tuning
the degradation rate of polymeric systems containing acid-labile linkers. Ramakrishnan et al.
investigated how the hydrophobic end-groups affected the degradation of hyperbranched polyacetals
(Figure 8) [74]. They changed the structure of hyperbranched polymers by altering the pendant alkyl
groups of monomers. Results indicated that the degradation rates of the acid-responsive polymers
were significantly affected by the hydrophobic nature the terminal alkyl substituents, where more
hydrophobic alkyl groups generally contributed to slower degradation and prolonged release of cargos.
Figure 8. Hydrophobic modification in tuning the degradation rate of hyperbranched polyacetals.
(a) Structure and synthetic route of hyperbranched polyacetals. Monomers with different
hydrophobic substituents (methyl, butyl, and hexyl) were used in the preparation of three model
branched polyacetals. (b) Branched polyacetal with least hydrophobic methyl groups showed fast
degradation within 10 h, whereas polyacetal with most hydrophobic hexyl group showed almost
no significant degradation after 4 days. Reproduced with permission from Saptarshi Chatterjee and
S. Ramakrishnan. Macromolecules; published by American Chemical Society, 2011.
3.2. Copolymerization with Non-Ionizable Polymers
Stayton group reported the development of a series of pH-responsive block copolymers for
the delivery of siRNA [75]. These polymers were composed of a positively-charged block of
dimethylaminoethyl methacrylate (DMAEMA) to mediate siRNA condensation, and a second
endosomal releasing block composed of DMAEMA and propylacrylic acid (PAA) in roughly equimolar
ratios, together with butyl methacrylate (BMA). The polymers self-organized into micelles at
physiological pH while rendered pH-induced disassembly upon exposure to acidic endosomal pH.
The transition pH where reversible micellization occurred could be precisely tuned by systemically
changing the fraction of non-ionizable hydrophobic segment (Figure 9), with increased BMA ratio
exhibited lower pKa values [76]. Moreover, experimental results also showed that higher fraction
of BMA also lead to enhanced homolytic activity, indicating that the transition pH was critical for
therapeutic effect associated with pH-triggered drug release.
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Figure 9. Preparation of a representative copolymer consisting of a cationic poly(DMAEMA)
(dimethylaminoethyl methacrylate) block and an endosomolytic hydrophobic block incorporating
DEAEMA and butyl methacrylate (BMA) at varying molar feed ratios. Reproduced with
permission from Matthew J. Manganiello, Connie Cheng, Anthony J. Convertine, James D. Bryers,
and Patrick S. Stayton. Biomaterials; published by Elsevier, 2012.
3.3. Copolymerization with Ionizable Polymers
Incorporation of additional polyelectrolytes that changes both hydrophobic interactions and
electrostatic repulsion has also been reported for the modification of the transition pH of polymers.
Gao et al. reported a strategy to design ultra-pH sensitive nanoparticles with broad tunability via
a copolymerization method [35]. A series of PEO-b-P(R1-r-R2) block copolymers were prepared.
The hydrophobic block P(R1-r-R2) contained two randomly distributed ionizable monomers R1 and R2
with different hydrophobicity. The molar fraction of the two monomers (R1 and R2) can be precisely
controlled prior to polymerization. A series of ionizable monomers with different alkyl groups
(e.g., ethyl, propyl, butyl, and pentyl) were applied in their study. The pKa values of PEO-b-PDPA
(propyl) and PEO-b-PDBA (butyl) were 6.2 and 5.3, respectively. They were able to get a series of
PEO-b-P(DPA-r-DBA) copolymers with pKa values between 6.2 and 5.3 successfully. A plot of pKa
values of the obtained block copolymers as a function of the molar fraction of monomers with butyl
group yielded a linear correlation. It is worth noting that matching of the hydrophobicity of the two
monomers is critical to maintain the ultra-pH sensitivity. Based on this method, they established a
library of nanoprobes with pH transitions cover the entire physiologic range of pH (4.0−7.4) (Figure 10).
Compared to simple molecular mixture method, this copolymerization strategy achieves robust and
broad tunability in transition pH.
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Figure 10. Ultra-pH sensitive (UPS) library based on a copolymerization strategy spanning a wide
pH range. Polymers prepared from different monomers ionizable tertiary amines were encoded with
different fluorophores. UPS polymers with more hydrophobic repeating unit showed lower transition pH
as quantified by fluorescence intensity. Reproduced with permission from Xinpeng Ma, Yiguang Wang,
Tian Zhao, Yang Li, Lee-Chun Su, Zhaohui Wang, Gang Huang, Baran D. Sumer, and Jinming Gao.
Journal of the American Chemical Society; published by American Chemical Society, 2014.
3.4. Mechanistic Insights into the Tunable pH-Responsive Behavior
Compared to small molecules, polymerization and supramolecular self-assembly represent
powerful strategies to produce high-performance materials at nanoscale [77–80]. Despite the promise
in a multitude of biomedical applications, polymeric materials also introduce significantly increased
complexity inherent to the multiple interacting components within the systems. The lack of molecular
understanding of polymeric systems frequently hampers our ability to rationally design nanomaterials
for medicine and healthcare.
In a recent study, Li and coworkers elucidated the molecular pathway of pH-triggered
supramolecular self-assembly, which may pave the way for future design of pH-sensitive polymers
with easily tunable pKa and pH transition sharpness. They found that hydrophobic phase separation
was critical in tuning the pKa values of amphiphilic pH-responsive polymers (Figure 11) [73].
For pH responsive polymers that are not hydrophobic enough at neutral state to self-assemble
into nanoparticles, the pH responsive behavior was very similar to that of small molecular pH
sensors. The hydrophobic phase separation changes the molecular pathway of protonation in
ionizable polymers that can form self-associated nanoparticles. For polyamines, the hydrophobic phase
separation significantly shifted the pKa values to lower pH ranges. It is reasonable to hypothesize
that the increased hydrophobicity in polyacid systems shifts the transition pH to more basic pH,
which is actually validated by hyaluronic acid modified liposomes as described previously [51].
A molecular cooperativity was observed in pH-induced protonation and phase separation, as observed
in thermo-responsive polymers and many natural macromolecular systems. This suggests that
supramolecular cooperativity may serve as a general strategy in tuning the responsive behavior
of stimuli-sensitive nanomaterials [73].
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Figure 11. Schematic illustration of phase separation induced cooperativity in pH-triggered
supramolecular self-assembly. (a) Hydrophilic polymers with ionizable amines were protonated
homogeneously, showing no cooperativity. (b) Hydrophobic phase separation (e.g., micellization)
drove cooperative protonation of amphiphilic pH-responsive polymers. Phase separation also drove
the pKa values of polymers to lower pH because of hydrophobic barrier, which required higher
proton concentration (lower pH) to initiate the protonation process. Reproduced with permission from
Yang Li, Tian Zhao, Chensu Wang, Zhiqiang Lin, Gang Huang, Baran D. Sumer, and Jinming Gao.
Nature Communications; published by Nature Publishing Group, 2016.
Thayumanavan and coworkers systematically investigated the substituent effects on the
pH-sensitivity of acetals and ketals [59]. It is well established that the degradation of acetals and
ketals operated through a resonance-stabilized caboxonium ion intermediate [81]. Their study
validated that electron-withdrawing substituents generally decreased the hydrolysis rate due to
the cationic nature of the intermediate. Benzylidene acetals that were unsubstituted or substituted
with electron-withdrawing groups, exhibited drastically slowed hydrolysis under the pH 5 conditions
(Figure 12). For examples, half of phenyl-substituted acetal groups were hydrolyzed after 4 min.
Incorporating an electron-withdrawing trifluoromethyl moiety increased the half-life to around 12.3 h.
The presence of a resonance-based electron-withdrawing functionality further increased the half-life
to 51.8 h. The structural fine-tuning of the linkers offers powerful and practical method in future
design of acid-degradable polymeric drug delivery systems.
 
Figure 12. Substituent effects upon the hydrolysis of benzylidene acetals. Electron-withdrawing
substituents significantly contributed to decreased hydrolysis rate of acetals. As compared to phenyl
substituent with half-life of 4 min, trifluoromethyl increased the half-life of acetal to around 12.3 h.
The presence of a resonance-based electron-withdrawing functionality further increased the half-life
to 51.8 h. Reproduced with permission from Bin Liu and S. Thayumanavan, Journal of the American
Chemical Society; published by American Chemical Society, 2017.
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4. Applications of pH-Responsive Nanomaterials in Cancer Diagnosis and Treatment
Cancer remains one of the leading causes of death around the world. Nanotechnology has marked
a new dimension in fighting against cancer. pH-responsive nanomaterials that target tumor acidosis
offer a new paradigm in addressing the deficiencies of conventional chemotherapy in the diagnosis
and treatment of various types of cancer.
4.1. pH-Sensitive Nanoprobe-Based Fluorescent Imaging and Image-Guided Surgery
Surgery is one of the main options for cancer treatment. When resecting a tumor, a surgeon needs
to precisely identify the spread of the cancer. If tumor is not completely removed, there is a great chance
of recurrence of cancer. The patients may suffer from crucial organ dysfunction or damage if normal
tissues are cut. Thus, intraoperative technologies that can help surgeons visualize the tumor margins
during the operations may significantly improve the long-term survival of cancer patients. There is an
urgent clinical need for the cheap and practical technology that can universally differentiate tumors
from adjacent normal tissues, which could potentially help the surgeons save numerous lives [82–84].
Wang et al. reported a pH-responsive nanoparticle-based strategy for the imaging of a broad
range of tumors by nonlinear amplification of tumor acidosis signals [85]. As shown in Figure 13,
the ionizable amines were neutralized and the amphiphilic block copolymers stayed at micelles state
with conjugated fluorescent dyes quenched due a self-quenching Forster resonance energy transfer
(HomoFRET) effect. Upon access to acidic tumor microenvironment or internalized into endocytic
organelles in the tumor endothelial cells. This system demonstrated a broad tumor specificity with an
extraordinary tumor-to-blood ratio (>300-fold) in a variety of tumor models. Following the exceptional
imaging outcome, they continued the study in image-guided surgery with several clinical-compatible
fluorescent cameras [86]. The real-time tumor-acidosis-guided detection and resection of tumors
significantly improved the long-term survival of tumor-bearing mice.
Figure 13. pH-activatable nanoparticles for tumor-specific fluorescent imaging. (Left panel)
The nanoparticles stayed in micelle state in normal physiological pH and the fluorescence was quenched
as a result of self-quenching Forster resonance energy transfer (HomoFRET) effect. Upon exposure to
acidic tumor microenvironment, protonation of tertiary amines lead to the dissociation of micelles and
resume of fluorescence. (Right panel) pH-responsive nanoparticles selectively light up tumors instead of
surrounding normal tissues in various tumor models. Reproduced with permission from Yiguang Wang,
Kejin Zhou, Gang Huang, Christopher Hensley, Xiaonan Huang, Xinpeng Ma, Tian Zhao, Baran D. Sumer,
Ralph J. DeBerardinis, and Jinming Gao. Nature Materials; published by Nature Publishing Group, 2014.
4.2. pH-Sensitive Nanoprobe-Based Magnetic Resonance Imaging
Magnetic resonance imaging (MRI) with a contrast agent has been widely used as a powerful
tool for cancer diagnosis [87]. However, most MRI contrast agents are non-targeted for cancer and
passively distributed throughout the body, which results in a low efficiency and a need for high doses.
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One approach to addressing these problems is to use pH-responsive amphiphilic block copolymers
that would work as platforms for the tumor-targeting delivery of MRI contrast agents and MRI signal
enhancement in the tumor region.
Kun Na and coworkers developed a cancer-recognizable MRI contrast agents (CR-CAs) using
pH-responsive polymeric micelles [88]. The micelles were self-assembled from copolymers of
methoxy poly(ethylene glycol)-b-poly(L-histidine) (PEG–p(L-His)) and methoxy poly(ethylene
glycol)-b-poly(L-lactic acid)–diethylenetriaminopentaacetic acid dianhydride–gadolinium
chelate (PEG–p(L-LA)–DTPA-Gd) (Figure 14a–c). In the micelles, p(L-His) blocks were the
pH-responsive component. The imidazole groups of p(L-His) blocks were protonated, causing
the broken of the micellar structure in acidic tumoral environment. Paramagnetic gadolinium (Gd3+)
chelates were the MRI contrast agents that enhance the signal intensity upon the exposure to water
molecules as the micelles broken. In addition, the CR-CAs’ core was positively charged by protonation
of the imidazole groups of p(L-His) blocks after extravasation, which rapidly facilitated accumulation
of CR-CAs compared with pH-insensitive micelle-based CAs (Ins-CAs) due to the strengthened
interaction between the positively charge CR-CAs and the negatively charged cellular membrane.
In vivo, the CR-CAs exhibit highly effective MR contrast enhancement in the CT26 murine tumor region
of Balb/c mice, while the MR contrast of the tumor treated with Ins-CAs did not show a significant
change over time. CR-CAs enabled the detection of small tumors (3 mm3) in vivo within a few minutes
(Figure 14d).
Lee et al. encapsulated Fe3O4 nanoparticles, which are frequently used as a contrast agent for
MRI, into the pH-responsive polymeric micelle [89]. This technique has been tested on mice and shown
an increased signal intensity over a 24-h period compared to a pH-insensitive contrast agent which
did not change in signal intensity.
244
Molecules 2019, 24, 4
 
Figure 14. A cancer-recognizable MRI contrast agents (CR-CAs) based on pH-responsive
polymeric micelles. (a) Schematic representation of the preparation of cancer-recognizable CR-CAs.
(b) Schematic representation of the pH-dependent structural transformation and related MR signal
change in CR-CAs. Inset: Chemical structural representation of the protonation of imidazole groups
in PEG-p(L-His) at acidic pH. (c) Schematic representation of the tumor-accumulation behavior of
(1) conventional micelle-based CAs and (2) CR-CAs. (d) Temporal color-coded in vivo longitudinal
relaxation time (T1)-weighted MR images of CT26 murine tumor bearing Balb/c mice after the
intravenous injection of CR-CAs and pH-insensitive micelle-based CAs (Ins-CAs). Reproduced with
permission from Kyoung Sub Kim, Wooram Park, Jun Hu, You Han Bae, and Kun Na. Biomaterials;
published by Elsevier, 2014.
4.3. pH-Responsive Polymeric siRNA Carriers for Cancer Treatment
The use of RNA interference (RNAi) as a tumor-specific gene therapy has attracted increasing
attention, and is considered one of the most promising platforms for cancer therapy [90].
However, naked siRNA is unstable, and the effective intracellular delivery of siRNA into the
cytoplasm remains a significant challenge. After cellular uptake by passive or receptor-mediated
endocytosis, siRNA predominantly locates in endosomes and is degraded by specific enzymes in
the lysosome. Thus, to achieve an effective treatment efficiency, escape of siRNA from endosomes
to reach cytoplasm is desired. pH-responsive polymeric carriers that facilitate the endosomal escape
have been demonstrated one effective approach to mediate intracellular siRNA delivery.
Shi et al. developed several pH-responsive nanoparticle (NP) platforms, captaining
Poly(2-(diisopropylamino)ethyl methacrylate) (PDPA) components, for cancer-specific in vivo siRNA
delivery [91,92]. PDPA is a type of polycations containing low pKa amines. Low pKa amine
group have been shown to exhibit “proton sponge effect” to induce the endosomal escape [93].
Polycations induce the endosomal escape by binding to the oppositely charged cellular membrane
and perturbing membrane integrity. In addition, to synergize the endosomal escape, cationic
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membrane-penetrating oligoarginine grafts or cationic lipid-like grafts were also incorporated into
the nanoparticles. After cellular uptake, the rapid protonation of the PDPA segment causes the
fast disassembly of the nanoparticles, endosomal swelling, and the exposed membrane-penetrating
oligoarginine grafts or cationic lipid-like grafts lead to efficient endosomal escape (Figure 15a).




Figure 15. A pH-responsive nanoparticle (NP) platform for cancer-specific in vivo
siRNA delivery. (a) Molecular structures of the oligoarginine functionalized sharp
pH-responsive polymer methoxyl-polyethylene glycol-b-poly(2-(diisopropylamino) ethyl
methacrylate-co-glycidyl methacrylate) (Meo-PEG-b-P(DPA-co-GMA-Rn, n = 6, 8, 10, 20, and 30))
and S,S-2-[3–[5–amino-1-carboxypentyl]-ureido]pentanedioic acid functionalized poly(ethylene
glycol)-b-poly(2-(diisopropylamino)ethyl methacrylate) (ACUPA-PEG-b-PDPA) and a schematic
illustration of the multifunctional envelope-type NP platform for in vivo siRNA delivery and therapy.
(b) NPs prepared from Meo-PEG-b-P(DPA-co-GMA-R10) was denoted as NPsR10. Relative tumor
size of the Luc-HeLa and PCa cell lines (LNCaP) xenograft tumor-bearing nude mice (n = 5) after
treatment by Luc siRNA-loaded NPsR10 (control NPs) and PHB1 siRNA-loaded NPsR10 (NPsR10) and
siRNA-loaded ACUPA-NPsR10 (ACUPA-NPsR10). * p < 0.05; ** p < 0.01. (c) Representative photograph
of the LNCaP xenograft tumor-bearing nude mice in each group at day 18. (d) Photograph of the
harvested LNCaP tumors after a 30-day evaluation. Reproduced with permission from Xiaoding Xu,
Jun Wu, Yanlan Liu, Phei Er Saw, Wei Tao, Mikyung Yu, Harshal Zope, Michelle Si, Amanda Victorious,
Jonathan Rasmussen, Dana Ayyash, Omid C. Farokhzad, and Jinjun Shi. ACS Nano; published by
American Chemical Society, 2017.
Stayton et al. synthesized a diblock polymer composed of PDMAEMA block to condense
siRNA and a second block composed of DMAEMA, BMA, and PAA for endosomal-releasing [75].
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PAA induced the endosomal escape as a pH responsive membrane-destabilizing polymer,
which respond to changes in pH by transitioning from an ionized, hydrophilic structure at physiologic
pH (~7.4) to a hydrophobic, membrane-destabilizing conformation at endosomal pH values (<6.6).
The diblock copolymers condensed siRNA into 80–250 nm particles. In HeLa cells, the siRNA-mediated
knockdown of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) increased as the percentage of
BMA in the second block increased.
4.4. pH-Responsive Polymeric Anti-Cancer Drug Carriers for Cancer Treatment
Among the various therapeutic strategies for cancer, such as surgery, chemotherapy, radiotherapy,
and gene therapy discussed above, chemotherapy is the most often used method in clinical
practice [94,95]. However, the side-effects, low therapeutic efficacy and cytotoxicity of the traditional
chemical drugs such as Dox, camptothecin and PTX, have hindered the treatment efficiency of cancer
chemotherapy [96]. Polymeric nanoparticles have been developed and used as approaches to remove
the problems because they can improve pharmacokinetics and biodistribution profiles of anti-cancer
drugs via the EPR effect [97]. However, the EPR impact can only improve the accumulation of
NPs in tumor tissues, the efficiency of cancer chemotherapy has always still been hindered by the
insufficient drug release that induced the concentration of anticancer drugs to the level below the
therapeutic window [98]. pH-responsive polymeric drug carriers, which enhance the triggered release
of anti-cancer drugs by responding to the tumour acidic microenvironment, have been demonstrated a
pathway to address this problem.
For tumor environment triggered drug release, anti-cancer drugs could be ether physically
encapsulated into pH-responsive nanoparticles or conjugated to polymer through acid-liable bonds.
Kim group physically encapsulated Dox into a variety of pHis-based polymeric micelles for the CT26
tumor treatment. In vitro, the destabilized pH-responsive pHis core enhanced the triggered release of
Dox into the cancer cell. In vivo, the Dox-loaded micelles showed a higher CT26 tumour suppression
than free Dox did [99]. Etrych et al. conjugated Dox onto an amphiphilic N-(2-hydroxypropyl)
methacrylamide (HPMA)-based polymer by hydrazone bonds [100]. HPMA copolymer−Dox
conjugates were stable in a buffer at pH 7.4, Dox was released in a mild acidic conditions of the
tumor microenvironment. In vivo, HPMA copolymer−Dox conjugates significantly reduced the toxic
side effects of Dox and enhanced the anti-tumor efficacy.
Liu group reported a drug delivery system with the combination of physical encapsulation and
covalent conjugation of anti-cancer drugs for cancer treatment [101]. Dox was conjugated to PEG
by Schiff’s base reaction. PEG-Dox prodrug formed stable nanoparticles (PEG-Dox NPs) in water at
physiological pH, and encapsulated curcumin (Cur) into the core through hydrophobic interaction
(Figure 16a). When the formed nanoparticles, denoted as PEG-Dox-Cur NPs, are internalized by tumor
cells, the Schiff’s base linker between PEG and Dox would break in the acidic environment that is often
observed in tumors, causing disassembling of the PEG-Dox-Cur NPs and releasing both Dox and Cur
into the nuclei and cytoplasma of the tumor cells, respectively. The PEG-Dox-Cur NPs demonstrated
enhanced anti-tumor activity in animals compared with free Dox-Cur combination (Figure 16b).
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Figure 16. pH-responsive nanoparticles with the combination of physical encapsulation and covalent
conjugation of anti-cancer drugs for cancer treatment. (a) Schematic illustration of the synthesis and
working principle of PEG-Dox-Cur NPs. A Synthesis of PEG-Dox NPs via Schiff’s base. B Preparation of
PEG-Dox-Cur NPs by nanopreciptated technique. C Passive tumor targeting was achieved by
EPR effect. D The PEG-Dox-Cur NPs could be internalized by cancer cells through endocytosis.
E Dox and Cur were released with the cleavage of the Schiff’s base in tumor cells and diffused
into nucleus. (b) Relative tumor volume and bodyweight change in Balb/C nude mice after treatment
by PBS, free DOX/Cur mixture, PEG-Dox NPs and PEG-Dox-Cur NPs. * p < 0.05; ** p < 0.01.
Reproduced with permission from Yumin Zhang, Cuihong Yang, Weiwei Wang Jinjian Liu, Qiang Liu,
Fan Huang, Liping Chu, Honglin Gao, Chen Li, Deling Kong, Qian Liu, and Jianfeng Liu. Scientific
Reports; published by Nature Publishing Group, 2016.
4.5. Challenges and Opportunities of Translating pH-Responsive Nanomaterials
Despite the wide range of success evidences from pre-clinical studies, there remains significant
challenges for pH-responsive polymeric nanomaterials to enter clinical path. In addition to the specific
cases aforementioned, several general aspects should be taken into account. First of all, the formulation
of the polymeric nanomaterial applications is much more complex than conventional technology, such
as tablets and injections; this brings difficulties in achieving Good Manufacturing Practice (GMP)
standards in large-scale production and quality control. Secondly, developing and standardizing
biological assays for human toxicity evaluation and monitoring in clinical trials has to adopt the
potential novel biology coming from these materials. Besides toxicity, assays are also needed for
clinically relevant biomarker identification and validation. In addition, the pharmacokinetics and
pharmacodynamics (PK/PD) study is obligated to grasp a deep understanding of the physiochemical
properties of polymeric theranostics, adding layers of complexity to high-throughput data acquisition
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and modeling. From a regulatory perspective, the clear guidelines for the nanomaterials to be
developed facing forward translation still requires collaborative efforts.
Promising efforts have been invested towards these challenges. The development of reproducible
and stable polymeric nanomaterial batch synthesis protocol can potentially benefit from advanced
nanoparticle preparation technology [102,103]. Human organs-on-a-chip platform, mimicking key
functions in a human body, offers a great opportunity to address the limited predictive value
of conventional pre-clinical cell and animal models, which may be readily applied to polymeric
nanomaterials for safety and efficacy evaluations [104].
5. Summary and Future Perspective
Various physiological abnormalities, including pH, reactive oxygen species, overexpressed
proteins or enzymes, associated with cancer offer great opportunities for the design
of stimuli-responsive polymeric materials for tumor-targeted delivery of diagnostic and
therapeutic agents. There has been rapid growing interest in the design of pH-responsive polymeric
materials to target tumor acidosis, a ubiquitous characteristic shared by almost all types of cancers.
Despite obvious promise in pH-responsive nanomaterials, several challenges may warrant
further exploration. First, design of pH-sensitive polymeric materials that are safe for medical
and pharmaceutical applications remains a major challenge. It is still highly desirable to explore
biodegradable pH-responsive polymers with improved biocompatibility and reduced toxicity.
Second, additional efforts should also be directed toward improved tumor targeting efficacy.
pH-sensitive polymeric materials that can specifically deliver payload to tumor’s microenvironment
with minimal accumulation in normal tissues or endosomal organelles of tumor cells can drastically
improve the therapeutic efficacy and decrease the side effects. However, the pH variation between
tumor and surrounding normal tissues is not very significant, and different types of tumors may have
slightly different level of acidosis. To meet the requirements of various applications that target tumor
microenvironment and intracellular organelles pH-responsive polymers with m tunable pKa values
are required. Incorporation of multiple modalities into the same polymer or nanoparticle has also
shown promise in enhancing tumor targeting efficiency. Intrinsic heterogeneity of tumors may require
the design of polymeric nanomaterial system with multiple transition pH values. Moreover, lack
of comprehensive mechanistic understanding of pH-triggered responsive behaviors, especially
interactions between nanomaterials and in vivo host environment, still hampers our capability in
rational design of more effective pH-responsive nanomaterials for cancer treatment. While continuous
development of pH-responsive polymers with improved therapeutic efficacy is of great importance,
the modification and optimization of existing polymeric materials with validated biocompatibility
may represent a more straightforward and efficient strategy.
It’s worth noting that nanomedicine is an interdisciplinary field that requires close collaboration
between physicists, chemists, biologists, and physicians. Many reviews’ proof-of-concept studies
need a substantial amount of work before potential successful clinical translation. Nevertheless,
recent advances in the polymer design, structure-property correlation, mechanistic understanding,
and applications of a multitude of pH-sensitive nanomaterials reviewed here provide general
guidelines for future rational design of more effective pH-responsive nanomaterials for cancer
diagnosis and treatment.
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Abstract: Glucose-sensitive drug platforms are highly attractive in the field of self-regulated drug
delivery. Drug carriers based on boronic acid (BA), especially phenylboronic acid (PBA), have
been designed for glucose-sensitive self-regulated insulin delivery. The PBA-functionalized gels
have attracted more interest in recent years. The cross-linked three-dimensional (3D) structure
endows the glucose-sensitive gels with great physicochemical properties. The PBA-based platforms
with cross-linked structures have found promising applications in self-regulated drug delivery
systems. This article summarizes some recent attempts at the developments of PBA-mediated
glucose-sensitive gels for self-regulated drug delivery. The PBA-based glucose-sensitive gels,
including hydrogels, microgels, and nanogels, are expected to significantly promote the development
of smart self-regulated drug delivery systems for diabetes therapy.
Keywords: phenylboronic acid; gel; glucose sensitivity; drug delivery; diabetes therapy
1. Introduction
Diabetes mellitus threatens human health seriously with a series of complications, such as
cardiovascular disease [1]. The worldwide prevalence of diabetics is predicted to be about 366 million
in 2030 with increasing attention for the treatment of diabetes [2]. The frequent injection of exogenous
insulin is the major treatment of diabetes. In spite of quickly decreasing the blood glucose level,
frequent insulin injection causes inevitable injection suffering and decline of the quality of life of
patients. Even though implantable insulin pumps are the current optimal therapy for type 1 diabetic
patients, their high cost limits their wide clinical application [3]. Smart insulin modified with an
aliphatic domain and a phenylboronic acid (PBA) has been developed to tune the pharmacokinetics
of insulin activity for personalized therapy, however, it must interface with insulin pumps, infusion
devices, or controlled release materials to further improve performance [4]. An alternative treatment
of diabetes with continuous and automatic regulation of drug release triggered by glucose directly is
required. Therefore, glucose-sensitive materials, a kind of “intelligent” polymer, have greatly been used
in self-regulated systems. Self-regulated systems, which are called an artificial pancreas, control insulin
release triggered by elevated level of blood glucose continuously and automatically. By integrating
glucose-triggered drug delivery with minimal patient intervention and improved diabetic life quality,
glucose-sensitive drug delivery systems may prove valuable in diabetes therapy and replace frequent
insulin injection [5].
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Three kinds of glucose-sensitive materials have attracted growing scientific attention and are
considered novel candidates to serve as self-regulated drug delivery systems. One strategy is
based on glucose oxidase (GOD), which converts glucose to gluconic acid upon a pH change
of the microenvironment, resulting in physicochemical changes of GOD-incorporated carriers [6].
The physicochemical changes of GOD-incorporated platforms induce glucose-triggered payload
release [7–10]. Concanavalin A (Con A) is also be used to design glucose-sensitive drug delivery
systems due to the specific binding capacity for glucose, glycopolymers, and polysaccharides [11–14].
However, GOD and Con A are protein-based components, and the instability and biotoxicity of
GOD and Con A during fabrication and storage restrict their application in self-regulated drug
delivery [15,16].
An alternative mechanism based on totally synthetic components, boronic acid (BA) and
especially PBA, and their derivatives, have been largely investigated for self-regulated drug delivery
systems [17–20]. Since Okano and coworkers firstly reported PBA-based glucose-triggered drug
release, PBA and its derivatives have been greatly employed to design glucose-triggered drug delivery
systems [21,22]. PBA-containing platforms are much more stable and suitable for long-term storage
than GOD- and Con A-based drug carriers [23]. The principle of the PBA-mediated glucose-sensitive
drug delivery system is based on the reversible reaction between PBA and cis-diol compounds [24].
There are two states of PBA in aqueous solution. One is the neutral trigonal-planar form and the
other is the negatively charged tetrahedral boronate form. Between the two states of PBA moieties
there is an equilibrium (Scheme 1). When in aqueous solution with pH above the pKa of PBA (i.e.,
8.2−8.6), most PBA moieties are negative and relatively hydrophilic. However, the PBA moieties are
neutral and hydrophobic when the pH of the solution is below the pKa of PBA [25,26]. In the presence
of glucose or other 1,2- or 1,3-diols, both kinds of PBA moieties form a 5- or 6-cyclic boronic ester.
However, the cyclic boronic ester between neutral trigonal-planar PBA and a diol cannot be formed
with easy hydrolysis. The negatively charged PBA state forms a more stable cyclic boronic ester with
cis-diol compounds, resulting in the increase of the negatively charged PBA content and improved
hydrophilicity of PBA-containing materials [27,28]. The increased hydrophilicity of PBA-modified
materials induces the swelling, disassembly, and/or destruction of PBA-mediated platforms with
subsequent release of the payload. Glucose can also form bis-bidendate complexes with PBA resulting
from the reaction between one glucose molecule and two cis-diols. Therefore, the bis-bidendate
complexes induce the shrinking of PBA-functionalized platforms [29]. All the swelling and shrinking
of platforms alter the diffusion behavior of the payload, triggered by glucose-sensitive volume phase
transition. PBA-functionalized materials present great potential applications in self-regulated drug
delivery [29,30].
Scheme 1. Complexation equilibrium between phenylboronic acid (PBA) and glucose.
There are many forms of PBA-functionalized platforms which have been exploited to investigate
glucose sensitivity. Polymer micelles, vesicles, and capsules are obtained by the self-assembly
of PBA-modified amphiphilic polymers, while layer-by-layer (LbL) films are obtained by the
256
Molecules 2019, 24, 1089
alternating adsorption of polymers with opposite charges. Even though these devices have
good glucose sensitivity, the concentration-dependent disintegration, unstably long-term storability,
and weakened mechanical strength restrict their applications in glucose-sensitive drug delivery.
PBA-functionalized mesoporous silica nanoparticles (MSN) have attracted improving interests
due to their characteristics of high biocompatibility, improved dug loading, and functionalized
surface. The glucose-sensitive nanocarriers and LbL films and microcapsules for self-regulated drug
delivery have been reviewed [26,31]. Besides, PBA-based hydrogels, microgels, and nanogels with
chemically or physically cross-linked structures have great potential applications in self-regulated
drug delivery systems. The 3-D structures endow the hydrogels, microgels, and nanogels with
reversible physicochemical changes that result in payload release. Usually, hydrogels are macroscopic
hydrogels. Microgels are microsized hydrogel particles, while nanogels are hydrogel nanoparticles
or nanohydrogels with nano-scale dimensions (typically 20~250 nm) [32,33]. The Zhang group
and Catargi group have discussed the fabrication and application of PBA-containing macroscopic
hydrogels and microgels with discussion of their further development [29,34]. However, studies of
PBA-based hydrogels, microgels, and nanogels for self-regulated drug delivery are rare. In summary,
this article reviews the recent development of self-regulated drug delivery based on PBA-mediated
glucose-sensitive gels.
2. PBA-Based Hydrogels
Hydrogels have received considerable attention for drug delivery applications. There have been
extensive studies on PBA-functionalized hydrogels for self-regulated drug delivery systems.
Low-molecular-weight hydrogels (LMWG) have been largely investigated for controlled drug
delivery due to their super-sensitivity to external stimuli. LMWG were formed by the self-assembly
of gelators with low-molecular-weight, where the gel-sol transition was easily achieved by changing
stimuli. An injectable glucose-sensitive LMWG was prepared by the self-aggregation of the
gelator which was synthesized with a pyrene moiety coupled with PBA by L-phenylalanine and
a 2,2′-(ethylenedioxy) bis(ethylamine) linker [35]. The pyrene unit and PBA moiety endowed the
physical cross-linked LMWG with glucose sensitivity, and the resulting compound was utilized to
detect glucose and control insulin release at physiological pH. Differently from chemically cross-linked
hydrogels, physically cross-linked networks have transient junctions arising from hydrogen bonding,
π–π stacking, and van der Waals interactions. The self-aggregation of the gelator provides a new
strategy for the design of PBA-based glucose-sensitive hydrogels.
Gao and coworkers investigated the dual-responsiveness of a PBA-based low-molecular-weight
organogel to both glucose and pH [36]. In addition, the group studied the gelation properties and
glucose sensitivity of a PBA-containing low-molecular-weight organogel based on an alkyl chain
(C2–C11), where the glucose sensitivity of the organogel was associated with the molecular structure
of the gelator [37]. Integrating an oligopeptide with PBA, the same group demonstrated that the
LMWG self-assembled from a gelator exhibited dual-responsive and long-lasting drug delivery [38].
The structure of the gelator is shown in Figure 1. The hydrophilicity of gelator was regulated by
the oligopeptide which was made of the natural amino acids L-phenylalanine, glycylglycine, and
L-glutamine. The alkyl chain of lauroyl chloride was introduced to adjust the hydrophobicity of the
gelator in favor of the sol-gel translation. PBA unit endowed the gelator with glucose sensitivity.
When the sol was cooled to body temperature, LMWG was obtained very quickly within two minutes.
The sol-gel translation resulted from the enhanced π–π stacking owing to the benzene units as well
as hydrogen bonding and van der Waals force within the gelators. The LMWG was very stable
during the drug release even for three months or with sever shaking, indicating its long-lasting
drug delivery. The pH-sensitivity of the hydrogels, a result of the ionization of the PBA and amide
moieties in acid or alkali solutions, was used for doxorubicin delivery for cancer therapy. Importantly,
PBA endowed the hydrogels with glucose sensitivity. The release of phenformin, an antidiabetic
drug, was regulated in response to changes in glucose concentration. The fact that increasing
257
Molecules 2019, 24, 1089
glucose concentration induced much more drug release indicated its promising application in a
self-regulated drug delivery system. Integrating the pH-sensitivity with glucose-triggered drug release,
the long-lasting glucose/pH-responsive hydrogels will have notable importance in the development
of self-tuning controlled-release systems for diabetes and cancer therapy.
Figure 1. The structure of the gelator used for self-regulated drug delivery. (Reprinted from ref. [38]).
Even though LMWG used as a drug carrier possesses good glucose-sensitive drug delivery,
the stability of LMWG is not sustainable enough for long-term drug delivery compared to the
supramolecular hydrogels with chemical cross-linked structure. A multiresponsive hydrogel
was synthesized by copolymerization of (2-dimethylamino) ethyl methacrylate (DMAEMA) and
3-acrylamidephenylboronic acid (AAPBA) using N,N′-methylenebisacrylamide (NNMBA) as a
cross-linker [39]. The P(DMAEMA-co-AAPBA) interpenetrating (IPN) hydrogels possessed
glucose-triggered drug release under physiological pH and temperature. The increased Lewis acidity
of the boron center lowered the pKa of the PBA residues. The Lewis acid–base interactions between
the electron-poor boron atom and the electron-rich nitrogen atom on poly(DMAEMA) endowed the
hydrogel with glucose sensitivity under physiological pH. These multiresponsive hydrogels have
important application in self-regulated drug delivery.
Also based on poly(DMAEMA), a novel triple-responsive semi-interpenetrating (semi-IPN)
hydrogel was exploited [40]. Poly(3-acrylamidephenylboronic acid-co-(2-dimethylamino) ethyl
methacrylate) (P(AAPBA-co-DMAEMA)) has a cross-linked structure incorporated with interpenetrating
β-cyclodextrin-epichlorohydrin (β-CD-EPI)—P(AAPBA-co-DMAEMA)/(β-CD-EPI) semi-IPN hydrogel.
The higher content of β-CD decreased the equilibrium swelling ratios (ESRs) of semi-IPN hydrogels
due to the complexation between PBA groups and the dihydroxyl of β-CD. Besides, pH, temperature,
ionic strength, and glucose concentration of the media significantly affected the ESRs of the hydrogels.
Using ibuprofen and aminophylline as hydrophobic and hydrophilic model drugs, the drug loading
and release profiles were investigated. The structure of the hydrogels affected the drug loading ratio.
Increased β-CD content led to of ibuprofen and a lower drug loading ratio of aminophylline. The
lower drug loading ratio of hydrophilic aminophylline in hydrogels with high β-CD content resulted
from the lower ESRs, which was induced by the increased complexation between PBA and β-CD.
However, the loading ratio of hydrophobic ibuprofen increased with the increase of β-CD content
in hydrogels. The reason was that hydrophobic ibuprofen formed inclusion complexes with β-CD
via host–guest interactions. The release profiles of drug from the hydrogels could be adjusted by pH,
temperature, glucose concentration, and type release medium. The semi IPN hydrogels may be useful
as a guideline for the optimal design of glucose-sensitive drug delivery systems.
To enhance the response of PBA-based hydrogel to blood glucose concentration, a comb-type
grafted poly(N-isopropylacrylamide-co-3-acrylamidophenylboronic acid) (poly(NIPAM-co-AAPBA))
hydrogel was exploited [41]. The hydrogel was introduced by grafting poly(NIPAM-co-AAPBA) side
chains onto cross-linked poly(NIPAM-co-AAPBA) networks. The comb-type hydrogel presented a
rapid response to the blood glucose concentration owing to the effects of the freely mobile ends of the
grafted poly(NIPAM-co-AAPBA). Grafted poly(NIPAM-co-AAPBA) side chains formed complexes
with glucose quickly without any restrictions than that between cross-linked poly(NIPAM-co-AAPBA)
hydrogel and glucose. The rapid response rate endowed the grafted hydrogel with attractive
applications in self-regulated drug delivery systems.
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Besides the structure of hydrogels, the composition of hydrogels also affects the glucose
sensitivity. Magda and coworkers studied the effect of chemical composition on the response of
zwitterionic glucose-sensitive hydrogels using DOE (design of experiments) methods [42]. Zwitterionic
glucose-sensitive hydrogels were prepared by the copolymeration of N-(3-(dimethylamino)propyl)
acrylamide (DMAPAA) and AAPBA. The molar ratio of AAPBA/DMAPAA and the wt % of the
monomer in the pregel solution were the primary factor for determining the value of the inverse of the
1st order rate constant, where a decreasing amount of cross-linker obtained faster glucose responses.
In addition to stable chemical cross-linked hydrogels using a small molecular as the cross-linker,
reversible dynamic cross-linked hydrogels have also been designed as glucose-sensitive drug carriers.
Hydrogels were obtained by the reversible covalent complexation of PBA with cis-1,2 or cis-1,3-diol
compounds as a dynamic link [43,44]. Glucose-sensitive solid-like hydrogels based on dynamic
covalent chemistry and inclusion complexation were also designed [45]. By simply mixing the solutions
of poly (ethylene oxide)-b-poly vinyl alcohol diblock polymer (PEO-b-PVA), α-cyclodextrin (α-CD), and
a double PBA-terminated PEO cross-linker, hydrogels were easily obtained. As shown in Figure 2, the
inclusion complexation between PEO and α-CD, and the dynamic covalent bonds between PBA and
PVA, strengthened the hydrogel network. In addition, the formation of hydrogels was the cooperative
interaction of the inclusion complexation and dynamic covalent chemistry. The increase of α-CD
content shortened the gelation time and enhanced the structural recovery ability with the significant
contribution of increased dynamic covalent chemistry to the cross-linking density of hydrogel network.
The release of FITC-labeled BSA from the hydrogels had no burst release property at physiological pH,
indicating that the FITC-labeled BSA was loaded inside the hydrogels instead of being adsorbed on
the surfaces of the hydrogels. These hydrogels have great potential as self-regulated drug delivery
vehicles with tunable glucose sensitivity.
 
Figure 2. Schematic and the glucose-sensitive mechanism of the hydrogel composed of PEO-b-PVA,
α-CD, and double PBA-terminated poly (ethylene oxide) (PEO) cross-linker. (Reprinted from ref. [45].)
Via dynamic boronic ester bonds, glycopolymer hydrogels were exploited to control insulin release
triggered by glucose [46]. The copolymerization of AAPBA and 2-lactobionamidoethyl methacrylate
(LAMA) was conducted by the reversible addition–fragmentation chain transfer (RAFT) method
and the obtained block glycopolymer formed hydrogels by phenylboronate-diol crosslinked binding
(Figure 3). The LAMA content played an important role in the swelling of the hydrogels. For the
hydrogels with the highest LAMA content, the equilibrium swelling ratio was up to 1856%. In
addition, with high LAMA content, the insulin loading capacity of the hydrogels increased. Higher
content of LAMA enhanced the charged phenylborates, which resulted in enhanced hydrophilicity
of the hydrogels and subsequently promoted drug permeation and adsorption. The introduction
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of carbohydrate moieties improved the cytocompatibility of the glycopolymer hydrogels. The
insulin release from the glycopolymer hydrogels exhibited glucose sensitivity due to glucose-induced
dissociation of boronic ester linkages of hydrogels. Importantly, the released insulin possessed an
original conformation compared with standard insulin. PBA-based glycopolymer hydrogels are an
alternative design of glucose-sensitive drug delivery systems.
Figure 3. The formation of PBA-containing glycopolymer hydrogel before and after. (Reprinted from
ref. [46]).
Another series of glucose-sensitive block glycopolymer hydrogels based on dynamic boronic
ester bonds were exploited for glucose-sensitive drug delivery [47]. As shown in Figure 4a,
block glycopolymer, (3-propionamidophenyl)boronic acid (N-(3-((2,3,4,5,6-pentahydroxyhexyl)
amino)propyl)propionamide) (noted polymer BG), was cross-linked through PBA–glucose
complexation within the glycopolymer and injectable self-healing hydrogels were obtained. The
glycopolymer with 10–60% content of PBA formed self-supporting hydrogels at 5% weight in water,
which could be easily loaded and extruded through a needle with the reformation of hydrogels
(Figure 4b). The hydrogels possessed rapid recovery with shear-thinning and self-healing behaviors
which were consistent with the injectable hydrogel. In addition, the glycopolymer hydrogels exhibited
glucose-triggered rhodamine B release. Integrating injectable and self-healing properties with
glucose-induced drug release, glycopolymer hydrogels have potential application in the treatment
of diabetes.
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Figure 4. (a) Structure of PBA-containing glycopolymer BG; (b) the soft and injectable hydrogel
formed by polymer BG with 50% PBA, and the SEM image of the obtained hydrogel. Scale bar: 1 μm.
(Reprinted from ref. [47]).
Hydrogels based on PBA-containing polymers for self-regulated drug delivery system have been
studied widely, while the bioconjugates of PBA-functionalized polymer and protein or peptide have
been rarely used for glucose-sensitive drug delivery. Multiresponsive hydrogels were prepared from
the bioconjugates of end-functionalized PBA containing copolymers and rod-like M13 viruses [48].
The end-functionalized PBA containing copolymer poly(NIPAM-co-PBA)-NHS was synthesized
by two steps (Figure 5a). Firstly, poly(NIPAM-co-PBA)-COOH was synthesized by chain transfer
free radical copolymerization of NIPAM and 4-(1,6-dioxo-2,5-diaza-7-oxamyl) phenylboronic acid
(DDOPBA) using 3-mercaptopropionic acid (MPA) as the chain transfer agent. Then, the −COOH of
the obtained poly(NIPAM-co-PBA)-COOH was transferred into N-hydroxysuccinidic ester. The hybrid
virus–polymer bioconjugate was prepared by the conjugation of poly(NIPAM-co-PBA)-NHS to rod-like
M13 virus, which was a natural protein assembly with a large amount of functional groups. The
gelation behavior of virus–polymer bioconjugates was multiresponsive and reversible. The gelation of
virus–polymer bioconjugates was owing to the collapsed hydrophobic state of poly(NIPAM-co-PBA),
which conferred the attractive interactions between the viruses and drove the viruses into the hydrogels.
AFM revealed that the rod-like virus was interconnected with itself inside the hydrogel with large
pores (Figure 5b). The virus–polymer bioconjugates were in sol state when the temperature was below
the critical gelation temperate (Tg), and in the gel state when the temperature was above Tg. The Tg of
virus–polymer bioconjugates was sensitive to pH. At pH 7.10, the Tg was 15 ◦C, and increased when
the pH increased. Furthermore, the Tg of the hybrid virus–polymer bioconjugates was 18 ◦C in the
absence of glucose, while it was 23 ◦C in the presence of glucose at pH 7.65. In addition, the negligible
hysteresis for the sol-to-gel and opposite gel-to-sol transition cycles indicated the reversible gelation
behavior of the virus–polymer bioconjugates. Besides, the temperature-sensitive gelation behavior
was in favor of the encapsulation of bioactive species inside the hydrogels with high loading capacity.
Insulin-loaded hydrogels were obtained by the injection of a mixture of insulin and polymer-grafted
virus at 4 ◦C into PBS buffer at 37 ◦C (inset of Figure 5c). Glucose-sensitive insulin release was also
observed (Figure 5c). Glucose-triggered insulin release, combined with reversible temperature-, pH-,
and glucose-regulated gelation behavior, endowed the PBA-containing polymer-virus bioconjugates
with great potential in self-regulated drug delivery.
Cross-linking glucose-sensitive hydrogels based on PBA provides suitable semiwetting with
reversible swelling/shrinking changes which are suitable for self-regulated drug delivery. However,
the glucose sensitivity of bulk hydrogels hysteretically results from the slow permeation of glucose
into the hydrogel network. In addition, the practical application of bulk hydrogels for the regulation
of blood glucose levels is restricted by the implantation or other surgical approach. Even though
injectable hydrogels are convenient to administrate, a lot of effort is needed to promote the practical
application of glucose-sensitive hydrogels for diabetes therapy.
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Figure 5. (a) Schematic representation of the preparation of the hybrid virus–polymer bioconjugate of
end-functionalized PBA- and N-isopropylacrylamide (NIPAM)-containing copolymer to the rod-like
M13 virus, and the multiresponsiveness of the hybrid virus–polymer bioconjugate; (b) Internal structure
of the gel as revealed by AFM; (c) insulin release behavior of the virus based hydrogel in the presence
or absence of glucose. Inset in (c) hydrogel forms instantly when the polymer grafted virus in the sol
state was injected into the aqueous solution at 37 ◦C. (Reprinted from ref. [48]).
3. PBA-Functionalized Microgels
Even though PBA-based hydrogels are glucose-sensitive, the implantation administration of bulk
hydrogels and the inconvenient injection of injectable hydrogels restrict the practical application of
glucose-sensitive hydrogels in self-regulated drug delivery. Compared with hydrogels, PBA-based
microgels have promising application in glucose-sensitive drug delivery [49]. Microgels are gel
particle dispersions with average diameters ranging between 50 nm and 5 mm [50]. The small size
endows the microgels with rapid swelling or shrinking in response to environmental changes. The
glucose-response time of PBA-containing microgels are much faster than that of hydrogels. Kataoka
and coworkers reported that gel beads containing AAPBA and NIPAM need a very long time (as long
as 400 min) for glucose sensitivity [51]. However, microgels with the same components need only
102 s for glucose-induced swelling [52]. Besides faster glucose-response time, the administration of
microgels using a minimally invasive method is another advantage of microgels for self-regulated
drug delivery. In addition, microgels display high stability, which is promising for glucose-sensitive
drug delivery vehicles.
A range of PNIPAM-based and PBA-functionalized microgels have been synthesized via
the copolymerization of NIPAM and PBA-containing comonomers or the postpolymerization of
functional PBA derivatives to PNIPAM microgels [53–57]. Poly(N-isopropylacrylamide-co-acrylic acid)
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P(NIPAM-co-AA) was modified by 3-aminophenylboronic acid (3-APBA), resulting in PBA-mediated
glucose-sensitive microgels [58,59].
Glucose-induced swelling of the poly(N-isopropylacrylamide-co-3-acrylamidophenylboronic acid)
(P(NIPAM-3-AAPBA)) microgel was explained by the formation of a 1:1 glucose–phenylboronate
complex, which increased the degree of ionization and created a Donnan potential between the gel
phase and the liquid phase [52,60].
For P(NIPAM-PBA) microgels, the swelling response of microgels to glucose relates to the microgel
composition and glucose concentration. Ravaine studied the effects of PBA content and glucose
concentration on the swelling of monodispersed PNIPAM submicrometric microgels modified with
AAPBA at different temperatures [61]. Compared to native PNIPAM particles, the incorporation of
AAPBA decreased the volume phase transition temperature (VPTT) of the P(NIPAM-PBA) microgels.
With the increase of PBA content, the swelling response of the microgels increased. However, the
swollen state of the microgels that was achieved with same PBA content was strongly dependent on
the initial temperature of the suspension with a constant glucose concentration. As shown in Figure 6,
when the initial temperature was above VPTT, the microgels were smaller and the swelling was slight.
In this case, glucose was unable to diffuse inside the microgel particle when it was initially collapsed.
Only a small part of glucose linked to the PBA which was incorporated on the surface of microgels.
However, when the initial temperature was below VPTT, a slight swelling of the microgels was aided
the permeation and diffusion of glucose to the inside of the microgel particle. As a result, all the PBA
was linked by glucose to form more hydrophilic boronic ester, inducing a much higher swelling degree
of the microgels.
Figure 6. Schematic representation of microgel swelling upon glucose addition, showing the importance
of the initial state. (Reprinted from ref. [61]).
Zhang and coworkers also studied the volume phase transitions of glucose-sensitive
PBA-functionalized P(NIPAM-3-AAPBA) microgels which were synthesized by the coupling of
3-APBA to P(NIPAM-co-AA) microgels [62]. The microgels presented a two-stage thermosensitive
volume phase transition in the presence of glucose. When temperature increased, the microgels
underwent a small degree of collapse and a large volume change followed. In addition, the glucose
sensitivity of the microgels was affected by pH. At pH = 7.5, which is below the pKa of PBA, the
glucose-induced size changes of the microgels were negligible. In this case, most PBA groups were
hydrophobic with few boronate esters produced. However, when the pH increased, the glucose
sensitivity of the microgels was enhanced as a result of the improved hydrophilicity of the microgels
with resultant boronate ester. The glucose-induced size expansion of the microgels was depressed
by high ionic strength due to the weakening of Donnan potential. At room temperature, remarkable
glucose-induced swelling was observed in the microgels with high content of PBA.
Most PBA-based microgels exhibit glucose-induced expansion due to the production of
glucose–mono(boronate) complexes [57,63]. The glucose–mono(boronate) complexes make the
ionization equilibrium of PBA shift from uncharged and hydrophobic state to the charged and
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hydrophilic state with the formation of tetrahedral boronate esters. The tetrahedral boronate
esters further increase the hydrophilicity of the microgels and induce the swelling of microgels
due to the glucose-induced increase in the Donnan potential. Besides glucose-induced swelling
of microgels, glucose-induced shrinking of microgels also has been reported. As shown in
Figure 7, glucose exhibits the unique property to form glucose–bis(boronate) complexes through
its furanose form [64–66]. However, most physiological relevant saccharides, such as galactose,
mannose, and fructose, can only bind to boronic acid as monodentate complexes [67]. Zhang
designed a poly(N-isopropylacrylamide-co-2-acrylamidophenylboronic acid) (P(NIPAM-2-AAPBA))
microgel, which was synthesized by modification of the poly(N-isopropylacrylamide-co-acrylic acid)
(P(NIPAM-AAc)) microgel with 2-aminophenylboronic acid (2-AAPBA) [17]. In the presence of
glucose, the size of the P(NIPAM-2-AAPBA) microgels decreased, showing contraction-type glucose
sensitivity. The glucose-induced shrinking of the microgels was related with the glucose–bis(boronate)
complexes in which one glucose molecule complexed with two PBA groups in a 1:2 binding model.
The resultant glucose–bis(boronate) complexes increased the cross-linking density and reduced the
degree of swelling of the microgels. The contraction-type glucose-sensitive microgels offer a new
strategy for the design of glucose-sensitive microgels.
 
Figure 7. Schematic representation of glucose-induced microgels shrinking with glucose–bis(boronate)
complexation (Reprinted from ref. [66]).
Except for contraction-type glucose-sensitive microgels, glucose-induced shrinking/swelling
microgels were also designed. Ravaine and coworkers firstly designed the PBA-containing
microgels cross-linked with bis-boronate complexes which either swelled or shrank
selectively depending on glucose concentration under physiological conditions [66]. The
microgels were obtained by copolymerization of DDOPBA with an alkylacrylamide (NIPAM,
N-isopropylmethacrylamide (NIPMAM), or N-ethylmethacrylamide (NEMAM)) and a cross-linking
agent (N,N′-methylenebis(acrylamide) (BIS), or ethylene glycol dimethacrylate (EGDMA)). The
effect of monomer composition on the swelling/shrinking behavior of the microgels was studied.
For microgels based on NIPAM and PBA (P(NIPAM-PBA) microgels), the VPTT was associated
with the PBA content. More PBA content lowed the VPTT of P(NIPAM-PBA) microgels, which was
conformed in the author’s earlier work [61]. However, high glucose concentration increased the VPTT
of P(NIPAM-PBA) microgels. In addition, at constant PBA content, the VPTT of NIPAM microgels
was lower than that of NIPMAM microgels, which was lower than that of NEMAM microgels. All
kinds of microgels displayed glucose-sensitive behaviors. When at a pH above the pKa of PBA,
EGDMA cross-linked NEMAM and NIPMAM microgels exhibited a two-step behavior wherein low
glucose concentration induced microgel shrinkage and high glucose concentration induced microgel
swelling. The shrinking behavior was associated with the additional cross-linking junctions due
to glucose-bis(boronate) complexes at low glucose concentration. When the glucose concentration
increased, the glucose–bis(boronate) complexes were converted to glucose–mono(boronate) complexes
owing to the glucose-induced cross-link disruption. As a result, the microgels swelled under high
glucose concentration due to the increased polymer charges and hydrophilicity. The glucose-response
behavior of the microgels was related to the nature of the cross-linker and the modification of the
PBA. The shrinking/swelling behavior was selective for glucose because the saccharide–bis(boronate)
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complexes were highly selective for glucose and could not occur with other sugars, such as fructose,
which was also demonstrated by Asher and coworkers [67].
As mentioned above, polymers based on NIPAM, NEMAM, and EGDMA are thermosensitive
and the VPTT of P(NIPAM-PBA) microgels are adjusted by glucose concentration and PBA content.
Some other kinds of PBA-based microgels also possess volume phase transition behavior. The
glucose-responsive volume phase transition behavior of poly(phenylboronic acid) (pPBA) microgels
was switchable [68]. The preparation of the pPBA microgels was comprised 3-VAPBA covalently
bonded onto the microgels of oligo(ethylene glycol)-based polymers (Figure 8). The stability of the
pPBA-2 microgels was improved by further addition of a poly(acrylamide) (poly(AAm)) gel layer onto
pPBA-1 microgels. In the presence of glucose, the glucose-response behaviors of pPBA microgels were
different under different temperatures. At lower temperatures below 29.0 ◦C, the microgels shrunk
when glucose was added, while at higher temperatures above 33.0 ◦C, the microgels swelled when
glucose was added. Around 31.0 ◦C, negligible volume change of the microgels was recorded upon
adding glucose. The pPBA microgels with switchable glucose-responsive volume phase transition
behavior provide guidelines for the design of glucose-sensitive microgels.
Figure 8. Illustration of the synthesis of the proposed pPBA microgels. (Reprinted from ref. [68]).
Another multifunctional microgel with high stability and degradability was designed [69].
As shown in Figure 9a, the microgels were prepared by free radical polymerization of NIPAM,
DMAEMA, and AAPBA through a precipitation emulsion method using reductive degradable
N,N′-bis(arcyloyl)cystamine (BAC) as the cross-linker. The as-synthesized microgels exhibited pH-,
temperature-, and glucose sensitivity at physiological conditions and gradual degradation. The porous
network structure of the microgels was in favor of the trapping of insulin. Higher glucose concentration
triggered the faster release of a larger amount of insulin. The microgels were degraded in the presence
of dithiothreitol (DTT), which has similar function to glutathione tripeptide (GSH). As a result, a
higher amount of insulin was released (90%) from the multiresponsive microgels in the medium
(Figure 9b). The degradable multifunctional microgels may provide a new strategy for the design of
PBA-functionalized self-regulated drug delivery systems.
Additionally, core–shell microgels based on NIPAM and PBA were exploited to investigate
their glucose sensitivity. PNIPAM (core)/P(NIPAM-AAPBA) (shell) microgels were prepared by the
modification of PNIPAM (core)/P(NIPAM-AA) (shell) microgels with 3-APBA [70]. The core–shell
microgels exhibited three structure-related phase transitions when heating (Figure 10). The first
phase transition was assigned to the P(NIPAM-AAPBA) shell, while the second and the third phase
transitions were related to the PNIPAM core. The structure of the PNIPAM core was heterogeneous.
The cross-linking density decreased gradually from the core towards the periphery due to the higher
polymerization rate of cross-linking monomer BIS than that of the PNIPAM monomer. As a result, the
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PNIPAM core had a quasi-core–shell-like structure with a “quasi-core” with a higher cross-linking
density and a “shell-like” with a lower cross-linking density. The phase transition temperature of the
“shell-like” structure was lower than that of the “quasi-core”, providing the two phase transitions of
the PNIPAM core. Besides, the core–shell microgels exhibited glucose-triggered swelling due to the





Figure 9. (a) Schematic illustration of smart multifunctional microgels with pH-, temperature-,
and glucose sensitivity at physiological conditions and gradual degradation; (b) Release profiles
of microgels in the presence of glucose in PBS of 7.4 at 37 ◦C. (Reprinted from ref. [69]).
Figure 10. Schematic illustration of the structure of PNIPAM (core)/P(NIPAM-AAPBA) (shell) microgel
particles, where the PNIPAM core can be further divided as highly cross-linked “core” with BIS-rich
and lightly cross-linked “shell” that is BIS-poor. (Reprinted from ref. [70]).
The glucose-induced shell permeability of core–shell microgels with the same components of
NIPAM and PBA was also demonstrated [71]. Differently, the core of P(NIPAM-AAPBA) microgels
was cross-linked by degradable cross-linker N,N′-(1,2-dihydroxyethylene)bisacrylamide (DHEA),
while the shell was cross-linked by BIS. The cross-linked core of the microgels could be degraded
by addition of stoichiometric amount of NaIO4. The permeability of the P(NIPAM-PBA) shell was
controlled by temperature and pH change. More importantly, glucose concentration also could tune
the shell permeability. The shell permeability increased with increased glucose concentration, which
resulted from the increased borate ester. The fundamental understanding of the glucose-induced
permeability control is very important for the design and potential application of PBA-based
glucose-sensitive microgels.
PBA-functionalized cross-linking microgels exhibit glucose-induced swelling or shrinking
depending on the structure of borate ester between PBA and glucose. At lower glucose concentration,
the glucose–bis(boronate) complexes induce the shrinking of microgels with a swollen state. In
this condition, there is contraction-type glucose sensitivity. At higher glucose concentration,
glucose–mono(boronate) complexes lead to glucose-induced expansion of microgels. Even though the
investigations were performed with in vitro studies, it is still worth emphasizing that the reversible
glucose-triggered swelling/shrinking changes of PBA-based microgels have potential application in
self-regulated drug delivery.
4. PBA-Functionalized Nanogels
Even though microgels are most commonly used as the glucose-sensitive drug delivery carrier,
the current studies are achieved with the VPTT and in vitro drug delivery. In contrast, nanogels
with cross-linking structure are more stable and have received much more attention in drug delivery
266
Molecules 2019, 24, 1089
systems [72]. Nanogels, nanosized particles with cross-linking polymer networks, combine the
properties of both hydrogels and nanomaterials [73]. Nanogels have enhanced stability with a long
blood circulation time because the particle size and surface properties can be manipulated to avoid
rapid clearance by phagocytic cells [74,75]. In addition, a larger surface area of the nanogel is convenient
for functionalization of the nanogel [76].
There are several methods for the preparation of glucose-sensitive nanogels based on
PBA. Li prepared glucose-sensitive nanogels by one-pot copolymerization of polyethylene glycol
methylacrylate (PEGMEM) and AAPBA with BIS as a cross-linking agent [77]. Hollow nanogels
composed of PNIPAM and poly(N-phenylboronic acid acrylamide) were obtained by two-step colloidal
template polymerization [78]. The nanogels had interpenetrating polymer network structure which
provided the stability of the nanogels. The morphological structure of inner cavity increased the
drug loading content of the nanogels. More importantly, the nanogels were both temperature-
and glucose-responsive.
By one-pot copolymerization of pentaerythritoltetra (3-mercaptopropionate) (QT), poly(ethylene
glycol) diacrylate (PEGDA), poly(ethylene glycol) acrylate (mPEGA), and AAPBA, a nanogel with a
disulfide cross-linked core and PEG shell was obtained [79]. The copolymerization of the monomers
was performed via thiol-ene click reaction between thiol and double bond. The obtained nanogels
had a core–shell structure. The core was performed by tetrathiol functional QT and bifunctional
PEGDA with the free mercapto groups in the nanogel, and the free mercapto groups were terminated
by AAPBA and mPEGA (Figure 11). The introduction of PBA group endowed the nanogels with
remarkable glucose sensitivity, which was confirmed by fluorescence spectrometry using Alizarin
red S (ARS) as a fluorescent probe. Insulin, a model drug, was released from the nanogels
with highly glucose concentration dependence. Additionally, methyl thiazolyl tetrazolium, lactate
dehydrogenase, and hemolysis assays confirmed the nontoxicity and biocompatibility of the nanogels.
The glucose-sensitive nanogel with good biocompatibility has promising potential for application in
self-regulated drug delivery.
Figure 11. Structure of the nanogel and glucose-sensitive behavior of ARS-loaded nanogel in PBS at
pH 7.4. (Reprinted from ref. [79]).
Nondegradable materials are unfavorable for blood clearance after drug delivery, which limits
their clinical application in self-regulated drug delivery. The glucose-sensitive nanogels with improved
biocompatibility and degradability have attracted more interest. A novel multifunctional chitosan and
PBA-based nanohydrogel with enhanced glucose sensitivity was designed, which was prepared by the
modification of chitosan-poly (acrylamide-co-methacrylic acid) nanohydrogel with 3-APBA [80]. The
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glucose-triggered volume phase transition and release profile of the model drug ARS (comparative to
insulin as a drug as well as a dye for bioseparation) were studied at various glucose concentrations, pH,
and ionic strengths. The nanohydrogel may find applications in bioseparation and glucose-induced
drug delivery with enhanced sensitivity toward glucose.
Besides chitosan, polypeptides are greatly used in drug delivery systems. Chen and coworkers
exploited a novel kind of glucose-sensitive polypeptide nanogels via a two-step procedure.
The glycopolypeptide, methoxy poly(ethylene glycol)-block-poly(γ-benzyl-L-glutamate-co-(γ-
propargyl-L-glutamate-graft-glucose) (mPEG-b-P(BLG-co-(PLG-g-Glu))) was fabricated by clicking
2′-azidoethyl-O-α-D-glucopyranoside to the PLG unit in mPEG-b-P(BLG-co-PLG). Then, the
mPEG-b-P(BLG-co-(PLG-g-Glu) was cross-linked through boronate esters between the glucose
moieties on glycopolypeptide with adipoylamidophenylboronic acid resulting in the glucose-sensitive
polypeptide nanogels [81]. Insulin, a model drug, was loaded in the nanogels and the insulin release
from the nanogels possessed excellent glucose sensitivity (Figure 12). There was a competitive binding
mechanism for glucose-triggered insulin release. When free glucose was added, the complexes between
PBA and glucose moieties on glycopolypeptide were destroyed due to the formed complexes between
PBA and free glucose. Therefore, more free glucose entered into the nanogel core and the cross-linking
density of the nanogels decreased, endowing the nanogels with more hydrophilicity and swelling.
As a result, the preloaded insulin was released, induced by glucose, and high glucose concentration
triggered more insulin release with a higher release rate. In addition, the polypeptide nanogels
exhibited good cytocompatibility and hemocompatibility. The biocompatible nanogels with intelligent





Figure 12. (a) Schematic illustration of glucose-triggered insulin release from PBA-functionalized
polypeptide nanogel; (b) Cumulative insulin release from the insulin-loaded nanogel in PBS with
various glucose concentrations at pH 7.4, 37 ◦C. (Reprinted from ref. [81]).
Also using polypeptide, glycol chitosan (GC)/sodium alginate(SA)-poly(L-glutmate-co-N-3-
L-glutamylphenylboronic acid) (PGGA) graft polymer (GC/SA-PGGA) double-layered nanogels were
prepared by an isotropic gelation method and electrostatic interactions between GC and SA-PGGA
(Figure 13a) [82]. In glucose solution, the binding between glucose molecules and PBA moieties on
PGGA converted the PGGA chains to hydrophilic structures. Therefore, the hydrophilicity of nanogels
was enhanced, resulting in the swelling of nanogels and consequent insulin release triggered by
glucose. Furthermore, a mouse study was conducted to demonstrate the controlled insulin release
capability of GC/SA-PGGA double-layered nanogel in vivo. Glucose was administrated to mice by
retro-orbital injection to raise the blood glucose levels to diabetic glucose ranges at 0 min. Excluding
the blank GC/SA-PGGA group, other groups were administrated glucose again at 70 min (Figure 13b).
The blood glucose levels of the groups (excluding blank GC/SA-PGGA group) possessed a similar
behavior with progressively lowered glucose levels before the second glucose injection. However, after
the second glucose injection, the blood glucose levels of the free insulin and insulin-loaded GC/SA
groups no longer had significant decrease. In contrast, the blood glucose level of insulin-loaded
GC/SA-PGGA nanogels group was kept relatively low for a longer time, indicating that the nanogels
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exhibited controlled insulin release with high pharmacological activity to decrease the blood glucose
levels. The glucose-triggered insulin release makes the GC/SA-PGGA double-layered nanogels a






Figure 13. (a) Schematic illustration of glucose-sensitive GC/SA-PGGA double-layered nanogel
controlled insulin release by complexation between PBA derivatives and glucose; (b) Normalized
blood glucose levels in mice by retro-orbital administration of blank GC/SA-PGGA nanogels, free
insulin (0.5 IU kg−1), insulin-loaded GC/SA (0.5 IU kg−1), and insulin-loaded GC/SA-PGGA nanogels
(0.5 IU kg−1). (Reprinted from ref. [82]).
An injectable nanogel with interpenetrating polymer networks of PNIPAM, dextran, and
poly(3-acrylamidophenylboronic acid) (P(NIPAM-Dex-PBA)) was exploited using maleic acid-dextran
as a cross-linker [83]. The nanogels presented reversible glucose sensitivity under physiological
conditions, which was related to dextran content. The preloaded insulin was released from the nanogels
with high dextran content triggered by glucose. More importantly, the considerable hypoglycemic
effect of the insulin-loaded nanogels was also confirmed. As shown in Figure 14, in vivo experiments
demonstrated that the blood glucose level of diabetic rats treated with insulin-loaded nanogels was
maintained in a low state for almost two hours. The reduction of blood glucose level for insulin-loaded
nanogels treated diabetic rats was 51% of the baseline level, which was associated with long-term
controlled insulin release triggered by glucose. In addition, insulin-loaded nanogels maintained
stable blood glucose levels without remarkable fluctuations of blood sugar. The insulin-loaded
nanogels with prolonged and stable blood glucose reduction effect may have potential applications for
diabetes treatment.
 
Figure 14. Profiles of glycemia after a subcutaneous administration of free insulin (2.0 IU kg–1),
insulin-loaded nanogels (4 IU kg–1), and blank nanogels in fed diabetic rats. Before the injections,
glycemia was 426 ± 13 mg mL–1. Results are expressed as mean ± SD (n = 8). (Reprinted from ref. [83]).
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Even though most PBA-functionalized nanogels are exploited to achieve the glucose sensitivity
and glucose-triggered hypoglycemic effect, the particular and comprehensive studies on the blood
compatibility of the nanogels have been reported rarely. Zhou and coworkers explored the
glucose-sensitive insulin controlled release and blood compatibility of PBA-based nanogels [84]. The
nanogels were prepared through a thermally initiated precipitation copolymerization of methacrylic
acid (MAA) and AAPBA monomers using ethylene glycol dimethacrylate (EGDMA) as a cross-linker.
By changing the molar ratio of MAA/AAPBA, nanogels with different PBA contents were obtained
and noted as Glu(a/b), in which a/b represent the molar ratio of MAA/AAPBA. The release of
FITC-insulin from Glu(2/3) was dependent on the glucose concentrations without initial burst release.
In particular, the blood glucose levels of diabetic rats treated with insulin-loaded Glu(2/3) nanogels
were maintained at a low concentration (below the 70% of initial blood glucose level) with a long-term
stable hypoglycemic effect compared with the free insulin group (Figure 15a). Moreover, a series of
blood assays and in vitro/vivo assays confirmed the good blood compatibility of PBA-based nanogels.
The nanogels did not cause aggregation and morphological change of the red blood cells (Figure 15b).
The activated partial thromboplastin time (APPT) is used to evaluate the intrinsic and common
coagulation pathways. The glucose-sensitive nanogels had no interactions with the coagulation factors
and/or partial thromboplastin reagent which was confirmed by APTT. In addition, the nanogels
had little effect on the extrinsic pathway of blood coagulation examined by prothrombin time (PT).
Thromboelastography (TEG) assay also indicated the anticoagulant effects which were attributed to
the removal of thrombin from the blood by the nanogels via electrostatic interactions. Toxicity studies
further confirmed the blood compatibility of the nanogels. This work provides a strategy for the
study of biocompatibility of glucose-sensitive drug carriers. Thus, compatible nanogels with good




Figure 15. (a) The profiles of rats’ blood glucose concentrations after injection with different samples;
(b) Effect of the different nanogels on the aggregation and morphology of red blood cells. (Reprinted
from ref. [84]).
5. Conclusions
PBA-functionalized hydrogels, microgels, and nanogels provide glucose-triggered drug release
due to reversible swelling and shrinking induced by glucose. PBA-based glucose-sensitive hydrogels
can be prepared by physical or chemical cross-linking, such as the self-aggregation of gelators,
cross-linkage by cross-linkers, or reversible covalent complexation of PBA with cis-1,2 or cis-1,3-diol
compounds. Even though the PBA-mediated hydrogels possess great glucose sensitivity, the poor
ease of administration, i.e., they cannot be administrated by injection but probably as an implant, limit
their application in diabetes therapy. In contrast, PBA-based microgels and nanogels with micro- or
nano-scale dimensions exhibit excellent biocompatibility, tunable sizes, large bioconjugated surfaces,
as well as convenient injection administration. For PBA-based microgels, studies are focused on
the VPTT and the mechanism of glucose sensitivity. The development of PBA-based nanogels has
seen significant progress in terms of glucose sensitivity, biocompatibility, and pharmacokinetic and
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hypoglycemic effect. PBA-functionalized nanogels with convenient administration via injection have
practical application for diabetes therapy.
Even though there is considerable progress of PBA-based hydrogels, microgels, and nanogels
for glucose-sensitive drug delivery, some challenges still have to be overcome to promote the clinical
application of PBA-mediated platforms in diabetes therapy.
Firstly, the specificity and selectivity of glucose sensitivity are important for the design and
application of glucose-sensitive platforms. Besides glucose, there are physiologically relevant
saccharides, such as fructose, mannose, and galactose, which can bind to PBA and form mono(boronate)
complexes. PBA and derivatives are able to form mono(boronate) complexes as well as bis(boronate)
complexes with glucose. The influence of sugars on glucose sensitivity of PBA-based platforms must
be considered. Additionally, the glucose sensitivity of drug carriers must be selective, that is, the
platforms must timely and rapidly adjust the insulin release on-demand. The ideal drug carrier should
release insulin quickly with precise dosage in response to hyperglycemic state, while not releasing
glucose during normoglycemic states to keep the blood glucose levels in the normal range.
Secondly, adopting simplified preparation of PBA platforms is conducive to maintain the
repeatability and controllability of the structure and property of glucose-sensitive carriers for different
preparations. In addition, the glucose-sensitive platforms with high bioactivity of preloaded insulin
should be administrated easily. Injection is an ideal approach because it can reach blood circulation
with enhanced glucose sensitivity. The drug delivery system must be designed ingeniously with easy
and repeatable preparation and convenient administration to promote its clinical application.
Thirdly, biocompatibility without long-term side effects of the platforms is a challenge for the
design of PBA-based glucose-sensitive drug delivery systems. Diabetes is a lifelong chronic disease
and the treatment of diabetes is a long-term process. Therefore, glucose-sensitive platforms must
be nontoxic and friendly to the body without inducing inflammation. By adopting biodegradable
and biocompatible materials, such as poly(acrylic acids) and polypeptides, the biocompatibility of
PBA-based matrices can be enhanced.
Although some issues still need to be overcome, self-regulated drug delivery systems have
promising application in diabetes treatment.
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Abstract: Conventional drug delivery approaches are plagued by issues pertaining to systemic
toxicity and repeated dosing. Hydrogels offer convenient drug delivery vehicles to ensure these
disadvantages are minimized and the therapeutic benefits from the drug are optimized. With
exquisitely tunable physical properties that confer them great controlled drug release features and the
merits they offer for labile drug protection from degradation, hydrogels emerge as very efficient drug
delivery systems. The versatility and diversity of the hydrogels extend their applications beyond
targeted drug delivery also to wound dressings, contact lenses and tissue engineering to name but
a few. They are 90% water, and highly porous to accommodate drugs for delivery and facilitate
controlled release. Herein we discuss hydrogels and how they could be manipulated for targeted
drug delivery applications. Suitable examples from the literature are provided that support the recent
advancements of hydrogels in targeted drug delivery in diverse disease areas and how they could be
suitably modified in very different ways for achieving significant impact in targeted drug delivery.
With their enormous amenability to modification, hydrogels serve as promising delivery vehicles of
therapeutic molecules in several disease conditions, including cancer and diabetes.
Keywords: hydrogels; applications; targeted drug delivery; drug release; hydrophobic drug delivery;
clinical translation; versatile platform; administration routes; diverse therapeutic areas
1. Introduction
Hydrophilic polymeric networks that are capable of imbibing huge volumes of water
and undergoing swelling and shrinkage suitably to facilitate controlled drug-release are called
hydrogels. Their porosity and compatibility with aqueous environments make them highly attractive
bio-compatible drug delivery vehicles. Their applications are manifold and for several biomedical
needs as they are moldable into varied physical forms such as nanoparticles, microparticles, slabs,
films and coatings. USA has been the largest producer of hydrogels and is expected to remain so for a
few more years [1]. Hydrogels are promising, trendy, intelligent and ‘smart’ drug delivery vehicles that
cater to the specific requirements for targeting drugs to the specific sites and controlling drug release.
Enzymatic, hydrolytic or environmental stimuli often suffice to manipulate the hydrogels for the drug
release at the desirable site [2]. Like the two sides of a coin, there are also the disadvantages associated
with their use. The primary disadvantage in drug delivery would be the hydrophobicity of most
drugs. The water-loving polymeric core is probably not very ideal to hold incompatible hydrophobic
drugs, which is a challenge since many that are currently used and effective in disease therapy are
hydrophobic. The tensile strength of these hydrogels is weak and this sometimes causes early release
of the drug before arrival at the target site. The following review discusses on how hydrogels are being
manipulated presently for improved targeted drug delivery. The modern trend in which the hydrogels
are exploited for drug delivery are covered.
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The attractive physical properties of hydrogels, especially their porosity, offer tremendous
advantages in drug delivery applications such as sustained release of the loaded drug. A high
local concentration of the active pharmaceutical ingredient is retained over a long period of time
via a suitable release mechanism controlled by diffusion, swelling, chemical or based on some
environmental stimuli.
Diffusion-controlled drug delivery with hydrogels uses reservoir or matrix devices that allow
diffusion-based drug release through a hydrogel mesh or pores filled with water. In the reservoir
delivery system, the hydrogel membrane is coated on a drug-containing core producing capsules,
spheres or slabs that have a high drug concentration in the very center of the system to facilitate
a constant drug-release rate. While the reservoir delivery system produces time-independent and
constant drug release, the matrix system works via the macromolecular pores or mesh. This type of
release is time-dependent drug release wherein the initial release rate is proportional to the square root
of time, rather than being constant (Figure 1).
Figure 1. (a). Drug-containing core is coated with hydrogel membrane and the drug concentration
is higher in the center of the system to allow constant release rate of the same in reservoir delivery
system. (b). Uniform dissolution or dispersion of the drug throughout the 3D structure of the hydrogel
is achieved using matrix delivery (reprinted (adapted) with permission from [3]; the article is open
access and the content reusable).
The swelling-controlled drug release from hydrogels uses drugs dispersed within a glassy polymer
which when in contact with a bio-fluid begins swelling. The expansion during swelling occurs beyond
its boundary facilitating the drug diffusion along with the polymer chain relaxation. The process,
otherwise referred to as Case II transport, supports time-independent, constant drug release kinetics.
Since the gradient between the dispersed drug in the hydrogel and its surrounding environment
allows the active ingredient diffusion from a region of higher concentration within the hydrogel to a
lower one, the process is also referred to as anomalous transport as it combines both the processes of
diffusion and swelling for enabling drug release.
Ocular drug delivery carriers have been developed using hydrogels that are covalently crosslinked.
These soft, biodegradable hydrogels with high swelling capacity remain in-situ in the lacrimal
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canal offering greater comfort for the patient. Collagen or silicone that may be used decides if
the punctal-plug system could be used temporarily or permanently, respectively. Poly(ethylene glycol)
hydrogels are commonly used for producing ophthalmic drug delivery systems.
Drug release in response to environmental changes would be an ideal delivery system as the
release becomes very controlled and non-specific side effects at off-target sites are alleviated. Thus,
sensitive drug delivery devices responsive to changes in pH, temperature, ionic strength or glucose
concentration have been developed that are advantageous in the therapy of diseases such as cancer,
and diabetes, characterized by local physiological changes specific to the various disease stages.
The polymer composition of the hydrogel responsive to the environmental stimuli is manipulated to
make it responsive to the environment [3].
Hydrogels considerably enhance the therapeutic outcome of drug delivery and have found
enormous clinical use. The temporal and spatial delivery of macromolecular drugs, small molecules,
and cells have greatly improved through hydrogel use for drug delivery [2]. Drug delivery using
hydrogels, however, has not been free of challenges, but constant improvements are being made to
identify the hydrogel design best suited for specific drug delivery purposes. Therefore, this paper
discusses the recent trends in drug delivery applications using hydrogels, including their translation
to the clinic and their applications to successfully deliver hydrophobic drugs.
2. Current Trend in Hydrogel Based Targeted Drug Delivery
2.1. Supramolecular Hydrogels
The supramolecular hydrogel system is composed of intermolecular interactions that are
non-covalent and has two or more molecular entities held together. The non-covalent cross-linking is a
very attractive aspect of these hydrogels as it helps circumvent the problems of limited drug loading
potential and drug incorporation for use only as implantables which would be the only possibility with
a covalently cross-linked network. Apart from offering the right physical stability for the hydrogels,
these achieve drug loading and gelation simultaneously in an aqueous environment without the need
for a covalent cross-linking. Recent progress has been made with supramolecular hydrogels using
self-assembled inclusion complexes between cyclodextrins and bio-degradable block copolymers that
provide sustained and controlled release of macromolecular drugs [4].
Natural cyclic oligosaccharides composed of six, seven or eight D-(+)-glucose units linked by
D-(+)-1,4-linkages (termed α-, β- and γ-CD, respectively), are called cyclodextrins and are well-suited
for use in supramolecular systems. They offer hydrophobic internal cavities with a suitable diameter
and their ability to generate supramolecular inclusion complexes with various polymers make them
ideal drug delivery vehicles.
A recent study involved development of a glycoconjugate prepared by amidation of homopoly-
L-guluronic acid block obtained from D. antarctica sodium alginate with mono-6-amino-β-CD. The
study was aimed at treating Chagas disease caused by Trypanosoma cruzi. Lipophilic non-hydroxylated
coumarins were loaded into the hydrophobic core of the β-cyclodextrin to render them with
trypanocidal activity. Interaction between the carboxylate groups of unconjugated α-L- glucuronate
residues with calcium ions was used to produce supramolecular hydrogels of glycoconjugate of
homopoly-L-guluronic block fraction (GG) with 6-NH2-β-CD. As the T. cruzi parasites have only
one mitochondrion, it is an ideal target for drugs to manipulate its energy process and apoptosis.
Mitochondrial membrane potential studies revealed that the cyclodextrin complex with the drugs
produced significant oxidative stress to destroy the parasites. The drug in the complex had increased
solubility, showed improved bio-availability, controlled drug release and improved trypanocidal
activity in comparison to the corresponding free amidocoumarins [5].
Cyclodextrin-functionalized polyhydrazines were used to prepare hydrogels in-situ via hydrazine
bond formation with aldehyde groups on dextran aldehyde. No toxicity was observed in vitro with
these hydrogels and they could accommodate nicardipine as hydrophobic drug into the cyclodextrin
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cavities. Steady release of nicardipine over 6 days was observed with the hydrogel preparation having
higher hydrazine linkages. Thus, a gel capable of hydrophobic drug release in an in-situ formed device
over extended periods was generated [6].
Bleeding control and wound healing by bio-adhesive hydrogels find enormous biomedical
applications. In situ forming hydrogels are used to heal injured tissues based on their ability to
accumulate and produce a fibrin bridge that permit fibroblast migration and collagen secretion for
healing tissue injury. β-Cyclodextrins are a non-toxic adjuvant for pharmaceutical and mucoadhesive
applications. Partly oxidized β-cyclodextrin was used in a recent study to exploit aldehyde groups
on a hydrogel matrix for favorable reaction with amines in the tissue to result in an imine bond
(Schiff’s base reaction) in order to adhere to the skin and to provide improved cyclodextrin solubility
in order to improve loading efficiency. Blending gelatin (the common extracellular component) with
the β-cyclodextrin partly oxidized with oxidation in the presence of H2O2/horseradish peroxidase,
resulted in very rapid formation of gelatin-β-cyclodextrin hydrogels (Figure 2). Hydrophobic drugs
such as dexamethasone could be released with 2.7 fold higher efficacy when delivered in presence of
the cyclodextrin relative to the gelatin-only hydrogels [7].
Figure 2. (A). Graphical representation of the methods for cross-linking to obtain gelatin-β-cyclo-
dextrin (GTA–ob-CD) hydrogels to load hydrophobic drugs. (B). Schematic representation of adhesive
GTA–ob-CD hydrogels in situ formed by combining HRP catalysis and the Schiff base reaction with
therapeutic release (reprinted [7] with permission from the The Royal Society of Chemistry. The article
is licensed by Creative Commons and the link to the license is https://creativecommons.org/licenses/
by/3.0/).
Curcumin has been shown to have several therapeutic benefits and found enormous applications
in conventional therapy. The challenging aspect of its delivery is the extremely low aqueous
solubility. However, a glycyrrhetinic acid (GA) molecule-modified curcumin-based hydrogel
has been developed to address the problem of delivery of the insoluble drug for hepatocellular
carcinoma. The GA molecule-modified curcumin supplied in the pro-gelator form could produce
a supramolecular hydrogel in vitro due to disulphide reduction by glutathione (GSH) and increase
curcumin bioavailability and solubility as reported in HepG2 cells. Higher cellular uptake and
potent anti-cancer activity were observed with the hydrogel in vitro relative to an already known
curcumin-targeting compound that was tested [8].
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2.2. DNA-Hydrogels
Hybrid bionanomaterials could be developed using DNA as the building block. Predictable
two- or three-dimensional structures are formed from DNA molecules. Highly structured networks
are formed by hybridizing complementary DNA molecules and the resultant hydrogel structures
expand upon encounter with an aqueous environment that result in swelling. Not only do these
materials append to any other type of nucleic acid molecules (such as siRNA, miRNA), but they can
also load DNA binding drugs. High solubility, bio-compatibility, versatility and responsiveness are key
features of such hydrogels. Apart from these features they can also be tagged with suitable fluorescent
molecules for tracking biological studies in vitro [9].
An interesting application of hydrogels has been made with the development of multi-functional
quantum dot (QD) DNA hydrogels. DNA hydrogels are composed of complementary strands of
DNA hybridized to form a crosslinked network that swells in an aqueous environment. However,
in order for biological studies to be more easily and effectively performed there has to be a tracer or
a fluorescent molecule attached to the hydrogel which would then be a superlative option offering
both targeted delivery and imaging. With this aspect in mind Zhang et al. recently developed a
QD-based DNA hydrogel that had highly tunable size, spectral and delivery properties and bound
to the DNA binding drug doxorubicin (Figure 3). The drug targeted cancer cells and the QD DNA
hydrogel increased the potency of the drug in vitro. The single-step assembling zinc sulphide QD
Doxorubicin DNA hydrogels showed increased tumor accumulation in vitro, high bio-compatibility,
was threefold more efficacious than free DOX and served as an excellent tool for in vivo bio-imaging in
monitoring tumor growth over time. Aptamers such as siRNA were used to target specific cell types
to deliver drug specifically and modulate protein expression in various cell types [9] (Figure 3).
Figure 3. (a). Schematic view of the synthesis process of the DNA functionalized QDs followed by the
formation of the QD hydrogel through hybridization with DNA. (b). Schematic view of the modification
process on the QD hydrogel for specific targeting of the cell using aptamer for drug delivery. Release of
Doxorubicin and siRNA happens after uptake into the cell via endocytosis (reprinted (adapted) with
permission from [9]; the article is open access and the content reusable. Creative Commons International
License 4.0 for the article is available from http://creativecommons.org/licenses/by/4.0/) [9].
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Drug-loaded cytosine-phosphate-guanine (CpG)-DNA hydrogels have been used for cancer
immunotherapy. These CpG sequences containing hydrogels elicit immune responses. As an example,
these DNA hydrogels containing CpG nucleotides stimulated innate immunity through Toll-like
receptor 9 and promoted immune responses of ovalbumin (OVA) incorporated into the gel by acting
as an adjuvant. Adverse reactions were considerably reduced with the use of the CpG-DNA hydrogel
in comparison to the OVA injected with alum or complete Freund’s adjuvant [10,11].
There has been significant advancement in hydrogel modifications for enhancing the shape
memory and the reversibility of the hydrogel shape after any prolonged stress on them. (example:
external stimuli such as temperature). This advances the thermal responsivity behavior of the hydrogels
and an example is the construction of supramolecular hydrogel with tunable mechanical properties and
multi-shape memory effects. These hydrogels make use of agar that is physically cross-linked to form
the hydrogel network and a supramolecular network that is cross-linked by suitable chemical bonds
that fix shapes temporarily and produces a multi-shape memory effect made possible by reversible
interactions (Figure 4). The supramolecular hydrogel possesses enormous bio-compatibility and
bio-degradability characteristics and rely on non-covalent interactions to drive the self-assembly of
small molecules in water. The formed structures have supramolecular architectures and encapsulate
water [12,13].
Figure 4. Schematic depiction of a novel Fe3+-, pH-, thermoresponsive hydrogel with tunable
mechanical properties easily changed by adjusting cross-linking densities of polymers. Moreover,
several co-ordination interactions along with supporting stimuli could be exploited to stabilize
temporary shapes in order to realize shape memory behavior. Programmable multi-shape memory
effect can be realized by combining the 3 reversible switches (reprinted (adapted) with permission
from [12]; copyright (2017) American Chemical Society).
A programmed temporary shape can turn into the memorized original shape when placed in an
appropriate environment or exposed to a trigger. Such shape-memory hybrid hydrogels could also
be synthesized using DNA cross-linkers. These hydrogels not only undergo phase transitions in the
trigger of the stimulus, but also possess memory code to recover to the original matrix shape. Guo et al.
developed a pH-controlled shape memory DNA hydrogel that was formed by co-polymerization
of acrylamide residues with acrydite modified with (1) cytosine-rich sequences (forming i-motif
subunits) and (2) nucleic acids exhibiting self-complementarity. Self- assembly of cytosine-rich nucleic
acid strands into an i-motif structure occurred at pH 5.0 and the disassembly to a random coil form
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happened at pH 8.0, leading to a quasi-liquid state for the hydrogel. Re-acidification to pH 5.0 restored
the original structure of the gel [14,15].
2.3. Bio-Inspired Hydrogels
A newer variety of hydrogels used for drug delivery applications are the bio-inspired hydrogels.
These 3D materials recapitulate the biological micro-environment relevant to the disease condition
and support studies on how the targeted drug delivery process could be optimized, how the therapy
behaved in vivo, how the disease progressed, and so on. These are particularly useful in cancer therapy
as the disease is particularly complex and normally associated with intricate cellular and physiological
changes that require progressive monitoring. Engineering such microenvironments would thus be a
very useful approach to promote research and study the disease condition and therapeutic process
better. The stiffness of the 3D model used for studying liver cancer is a critical attribute to regulate
molecular diffusivity and malignancy. The elastic moduli of the collagen gels were increased by
stiffening interconnected collagen fibers with varied amounts of poly(ethylene glycol) di(succinic acid
N-hydroxysuccinimidyl ester). The softer gels produced malignant cancer spheroids while the stiffer
ones showed suppressed malignancy. The model provided better understanding and regulation of the
emergent behaviors of cancer cells [16].
Contact lenses that are bio-inspired have been developed recently with improved drug delivery
properties suited to perfectly match the eye condition in the diseased state, especially of the
anterior-eye segment.
Inner layer of ethyl cellulose and Eudragit S 100 hydrogels encapsulated with diclofenac sodium
salt showed sustained drug release in simulated tear film. Sustained drug levels in tear fluid for
a prolonged period of time in relation to eye drops was observed. The drug timolol was released
in response to lysozyme in the medium and not in PBS. Enzyme cleavable polymers in hydrogels
enabled this.
Ergosterol-liposome grafted silicone materials loaded with nystatin (an anti-fungal agent)
resembled a fungal infection and triggered nystatin release through a competitive mechanism. In the
absence of the ergosterol (important sterol in the cell membranes of fungi) in the medium, the drug
release was very negligible [17–20].
With recent progress in cancer therapy using immunology, the research has progressed in the
area with the use of cells such as erythrocytes, macrophages, stem cells, dendritic cells and bacteria as
building blocks to create targeted delivery systems. Stem cell membrane coated gelatin nanogels that
were high tumor targeting and bio-compatible drug delivery systems were developed recently.
Those gelatin nanogels had excellent stability and tumor-targeting ability in vitro and in vivo.
Targeting doxocrubicin (DOX) enhanced anti-tumor therapeutic efficacy significantly higher than the
gelatin-DOX of free DOX nanogels. Evident side effects were absent in the tissues of heart, liver, spleen,
lung and kidney as was revealed with histopathology staining of treated mice [21].
A similar bio-mimetic drug delivery carrier is the endosomal membrane-coated nanogel extracted
from the source cancer cells for specific delivery of the small molecule drug. Hyaluronic acid nanogel
composed of SiO2/Fe3O4 nanoparticles formed the inner core of the hydrogel and the endosome
membrane outer shell was used. The hyaluronic acid could target CD44 receptors overexpressed in
a variety of tumor types. Core-shell mesoporous silica nanoparticles with Fe3O4 nanocrystals were
used as the core to encapsulate photo-initiators and cross-linkers, followed by hyaluronic acid coating
on the surface via electrostatic interaction. Photo-polymerization upon UV irradiation resulted in
the in situ formed nanogel in endosomes following incubation of resultant nanoparticles with the
source cells. In the presence of the loaded anti-cancer drug doxorubicin, the endosomal membrane
nanogels could specifically interact with the target source cells followed by internalization to release
doxorubicin. High targeting specificity, cytotoxicity and uptake of the prepared endosomal membrane
coated nanogels with DOX over the bare DOX-nanogels was observed in vitro [22].
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Detoxification of pore-forming toxins resulting from animal bites/stings using a 3D bio-inspired
hydrogel matrix resembling the 3D structure of liver is a recent achievement. The 3D matrix resembling
the liver is created by the hydrogel while the polydiacetylene nanoparticles installed in the hydrogel
matrix serve to attract, capture and sense toxins. The 3D printed biomimetic detoxification device with
installed nanoparticles would be a breakthrough innovation replacing vaccines, monoclonal antibodies,
antisera to eliminate toxins from blood. Commonly used conventional antidote molecules target
specific epitope structures on the pore forming toxins warranting specific treatments for the various
toxins. IV-nanoparticle administration for binding and removal of toxins may cause secondary risk by
poisoning from nanoparticle accumulation in liver. While challenges do not limit nanoparticle use for
toxin clearance, the 3D printed in vitro devices have been clinically approved for toxin removal [23].
Adhesive bio-inspired gels comprising of sodium alginate, gum arabic, and calcium ions have
been developed in order to mimic properties of natural sundew-derived adhesive hydrogels. Mouse
adipose-derived stem cells were used in combination with the sundew-inspired hydrogel to confer
interesting properties such as improved wound healing, enhanced wound closure, less noticeable
toxicity and inflammation. Sundew plant’s natural adhesive hydrogels were quite promising, but the
researchers were quite intrigued about collecting the desirable quantity from the natural source. This
inspired development of the above described hydrogel type with improved properties [24].
Magnetically actuated gel-bot (Mag-bot) is yet another recent discovery that facilitates remote
control of the motion of magnetically actuated hydrogels. These hydrogels adopt a crawling motion
resembling that of a maggot and move in a confined space of 3D porous media including, foams,
tissues, fibres and so on, opening up broad options for targeted drug delivery. Pattern structures
and lubrication effects on hydrogel mobility in the confined 3D space have been experimented in the
paper [25].
It is not just the maggot that has inspired development of a new generation of hydrogels with
applications in targeted drug delivery but also the drosera. The drosera-inspired model of hydrogel for
targeted drug delivery with a bifunctional attribute to it has been developed recently. These hydrogels
use the ‘catch and kill prey’ mechanism as a drosera would. They have a bottom layer functionalized
with double stranded DNA that can bind the anti-cancer drug doxorubicin and there are aptamers on
top that offer targeting advantages to these particles. Though there is requirement for in vivo studies,
the sustained expression of specific aptamer on surface and the continuous killing of cancer cells by
sustained drug release make these hydrogels an ideal targeted drug delivery vehicle for killing cancer
cells [26].
2.4. Multi-Functional and Stimuli-Responsive Hydrogels
Hydrogels that were multi-functional and carriers of anti-cancer drugs are a typical example of
the versatility of these delivery vehicles and their amenability to chemical modifications to enhance
their therapeutic effects. Magnetite nanoparticles that supported increased intracellular uptake by
HeLa cells also had folate ligand on them to enable targeted delivery. Moreover, the hydrogel polymers
were thermally responsive and DOX loaded. Those modified hydrogels offered advantages such as
increased cellular uptake and apoptotic activity in vitro [27].
Another stimuli-responsive hydrogel developed very recently made use of biocompatible
thermally responsive polymers that facilitated rupture of cancer cells. The study was conducted
in vitro with an external source of heat and showed successful cell rupture. Those hydrogel particles
had RGD (Arginine, Glycine, Aspartate) peptides attached to their surface that could bind to cells
(Figure 5). The paper discussed experiments performed to confirm firmness of the RGD peptides with
the cells (ex: MDAMB21) and their rupture using external heat stimulation.
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Figure 5. (a). Schematic illustration of the cancer cell attachment on stimuli-responsive hydrogel
surface. External stimulus such as temperature causes expansion of the hydrogels and rupture of
the cancer cells. (b). Schematic depiction of the surface modification of hydrogel. The first layer of
coating was polydopamine (PDA) and poly-L-lysine (PLL) followed by a layer of RGD peptides for
binding cancer cells (reprinted (adapted) from [28]; the article is open access and the content reusable.
Creative Commons International License 4.0 for the article is available in https://creativecommons.
org/licenses/by/4.0/) [28].
Since in vivo conditions in tumors normally produce a higher temperature than the surrounding
areas, and also that it has been proved that the physical force generated from the expansion of the cells
when they were heated was sufficient to kill them, that type of thermally responsive hydrogels proved
to be highly advantageous options for achieving targeted cell killing [28].
Hydrogen peroxide trigger-mediated release of drugs could be achieved using hydrogels. This has
been demonstrated previously with the use of ABC type triblock copolymer poly [(propylenesulfide)-
b-(N,N-dimethylacrylamide)-b-(N-isopropylacrylamide)] [29,30] (PPS-b-PDMA-b-PNIPAM). A model
hydrophobic drug, the dye red Nile was encapsulated in the hydrogel in order to demonstrate
this. The gelation to form the cross-linked hydrogel happened above 37 ◦C and the ambient 25 ◦C
temperature was sufficient to encapsulate the hydrophobic drug through the formation of micelles.
Thus, the temperature-responsive polymer could cross-link to be a stable hydrogel carrying the
hydrophobic drug based on the temperature modification and also showed a release of the red colored
dye based on the H2O2 release in the environment (Figure 6).
Apart from the polymer solubility switch mechanism that helped release based on the presence of
the reactive oxygen species in the environment, cleavable units of polymer that underwent scission in
presence of ROS have also been developed. These are also bio-degradable and help avoid any toxic
build up or unwanted immune response in the system from the presence of the hydrogels [31,32].
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Figure 6. Drug release dependent on Reactive Oxygen Species concentration as displayed by
PPS60-b-PDMA 150-b-PNIPAAM150 triblock polymer-based thermos-responsive Nile red-loaded
hydrogels. Nile red-loaded hydrogels (5 wt% triblock copolymer concentration) in PBS (pH 7.4) have
been used to demonstrate Hydrogen Peroxide dependent drug release kinetics in vitro at 37 ◦C. 1, 100
and 500 mM concentrations of H2O2 over a 64 h time course were incubated with the hydrogel samples
to study ROS dependent drug release (reprinted (adapted) with permission from [31]; copyright (2014)
American Chemical Society).
Diselenide-containing block copolymer and a peptide amphiphile were used as building blocks
for the construction of a UV responsive hydrogel. The gel sol transition of the hydrogel occurred in
presence of gamma irradiation. The peptide amphiphile was composed of nalproxen, the drug and a
hexapeptide sensitive to UV irradiation, the radiation trigger was sufficient to cause release of the drug
from hydrogel. The stimuli responsive hydrogel system was thus capable of providing both chemo-
and radiotherapy benefits on application [13].
Covalently cross-linked hydrogels are typically stable and elastic while the physically cross-linked
hydrogels produced through ionic interactions are less stable and exhibit reduced mechanical
properties. The dynamic covalent chemistry is an option to acquire stability, elasticity and also
shear-thinning and self-healing characteristics for the hydrogel. Based on this, Volkan et al. reported
the synthesis of hydrogel networks from reversible interactions between phenylboronic acid and
cis-diols. The gel strength was dependent on pH and the hydrogel was evaluated for protein delivery
in vitro. The pKa of phenylboronic acid and the pH of the environment were the determining factors
for establishing the extent of hydrogel cross-linking. Soft, moldable hydrogels were produced that
could be injected using standard syringe needles and were demonstrated to exhibit shear thinning and
healing properties in addition to their injectable nature. Protein encapsulation was performed with
the hydrogel, and the release effect monitored. Size-dependent protein release could be attributed
to the mesh size of the hydrogel network. Insulin and IgG release from the hydrogel network was
monitored in presence of glucose. Glucose-responsiveness of the hydrogel was confirmed, and the
release kinetics could be controlled by the mesh size of the hydrogel. 3T3 fibroblast cells showed no
significant toxicity as quantified using MTT assay for 24 hr. No chronic inflammation was observed
in vivo and the materials were quite bio-compatible [33].
The temperature sensitive hydrogels respond by undergoing sol-gel transitions with changes
in temperature from room ones to the physiological ones. Recently developed hydrogels were
that were thermo-responsive and accommodated hydrophobic drugs efficiently were built from
amphiphilic triblock co-polymers, poly(N-isopropylacrylamide)-b-poly(4-acryloylmorpholine)-b-poly
(2-((((2-nitrobenzyl)oxy)carbonyl)amino)ethylmethacrylate)(PNIPAM-b-PNAM-b-PNBOC). The hydrogel
carried the hydrophilic drug gemcitabine and the hydrophobic drug doxorubicin. The triblock
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co-polymers first assembled into micelles that had the hydrophobic and temperature responsive
components formed below the lower critical solution temperature, while higher polymer concentration
and temperature above the critical gelation temperature were used to form the hydrogels of physically
cross-linked micellar nanoparticles. The study demonstrated the synthesis, characterization and the
temperature and UV irradiation triggered synergistic release of both the hydrophobic and hydrophilic
drugs in vitro [34,35].
Hydrogels formed by covalent cross-linking of polymers to facilitate targeted drug delivery have
been achieved in recent years. The nanoparticle-hydrogel is a hybrid system that is formed in three
different ways. The first method is to entrap a hydrogel within a nanoparticle, the second one is to
form a 3D hydrogel network with the nanoparticles by crosslinking of the latter using hydrophobic
interactions or mixing up nanoparticles of opposite charges and the final one is to covalently couple
the nanoparticle with the hydrogel [36]. A liposome cross-linked hybrid hydrogel has been developed
recently. Glutathione-triggered release from the stimuli responsive polymer favored drug release.
Arylthioether succinimde cross-links were introduced between the Peg polymers and the liposome
nanoparticles to produce the 3D hydrogel network. In presence of glutathione, the matrix was
degraded, and the encapsulated drug molecules were released. Malemimide-functionalized liposomes
crosslinked using peg polymers were constructed for co-delivery of doxorubicin and cytochrome-C
(apoptotic cascade initiatior) and their release testing in vitro was monitored in presence of glutathione.
The presence of glutathione is a trigger for release from the hydrogel in a reducing microenvironment
such as a tumor [37].
3. Diverse Physical Attributes of Hydrogels for Drug Delivery
Structural-modification amenability of the hydrogels renders them in various shapes and sizes.
This feature is particularly interesting for drug delivery applications in order to design the hydrogels
as per the target sites to which the drugs have to be delivered. The hydrogel-based dosage forms can
have different designs and shapes depending on the route of drug administration (Table 1).






Spherical beads 1 μm to 1mm
Discs Diameter of 0.8 cm and thickness of 1 mm
Nanoparticles 10–1000 nm
Rectal Suppositories Conventional adult suppositories dimensions (length ≈ 32 mm) with acentral cavity of 7 mm and wall thickness of 1.5 mm
Vaginal Vaginal tablets Height of 2.3 cm, which of 1.3 cm and thickness of 0.9 cm
Torpedo-shaped
pessaries Length of 30 mm and thickness of 10 mm
Ocular
Contact lenses Conventional dimensions (typical diameter ≈ 12 mm)
Drops Hydrogel particles present in the eye drops must be smaller than 10 μm
Suspensions Ointments N/A
Circular inserts Diameter of 2 mm and total weight of 1 mg (round shaped)
Transdermal Dressings Variable
Implants Discs Diameter of 14 mm and thickness of 0.8 mm
Cylinders Diameter of 3 mm and length of 3.5 cm
Reprinted (adapted) with permission from [3]; the article is open access and the content reusable. The article is licensed
by Creative Commons and the link to the license is available at https://creativecommons.org/licenses/by/3.0/.
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4. Specific Therapeutic Areas Using Hydrogels for Drug Delivery at Present
4.1. Ophthalmic
Conventional eye drops have problems with sustained drug delivery and there is huge wastage
of drug immediately following application through eye drainage. Dextenza is a very recently FDA
approved (3 December 2018) ocular therapeutic hydrogel formulation for human use. This is used for
ocular pain following ophthalmic surgery and is the first intracanalicular implant developed for drug
delivery and developed by the company Ocular Therapeutix (Bedford, MA, USA) [51].
Thermo-responsive polymer developed by mixing poly(acrylic acid-graft-N-isopropylacrylamide)
(PAAc-graft-PNIPAAm) with PAAc-co-PNIPAAm geL and incorporating epinephrine was used in
the in vitro evaluation of ophthalmic drug release. The approach augmented the effect of intraocular
pressure reduction from 8 h with the traditional drops to 36 h. The cross-linking density of the hydrogel
affected the capillary network formation and offered a convenient controlled drug release method for
ophthalmic drug delivery [52].
Intra-ocular pressure (IOP) elevates during glaucoma and alleviating this pressure has been quite
challenging. Hydrogels could be used to resolve this problem by using them to prepare soft contact
lenses composed of polymers to form networks. The highly hydrated polymer networks of hydrogels
cause the drug to elute out very rapidly and this is not favorable for glaucoma therapy, which mainly
uses hydrophilic drugs. However, with suitable modifications, soft contact lenses have been developed
using polymers of N,N-diethylacrylamide and methacrylic acid, which delivered the hydrophilic drug
timolol for about 24 h, thereby opening up ways to allow sustained hydrophilic drug delivery using
hydrogels. Storing the contact lenses in a hydrated state can leach out drug and to wear them all the
time are the limitations though [53].
Inner layer-embedded contact lenses have been investigated for the sustained release of highly
water-soluble drug betaxolol hydrochloride on the ocular surface. Cellulose acetate and Eudragit
S-100 were selected as the inner layer of the contact lenses which showed a promising sustained drug
release for over 240 h in tear fluid of rabbits in vivo to create a controlled-release carrier of the drug in
ophthalmic drug delivery [19].
Controlled drug release behavior from hydrogels was also evaluated using nepafenac as the
model drug. 3D cross-linked thermos and pH sensitive hydrogel was designed that was composed of
carboxymethylchitosan (CMC) and poloxamer with glutaraldehyde as the cross-linking agent. The
hydrogel was found to undergo reversible sol-gel transition at temperature and/or pH alteration at a
very low concentration. Sustained release of the drug nepafenac was observed in the in vitro model
and maximum release was observed at 35 ◦C and pH 7.4. Cytocompatibility of the hydrogel with
human corneal epithelial cells was high [54].
4.2. Oral, Intestinal
Gastroretentive drug dosage forms (GRDDFs) are particularly attractive for drugs that are
absorbed in the proximal part of gastroinstestinal tract. Enhancing the retention time of the drugs in
the GI tract is very important in order to improve their bioavailability and enhance their therapeutic
effects. These dosage forms could be exploited for their muco-adhesion to the gastric mucosa, modified
to float or sink in order to prevent leaving the stomach or increase their swelling behavior and
make them as large to prevent passage through pylorus for prolonged periods. Based on these
ideas, polyionic complex hydrogels of chitosan with ring-opened PVP have been developed for
Osteoporosis therapy. The formulation was used to release alendronate in the upper GI tract. Enhanced
muco-adhesion, delayed clearance from swelling, minimal localized irritation, improved bioavailability
and slower release of the active ingredients are the interesting aspects of the preparation. Also, in vivo
experimentation showed that these hydrogels could provide optimized PK properties that maintained
the drug in the therapeutic levels for a sustained period of time, minimizing fluctuations in therapeutic
levels, hence also the possible side effects [55].
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Inflammatory diseases such as irritable bowel syndrome have been recently treated using
hydrogels. These provided safer alternatives to delivery methods that may cause systemic toxicity.
Zhang et al. developed negatively charged hydrogels that preferentially accumulated in the positively
charged inflamed colon and acted as carriers of the corticosteroid drug dexamethasone (Dex). The
hydrogel was prepared from ascorbyl palmitate which had labile bonds responsive to inflammatory
conditions and was Generally Regarded as Safe (GRAS) for administration. Enema administration to
the colon of inflammation targeting (IT) hydrogel microfibers not only reached the target site but also
stayed there owing to charge interaction. The formulation was therapeutically very efficacious and
revealed lesser systemic drug exposure than with free Dex in the IBS mice model in vivo [56].
Complexation hydrogel prepared from poly (methacrylic acid-g-ethylene glycol) [P(MAA-g-EG)
has been described. The targeting ligand used is the octarginine cell-penetrating peptide that causes
specific delivery of insulin to the intestine. This method facilitated ideal targeting, absorption at target
and allowed immediate release of insulin from absorption site. Great hypoglycemic responses were
achievable and increased insulin absorption was noted from diabetic rat models used for testing. 18%
glucose reduction was observed immediately on administration of the hydrogel containing insulin [57].
4.3. Cardiac Illness and Cancer
Myocardial infarction is a leading cause of death and disability in the world. Intramyocardial
administration of biomaterials such as hydrogels along the perimeter region of myocardial infarction
has proven to be beneficial.
Chen et al. proposed the use of a combination of curcumin (known for its anti-oxidant, anti-
inflammatory and anti-oxidation properties) and nitric oxide (known as an anti-angiogenesis agent) in
a hydrogel to treat myocardial infarction. The mixed component hydrogel created with the combination
drugs improved therapeutic efficacy synergistically. Protective effects such as myocytic apoptotic
death alleviation, reduced collagen deposition, increased vessel density (attributable to NO in the
combination) and upregulated Silent Information Regulator 1 (SIRT-1), a histone deacetylase that
confers resistance to the heart from ischemic injury were observed in diseased mice models in vivo.
The hydrogel was prepared using peptide derivatives of curcumin and NO in a ratio of 4:1 and showed
sustained curcumin release at a low concentration of 2.5 μg per ml per 24 h. NO was released in
presence of the enzyme β-galactosidase that could break glucosidic bonds to release NO [58].
Growth factors and cytokines (paracrine factors) secreted by stem cells have been proven to
be effective in repairing damaged myocardial tissue. The whole cocktail of the paracrine factors is
referred to as a secretome and is isolated in vitro. The biomolecular composition of the secretome can
be manipulated suitably by varying stem cell culture conditions. An injectable hydrogel to deliver to
peri-infarct myocardium has been recently developed using secretome from human adipose derived
stem cell secretome. Nano-composite hydrogel was formed from a combination of gelatin and laponite
carrying the secretome and tested both in vitro and in vivo for their therapeutic effects via monitoring
angiogenesis, scar formation and heart function. Significantly reduced scar area and improved cardiac
function were observed in vivo in the secretome loaded hydrogel group in relation to the control [59].
The very recent development of a paintable hydrogel to serve as cardiac patch for treating
myocardial infarction is worth mentioning in this context. The hydrogel eliminates the damage to
tissue through suture or light triggered reactions as it is paintable. It has been constructed by a
Fe3+ triggered polymerization reaction wherein the covalently linked pyrrole and dopamine undergo
simultaneous polymerization with the trigger and the conductive polypyrrole produced also uniquely
cross-links the network further. The functional patch is both adhesive and conductive and forms a
suture-free alternative for reconstruction of cardiac function and revascularization. Bonding within
4 weeks to the beating heart boosts the transmission of electrophysiological signals with conductivity
profiles equivalent to that of the normal myocardium [60].
Bio-material based immunotherapy platforms for targeted drug delivery to cancers are the latest
trend observable in cancer therapy. Based on this idea, novel STINGels have been developed by Leach
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et al, that are peptide hydrogels to show controlled delivery of cyclic dinucleotides (CDns). Dramatic
improvement in survival was observed in murine models of head and neck cancer in comparison to
CDN alone or CDN delivered from a collagen hydrogel [61].
Thyroid cancer treatment using local drug delivery system formed of glycol chitosan (GC)
hydrogel and doxorubicin hydrochloride (DOX·HCl) called GC10/dox has been recently developed
(Figure 7). Visible light regulated the storage and swelling aspects of the hydrogel and a controlled
sustained release followed the initial burst release within 18hours. Potent antitumor effects were
observed in vivo and in vitro in comparison to free DOX·HCl and this is a promising research direction
for thyroid cancer therapy [62].
Figure 7. To glycol chitosan solution glycidyl methacrylate (GM) was added in water (adjusted to
pH 9) and maintained for 2 days at room temperature. The white solid conjugate of GM was dissolved
in water and riboflavin added. DOX·HCl was added and the mixture was irradiated using blue
visible light (430–485 nm, 2100 mW/cm2) for 10 minutes in order to promote hydrogelation (reprinted
with permission from [62]; the article is open access and the content reusable. Creative Commons
International License 4.0 for the article is available in https://creativecommons.org/licenses/by/4.0/).
Injectable hydrogels responsive to Reactive Oxygen Species that degrade in the presence of ROS
and promote immunogenic tumor phenotype via local gemcitabine delivery is a recent discovery.
The PVA cross-linked hydrogel with ROS-labile linkers enhance anti-tumor response with a localized
release of immune checkpoint blocking antibody (anti-PD-L1 blocking antibody (aPDL-1) in in vitro
and immunogenic in vivo mouse models. Tumor recurrence prevention after primary resection is the
therapeutic advantage of this chemo-immunotherapy [63].
5. Translation to the Clinic
With enormous potential for therapeutic applications, several hydrogel formulations have crossed
the barriers of in vitro/pre-clinical studies and found their way into the market. Some of them are
still in the clinical study phases. Hydrogels have evolved over time to one of the best and the most
versatile drug delivery platforms. Table 2 lists the widespread practical applications of the hydrogel
concept that have been translated to the clinical level.
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Table 2. Examples of hydrogels translated to clinical use [64–68].
Product Type of Hydrogel Therapeutic Application Drug Delivered
Sericin Dextran
Optically trackable drug














Regranex Carboxymethyl cellulose Diabetic foot ulcer
Recombinant human platelet
derived growth factor
muGard Mucoadhesive Oral lichen planus
2% Poloxamer Cervical cancer recurrence Carboplatin
6. Conclusions
Hydrogels offer a versatile platform for the therapy of several diseases including cancer and
diabetes. The water-loving nature of hydrogels and the ability to shrink and swell depending on
several environmental cues or the mere presence of water is attractive for drug delivery applications.
They have a high degree of porosity and the polymers building them could be cross-linked to varying
degrees by adjusting their densities. With a physical structure highly amenable to modification in
several ways, the hydrogel applications are not just limited to targeted drug delivery. They also find
applications in hygiene products, wound dressings, contact lenses and tissue engineering.
Recent developments of hydrogels in the field of targeted drug delivery have been tremendous.
They are modified with targeting ligands and diverse polymer types that confer very interesting
properties on them for drug delivery. Ophthalmic drug delivery is an area seeing significant impact
in therapy from hydrogels. From comfortable contact lenses to biodegradable drug delivery the
applications in eye care have been enormous. They are 90% water, provide steady state drug release
over days or months, deliver small molecules or large proteins, are fully absorbed in delivery and
remain visible during monitoring [51].
Noteworthy is the application of pH responsive hydrogels for cancer therapy and glucose
responsive hydrogels for diabetes. The use of modified stem cell membranes for targeted delivery is a
very recent and attractive strategy for drug delivery. These membranes coated on hydrogels (nanogels)
loaded with drugs are highly specific to the disease site in cancer and are highly bio-compatible.
Immunotherapy platforms using hydrogels are very significant in cancer therapy. Hydrogels
enabling localized delivery of antibodies and other immune-regulatory molecules at cancer sites are
promising drug delivery vehicles for cancer therapy. Gastro-retentive drug dosage forms (GRDDFs)
are versatile drug delivery platforms for intestine and they offer the advantages of adjusting the
nanoparticle size to facilitate retention of the active ingredient in the GI tract for as long as required.
Though the hydrogel-based drug delivery was originally influenced by the hydrophobicity of
the drugs, several improvements have been made recently including development of cyclodextrins
modified to accommodate the hydrophobic drug sufficiently. Adhesive and conductive patches
developed using hydrogels are useful in cardiac repair and vascularization. Remotely controlled
motility of hydrogel (mimicking motion of a magbot) and the QD DNA hydrogels are novel ideas to
facilitate targeted drug delivery.
As discussed in the paper, though there are several hydrogel formulations in clinical use, there
is always scope for improvement and modification of hydrogels to enhance their applications. With
subtle modifications to the existing ones, the hydrogels could become superlative drug delivery
vehicles surpassing the disadvantages and current limitations with the use of several conventional
delivery forms and provide promising results for therapy of several illnesses.
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